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Endocrine disrupting chemicals (EDCs) can enter the aquatic environment via wastewater 
treatment work (WwTW) effluents. Oestrogenic and (anti-)androgenic chemicals present in 
effluents affect the reproductive health of fish living downstream of these effluents. 
The effects of WwTW effluent before and after the addition of an advanced granular 
activated carbon (GAC) treatment; installed to reduce EDCs, are compared. In laboratory 
studies, no oestrogenic effects of standard or GAC effluent were observed in fathead 
minnows (FHM; Pimephales promelas). However, the standard effluent elicited possible anti-
androgenic effects not observed in the GAC-treated effluent. In the river receiving this 
effluent, wild roach (Rutilus rutilus) were sampled before and after the GAC addition. Here 
oestrogenic effects were observed in the roach, and these effects were reduced following 
the GAC addition to the WwTW, but not completely removed. 
Over 100 chemicals previously detected in WwTW effluents were examined for (anti-
)androgenic activity using an in vitro yeast-based assay. Toxicity can cause false positive 
results in this assay. Investigations, including employing a modified version of the in vitro 
assay, were conducted to improve the assay’s reliability. Then, assessments of the most 
potent anti-androgenic chemicals were made to determine if they were likely to cause a risk 
to the environment. 
Currently, the best in vivo fish screen for (anti-)androgenic activity utilises the induction of 
spiggin, an androgen dependent glue-like protein, normally produced by male 3-spined 
stickleback (Gasterosteus aculeatus) during nest building. Male FHMs also glue their mates’ 
eggs to substrate. Therefore, FHM may have homologous androgen dependant 
genes/proteins which could serve as biomarkers of (anti-)androgenic activity. Spiggin-like 
primers were designed and used to look for spiggin-like genes in tissues collected from 
FHM. However, none of the spiggin-like primers were male specific and further work is 





It was at Professor Susan Jobling’s suggestion that I started my PhD journey, and I am very 
grateful to Sue for giving me this wonderful opportunity. Fitting in a part-time PhD around a 
demanding full-time job at Brunel University London has not been easy, and I must also 
thank Dr Alice Baynes (my first supervisor) and Professor John Sumpter (my second 
supervisor) who were both extremely supportive and encouraged me on such that I finished 
before my deadline. 
I would also like to thank Brunel University London in agreeing to me pursuing this PhD 
(something that I first dreamt of doing in the 1980s) and supported me financially both with 
fees and consumable costs, as well as approving me taking some sabbatical leave. The 
Technical Team at Brunel have also supported me in smoothly running the Environmental 
Sciences laboratories in my absence, so that I could take this leave to write up my thesis.  
Additionally, I would like to thank fish facility staff and Environmental Sciences staff and 
students at Brunel University London for their support with fish work, along with Hull 
International Fisheries Institute, University of Hull for electrofishing roach for me in 2013 and 
Scymaris, Brixham for providing me with fathead minnows in 2018. Additional thanks must 
go to Dr Anne Lockyer and Ms Marjo Broeder for their support with my molecular chapter. 
My long suffering family have also stood by me, particularly my daughter Amelia Dittmann. 
She was 10 years old when I started my PhD and for most of her secondary school life, I 
have worked long hours. I can only hope that some of this hard working mindset has rubbed 
off onto her to make up for my lack of parenting. For so many years family and friends have 
encouraged me and regularly asked ‘how is it going?’ and I’m so pleased that I can finally 





Research that originated from this thesis and has been presented: 
• Beresford, N., Baynes, A. and Jobling, S. Testing for (anti-)androgenic activity; pitfalls 
and possible misinterpretations. Poster Presentation. 16th Environmental Toxicology 
and Biological Systems Annual Meeting 2018, London, UK. 
• Beresford, N., Baynes, A. and Jobling, S. Oral Presentation. 4th Annual College of 
Health and Life Sciences PG Student Conference 2018, Brunel University London, 
UK. 
Additional research published but not included in this thesis: 
• Hettwer, K., Jahne, M., Frost, K., Giersberg, M., Kunze, G., Trimborn, M., Reif, M., 
Turk, J., Gehrmann, L., Dardenne, F., De Croock, F., Abraham, M., Schoop, A., 
Waniek, J.J., Bucher, T., Simon, E., Vermeirssen, E., Werner, A., Hellauer, K., 
Wallentits, U., Drewes, J.E., Dietzmann, D., Routledge, E., Beresford, N., Zietek, T., 
Siebler, M., Simon, A., Bielak, H., Hollert, H., Muller, Y., Harff, M., Schiwy, S., Simon, 
K. and Uhlig, S.  2018.  Validation of Arxula Yeast Estrogen Screen assay for 
detection of estrogenic activity in water samples: Results of an international 
interlaboratory study. Science of the Total Environment 621, 612-625. 
• Beresford, N., Baynes, A., Kanda, R., Mills, M.R., Arias-Salazar, K., Collins, T.J. and 
Jobling, S.  2016.  Use of a battery of chemical and ecotoxicological methods for the 
assessment of the efficacy of wastewater treatment processes to remove estrogenic 
potency. Journal of Visualized Experiments 115, 54243. 
• Mills, M.R., Arias-Salazar, K., Baynes, A., Shen, L.Q., Churchley, J., Beresford, N., 
Gayathri, C., Gil, R.R., Kanda, R., Jobling, S. and Collins, T.J.  2015.  Removal of 
ecotoxicity of 17α-ethinylestradiol using TAML/peroxide water treatment. Scientific 
Reports 5, 10511. 
• Runnalls, T.J., Beresford, N., Kugathas, S., Margiotta-Casaluci, L., Scholze, M., 
Scott, A.P. and Sumpter, J.P.  2015.  From single chemicals to mixtures-
Reproductive effects of levonorgestrel and ethinylestradiol on the fathead minnow. 





LIST OF FIGURES 
Figure 1. The hypothalamic-pituitary-gonad axis and its role in sex development. ................ 3 
Figure 2. Schematic representation of the main steroidogenic pathways in teleost fish. ........ 5 
Figure 3. The linear domain structure of a steroid hormone receptor comprising; an N-
terminal domain (NTD), a DNA-binding domain (DBD), a hinge region and a ligand 
binding domain (LBD). ................................................................................................... 7 
Figure 4. An overview of the signalling processes of steroid hormone receptors (SHRs). This 
multistep process starts with ligand binding and ends with transcriptional activation. ..... 9 
Figure 5. Generalised illustration of the pituitary-gonad axis demonstrating induction of the 
egg yolk protein, vitellogenin, in female fish. ................................................................ 10 
Figure 6. Model for ligand-dependent activation of the androgen receptor. ......................... 12 
Figure 7. This figure illustrates the >145,000 substances pre-registered with the European 
Union and >86,000 registered in the United States. ..................................................... 23 
Figure 8. Schematic of (A) a conventional wastewater treatment works, and (B) end-of-
pipeline additional (tertiary) and advanced treatments necessary to improve effluent to 
meet the EQSs of the EU Urban Wastewater Treatment Directive and the Water 
Framework Directive. ................................................................................................... 34 
Figure 9. Schematic showing the timescale and endpoints for the fathead minnow exposure 
studies. A) the Vitellogenin Test (Experiments 1 and 2), and B) the Pair Breeding Test 
(Experiments 3 and 4). ................................................................................................. 43 
Figure 10. The spawning chamber; PVC half guttering inserted on top of a glass tray 
containing a stainless steel mesh. ................................................................................ 45 
Figure 11. Locations of the 2005 and 2013 fish sampling sites along the River Ray together 
with the location of the Swindon Wastewater Treatment Works (WwTW)..................... 50 
Figure 12. Locations of the two 2013 sampling sites; Site 1, National Grid Reference: 
SU124866, and Site 2, National Grid Reference: SU122873........................................ 51 
Figure 13. Measurements of steroid oestrogens taken to investigate how the concentrations 
in either standard treated effluent (black bars) or GAC treated effluent (grey bars) 
changed through the course of each short-term experiment......................................... 61 
Figure 14. Mean concentrations of individual steroid oestrogens (E1, E2 and EE2, measured 
by LC-MS/MS) and oestrogenic activity (E2EQ measured in the YES) in the fish tanks (± 
standard deviation). ..................................................................................................... 64 
Figure 15. Lengths and weights of male fathead minnows measured at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A, 
lengths; C, weights) and GAC treated effluent (B, lengths; D, weights). ....................... 65 
Figure 16. Condition factor and Gonadosomatic Index (GSI) of male fathead minnows 
measured at the end of the baseline period and after 21 days exposed in the VTG Test 
ix 
 
to the standard effluent (A, condition factor; C, GSI) and GAC treated effluent (B, 
condition factor; D, GSI). .............................................................................................. 66 
Figure 17. Vitellogenin concentrations measured in the plasma of male fathead minnows at 
the end of the baseline period and after 21 days exposed in the VTG Test to the 
standard effluent (A) or GAC treated effluent (B). ......................................................... 67 
Figure 18. Mean Fatpad Indices (FPI) measured in male fathead minnows at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A) 
and GAC treated effluent (B). ....................................................................................... 68 
Figure 19. Mean tubercle number measured in male fathead minnows at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A) 
and GAC treated effluent (B). ....................................................................................... 69 
Figure 20. Lengths of male and female fathead minnows measured after being exposed in 
the Pair Breeding Test for 21 days to the standard effluent (A, males; C, females) and 
GAC treated effluent (B, males; D, females). ............................................................... 71 
Figure 21. Weights of male and female fathead minnows measured after being exposed in 
the Pair Breeding Test for 21 days to the standard effluent (A, males; C, females) and 
GAC treated effluent (B, males; D, females). ............................................................... 72 
Figure 22. Condition factor of male and female fathead minnows measured after being 
exposed in the Pair Breeding Test for 21 days to the standard effluent (A, males; C, 
females) and GAC treated effluent (B, males; D, females). .......................................... 74 
Figure 23. Gonadosomatic Index (GSI) of male and female fathead minnows measured after 
being exposed in the Pair Breeding Test for 21 days to the standard effluent (A, males; 
C, females) and GAC treated effluent (B, males; D, females). ...................................... 75 
Figure 24. Vitellogenin concentrations measured in the plasma of fathead minnows after 21 
days in the Pair Breeding Test exposed to the standard effluent (A; males, C; females) 
and GAC treated effluent (B; males, D; females). ......................................................... 76 
Figure 25. Mean Fatpad Indices (FPI) measured in male fathead minnows after 21 days in 
the Pair Breeding Test in which they were exposed to the standard effluent (A) and GAC 
treated effluent (B). ...................................................................................................... 77 
Figure 26. Mean tubercle number measured in male fathead minnows after 21 days in the 
Pair Breeding Test in which they were exposed to the standard effluent (A) and GAC 
treated effluent (B). ...................................................................................................... 78 
Figure 27. Experiment 3; cumulative egg production in Pair Breeding Test fathead minnows 
over a 21-day pre-exposure period (all FHMs exposed to control water; filled symbols) 
and then over a 21-day exposure period (unfilled symbols).......................................... 79 
x 
 
Figure 28. Experiment 4; cumulative egg production in Pair Breeding Test fathead minnows 
over a 21-day pre-exposure period (all FHMs exposed to control water; filled symbols) 
and then over a 21-day exposure period (unfilled symbols).......................................... 79 
Figure 29. Fork lengths of male and female roach sampled from the River Ray in 2005 
(dotted plots) and 2013 (striped plots). ......................................................................... 80 
Figure 30. Weights of male and female roach sampled from the River Ray in 2005 (dotted 
plots) and 2013 (striped plots). ..................................................................................... 81 
Figure 31. Condition factor of roach sampled from the River Ray in 2005 (dotted plot) and 
2013 (striped plot). ....................................................................................................... 81 
Figure 32. Age structure and length of roach sampled from the River Ray in 2005 (red 
circles) and 2013 (blue triangles). ................................................................................ 83 
Figure 33. Sex ratio of the fish collected from the River Ray downstream of the Swindon 
WwTW; (A) in 2005, and (B) in 2013. ........................................................................... 84 
Figure 34. Severity of intersex of the male roach with intersex gonads (testicular oocytes 
and/or an ovarian cavity). ............................................................................................. 85 
Figure 35. Male histology. ................................................................................................... 87 
Figure 36. Female histology. ............................................................................................... 88 
Figure 37. Gonadal stage of maturity of female roach sampled from the River Ray in 2005 
(A) and 2013 (B) plotted against GSI. .......................................................................... 89 
Figure 38. Gonadal stage of maturity of female roach sampled from the River Ray in 2005 
(red circles) and 2013 (blue triangles) plotted against fish age. .................................... 89 
Figure 39. Adjusted plasma VTG concentrations in male (including intersex) and female 
roach sampled from the River Ray in 2005 (dotted plots; prior to the GAC installation) 
and in 2013 (striped plots; after the GAC WwTW upgrade). ......................................... 94 
Figure 40. Comparing plasma VTG concentrations in (A) male and (B) female roach 
sampled from the River Ray in 2005 (prior to the GAC WwTW upgrade) plotted against 
GSI. ............................................................................................................................. 94 
Figure 41. Comparing plasma VTG concentrations in (A) male and (B) female roach 
sampled from the River Ray in 2013 (after the GAC WwTW upgrade) plotted against the 
GSI. ............................................................................................................................. 95 
Figure 42. Bile oestradiol equivalent (E2EQ) concentrations collected from male and intersex 
fish in 2005 (dotted plots; prior to the GAC WwTW upgrade) and 2013 (striped plots; 
after the GAC WwTW upgrade). .................................................................................. 96 
Figure 43. Photos showing typical yeast screen results after 3 days incubation with the 
chromogenic substrate CPRG. ................................................................................... 128 
Figure 44. Response of the yeast androgen screen to dihydrotestosterone (DHT) positive 
control and ethanol negative control (mean ± SE). ..................................................... 129 
xi 
 
Figure 45. Response of the yeast anti-androgen screen to flutamide positive control and 
ethanol negative controls (ethanol and ethanol minus DHT in the medium) (mean ± SE; 
mean ± SE). ............................................................................................................... 129 
Figure 46. Examples of standard curves produced using SoftMax Pro version 5.0.1 
(Molecular Devices Limited, Wokingham, UK)............................................................ 130 
Figure 47. Yeast androgen results showing plots for the DHT positive control, ethanol 
negative control, and the 3 test chemicals showing very weak androgenic activity; 
methyl decanoate, 2-ethylhexanoic acid and ibuprofen. ............................................. 131 
Figure 48. Yeast anti-androgen results showing plots for the flutamide positive control and 
ethanol (etOH) negative control, together with 4 of the test chemicals showing anti-
androgenic activity; fluoranthene, triphenyl phosphate, triclosan and methyl triclosan.
 .................................................................................................................................. 133 
Figure 49. Photos showing typical yeast screen results after 3 days incubation followed by 
cell lysis and incubation with the chromogenic substrate oNPG. ................................ 154 
Figure 50. Mean ± SEM of the positive control, DHT, and the negative control, ethanol, from 
6 androgen screens using the cell lysis method. ........................................................ 155 
Figure 51. Mean ± SEM of the positive control, flutamide, and the ethanol negative controls 
(ethanol and ethanol minus DHT in the medium) from 11 anti-androgen screens using 
the cell lysis method. .................................................................................................. 155 
Figure 52. Androgen screen results seen in (A) the standard androgen screen with no cell 
lysis and (B) the modified anti-androgen screen with cell lysis. .................................. 157 
Figure 53. Anti-androgen screen results; mean potency values (± SEM; n≥2) for 20 
chemicals (see Table 16 for chemical details) using the standard anti-androgen screen 
with no cell lysis (red bars) and the modified method with cell lysis (blue bars). ......... 159 
Figure 54. Structures of the eighteen anti-androgenic chemicals with activity observed using 
both yeast screen methods, grouped in order of activity; strong to very weak activity. 161 
Figure 55. Superagonist results seen in (A) the standard anti-androgen screen with no cell 
lysis and (B) the modified anti-androgen screen with cell lysis. .................................. 164 
Figure 56. Results from screens monitoring yeast turbidity using nystatin as a positive 
control to kill the yeast (highest concentration in Well 1 (6 mg/L nystatin) diluting to 
lowest concentration in Well 12 (0.3 mg/L nystatin)). ................................................. 166 
Figure 57. The influence of the plate column and plate row on the ‘edge effect’ at 540 nm 
(colourimetric) and 620 nm (turbidity) absorbance values using the standard anti-
androgen screen method without lysis. ...................................................................... 168 
Figure 58. Different sealing tapes and their influence on the ‘edge effect’ values in the 
standard AYAS without cell lysis. ............................................................................... 170 
xii 
 
Figure 59. Different sealing tapes and their influence on the ‘edge effect’ values in the 
modified AYAS with cell lysis. .................................................................................... 172 
Figure 60. Pipetting to different positions in the multiwell plate and effect on chemical 
potency. ..................................................................................................................... 174 
Figure 61. Gel-forming mucins are evolutionarily related to the von Willebrand factor and 
possess domain structures that are highly conserved (D1-D4). .................................. 187 
Figure 62. Photograph showing tank of male FHMs with dorsal fatpads of varying sizes. . 192 
Figure 63. Photograph of male FHM snout showing raised nuptial tubercles. ................... 192 
Figure 64. Image of RNA samples run on a 2% agarose gel alongside a 1 kb 
HyperLadder™........................................................................................................... 194 
Figure 65. An example of an amplification plot; NTC (no amplification), inter-plate calibrator 
(IPC; FHM liver; Cq ~25) and FHM snout samples with one primer set (Cq ~20). ...... 199 
Figure 66. Image of qPCR products run on a 0.8% agarose gel alongside a 50 bp 
HyperLadder™ (loaded into the outer and middle wells). ........................................... 199 
Figure 67. Typical denaturation curve (melt peak) performed after qPCR cycling; NTC (no 
melt peak), inter-plate calibrator (IPC; FHM liver) and FHM snout samples with one 
primer set with melt peak at approximately the same temperature (~79oC). ............... 200 
Figure 68. Multiple alignments of gel-forming mucin sequences together with the three FHM 
spiggin-like ESTs (DT131813, DT347638 and DT267220, highlighted in blue), created 
using Clustal Omega with default settings. ................................................................. 205 
Figure 69. Phylogenetic tree analysis of the gel-forming mucins together with the three FHM 
spiggin-like ESTs, created with Geneious Tree Builder using the Neighbour-Joining 
method. ...................................................................................................................... 206 
Figure 70. Bar chart showing normalised expression (ΔΔCq) of two positive control genes of 
interest (A; ff1d and B; vtg) in different tissues from one male (blue bars) and one 
female (red bars) FHM. .............................................................................................. 208 
Figure 71. Bar chart showing normalised expression (ΔΔCq) of three spiggin-like genes (A; 
DT131813, B; DT267220 and C; DT347638) in different tissues from one male FHM 
(blue bars) and one female FHM (red bars). .............................................................. 209 
Figure 72. Graphs for the biological endpoints (weight, fork length, condition factor and 
Gonadosomatic Index (GSI)) of the ten male (blue bars) and ten female (red bars) FHM 
fish. ............................................................................................................................ 212 
Figure 73. Plot of tubercle number against Fatpad Index (FPI) for the ten male FHM fish. 213 
Figure 74. Bar chart showing normalised expression (ΔΔCq) of the three spiggin-like genes 
(DT131813, DT267220 and DT347638 primer sets) in snout tissues from ten male FHM 




LIST OF TABLES 
Table 1. Age and average weight of fathead minnows at the start of the Vitellogenin Test and 
Pair Breeding Test exposures to standard and GAC treated effluent. .......................... 44 
Table 2. Scoring systems used to derive stage of maturity based on Billard (1986) for male 
fish and Tyler and Sumpter (1996) for female fish. ....................................................... 54 
Table 3. Scoring system used to determine the Intersex Index score for each section (from 
Jobling et al., 2006). ..................................................................................................... 55 
Table 4. Stainless steel holding tank concentrations of E1, E2, EE2 and E2 equivalent 
concentrations (E2EQ) measured in batches of standard effluent on collection, arrival at 
the laboratory, and at the end of the batch (taken from the stainless steel holding tank).
 .................................................................................................................................... 62 
Table 5. Stainless steel tank concentrations of E1, E2, EE2 and E2 equivalent 
concentrations (E2EQ) measured in batches of GAC treated effluent on collection, 
arrival at the laboratory, and at the end of the batch (in the stainless steel holding tank).
 .................................................................................................................................... 62 
Table 6. Mean length and age of wild roach sampled from the River Ray in 2005. One fish 
could not be aged. ....................................................................................................... 82 
Table 7. Mean length and age of wild roach sampled from the River Ray in 2013. One fish 
could not be aged. ....................................................................................................... 82 
Table 8. Gonadosomatic indices (GSIs) of wild roach sampled from the River Ray in 2005 
and 2013 (mean ± standard deviation). ........................................................................ 85 
Table 9. Number of atretic oocytes (average of 6 sections) found in the ovaries of wild roach 
sampled from the River Ray downstream of Swindon WwTW in 2005 and 2013 (mean ± 
standard deviation). ..................................................................................................... 90 
Table 10. Comparison of 2005 plasma sample vitellogenin concentrations analysed by the 
two different carp ELISA methods (a carp VTG ELISA, previously validated for use with 
roach (Tyler et al., 1996) and the commercial Biosence ELISA). .................................. 91 
Table 11. Comparison of 2013 male plasma sample vitellogenin concentrations analysed 
using the same method (Biosense carp VTG ELISA kit) but in different years (2015 and 
2017). .......................................................................................................................... 92 
Table 12. Comparison of unadjusted VTG concentrations measured in wild roach samples 
collected from the River Ray in 2005 and 2013. ........................................................... 92 
Table 13. Comparison of adjusted VTG concentrations measured in wild roach samples 
collected from the River Ray in 2005 and 2013. ........................................................... 93 
Table 14. Summary table of changes (one arrow) and statistically significant changes (two 
arrows) of different parameters. ................................................................................... 97 
xiv 
 
Table 15. This table gives details of all the chemicals tests, including alternate names, a 
description, the Catalogue Number, CAS Number, molecular weight, and purity: ...... 118 
Table 16. Results of all chemicals tested in the yeast (anti-)androgen. ............................. 134 
Table 17. Comparison of potency values for 20 chemicals possessing anti-androgenic 
activity using the standard yeast anti-androgen screen without cell lysis and the 
modified method with cell lysis. .................................................................................. 158 
Table 18. Chemical characteristics of the most potent anti-androgens (strong and moderate 
activity) together with their reported environmental concentrations (no information was 
available for methyl triclosan as this is a metabolite and not a parent compound). ..... 162 
Table 19. qPCR primers and product size for FHM reference genes (Filby and Tyler, 2007)
 .................................................................................................................................. 197 
Table 20. qPCR primers and product size for FHM ff1d, vtg and spiggin-like ESTs designed 
using NCBI Primer-BLAST ......................................................................................... 197 
Table 21. Accession numbers for mucin and spiggin protein sequences found on the NCBI 
website. ..................................................................................................................... 203 
Table 22. Biological endpoints for the ten male FHM fish including the secondary sexual 
characteristics; tubercle number and Fatpad Index (FPI). .......................................... 210 





AF1  Activation Function region 1  
AFSS  Androgenised Female Stickleback Screen 
AGD  Anogenital distance 
AOP  Adverse outcome pathway 
AR  Androgen receptor 
AYAS  Yeast anti-androgen screen 
A-YES  Yeast oestrogen screen (Arxula adeninivorans)  
BF3  Binding Function 3 
BLAST  Basic Local Alignment Search 
cDNA  Complementary deoxyribonucleic acid 
CPA  Congenital penile anomaly 
CPRG  Chlorophenol red-β-D-galactopyranoside 
Cq  Quantification cycle 
CuSO4  Copper sulphate 
DBD  DNA binding domain 
DBP  Dibutyl phthalate 
p,p’-DDE  Dichlorodiphenyldichloroethylene 
DDT  Dichlorodiphenyltrichloroethane 
DEHP  Di(2-ethylhexyl) phthalate 
DEP  Diethyl phthalate 
DEPC  Diethyl pyrocarbonate 
DES  Diethylstilbestrol 
DHT  Dihydrotestosterone 
DL  Detection limit 
Dmrt1  Doublesex and mab-3 related transcription factor 1  
xvi 
 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
DO-medium  Dropout medium 
E1  Oestrone 
E2  Oestradiol 
E2EQ  Oestradiol equivalent 
E2-G  β-Oestradiol 17-(β-D-glucuronide) 
E2-S  β-Oestradiol 3-sulphate 
EC50  Effective concentration, half maximal 
EDA  Effect directed analysis  
EDC  Endocrine disrupting chemical 
EDDP  Endocrine Disruption Demonstration Programme 
EDSP  Endocrine Disrupter Screening Program  
EE2  Ethinylestradiol 
ELISA  Enzyme-linked immunosorbent assay 
EPA  Environmental Protection Agency 
EQS  Environmental Quality Standard 
EQSD  Environmental Quality Standards Directive 
ER  Oestrogen receptor 
EST  Expressed sequence tag 
EtOH  Ethanol 
EU  European Union 
FHM  Fathead minnow 
FLUT  Flutamide 
FLUTEQ Flutamide equivalent 
Foxl2  Forkhead box l2 
xvii 
 
FPI  Fatpad Index 
FSH  Follicle stimulating hormone 
GAC  Granular activated carbon 
β-gal   β-galactosidase 
GC-MS  Gas chromatography–mass spectrometry 
gDNA  Genomic deoxyribonucleic acid 
GnRH   Gonadotropin releasing hormone 
GOI  Gene of interest 
GR  Glucocorticoid receptor 
GSI  Gonadosomatic Index 
H12  Helix-12 
HHCB   Galaxolide 
HPG  Hypothalamic-pituitary-gonad axis 
HPLC  High-performance liquid chromatography 
hprt1   Hypoxanthine phosphoribosyltransferase 1 
HSD  Hydroxysteroid dehydrogenase 
HTP  High throughput 
IC50  Inhibitory concentration, half maximal 
ISO  International Organisation for Standardisation 
IPC  Inter-plate calibrator 
KEH  Kidney epithelial height 
11-KT   11-Ketotestosterone 
LBD  Ligand binding domain 
LBP  Ligand binding pocket 
LDH  Lactate dehydrogenase  
LH  Luteinising hormone 
xviii 
 
LogBCF  Log bioconcentration factor 
Log/Kow Octanol/water partition coefficient 
MS222  Ethyl 3-aminobenzoate methanesulfonate 
MT  Methyltestosterone 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NCBI  National Center for Biotechnology 
NRT  No reverse transcriptase control 
NTC  No template control 
NTD  NH2-terminal domain 
OECD  Organisation for Economic Co-operation and Development 
oNPG  ortho-Nitrophenyl-β-galactoside  
PAH  Polycyclic aromatic hydrocarbon 
PNEC  Predicted no effect concentration 
PR  Progesterone receptor 
PTS  Proline, threonine, serine rich domain 
qPCR  Quantitative polymerase chain reaction 
QSAR  Quantitative structure–activity relationship 
REACH Registration, Evaluation, Authorisation and Restriction of Chemicals 
RNA  Ribonucleic acid 
RO  Reverse osmosis 
rpl8  Ribosomal protein l8 
RQ  Relative quantity 
SD-medium  Synthetic defined medium 
SHR  Steroid hormone receptor 
SSC  Secondary sexual characteristic 
T  Testosterone 
xix 
 
tbp  Tata box binding protein 
TIL  Trypsin inhibitor like cystine rich domain 
TSCA  Toxic Substances Control Act 
VTG  Vitellogenin 
VWD  von Willebrand factor type D domain  
VWF  von Willebrand factor 
WFD  Water Framework Directive 
WwTD  Wastewater Treatment Directive 
WwTW  Wastewater Treatment Works 
YAS  Yeast androgen screen 
YES  Yeast oestrogen screen 




1. Introduction  
Ever since Silent Spring was published in the 1960s (Carson, 1962) there has been a 
growing interest regarding chemical pollution impacting wildlife reproduction and 
development. The field of endocrine disruption has gathered momentum since the 1990s, as 
both scientists and policymakers have started to appreciate the importance of the issue. 
There are now many papers that address the effects of chemicals on wildlife and collectively 
they support a connection between environmental pollution and effects on wildlife 
populations (Bernanke and Kohler, 2009). 
In 2010, the international community, with the support of the Convention on Biological 
Diversity, agreed on 20 biodiversity-related ‘Aichi Targets’ to be achieved within a decade, 
and at the mid-term review it was noted that additional effort was required to reduce 
pressures caused by pollution (Tittensor et al., 2014). In a more recent report, one of the five 
main causes of biodiversity loss was considered to be pollution, and this anthropogenic 
driver of biodiversity loss continues to increase globally, despite national efforts to meet the 
Aichi Targets (IPBES, 2019). 
The World Health Organisation defines an EDC as ‘an exogenous substance or mixture that 
alters function(s) of the endocrine system and consequently causes adverse health effects in 
an intact organism, or its progeny, or (sub)populations’ (Damstra et al., 2002). More simply 
put, an EDC is an exogenous chemical, or mixture of chemicals, that interferes with any 
aspect of hormone action (Zoeller et al., 2012).  
EDCs can interfere with the endocrine system in a number of ways; mimic the effect of 
endogenous hormones (e.g. oestrogens, androgens, thyroid), antagonise the effect of 
endogenous hormones, disrupt the synthesis and metabolism of endogenous hormones, 
and disrupt the synthesis and metabolism of hormone receptors (Sonnenschein and Soto, 
1998). This can then lead to a range of developmental, reproductive, immune, neurological 
or metabolic diseases in humans and animals.  
Here I provide some background relating to the endocrine system of vertebrates, specifically 
concentrating on fish, as endocrine disruption in fish is the main focus of this PhD thesis. 
 
1.1. The endocrine system 
1.1.1. The hypothalamic–pituitary–gonadal axis 
In common with all vertebrates, reproduction in teleost fish is regulated by coordinated 
interaction among hormones of the hypothalamic-pituitary-gonad axis (HPG; Figure 1). In 
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seasonally spawning fish, external factors such as light and water temperature control the 
timing of gonadal recrudescence and maturation via the brain (Scholz and Mayer, 2008). 
Kisspeptin stimulates the release of gonadotropin releasing hormones (GnRHs) from the 
hypothalamus, that in turn stimulate the release of gonadotropins (luteinising hormone (LH) 
and follicle stimulating hormone (FSH)) from the pituitary gland. The gonadotropins in turn 
regulate the production and secretion of sex steroid hormones (steroidogenesis) from the 
gonad (Ji et al., 2013). Through interactions with membrane-bound gonadotropin receptors 
(e.g. LH receptor and FSH receptor) on the surface of gonad cells, pituitary gonadotropins 
including LH and FSH play a key role in regulating steroidogenic gene expression via 
negative or positive feedback mechanisms (Villeneuve et al., 2007). This constant feedback 
from the target glands to the hypothalamus and pituitary gland ensures homeostasis of the 
hormone system, and when the correct blood levels of those hormones are reached, the 
hypothalamus and/or the pituitary cease hormone release, thereby turning off the cascade 
(Hiller-Sturmhöfel and Bartke, 1998). 
In addition, the major carrier of endogenous sex steroids, sex hormone-binding globulin, 
regulates the plasma levels and biological actions of sex steroids by modulating their 
bioavailability and accessibility and protecting the sex steroids from rapid degradation and 
excretion (Liu et al., 2017). 
In mammals, LH enables Leydig cells (in the testis) to generate androgens whereas FSH 
stimulates granulosa cells (in the ovary) to produce oestrogens. Although the precise 
function of these hormones in teleost is still not clear, much evidence indicates that their 
roles in steroidogenesis are similar to those in mammals (Gong et al., 2017). 
1.1.2. Gonadal steroidogenesis 
Steroids are synthesised from cholesterol through a series of reactions catalysed primarily 
by several cytochrome P450s (Figure 2). Aromatase cyp19 is the key enzyme responsible 
for the conversion of 19-carbon androgens (mainly testosterone (T) and androstenedione) to 
18-carbon oestrogens, regulating local and systemic levels of oestrogens in the body 







Figure 1. The hypothalamic-pituitary-gonad axis and its role in sex development. 
Gonadotropin releasing hormones (GnRHs) produced by the hypothalamus stimulate the 
release of gonadotropins (luteinising hormone (LH) and follicle stimulating hormone (FSH)) 
from the pituitary gland. The gonadotropins then control the production and secretion of sex 
steroid hormones by the gonads. The LH and FSH regulate steroidogenic gene expression 
via negative (-) or positive (+) feedback mechanisms, and this constant feedback from the 







Figure 2. Schematic representation of the main steroidogenic pathways in teleost fish. The 
coloured arrows indicate the different conversion enzymes required for the generation of sex 
steroids from cholesterol;  
Black, cytochrome P450 family 11 subfamily A member 1 (P450scc); Cyp11a1 
Dark green, cytochrome P450 17α-hydroxylase/C17, 20-lyase; Cyp17 
Light blue, 17β-hydroxysteroid dehydrogenase; 17β-HSD 
Light red, 5α-reductase; 5α-R 
Dark red, aromatase; Cyp19 
Purple, 3β-hydroxysteroid dehydrogenase; 3β-HSD 
Pink, 11β-hydrolase 
Dark blue, 11β-hydroxysteroid dehydrogenase; 11β-HSD 
Light green, 20β-hydroxysteroid dehydrogenase; 20β-HSD 
 
Sex steroid hormones such as oestradiol (E2) and T in females, and DHT and T in males, as 
well as maturation-inducing hormones in both sexes, initiate changes in secondary sexual 
characteristics (SSCs) and behaviour, as well as development and maturation of gametes 
(Scholz and Mayer, 2008).  
Androgens (based on transcriptomics and proteomics) also have functions in apoptosis, 
transport and oxidation of lipids, synthesis and transport of hormones, protein metabolism, 
and cell proliferation (Martyniuk and Denslow, 2012). 
Androgens are all steroids with 19 carbons (Marcoccia et al., 2017). The majority of naturally 
occurring steroids with androgenic activity are, in decreasing order of potency relative to T; 
DHT (150-200%), androstanediol (65%), androst-4-ene3,17-dione (25%), androsterone 
(10%) and dehydroepiandrosterone (10%). Over 95% of T is produced and secreted by 
Leydig cells in the testis, whereas the remaining 5% is produced in the adrenal glands by 
conversion of precursors. DHT is one of the most important steroids in many male 
vertebrates with the exception of teleost fish, where T and 11-ketotestosterone (11-KT) were 
thought to be the major circulating male androgens as well as the most potent ones (Borg, 
1994). However, it is now considered that DHT does have a role in the mediation of 
androgenic responses in teleost fish (Margiotta-Casaluci and Sumpter, 2011). 
The traditional view of E2 as the female hormone and T as the male hormone has been 
challenged in recent years. Now oestrogen is thought to have a regulatory role in the testis 
because oestrogen biosynthesis occurs in testicular cells and the absence of oestrogen 
receptors (ERs) causes adverse effects on spermatogenesis and steroidogenesis 
(Akingbemi, 2005). Also, a direct role for androgens (as the precursor for E2), acting via the 
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AR in female reproductive function has been confirmed as key to optimal ovarian function 
(Walters and Handelsman, 2018). 
1.1.3. Hormone receptors 
Steroid hormone receptors (SHRs) are hormone-activated nuclear transcription factors with 
distinct specificities for endogenous steroid hormones. In all steroid receptors, the activating 
hormone binds to an internal cavity within a well-conserved ligand binding domain (LBD), 
causing the LBD to change conformation, attract co-activator proteins and increase 
transcription of target genes. Humans have two phylogenetic classes of steroid receptors 
depending on the endogenous ligand (Eick et al., 2012). In the first class, the ER, the 
endogenous ligands are 18-carbon steroids with an aromatised A-ring and a hydroxyl 
attached to the C3 on the steroid skeleton. The other class comprises receptors for 
androgens (AR), progestogens (PR), glucocorticoids (GR) and mineralocorticoids, and all 
the ligands for these receptors contain a non-aromatisable A-ring, an additional methyl at 
C19, and in most cases a ketone at C3. 
The AR is consistent with the characteristic nuclear receptor modular structure; consisting of 
three major functional domains (1) NH2-terminal domain (NTD) containing the Activation 
Function region 1 (AF1)), (2) highly conserved deoxyribonucleic acid (DNA)-binding domain 
(DBD), and (3) a conserved C-terminal domain containing the LBD (Figure 3). The AR-LBD 
has three different binding or active sites where an agonist or antagonist can bind and alter 
AR functions (Sakkiah et al., 2018); the ligand binding pocket (LBP), the AF2 site and the 
Binding Function 3 site (BF3). The hinge region acts as a bridge between the DBD and LBD. 
The three-dimensional structure of the AR-LBD consists of 12 bundles of helices forming 
three layers. Among these 12 helices, the Helix-12 (H12) plays a major role in AR activation 
and when an androgen binds the LBP of the AR, H12 tightly holds co-activator proteins and 
initiates function. 
AR activation can occur through direct or indirect pathways (Lynch et al., 2017). Direct AR 
activation occurs through a multi-step process (Figure 4). In the absence of a ligand, SHRs 
are predominantly monomeric and bind to chaperones/ cochaperone complexes to remain 
stabilised in the cytoplasm (Chen et al., 2018). To dissociate from chaperones/ 
cochaperones and translocate to the nucleus, the AR must be bound by ligands. Once in the 
nucleus, the SHRs forms dimers, binding to specific genomic response elements and 
recruiting coregulators. The SHRs then bind other transcription factors to form transcription 
regulatory complexes to activate transcription. Hence, the subcellular signalling of SHRs is 





Figure 3. The linear domain structure of a steroid hormone receptor comprising; an N-
terminal domain (NTD), a DNA-binding domain (DBD), a hinge region and a ligand binding 
domain (LBD). Embedded in the NTD is the Activation Function 1 (AF1), and embedded in 
the LBD is the AF2, the Binding Function 3 (BF3), and the Helix-12 (H12). 
Adapted from Chen et al. (2018) 
 
The presence (in some fish species) of multiple AR isoforms with various binding 
specificities and tissue distributions suggests that different androgens may mediate the 
androgenic response according to the species and to the differential expression and 
abundance of AR isoforms in each tissue (Margiotta-Casaluci and Sumpter, 2011). For 
example, expression analysis of medaka ARα and ARβ in several adult tissues of both 
sexes revealed both ARs to be highly expressed in male kidney in which the enzymes for 
androgen production are expressed (Kusakabe et al., 2002). Quantitative polymerase chain 
reaction (qPCR) suggested that the ARα was more highly expressed in the testis than the 
ovary whereas ARβ did not show such sexual dimorphic expression in adult gonads. 
1.1.4. Gonadogenesis 
In almost all vertebrates, sexual reproduction requires two sexes (males and females) to 
maintain genetic variation. Hence, sex determination and differentiation is one of the most 
important processes for species survival. The gonad is a unique organ due to its bipotential 
nature; either testis or ovary can develop from a single primordium (Brennan and Capel, 
2004). 
However, sex determination mechanisms vary greatly among taxa (Devlin and Nagahama, 
2002). In vertebrates, sex is determined either genetically or environmentally, or a 
combination of both (Chen et al., 2016). In most mammals, sex determination is genetically 
controlled by the presence or absence of the Y-chromosome, and the initiation of the male 
pathway depends on the gonadal expression of the Y-linked gene, Sry. The development of 
SSCs, including external genitalia, depends on whether the gonad differentiates into a testis 







Figure 4. An overview of the signalling processes of steroid hormone receptors (SHRs). This 
multistep process starts with ligand binding and ends with transcriptional activation. Agonists 
induce an active conformation of the SHR that recruits co-activators and activates 
transcription. Conversely, an antagonist induces the inactive conformation of the SHR that 
recruits co-repressors and represses transcription. 
Adapted from Chen et al. (2018) 
 
Whilst in certain families of fish hermaphroditism or sex reversal represent the normal mode 
of reproduction, the vast majority of species are gonochoristic, in which distinct males and 
females are independent and stable (Nolan et al., 2001). In many gonochoristic fish species, 
sex determination is genetic, but in other cases, sex is determined by environmental factors 
such as temperature (Baroiller et al., 1999). Sex differentiation is correlated with sex steroid 
production and receptor signalling pathways involving androgens and oestrogens (Wood et 
al., 2015). In teleosts, endogenous oestrogens act as the natural inducer of ovarian 
differentiation, while androgen is not synthesised in the gonad during the critical period of 
sex determination (Nagahama, 2000). Consequently, sex differentiation and meiosis initiate 
earlier in female than in male, and this may be because oogenesis takes more time than 
spermatogenesis (Chen et al., 2016).  
The Doublesex and Mab-3 Related Transcription Factor 1 (Dmrt1) gene is proposed as the 
major player in fish sex differentiation and its expression has been related with testis 
development and spermatogenesis in several species, for example, Nile tilapia and medaka 
(Herpin and Schartl, 2011). In addition, the Forkhead Box I2 (foxI2) gene is involved in 
ovarian development and oocyte maintenance, and is thought to be associated with the 
regulation of aromatase expression in different fish species (Baron et al., 2004). Alterations 








Figure 5. Generalised illustration of the pituitary-gonad axis demonstrating induction of the egg yolk protein, vitellogenin, in female 
fish.Oestradiol produced by the ovaries stimulates the liver to produce vitellogenin. Vitellogenin is then transported by the blood to the ovary 




Gametogenesis is the process by which gametes, or germ cells, are produced in an 
organism. The formation of egg cells, or ova, is called oogenesis, and the formation of sperm 
cells, or spermatozoa, is called spermatogenesis. 
In the testis, FSH and LH are the most important pituitary hormones regulating fish 
spermatogenesis; FSH plays a regulatory role in the early stages of spermatogenesis and 
LH is mainly involved in later stages of maturation, e.g. regulation of spermiation (Gong et 
al., 2017). 
Vitellogenin (VTG) is a female-specific egg-yolk precursor that is synthesised in the liver in 
response to circulating oestrogens and transported by blood to the ovary, where it is taken 
up by oocytes and deposited as yolk (Tyler and Sumpter, 1996) (Figure 5). Oocyte growth 
can be divided into two main stages of development, classified as primary or previtellogenic 
growth and secondary or vitellogenic growth (Basili et al., 2018). FSH in fish has a dominant 
role in regulating the vitellogenic growth of follicles, partly through stimulation of E2 
biosynthesis by ovarian follicles. LH is involved in final oocyte maturation and ovulation, 
partly through the stimulation of production of maturation hormone (Nagahama and 
Yamashita, 2008).  
 
1.2. Mechanisms of disruption 
EDCs have been reported to act via several mechanisms which can disrupt the HPG axis, 
including those that are receptor and non-receptor mediated effects (Wilson et al., 2007). 
These include the activation/inhibition of hormone receptors, inhibition of hormone synthesis, 
disruption of hormone transport proteins, and inhibition of hormone metabolism (Liu et al., 
2017).  
Most studies currently focus on SHRs and this thesis specifically examines chemicals that 
act as oestrogens and (anti-)androgens. Known androgen antagonists (for example, 
pharmaceutical anti-androgens flutamide and bicalutamide) have demonstrated that 
antagonists inhibit AR function by competitive binding with natural androgens (Perera et al., 
2017).  
One widely proposed mechanism for AR antagonism is the displacement of the H12 upon 
ligand binding, leading to distortions in the AF2 site, preventing co-activator binding; during 
binding the H12 functions as a lid, which closes (agonist) or moves away from the LBP 
(antagonist) (Tan et al., 2015) (Figure 6). AR antagonists are usually bulkier than agonists 




Figure 6. Model for ligand-dependent activation of the androgen receptor. During ligand 
binding, the H12 functions as a lid and (A) closes when the ligand binding pocket (LBP) is 
presented with an agonist (illustrated by the blue triangle) or (B) moves away from the LBP 
in the presence of a bulkier antagonist (illustrated by the red diamond).  
Adapted from Tan et al. (2015) 
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antagonists push the residues in H12 outward to expand the active site. These structural 
changes in the LBP cause the AF2 site to undergo conformational changes, preventing co-
activator binding. When a small molecule binds to the AR a conformational change can 
occur which impacts subsequent binding of the co-regulator proteins and DNA. Thus, an 
agonist induces an active conformation of the SHR that recruits co-activators and activates 
transcription (Figure 4). Conversely, an antagonist induces the inactive conformation of the 
SHR that recruits co-repressors and represses transcription. Co-activators and co-
repressors are therefore recruited by SHRs upon binding of agonist and antagonist ligands 
respectively and play an essential role in the regulation of transcription (Chen et al., 2018).  
In addition to receptor mediated effects, steroidogenic enzymes can also be a target for 
EDCs. For example, cyp19 (aromatase) catalyses the conversion of androgen to oestrogen 
and therefore changes in aromatase activities (whether up or down regulation) can influence 
the concentration and balance of sex hormones (Cheshenko et al., 2008). Similarly, 5α-
reductase inhibitors will block the conversion of T to DHT and this leads to an increase in T 
(Azzouni et al., 2012). 
 
1.3. What evidence is there of endocrine disrupting chemicals having harmful 
effects? 
To date, there is evidence of endocrine disruption occurring in many invertebrate and 
vertebrate species, and here I provide a few key examples of reported reproductive 
disruption in vertebrates caused by chemical(s) exposure.  
1.3.1. Humans and rodent models 
Pesticides have been directly linked to endocrine disruption in humans following 
occupational exposure; for example, reduced sperm counts following handling of the 
insecticide dichlorodiphenyltrichloroethane (DDT; Singer, 1949) and reduced sperm motility 
through exposure to the insecticide chlordecone (kepone; Guzelian, 1982). 
In addition to these occupational exposure cases, in another well documented case of 
endocrine disruption, the pharmaceutical oestrogen diethylstilbestrol (DES) was prescribed 
to pregnant women during the 1940s to 1970s to prevent miscarriage (Ho et al., 2017). In 
1971, DES was shown to cause a rare vaginal tumour in girls and women who had been 
exposed to this medication in utero (Swan, 2000). In addition, the gestational exposure to 
DES increased the infertility rate and poor pregnancy outcomes in daughters and caused an 
increase in the incidence of genital abnormalities in sons (Schrager and Potter, 2004). 
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Congenital penile anomalies (CPAs) are amongst the most common birth defects and 
encompass a range of malformations, including failure of urethral tube closure 
(hypospadias), penile curvature (chordee), micropenis, and feminisation of male genitalia. 
Reports of CPAs have risen sharply in recent decades, and the most common of these 
malformations, hypospadias, now affect 1:125 live male births in the U.S. (Zheng et al., 
2015). Matlai and Beral (1985) also examined the rates of malformations of male external 
genitalia reported at birth and found a significant increase in cases of cryptorchidism (a 
condition in which one or both of the testes fail to descend from the abdomen into the 
scrotum), hypospadias and hydrocele (a swelling in the scrotum that occurs when fluid 
collects in the thin sheath surrounding a testicle) between 1969 and 1983. Existing research 
indicates that the male reproductive system is the target organ of EDCs, and that exposure 
to EDCs may result in significantly lower T levels and as a result be responsible for the 
cryptorchidism, hypospadias, and other urogenital disorders (Liu et al., 2015). Studies of 
paternal and maternal pesticide exposures reported associations with cryptorchidism and 
hypospadias but could not pin-point specific chemicals (Pierik et al., 2004).  
The anogenital distance (AGD) is naturally shorter in females compared to males and has 
been used as a marker of a feminised or demasculinised phenotype in rodent models and 
other mammals. In addition to the CPAs reported in humans, exposures to anti-androgenic 
pesticides and plasticisers during the critical development window in male reproductive 
development have also been linked to shortened AGD in humans and rodents (reviewed by 
Schwartz et al., 2019). In humans, shorter AGD has also been associated with poor semen 
quality in adult men (Lind et al., 2017).  
Testicular dysgenesis syndrome arises from insufficient androgen in foetal life (Arrebola et 
al., 2015). Due to a disturbance of testicular development, poor semen quality and germ cell 
cancers can occur (Arrebola et al., 2015). Carlsen et al. (1992) carried out a meta-analysis 
on data from 14,947 men, and this indicated that there had been a decline in semen quality 
during a period of half a century. Most individual cases of poor semen quality have no known 
aetiology as people are exposed to low concentrations of thousands of chemicals and so 
proving specific cause and effect is challenging. Also, individuals are exposed to chemicals 
as mixtures and these could be acting together to cause effects rather than a single 
chemical being responsible for the effects (Silva et al., 2002).  
The timing of reproductive system differentiation is different in females and males, and 
female germ cells enter meiosis prenatally and complete initial phases of meiosis before 
birth, whereas male germ cells only begin to enter meiosis postnatally and continuously do 
so throughout adulthood. The belief was that androgens induced and completed 
masculinisation of the reproductive tract during the time when morphological differentiation 
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could be observed. However, Welsh et al. (2008) discovered that androgens could 
‘preprogram’ masculinisation before morphological changes were actually observed in rats, 
and this was termed the ‘masculinisation programming window’. Only within this window did 
blocking androgen action induce hypospadias and cryptorchidism and alter penile length in 
male rats, all of which correlated with AGD. Androgen-driven masculinisation of females was 
also confined to the same window.  
1.3.2. Fish 
The aquatic environment represents the ultimate sink for a vast number of anthropogenic 
contaminants, and fish populations are directly exposed to a wide variety of EDCs originating 
from industrial, agricultural, or municipal effluents. Thus, fish are considered as one of the 
primary risk organisms for EDCs (Scholz and Mayer, 2008). Sex determination in teleosts is 
characterised as being very labile and can be disturbed or even functionally reversed by the 
external application of natural or synthetic hormones and/or aromatase inhibitors (Nolan et 
al., 2001). Indeed, steroid hormones are widely used to control fish sex in aquaculture (Chen 
et al., 2016). The labile period when fish are most susceptible to endocrine perturbation is 
just following hatching or at the juvenile stage (Jobling et al., 1998), and the timing of 
exposure has been shown to be a crucial factor that determines the potency of EDCs (Gore 
et al., 2014).  
Most teleost fish have external fertilisation, but some species develop copulatory organs 
formed from an elongation of the anterior region of the anal fin, termed gonopodium, for 
internal fertilisation (Ogino et al., 2004). The mosquito fish (Gambusia affinis holbrooki) has 
sex dimorphism driven by androgenic hormones mediated by the testis and this becomes 
apparent in the gonopodium formation at late juvenile stage.  
The only androgenic industrial effluent identified to date is pulp mill effluent and reports focus 
on masculinisation of wild female mosquito fish; both the development of a male-like 
gonopodium and male-like reproductive behaviours (Howell et al., 1980). Subsequent 
studies confirmed the presence of androgenic compounds in paper and pulp mill effluent, but 
these effluents contain a complex mixture of organic and inorganic pollutants and the exact 
chemical(s) responsible for the androgenic activity have yet to be identified (Kamali et al., 
2016; Parks et al., 2001; Singh and Chandra, 2019). 
Another widely documented source of environmental androgens are the growth promotor 
implants used in the cattle industry. Male fathead minnow (FHM; Pimephales promelas) 
collected from rivers downstream of feedlots were found to be demasculinised (decreased 
plasma T, altered head morphology, smaller testis size) due to androgenic activity either 
from natural androgens or androgenic pharmaceuticals used in growth implants (trenbolone 
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acetate is metabolised to the potent 17β-trenbolone; Orlando et al., 2004). Female FHM 
collected from the same river had a decreased E2:T ratio due to a reduction in E2 synthesis 
and an increase in T synthesis, indicative of the presence of androgenic compound(s). That 
is, the presence of endogenous androgen(s) leads to negative feedback via the HPG axis 
and results in either increased or decreased exogenous T as the FHM attempts to maintain 
equilibrium (Section 1.1.1). 
Additionally, EDCs in the environment have also been shown to feminise fish. For example, 
exposure to domestic sewage has been shown to feminise male roach (Rutilus rutilus), and 
this effect has been attributed to ethinylestradiol (EE2), the synthetic oestrogen in the oral 
contraceptive pill found in sewage effluents (Purdom et al., 1994). Jobling et al. (1998) also 
collected roach from a number of UK rivers and found a widespread incidence of intersex, 
and the presence of oocytes in male testicular tissue, which is not normally seen in this 
single-sex (gonochoristic) fish species.  
In 2004, the Environment Agency sampled roach from 51 UK sites and found 44 of the sites 
to have feminised male (intersex) fish. The severity of the feminisation correlated with 
predicted exposure to oestrogens, with the most severely intersex fish being found in the 
older year classes (Gross-Sorokin et al., 2006). In later studies, the presence of anti-
androgenic activity (determined in vitro) in UK wastewater treatment works (WwTW) effluent 
was also found to be statically associated with the feminised responses seen in the wild 
roach living in those rivers (Jobling et al., 2009).  
 
1.4. What are the sources of chemicals in the aquatic environment?  
1.4.1. Steroidal EDCs with understandable biologically activity 
Globally, it is likely that over 80% of wastewater is released to the environment without 
adequate treatment (WWAP, 2017). In Central European countries, connection rates to 
WwTWs have increased since 1995 and are now at 97%, with about 80% receiving tertiary 
treatment (European Environment Agency, 2017). In the UK, all wastewater effluent is 
treated; 43% receiving secondary treatment and 57% receiving tertiary treatment (European 
Environment Agency, 2017). 
One major group of chemicals found in the environment are steroids; either natural (e.g. 
oestrone (E1), E2 and T) or synthetic (e.g. EE2 and trenbolone). The natural oestrogens, E1 
and E2, and the synthetic compound EE2, were found to contribute a large fraction of the 
total oestrogenicity of wastewater (Arlos et al., 2018b). Thomas et al. (2002) also found that 
99% of the androgenic activity of WwTW effluent, determined in vitro, was due to natural 
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steroids/metabolites. Of these, androstenedione (direct metabolism of T in the human body 
followed by excretion) accounted for 33%. Similarly, Houtman et al. (2018) analysed 24 
steroid hormones in WwTW effluent and androgenic activity was explained by the presence 
of T and androstenedione. 
Wastewater treatment works utilise a number of different processes depending on the 
amount of effluent that the works receives; ranging from primary settlement, secondary 
biological treatment, and tertiary treatment with another settlement step (discussed further in 
Chapter 2). Wastewaters are complex mixtures of chemicals and nutrients that can vary 
temporally (Fuzzen et al., 2016), and the removal of micropollutants depends on the physical 
and chemical properties of the compound as well as the characteristics of the WwTW, i.e. 
the degree and type of treatment process. The incomplete removal of chemicals during 
wastewater treatment means that some of these compounds are discharged with final 
effluent, causing aquatic organisms to be continuously exposed (Petrie et al., 2015). Many 
EDCs are sufficiently stable to survive the wastewater treatment process and can even be 
reactivated during treatment, for example, conjugated steroids can by hydrolysed to their 
free form during biological treatment (Zhang and Zhou, 2005). Incomplete mineralisation 
during wastewater treatment can also result in the formation of transformation products with 
a potential to produce more toxicity than the parent compound (Maya et al., 2018).  
Given that food production consumes more than two-thirds of the world’s extracted water 
and is expected to rise by 70% by 2050 due to population growth (Gilbert, 2012b) there is a 
need to evaluate the efficiency of current tertiary wastewater treatment processes and to 
develop advanced treatment processes (Hamilton et al., 2014). 
In addition to chemicals entering our aquatic environment via WwTW effluents (point 
sources), chemicals also enter via non-point sources from land run-off, precipitation, 
atmospheric deposition, drainage, seepage, or hydrologic modification. Non-point source 
pollution originates from many diffuse sources and is caused by precipitation moving over 
and through the ground, picking up and carrying pollutants and finally depositing them into 
lakes, rivers, wetlands, coastal waters, and ground waters (Gang et al., 2006). Agricultural 
activities that cause non-point source pollution include poorly located or mismanaged animal 
feeding; overgrazing; mismanaged ploughing; and improper, excessive, or poorly timed 
application of fertiliser (e.g. run-off from land-applied animal manure; Abdel-moneim et al., 
2017).  
Oestrone can be readily measured in run-off, soil, and groundwater, and the major source of 
this steroid in the environment appears to be cattle and chickens (Shore and Shemesh, 
2003). Additionally, wild FHM from a cattle feedlot in the USA were found to be 
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demasculinised with reduced T synthesis, altered head morphology and smaller testes. As 
there was no evidence of feminisation (i.e. no oestrogens), the effluent was thought to be 
androgenic due to the growth promoter administered to the cattle, 17β-trenbolone (Orlando 
et al., 2004). Whilst use of trenbolone is no longer allowed in the European Union (EU), the 
use of hormones as production aids is still permitted in North American countries. 
1.4.2. Industrial compounds with unforeseen biological activity 
Globally, 400 million tons of chemicals were produced in 1995 and Europe was the largest 
chemical producing region in the world, accounting for 38% of this production (EEA/UNEP, 
1998). However, worldwide competition has shifted significantly over the last ten years and 
now China holds the top ranking in sales (ECIC, 2020). In 2007, the European Registration, 
Evaluation, Authorisation and Restriction of Chemicals (REACH) entered into force and 
during the first six month period, 143,000 existing substances were pre-registered by 65,000 
companies. The REACH deadline for registering existing substances manufactured or 
imported in quantities from 1 to 100 tonnes per year in the EU was on 31 May 2018 and 
since 2008, 145,297 substances have now been pre-registered 
(https://echa.europa.eu/information-on-chemicals/pre-registered-substances, downloaded 
22/12/2020) and 23,118 substances have been registered 
(https://echa.europa.eu/information-on-chemicals/registered-substances, downloaded 
22/12/2020). Similarly, the 1976 Toxic Substances Control Act (TSCA) requires the US 
Environmental Protection Agency (EPA) to compile and keep a current list of every 
substance that is manufactured or processed in the US, and this list has also continued to 
grow and now has over 86,000 chemicals on it (https://www.epa.gov/tsca-inventory/about-
tsca-chemical-substance-inventory). 
The chemical bisphenol A is the monomer used to produce polycarbonate and was, by 
chance, found to be oestrogenic when the chemical leached from autoclaved tissue culture 
flasks and caused MCF-7 breast cancer cells to proliferate (Krishnan et al., 1993). 
Alkylphenol polyexthoxylates, used in the textile industry for wool scouring, were also found 
to be broken down by wastewater treatment to oestrogenic alkylphenols, e.g. octylphenol 
and nonylphenol (Desbrow et al., 1998). These chemicals were discharged to rivers and this 
led to the induction of the female-specific protein, VTG, in caged male trout sited in rivers 
below WwTWs (Harries et al., 1997). Due to these results, many other chemicals have now 
been tested for oestrogenic activity, and other classes of chemicals have been found to have 
activity too, e.g. phthalates (Harris et al., 1997) and parabens (Routledge et al., 1998).  
Phthalates or plasticisers enhance the flexibility of plastics and are widely used in consumer 
and industrial products such as medical devices, food wrappings, toys, paints, finishes, and 
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upholstery. As a result of their oil solubility and viscous nature, they are similarly constituents 
of personal care products (Witorsch and Thomas, 2010). Parabens are preservatives widely 
used in cosmetics and pharmaceuticals and, along with phenols, include some of the highest 
volume production chemicals in the world (Pollack et al., 2016). Many man-made chemicals 
find their way into aquatic ecosystems, for example, numerous consumer products are 
flushed down drains and discharged with wastewater effluent and thence enter the aquatic 
environment (Jobling et al., 1998), and this wide usage has meant that synthetic chemicals 
are now ubiquitous in water systems (Wangmo et al., 2018).  
The classes of EDCs known to interfere with the androgen signalling pathway include 
dicarboximide fungicides (e.g. vinclozolin; van Ravenzwaay et al., 2013), organochlorine-
based fungicides (e.g. the DDT metabolite, dichlorodiphenyldichloroethylene (p,p’-DDE); 
Kelce et al., 1995), conazole fungicides (e.g. prochloraz; Vinggaard et al., 2002), plasticisers 
(e.g. phthalates; Svechnikov et al., 2016), polybrominated diphenyl ether flame retardants 
(Stoker et al., 2004) and urea-based herbicides (e.g. linuron; Gray et al., 2001). 
Man-made chemicals also include pharmaceuticals and there over 4,000 approved drug 
products for human, veterinary, agriculture and farming use (Lee et al., 2017). 
Pharmaceuticals are designed to be biologically active and maintain their therapeutic action, 
resulting in the occurrence of pharmaceuticals in the aquatic environment (Lee et al., 2017). 
These drugs are currently available under various formulations and comprise a large number 
of chemical classes and modes of action (Meador et al., 2016).  
Whilst for humans, exposure is transient, aquatic organisms will be exposed continually to a 
cocktail of drugs (Rand-Weaver et al., 2013). Gunnarsson et al. (2008) looked at 1318 
human drug targets and found 86% to be conserved in zebrafish, 61% in Daphnia pulex 
(water flea) and 35% in Chlamydomonas reinhardtii (green algae), indicating the potential for 
lower vertebrates to respond to the pharmaceuticals present in the aquatic environment. 
This is of concern as Scott et al. (2018) found 40% of mosquitofish sampled from Australian 
river sites to contain active pharmaceuticals. 
Man-made chemicals enter our aquatic environment via non-point sources. The types of 
chemicals found in the aquatic environment in agricultural landscapes are typically 
herbicides, fungicides and insecticides, as well as hormones and pharmaceuticals from 
livestock, and these will differ from those found in urban landscapes that will typically be oil, 




1.5. Methods for assessing oestrogenic and (anti-)androgenic chemicals in the 
aquatic environment? 
1.5.1. Chemical analysis 
The highly diversified chemical structures, properties, and mechanisms of action of 
environmental EDCs present a major challenge to their chemical detection/quantification 
(Tse et al., 2013). Chemical analysis of environmental samples is required if observed 
effects need to be linked to specific chemical(s), however, many EDCs often occur at very 
low concentrations that are often close to or below detection limits (DLs) of analytical 
chemistry methods (Arlos et al., 2018a).  
Water samples can be collected as grab-water samples which enable the determination of 
water chemistry at a moment in time, but it is difficult to use this method to ascertain the 
variability in the presence of EDCs and may be more susceptible to extreme events (Perkins 
et al., 2017). Other approaches such as composite water sampling strategies can 
compensate for this, although chemical concentrations are then averaged over the time that 
the composite sample is made, and extreme events may be missed. An alternative is to 
utilise passive samplers, such as the polar organic chemical integrative sampler, that allow 
hydrophilic chemicals to permeate the sampler membrane and be taken up by a sorptive 
sequestering medium over a prolonged exposure period, thus providing a time-integrated 
record of EDCs present (Jorgenson et al., 2018). Because of accumulation of chemicals 
over the exposure time, the use of passive samplers allows the detection of EDCs at 
concentrations much lower than can be achieved with grab-water samples (Lahti et al., 
2012) and they have been applied to better understand exposure of biota over time 
(Hamilton et al., 2016). This information, however, is not readily translated to environmental 
concentrations of the detected compounds and excludes hydrophobic compounds. 
Other substances in water can alter the bioavailability and potency of EDCs, e.g. 
hydrophobic contaminants in water can associate with dissolved or particulate organic 
matter such as humic acid (Matthews et al., 1995). Water concentrations may therefore 
underestimate the concentration present in the environment (Yarahmadi et al., 2018). 
Indeed, Alvarez-Munoz et al. (2015) found that the presence of anti-androgenic activity was 
significantly correlated with total organic carbon and silt content. That is, the moderately 
hydrophobic anti-androgenic compounds associated with the organic matter and sorbed onto 
particles (Rostkowski et al., 2011). 
A wide range of EDCs can bioconcentrate in fish bile at concentrations that are many 
thousands of times greater than in the aquatic environment, facilitating the structural 
identification of bioavailable contaminants present in that environment (Rostkowski et al., 
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2011). Some authors have found a significant relationship between oestrogenic activity and 
levels of oestrogenic substances in surface waters (Larsson et al., 1999; Yang et al., 2014), 
illustrating that analysis of fish bile could be used to identify EDCs present in water. EDC 
concentrations in bile and plasma revealed strong accordance in caged trout (Lahti et al., 
2012). Good correlation has also been found between bile E2 equivalent concentrations 
(E2EQs, measured in vitro) and plasma VTG (biomarker of oestrogenic exposure) induction 
in male bream (Legler et al., 2002).  
1.5.2. Current tests for assessing chemicals for oestrogenic and (anti-)androgenic activity 
In the USA, the original 1976 TSCA did not require chemicals to be tested prior to their use 
in many consumer products and industrial applications (Trasande and Liu, 2011). Since 
then, new regulations have come into force to increase the protection of human health and 
the environment from the risks that can be posed by chemicals. 
The development of non-animal test methods for the detection of EDCs has been confirmed 
as high priority for regulatory authorities in most countries and in 2012 the Organisation for 
Economic Co-operation and Development (OECD) investigated test methods in the scientific 
literature that could be standardised and used in chemical regulations to detect and 
characterise hazards posed by EDCs. This resulted in a Conceptual Framework for Testing 
and Assessment of Endocrine Disruptors and the issuing of the OECD Standardised Test 
Guidelines (revised guidelines; OECD, 2018d). These guidelines give the background of 
each standardised assay, its applicability domain and conceptual framework for testing 
(Dvorakova et al., 2016). The framework consisted of five levels, each corresponding to a 
different level of biological complexity; Level 1 using existing data and non-test information, 
Level 2 utilising in vitro assays to provide mechanistic information and Levels 3-5 using in 
vivo test systems for a more definitive understanding of the effects (revised guidelines; 
OECD, 2018d). The OECD Standardised test guidelines have been updated more recently 
(OECD, 2018d) and high throughput (HTP) screening techniques are now included, in 
conjunction with computational methods and information technology, to aid screening of the 
large number of chemicals still untested.  
Similarly, the US EPA Endocrine Disrupter Screening Program (EDSP) was established to 
identify potential endocrine bioactivity of pesticides and chemicals found in sources of 
drinking water. The EDSP focussed on chemicals perturbing the oestrogen, androgen and 
thyroid hormone pathways following a 2-tiered approach consisting of a battery of eleven in 
vitro Tier 1 screening assays and four Tier 2 in vivo tests to characterise adverse outcomes 
(Pinto et al., 2018). While there are about 10,000 chemicals covered by the EDSP chemical 
universe, only 52 of these chemicals have undergone Tier 1 screening. To evaluate potential 
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EDCs more quickly and cost-effectively, the EDSP has been transitioning from traditional 
Tier 1 screening methods to HTP in vitro assays to prioritise chemical screening and to 
provide alternative data for Tier 1 endpoints (Coady et al., 2017).  
With the move to HTP assays, more chemicals are being tested, e.g. the US EPAs Tox Cast 
program has screened thousands of chemicals for biological activity, primarily using HTP in 
vitro bioassays (Fay et al., 2018). However, with over 145,000 pre-registered substances in 
the EU and more than 86,000 synthetic chemicals registered in the US, only a small fraction 
of these have been tested for endocrine disrupting activity, and of those tested so far, only 
around 320 chemicals are considered to be EDCs or probable EDCs (Trasande et al., 2016) 
(Figure 7). Additionally, these assays are in vitro assays, any EDCs identified as endocrine 
active in in vitro tests will then require in vivo testing.  
There is a lack of data on the hazards (toxicity and ecotoxicity) of chemicals registered with 
REACH and in the US TSCA Chemical Substance Inventory. This presents a challenge for 
regulatory decision making, especially as the number and variety of potentially hazardous 
chemicals continues to increase. Due to the untenable nature of identifying all contaminants 
at increasingly lower concentrations and then assessing each of these individually, alternate 
approaches are needed (Davis et al., 2016).  
Regulatory authorities have approached the task of assessing all these chemicals by 
applying rapid and inexpensive quantitative structure-activity relationship (QSAR) Tier 1 
methods as decision support tools to address the data gaps and provide provisional data in 
the toxicity database of a chemical (Morger et al., 2020; Ruiz et al., 2017; Thomas et al., 
2019). Also, the call to reduce animal testing in toxicity evaluation has led to an expansion of 
these tools. QSAR is thus used to prioritise and reduce the number of chemicals requiring 
further testing, so that efforts can be focussed on those most likely to be endocrine active.  
1.5.2.1. In vitro testing of environmental samples for ED activity 
Tier 1 in vitro screening bioassays are more precise at predicting in vivo effects than 
chemical analysis alone (Volker et al., 2016). Environmental samples can contain both 
agonists and antagonists and in vitro bioassays provide information about the net effect of all 
active chemicals. This means that the presence of antagonists may reduce the observed 
effect (Grover et al., 2011a). Prior to in vitro screening, fractionation of samples can help to 
separate these effects (Leusch et al., 2017). In vitro bioassays are therefore often used as a 
pre-screening to give an overview of a sample’s hormonal activity before analytical detection 
to determine the compounds that are present (Chamas et al., 2017). 
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Discrepancies are sometimes found between analytical chemistry measurements and the 
results of bioassays, and Sun et al. (2017) thought that this was because partially 
decomposed samples were not picked up by gas chromatography–mass spectrometry (GC-
MS) but were still active in the yeast oestrogen screen (YES). Similarly, Kanda and 
Churchley (2008) found considerable discrepancy between E2EQs determined with the YES 




Figure 7. This figure illustrates the >145,000 substances pre-registered with the European 
Union and >86,000 registered in the United States. Only the ‘tip of the iceberg’ has been 
tested for endocrine disrupting activity and many more await testing. EPA, Environmental 
Protection Agency 






due to matrix effects of the wastewater samples, as these can either suppress or enhance 
the analytical signals (Taylor, 2005). 
In addition to receptor mediated mechanisms, chemicals may also affect processes involved 
in the synthesis, release, metabolism, transport, and elimination of endogenous hormones, 
which can lead to alterations in the levels of circulating sex hormones (Pinto et al., 2018). 
The EPA's EDSP has incorporated the OECD validated H295R-based in vitro 
steroidogenesis assay as part of the Tier 1 screening battery (US Environmental Protection 
Agency, 2009). As H295R cells synthesise most major steroid hormones, chemically 
induced toxicity can easily be evaluated using this assay. 
In vitro assays provide a rapid, low-cost and sensitive means to assess a wide range of 
biological effects, and are typically mechanism-based (Cavanagh et al., 2018). However, 
translating in vitro results to in vivo is quite complicated and Wangmo et al. (2018) only 
observed good correlations for compounds acting via direct binding to sex steroid receptor. 
Konig et al. (2017) also did not find in vitro tests to be directly predictive of effects at the 
whole organism level and population level. It is often hard to compare results because of 
variability in assay responses with different cell lines, and a greater focus on standardising 
bioassay protocols is needed if they are to be incorporated into robust environmental 
assessment frameworks.  
In vitro methods are beneficial as they reduce the need for animal testing and are cheaper to 
run. However, in vitro assays must be used in conjunction with in vivo testing, as in vitro 
systems cannot fully take into account bioaccumulation, metabolism, and availability to the 
target cell, or alternative pathways for endocrine disruption. 
Issues and uses of in vitro testing are discussed further in Chapter 3. 
1.5.2.2. In vivo testing 
Unlike QSAR models and in vitro screening, in vivo studies use intact organisms with 
metabolic function, normal architecture, normal cell-cell and tissue-tissue interactions (Cote 
et al., 2016). In vivo assays therefore take into account the pharmacokinetics of the 
compounds (uptake, transport, metabolism, differences in binding efficiencies) and thus are 
measuring final health effects. In vivo assays though are less suitable for HTP screening. 
Hence for comprehensive characterisation of complex environmental pollution, a 
combination of analytical chemistry, in vitro and in vivo assessment should be applied. 
The gold standard in vivo assays for identifying oestrogenic or androgenic compounds were 
initially developed in mammal models. The uterotrophic assay (Ankley and Gray, 2013) is an 
in vivo assay that utilises rats to detect oestrogenic chemicals. For this assay, immature or 
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ovariectomised adult female rats are treated with test chemicals for three consecutive days. 
After exposure, the uterus is weighed, and increases are indicative of chemicals acting as 
ER agonists (OECD, 2007).  
The OECD Hershberger in vivo androgenic screen relies on castration removing 
endogenous androgen in prepubertal male rats, so that exogenous androgens are needed 
for the target tissues to grow and gain weight. This assay has several advantages; the 
tissues are the natural targets for androgens, the tissue growth response is relatively rapid, 
and the tissue weights are quantitative (Owens et al., 2006). This assay can also be used to 
detect AR antagonists. Another rat assay, the male pubertal system, will more effectively 
detect other AR antagonists in the intact developing rat (e.g. those affecting 
steroidogenesis), and is important for confirming observations made in the Hershberger 
assay (Ankley and Gray, 2013). 
Questions remain as to whether the mechanistic information from mammalian studies can be 
used to predict toxicant effects in fish and wildlife (Wells and Van Der Kraak, 2000).  
Sex determination in teleosts can be disturbed or even functionally reversed by the external 
application of hormones, and this forms the basis of a number of fish assays. For assessing 
aquatic contaminants, fish are ideal, either collected in the field or exposed in laboratories. 
Small fish model species (zebrafish, FHM, medaka and 3-spined stickleback) are regularly 
used for biomonitoring, due to their short life-cycles allowing for assessment of reproductive 
performance, which is one of the most important endpoints for long-term effects, with 
implications for population development (Scholz and Mayer, 2008). 
Small-bodied freshwater fish are commonly used in regulatory testing for EDCs but most 
lack a sensitive and quantifiable androgen specific biomarker (Muldoon and Hogan, 2016). 
The FHM is extensively used both for regulatory testing and research for the assessment of 
chemicals for oestrogenic and androgenic activity. Several endpoints are responsive to 
oestrogens (VTG, sex-steroid production, decreased nuptial tubercle counts in males, 
delayed maturation and decreased fecundity and fertility) and others are responsive to 
androgens (SSCs – nuptial tubercle growth, alterations in size of the dorsal fat pad, 
alterations in shape, colouration and breeding behaviours). These SSCs are often not 
sensitive to low concentrations of androgenic compounds and are scored using a subjective 
scale and thus may be subject to bias. SSCs can also be affected by the hierarchical status 
of the fish, making it difficult to attribute a change in appearance to exposure to an EDC. 
Measurement of FHM SSCs in response to androgens and anti-androgens can therefore be 
ambiguous (Collette et al., 2016). 
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One of the best-documented physiological responses under tight androgen control is 
‘spiggin’ production in sticklebacks (Sebillot et al., 2014). The kidney of the male stickleback 
hypertrophies during the breeding season, when the secondary proximal epithelial cells 
synthesise a glue glycoprotein, spiggin (the Swedish name for the three-spined stickleback 
being spigg). The spiggin is secreted into the urinary bladder and is then used to stick plant 
material together to form a nest (Borg, 1994). Spiggin levels are almost undetectable in 
female stickleback fish under natural conditions, but androgen-dependent spiggin can also 
be induced in the kidneys of female stickleback in response to exogenous androgens, where 
it can be determined by measuring the kidney epithelial height (KEH) or by using an 
enzyme-linked immunosorbent assay (ELISA; Katsiadaki et al., 2002). Since the detection, 
characterisation and cloning of spiggin, this appropriate and quantifiable biomarker can now 
be used for the screening of androgens in sticklebacks (Scholz and Mayer, 2008). In the 
stickleback a clear and quantifiable androgenic response can be measured at 100ng/L 
methyltestosterone (MT; Muldoon and Hogan, 2016). The stickleback is more sensitive to 
androgens than the FHM (tubercle formation in females occurs at a concentration of 1 µg/L 
or greater; Pawlowski et al., 2004), and less sensitive than the Japanese medaka (formation 
of papillary processes in females occurred at 22.5 ng/L of MT; Kang et al., 2008). The 
advantage of using stickleback is that it is possible to simultaneously assess androgen and 
oestrogen exposure in a single fish using fully quantitative endpoints (Muldoon and Hogan, 
2016). However, due to the large variability and high levels of spiggin in males, for the anti-
androgen screen female co-exposure with androgens has been preferred. Spiggin as a 
biomarker is only applicable to sticklebacks, but sticklebacks are not as widely used in 
toxicology as, for example, FHM or medaka. Therefore, fish assays that are sensitive to 
androgenic/anti-androgenic chemicals and not prone to subjectivity (such as current SSCs) 
need to be developed. In terms of oestrogen responsiveness, the FHM, medaka and 
zebrafish may be more suitable species as test methods are better established. These 
species could therefore hold promise if robust androgenic/anti-androgenic biomarkers or 
endpoints could be developed. This topic will be developed further in Chapter 5 of this 
thesis.  
 
1.6. My aims 
The aim of my thesis was three-fold: 
To determine the extent of endocrine disruption in fish exposed to a WwTW effluent before 
and after the addition of an advanced water treatment process, Granulated Activated Carbon 
(GAC), was implemented to investigate the technology’s ability to reduce EDCs being 
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released into the environment. Both laboratory and field-based assessments of the same 
effluent were conducted to investigate the impacts of the traditional and advanced treatment 
processes on well characterised markers of endocrine disruption in fish namely, occurrence 
of intersex phenotypes (both eggs and sperm in the gonad), VTG induction in male fish, and 
disruption to reproductive output and SSCs.      
To examine over 100 chemicals found in WwTW effluents for (anti-)androgenic activity in an 
in vitro yeast test system and determine the potencies of these chemicals. 
To search for male-specific molecular markers in a sexually dimorphic fish species, in order 
to identify possible biomarkers which could provide promising additional endpoints for 
detecting (anti-)androgenic activity in fish in vivo regulatory assays. 
 
1.7. My research questions: 
Question 1: Does the addition of an advanced treatment process to a full-scale 
wastewater treatment plant lead to a reduction in endocrine disruption in fish? 
Whilst investigating Question 1 (described in Chapter 2), further questions arose around 
whether the endocrine effects seen in the effluent exposed fish were driven purely by well 
characterised oestrogenic chemicals or if they were also caused by less well identified anti-
androgenic compounds (raised in Question 2, described in Chapters 3 and 4) and if it 
would be possible to identify a novel specific biomarker of anti-androgenic exposure in the 
FHM, a well characterised and commonly used fish species in OECD regulatory test 
guidelines (raised in Question 4, investigated in Chapter 5).  
Prior to my thesis, an effect directed analysis (EDA) approach was used to tentatively 
identify chemicals present in environmental samples as having (anti-)androgenic activity 
using an in vitro yeast-based assay. Following on from this work, I then asked the question - 
Question 2: Which individual chemicals from wastewater treatment work effluents 
have (anti-)androgenic activity and how potent are these chemicals? 
Whilst testing these chemicals for (anti-)androgenic activity, several issues were 
encountered that affected data interpretation which could lead to the mislabelling of certain 
chemicals as endocrine disruptors. Therefore, to refine these results, two in vitro assays for 
the determination of (anti-)androgenic activity of environmental chemicals were then 
compared, and the question asked was – 
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Question 3: Do both in vitro assays for (anti-)androgenic activity produce the same 
results and if not, which is the most reliable, i.e. least likely to produce false positive 
results? 
In stickleback, a sexually dimorphic fish species, males secrete a glue-protein, known as 
spiggin, which is used to build a nest in preparation for female egg laying. Once the eggs are 
laid the male then cares for the eggs until shortly after they hatch. Spiggin is known to be 
produced under the control of androgens in males. The presence of spiggin in female 
sticklebacks indicates exposure to environmental androgens, and a reduction in spiggin in 
male fish indicates exposure to environmental anti-androgens. Here I ask the question – 
Question 4: Do FHMs, another sexually dimorphic fish species exhibiting paternal 
parental care, possess a similar spiggin-like protein that could be used as a sensitive 
biomarker of (anti-)androgen exposure, to provide an additional endocrine endpoint to 
commonly used OECD regulatory test guidelines?   
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2. Investigating the efficacy of an advanced wastewater treatment process, 
granular activated carbon (GAC), at removing endocrine-disrupting activity; 
laboratory and field-based studies of standard and GAC treated wastewater 
effluents  
2.1. Introduction 
2.1.1. Brief history of oestrogenic endocrine disruption in wild fish 
Whilst in certain families of fish hermaphroditism or sex reversal are the normal mode of 
reproduction, the vast majority of species are gonochoristic, in which distinct males and 
females are independent and stable (Nolan et al., 2001). The gonad is a unique organ due 
to its bipotential nature; either testis or ovary can develop from a single primordium (Brennan 
and Capel, 2004). In teleosts, endogenous oestrogens act as the natural inducer of ovarian 
differentiation, while androgen is not synthesised in the gonad during the critical period of 
sex determination (Nakamura et al., 1998). Consequently, sex differentiation and meiosis 
initiate earlier in female teleosts than in male teleosts. Under experimental or aquaculture 
conditions, the phenotypic sex of gonochoristic fish species can be affected by exposure to 
sex steroids, and, in general, exogenous exposure to oestrogens will produce a female 
phenotype whereas exposure to androgens will produce a male phenotype (Ankley et al., 
1998).  
A wide variety of chemicals discharged into the aquatic environment are thought to disrupt 
endocrine function in fish, leading to reproductive disorders and abnormalities (reviewed in 
Sumpter, 2005). Roach (Rutilus rutilus), of the family Cyprinidae, is a gonochoristic fish 
species native to the UK. The occurrence of oocytes in testicular tissue in gonochoristic fish 
(intersex) is thought to be rare (Nolan et al., 2001). However, when Jobling et al. (1998) 
carried out a survey of roach collected from eight UK lowland rivers, the incidence of 
intersexuality was much higher in those rivers that received sewage effluents (proportion of 
intersex males at downstream sites ranged from 16-100%) than at the control sites 
(proportion of intersex males ranged from 4-18.1%). An association was also confirmed 
between the widespread incidence of intersexuality (gonads containing male and female 
tissue and/or female-like reproductive ducts) in roach and the degree of exposure to WwTW 
effluents (Jobling et al., 1998). The severity of intersex in roach was observed to range from 
single primary oocytes scattered throughout the testicular tissue, to continuous areas of 
ovarian tissue set apart from the testicular tissue (Jobling et al., 1998).  
Jobling et al. (1998) found that the number of male roach with normal testes was inversely 
proportional to the number of intersex fish, indicating that this trend was due to the 
feminisation of genetically male fish rather than the masculinisation of genetically female 
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fish. Exposure to WwTW effluents has also been shown to induce the synthesis of VTG 
(Harries et al., 1997; Purdom et al., 1994) in male fish and to also inhibit testicular growth 
(Harries et al., 1997). In addition, exposure of juvenile roach to WwTWs effluent has been 
shown to induce a dose-dependent formation of female-like reproductive ducts (oviducts) in 
otherwise ‘male’ looking fish (Rodgers-Gray et al., 2001). More recent work, looking to see if 
male intersex impacts reproduction, found a significant negative relationship between the 
severity of intersex and reproductive success; the intersex condition reduced the average 
contribution to the offspring from 19% for non-intersex fish to 4.5% for severely feminised 
fish (>100 oocytes within the testicular tissue; Harris et al., 2011). 
Intersexuality in fish associated with WwTW effluents is not restricted to roach in the UK, and 
has also been reported in other fish species and a number of other countries (for example, 
intersex gudgeon in the UK (van Aerle et al., 2001); intersex roach in France (Geraudie et 
al., 2017); intersex roach in Denmark (Bjerregaard et al., 2006); intersex rainbow darter in 
Canada (Bahamonde et al., 2015); intersex smallmouth bass in the USA (Blazer et al., 
2014)). 
To identify the chemical(s) in the effluent responsible for the feminising effects seen in male 
roach, Desbrow et al. (1998) adopted an EDA approach, using a combination of biotesting, 
fractionation procedures and chemical analysis. Following the EDA approach, the 
oestrogenic activity of WwTW effluent was attributed to natural steroid oestrogens; E2, E1, 
the synthetic birth-control pharmaceutical, EE2 (predominantly excreted by women), and 
alkylphenols from domestic and industrial sewage effluent, and these chemicals were 
considered to be the primary agents responsible for the feminisation of fish downstream of 
the WwTW (Desbrow et al., 1998; Harries et al., 1997). 
2.1.2. (Anti-)androgens present in the environment 
In addition to work looking at oestrogens in the environment, now chemicals possessing 
other mechanisms of endocrine modulation are being examined. There are a growing 
number of anthropogenic chemicals being identified in influents and rivers, and there is 
increasing evidence showing that discharges are having adverse environmental effects 
(Prasse et al., 2015). In addition to chemicals in WwTW effluent acting as agonists of the 
ER, the feminisation of male fish is also thought to be due to anti-androgens, and statistical 
modelling shows a strong correlation between fish intersex and the predicted exposure to 
the combination of oestrogens and anti-androgens in effluent (Jobling et al., 2009). However, 
Johnson et al. (2007b) saw no clear relationship between the presence of oestrogenic 
activity and anti-androgenic activity in individual effluent samples and suggested that 
different chemical(s) may be causing the oestrogenic and anti-androgenic effects.  
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In fish, androgens are important as they regulate male sexual differentiation and maturation 
(Borg, 1994). Most environmental (anti-)androgenic contaminants can bind with the AR to 
either mimic or block the response, thereby acting as either androgens or anti-androgens 
(Wong et al., 1995). WwTWs effluents are often found with in vitro anti-androgenic activity at 
concentrations known to cause effects on fish (for example, Fang et al., 2012; Johnson et 
al., 2007b). Laboratory studies have shown that anti-androgenic chemicals can cause 
demasculinisation of male fish, for example, the fungicide vinclozolin and the clinical anti-
androgen cyproterone acetate induced intersex and inhibited spermatogenesis in medaka 
(Kiparissis et al., 2003) and reduced SSCs in FHM (Filby et al., 2007). In addition, in 
laboratory studies using stickleback kidney cell primary culture, spiggin production (a 
biomarker of androgen exposure) could be inhibited with anti-androgens (Jolly et al., 2009).  
2.1.3. Measurement of endocrine disrupting activity in fish 
It is not possible to identify every chemical present in an effluent as to do so analytically 
would be extremely time consuming and costly. Especially as thousands of chemicals are 
discharged into our rivers (Tyler et al., 2007) and these are transformed in WwTWs and 
rivers into additional compounds (Escher et al., 2014). A wide range of EDCs have been 
shown to bioconcentrate in fish bile (to concentrations many thousand times more than 
concentrations in the environment; Rostkowski et al., 2011), prior to excretion into the 
intestines as the parent compound or as conjugates (Hill et al., 2010). As with effluent, it 
would be too time-consuming and costly to measure every chemical present by analytical 
chemistry. However, the total activity present in fish bile when measured using a bioassay is 
a much more practical approach and this activity gives a good indication of the types of 
contaminants that would have been present in the river and that have bioconcentrated in the 
fish bile over a period. 
2.1.4. Wastewater effluents are a major source of aquatic pollution  
2.1.4.1. Regulations relating to wastewater and aquatic pollution 
The continued occurrence of contaminants in rivers downstream of WwTWs has led to 
discussion regarding the need for improved wastewater treatment processes. In 1991, the 
EU Urban Wastewater Treatment Directive (WwTD) 91/271/EEC (European Commission, 
1991) was adopted to protect the environment from adverse effects of wastewater 
discharges from cities and certain industrial sectors. This directive prescribed secondary 
treatment (e.g. biological treatment with a secondary settlement) for urban areas with a 
population equivalent of greater than 2,000 and more advanced treatment in places with 
population equivalents of greater than 10,000 in sensitive areas (e.g. shellfish and 
freshwater fisheries or where water is used for the abstraction of drinking water) or greater 
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than 15,000 in areas where the effluent is not discharged into sensitive areas. This EU 
Urban WwTD established parameters that discharges from urban WwTWs must satisfy; 
organic content (biological oxygen demand and chemical oxygen demand) and total 
suspended solids, and for sensitive areas, parameters for total phosphorus and nitrogen 
must also be satisfied. This directive, however, does not provide acceptable parameters for 
EDCs. 
More recently, the EU Water Framework Directive (WFD) (European Commission, 2000) set 
out ‘Strategies against pollution of water’, that assesses the ecological and chemical status 
of surface waters for biological, hydromorphological, physio-chemical and chemical quality. 
The WFD outlines a list of priority substances and these substances were selected from 
amongst those presenting a significant risk to or via the aquatic environment. The original 
list, agreed in 2001, contained 33 priority substances (Decision 2455/2001) and in 2008, the 
Environmental Quality Standards (EQSs) for these substances were established 
(Environmental Quality Standards Directive (EQSD) 2008/105/EC, also known as the Priority 
Substances Directive). This list was further reviewed in 2012, and the amendment (Directive 
2013/39/EU) now lists 45 priority substances and 21 of these are thought to pose the 
greatest threat and are labelled ‘priority hazardous substances’. The Priority Substances 
Directive requires the progressive reduction and phasing out of these ‘priority substances’. 
These include di(2-ethylhexyl) phthalate (DEHP), nonylphenols, polycyclic aromatic 
hydrocarbons (PAHs), and tributyltins. In 2015, the most ubiquitous and potent steroid 
oestrogens, namely the natural steroid oestrogens E1 and E2, and the synthetic steroid 
oestrogen EE2 were added to the EU WFD chemical ‘1st watch list’ (Carvalho et al., 2015). 
Standard biological WwTW processes (e.g. trickling filters, activated sludge) do not 
completely remove steroid oestrogens entering the WwTW, although they can frequently 
reduce the concentrations down to low ng/L range in the effluent (Bain et al., 2014; Hicks et 
al., 2017; Kanda and Churchley, 2008; Volker et al., 2016). However, fish are extremely 
sensitive to these steroids (Caldwell et al., 2012), resulting in predicted no effect 
concentrations (PNECs) as low as 0.035 ng/L for EE2, 0.4 ng/L for E2 and 3.6 ng/L for E1 
(Loos et al., 2018). Therefore, in receiving water with little dilution, surface water 
concentrations may be close to, or exceed, these PNECs (Johnson et al., 2013). Better 
analytical techniques will also be required to determine if regulations regarding the 
concentrations permitted in final effluents entering rivers are being met. 
Natural hormones (T, E1, E2) are EDCs excreted by humans and other animals, and are 
therefore abundant in effluents. Whilst it would be possible to try to find safer alternatives to 
replace some man-made chemicals (e.g. alternatives that are more readily degraded), it 
would harder if not impossible to reduce the amount of natural steroid and pharmaceuticals 
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entering WwTWs. Therefore, other measures are required to reduce their release into the 
environment, and one option would be to improve effluent treatment technology at the 
WwTW. Another option would to be to reduce the number of new chemicals produced, 
unless these are specifically produced as safer alternatives.  
2.1.4.2. Traditional wastewater treatment methods  
Conventional WwTWs rely on physical, chemical, and biological methods that remove solids, 
pathogens, organic matter, and nutrients. For removal of EDCs this process would be by 
biodegradation, sorption to sludge, chemical transformation and volatisation (Kanda and 
Churchley, 2008). Depending on the chemical structure, biodegradation and/or sorption can 
lead to differing removal rates during the wastewater treatment process (Prasse et al., 
2015).  
Figure 8 illustrates different types of WwTWs processes, and the type of chemicals that are 
likely to be removed at the different treatment stages. 
The first step in the wastewater treatment process, the preliminary treatment, involves the 
removal of grit and gravel by slowing flows down to enable settlement. After this de-gritting 
step, the effluent is screened to remove large solids. Primary treatment then involves the 
passive and/or chemically-enhanced process of settlement of suspended solids not removed 
by preliminary treatment. Removal of chemicals from effluent during primary treatment relies 
on the hydrophobicity of the chemicals, the suspended solids content and their subsequent 
settling, and hydrophobic compounds are likely to bind to particles and settle out (Koh et al., 
2008).  
Secondary treatment is a biological process whereby dissolved organic matter is removed 
typically by either trickling filters or activated sludge plants. The major process difference is 
that in trickling filters the biomass is steady (sewage trickled over coarse aggregate coated 
with bacteria), and in activated sludge plants the biomass is in suspension (aerated agitated 
liquor). In the England and Wales, most WwTWs use trickling filters for secondary treatment 
(Johnson et al., 2007a), whereas the activated sludge process is the most widely used 
wastewater treatment system in the world (Liu et al., 2009b). Typically, the retention time of 
most European activated sludge systems is between 4 and 14 hours (Johnson and Sumpter, 
2001) compared with a trickling filter which might have a retention time of less than one 
hour. These longer retention times in the activated sludge system will give longer for 
biodegradation to take place and hence removal rates for EDCs will be better (Zeng et al., 
2013). For example, Korner et al. (2000) found 90% reduction in oestrogenic activity of 




Figure 8. Schematic of (A) a conventional wastewater treatment works, and (B) end-of-
pipeline additional (tertiary) and advanced treatments necessary to improve effluent to meet 
the Environmental Quality Standards of the EU Urban Wastewater Treatment Directive and 
the Water Framework Directive. The removal process describes the types of compounds 
that will be removed at the different treatment stages. 
 




































biodegradation because only 2.8% of the activity had adsorbed to the sludge.  
Tertiary treatments such as sand filtration and reed beds increase the surface area and the 
retention time of the effluent and allow bacteria to work for longer, thus ‘polishing’ the 
effluent further. Baynes et al. (2012) found roach exposed to activated sludge process 
treated effluent to have evidence of significant feminisation compared with the roach 
exposed to river water, but the effect was much reduced with the addition of sand filtration 
following the activated sludge process. 
There are two approaches for removing EDCs from tertiary treated wastewater; optimising 
existing treatment technologies or upgrading existing WwTW with new end-of-pipe 
technologies (Koh et al., 2008), and here we consider end-of-pipe technologies for 
upgrading existing works with an advanced treatment process. Unlike the tertiary treatments, 
advanced treatments tend to rely on physical or chemical treatments. 
2.1.4.3. Advanced wastewater treatment methods 
Advanced treatments include membranes, activated carbon filtration, the application of 
ozone, and advanced oxidative processes. Removal of EDCs by physical means (e.g. 
membranes and activated carbon filtration) does not lead to metabolites or by-products, 
unlike biological or oxidative processes, and removal efficiencies are therefore easier to 
evaluate (Liu et al., 2009b). 
Membrane bioreactors combine conventional activated sludge treatment with micro/ultra-
membrane separation and can produce higher quality effluent compared to conventional 
activated sludge treatment (Li et al., 2015). Trinh et al. (2012) examined the efficiency of a 
membrane bioreactor at removing trace organic chemical contaminants and found 97-100% 
removal rates for steroid hormones. However, pharmaceuticals such as carbamazepine, 
diazepam, diclofenac, fluoxetine, and trimethoprim were less effectively removed (24-47%), 
and this was believed to be because they were not readily biodegraded or adsorbed to 
particles. Similarly, Snyder et al. (2007) tested a membrane bioreactor for its efficiency to 
remove 18 endocrine disruptors and pharmaceuticals and found that some compounds were 
well removed whilst others were not. In fact, some compounds appeared to increase in 
concentration in the membrane bioreactor. Snyder et al. (2007) further tested the membrane 
bioreactor followed by reverse osmosis (RO) and found the RO removed nearly all the 
compounds tested to below reporting levels. These membrane bioreactors have a lower 




Activated carbon is used as either GAC, as a packed bed filter, or as a powder added 
directly to the wastewater and subsequently filtered out. The powder form may not be 
retained by downstream sand filtration, and may therefore enter the environment (Prasse et 
al., 2015). Additionally, the powder becomes highly contaminated with time and disposal of 
this waste then also becomes an issue. Granular activated carbon is therefore more widely 
used and can remove a large variety of organic contaminants (Grover et al., 2011b; Snyder 
et al., 2007; Ternes et al., 2002). This GAC removal process is based solely on sorption with 
no formation of potentially reactive transformation products. However, Snyder et al. (2007) 
did find that water soluble compounds can break through the GAC much faster than tightly 
bound hydrophobic compounds. Similarly, Baynes et al. (2012) found good removal of 
steroid oestrogens following a 6-month exposure period of roach to GAC effluent as 
indicated by total removal of intersex induction in fish, but did find elevated EE2 
concentrations in some of the final samples, suggesting GAC saturation and subsequent 
breakthrough of the chemical into the effluent.  
Ozone has been shown to be an effective means of oxidising trace organic contaminants 
while also providing effective disinfection (Snyder et al., 2006). Giebner et al. (2018) used 
the YES to check for removal efficiency of oestrogenic activity and found 18.9% receptor 
activation after secondary treatment and this reduced to 3.2% with ozone treatment and 
2.9% with GAC treatment. Giebner et al. also measured androgenic activity using the yeast 
androgen screen (YAS) and found that there was almost total removal of activity following 
secondary treatment; receptor activation was 2.2%. Removal rates for anti-androgenic 
activity were not described as no activity was seen in primary treated samples. 
Ozonation can remove >90% of oestrogenic activity and 78% of anti-androgenic activity 
(Stalter et al., 2011), however, the resultant oxidation products can be more toxic to biota. 
For example, Rosal et al. (2009) found that the ozonation of clofibric acid produced oxidation 
products that were more toxic to Daphnia magna due to the formation of open-ring by-
products. Furthermore, Prasse et al. (2012) found the oxidation product of the antiviral drug 
acyclovir to be toxic to the bacteria Vibrio fischeri, and following 14 days of activated sludge 
treatment only 40% of this toxic product was removed. Magdeburg et al. (2012) tested 
ozonated effluent on five different invertebrate species and the results also indicated the 
formation of adverse oxidation products with a tendency towards increased toxicity in three 
of the species. The toxic effects of ozonation products have, however, been shown to be 
removed or detoxified by downstream sand filtration; based on studies using invertebrate 
species (Magdeburg et al., 2012) and rainbow trout (Magdeburg et al., 2014) as 
bioindicators. Similarly, Giebner et al. (2018) found that ozone-induced mutagenicity seen in 
the Ames test could be removed by a post-ozonation filtration step.  
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Similar to ozonation, advanced oxidation processes are based on the in situ generation of a 
powerful oxidising agent such as hydroxy-radicals. The generation of hydroxy-radicals by 
means of various chemical, photochemical, sonochemical, or electrochemical reactions 
leads to effective removal of chemicals of environmental concern, but also leads to the 
formation of oxidation products that may be more toxic (reviewed by Oturan and Aaron, 
2014).  
2.1.5. UK Endocrine Disrupting Chemicals National Demonstration Programme: 
assessment of the performance of WwTW in removing oestrogenic substances 
The Environment Agency, in collaboration with the government and the UK water industry, 
developed an Endocrine Disruption Demonstration Programme (EDDP) to evaluate different 
wastewater treatment plant processes for the removal of endocrine disruption. The 
programme considered the current wastewater treatment technologies for removing steroids 
from effluent and conducted both pilot-scale (GAC, Cl2 and ozone) and full-scale 
demonstration trials of promising advanced treatment technologies (Butwell et al., 2010; 
Gross-Sorokin et al., 2006; UKWIR, 2009). One of the test sites chosen for demonstrating a 
full-scale advanced wastewater treatment was Swindon WwTW (Rodbourne, Wiltshire, UK) 
that serves a population of approximately 180,000. The River Ray is in the non-tidal area of 
the upper River Thames catchment and the main discharge into the river comes from 
Swindon WwTW.  Due to the small size of the river, there is limited dilution of the effluent on 
entering the River Ray and in mid-summer approximately 80% of the flow is effluent at the 
point of discharge (Balaam et al., 2010). Furthermore, even 11 km downstream of the point 
of discharge just above the confluence of the River Ray with the River Thames, 
approximately 65% of the flow is effluent. 
Prior to the upgrade as part of the Demonstration Program, the Swindon WwTW consisted of 
primary treatment; screening followed by settlement, and secondary treatment; activated 
sludge processing and final settlement.  As part of this demonstration program, the Swindon 
WwTW was chosen for investigation into the efficacy of an advanced treatment step; the 
installation of a full-scale GAC plant, to extend the existing conventional treatment line, was 
implemented to investigate the technology’s ability to reduce concentrations of EDCs being 
released into the environment. In total, the plant used 1,900 m3 of GAC (Norit, Glasgow, 
UK), and had the following properties: 0.50 g/ml apparent density, 1.0 mm effective size, 920 
mg/g iodine number (Grover et al., 2011b). 
2.1.6. Endocrine sensitive endpoints and biomarkers of endocrine disruption in fish 
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Vitellogenin is present in high concentrations in the plasma of sexually mature female fish 
(Sumpter and Jobling, 1995). Vitellogenin is produced in the liver in response to oestrogens 
from the ovaries. Under normal circumstances, VTG concentrations in male fish are either 
undetectable or low (about 10,000-100,000 times lower than typical female concentrations; 
Ankley and Johnson, 2004). However, when male fish are exposed to oestrogenic 
substances, they are capable of producing a large amount of VTG, and blood concentrations 
can reach values similar to those in females. Thus, VTG induction in male fish is commonly 
used as a specific biomarker for the detection of oestrogenic endocrine disruptors in the 
environment, and also in OECD tests (OECD, 2018a; b) of suspected oestrogenic chemicals 
(Jobling et al., 1996). 
The simultaneous occurrence of male and female reproductive stages in the same gonad at 
the same time in teleost fish is atypical (Bahamonde et al., 2013) and is referred to as 
‘intersex’, and the presence of oocytes in testicular tissue is termed ‘ovotestes’. Sexual 
differentiation involves gonadogenesis (development of gonads and ducts) and 
gametogenesis (development of germ cells). Fish (and other animals) are most susceptible 
to perturbation during early life (Gimeno et al., 1996). Both gametogenesis and 
gonadogenesis can be altered by exposure to sex steroids and sex steroid mimics during 
development (Jobling et al., 1998), and the presence of ovotestes and/or an ovarian duct 
(cavity) in male fish are used as indicators of exposure to EDCs. It is not possible to alter 
gonadogenesis in adulthood, and the presence of an ovarian cavity in a male fish is an 
indication of exposure during development rather than adulthood (Jobling et al., 1998).  
Severely intersex fish (those with many oocytes in the testes) have been reported to have 
reduced fertility and fecundity (Fuzzen et al., 2015; Harris et al., 2011; Jobling et al., 2002b; 
Thorpe et al., 2009). Egg counts give an indication of fecundity, important as changes in 
fecundity could also lead to population level effects. This is especially significant for short 
lived species, as was observed by Kidd et al. (2007) when a whole lake exposure of FHM to 
EE2 impacted on gonadal development (intersex in males and altered oogenesis in females) 
and resulted in near extinction of this species from the lake. 
Secondary sexual characteristics are features that appear at sexual maturity and distinguish 
the two sexes of a species. The development of SSCs, including external genitalia, depends 
on whether the gonad differentiates into a testis or ovary, and the expression of the male 
SSCs in fish is under the control of the AR (Borg, 1994). Several SSCs are responsive to 
androgens, and monitoring for changes in SSCs is the basis of some fish tests for assessing 
chemicals for (anti-)androgenic activity; examples are gonapodial development in mosquito 
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fish (Howell and Denton, 1989), papillary process development in medaka (Seki et al., 
2006), and tubercle number and size of fatpad in FHM (Ankley et al., 2001).  
For my research outlined in this chapter, I have investigated endocrine disruption in two test 
species, namely the UK native roach (Rutilus rutilus), which is frequently found across 
Europe in effluent impacted rivers, and the FHM (Pimephales promelas), a North American 
species routinely used in regulatory testing for investigating possible EDCs. The following 
sections provide more details about these two species, their life histories, and specific 
endocrine sensitive endpoints and biomarkers.    
2.1.7. Test species 
Roach 
The roach is a slow growing and long-lived freshwater species and takes a relatively long 
time to sexual maturity (2–3 years for males and 3-4 years for females; Epler et al., 2005). 
For both males and females, the sexual maturation rate is also highly dependent on growth 
(Hamilton et al., 2015).  In addition to fish size, environmental conditions can influence the 
time roach take to reach sexual maturity (Paull et al., 2008). In most cyprinid species, 
including roach, the predominant cue for the annual rhythm of reproduction is a combination 
of annual photoperiod and/or temperature, and also social interactions (Jalabert, 2005). 
Roach typically spawn April-June, stimulated by an increase in day length and an increase in 
water temperature to above 12 oC (Paull et al., 2008).  
As highlighted above (Section 2.1.1), in the UK the majority of investigations of endocrine 
disruption in wild fish have focused on roach, involving assessments for intersexuality and 
VTG induction (for example, Baynes et al., 2012; Hamilton et al., 2015; Jobling et al., 1998; 
Tyler et al., 2007). The roach has proved a useful model for examining the effects of WwTW 
effluent on wild fish living in impacted rivers. However, roach are a relatively large (15-25 
cm; Geraudie et al., 2010) and slow maturing species that breeds only once a year, and the 
species lacks sexually dimorphic traits. It therefore has limited utility as a laboratory test 
species.   
Fathead minnow 
The FHM is a member of the Cyprinidae family with a broad distribution across North 
America. FHM males are larger than the female (3-5 g compared with 2-3 g, respectively) 
and when reproductively active, the male exhibits several SSCs (e.g. nuptial tubercles and 
dorsal fatpad; Smith and Murphy, 1974). Under optimal conditions the FHM reach maturity 
within 4-5 months post hatch, and depending on the water temperature and photoperiod, 
can spawn continuously for several months.  
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The FHM is extensively used both for regulatory testing and research, especially in North 
America (Ankley and Villeneuve, 2006), and along with the zebrafish is among the most 
widely used fish species for testing endocrine disrupting effects (Holbech et al., 2012). For 
example, the FHM is the recommended fish species in the OECD Fish Short Term 
Reproduction Assay (OECD, 2018b) and one of three fish species that can be used in the 
OECD 21-Day Fish Test; A Short-Term Screening for Oestrogenic and Androgenic Activity, 
and Aromatase Inhibition (OECD, 2018a). 
Several endpoints are responsive to oestrogens (VTG, sex-steroid production, decreased 
nuptial tubercles counts in males, delayed maturation and decreased fecundity and fertility) 
and responsive to (anti-)androgens (SSCs – nuptial tubercle growth, alterations in size of the 
dorsal fatpad, alterations in body shape, colouration and breeding behaviours). Some of 
these are short-term transient effects that the FHM is able to recover from once the 
oestrogen is no longer present (e.g. VTG induction).  
2.1.8. The aim of Chapter 2 
The aim of this chapter was to determine the extent of endocrine disruption in fish exposed 
to a WwTWs effluent before and after the addition of an advanced water treatment process; 
GAC. Two different approaches were used to investigate the impacts of the conventional 
and advanced treatment processes on well characterised markers of endocrine disruption in 
fish, namely the occurrence of intersexuality (oocytes in testicular tissue and/or feminised 
sperm ducts) in male fish, VTG induction in male fish, and disruption to reproductive output 
and SSCs. The first approach used short-term laboratory studies using the OECD test 
species, FHM, where the fish were directly exposed to effluent under controlled laboratory 
conditions. The second approach was chosen due to a wealth of historical data being 
available for the roach species, including roach from the River Ray, where the wild fish are 
continuously exposed to effluent in the field under environmental conditions. By using both 
types of studies, lab-based for short-term effects and field-based for realistic long-term 
effects, I was able to investigate whether the GAC was actually improving the quality of 
effluent enough to improve the reproductive health of the fish living in the river. 
For the laboratory studies using FHM, flow-through exposure studies were carried out with 
final effluent from the WwTW, both pre- and post-GAC, to determine the efficacy of GAC at 
removing endocrine-disrupting activity. At Brunel University London, the effluent was tested 
using two well documented and sensitive in vivo tests of endocrine disruption in fish using 
the FHM; (1) the VTG Test to measure the induction of VTG in male fish (Thorpe et al., 
2008), and (2) the Pair Breeding Test to measure the development of SSCs (tubercle 
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number and Fatpad Index (FPI)) and the cumulative egg production (an assessment of 
impacts on reproductive success) (Thorpe et al., 2009).  
For the assessment of the GAC addition on wild fish living in the river, wild roach were 
collected from the River Ray to see if field-based wild fish analysis supported the results 
found in our lab-based studies. In 2013 roach were collected downstream of the Swindon 
WwTW 5 years after the upgrade of the works with the GAC, and the results were compared 
with historical data from roach sampled from the River Ray in 2005 (prior to GAC addition). 
The effects of the advanced GAC treatment on the fish plasma VTG concentrations and the 
fish gonad histopathology were examined and compared with the 2005 dataset. In both 2005 
and 2013, bile samples were also collected from the fish for the measurement of oestrogenic 
activity and anti-androgenic activity using yeast-based assays; the YES and yeast anti-
androgen screen (AYAS), to look for changes in the amount of activity present. 
 
2.2. Materials and methods 
2.2.1. Ethics statement 
All fish studies that contributed data to this thesis were carried out in strict accordance with 
the recommendations of the United Kingdom Animals (Scientific Procedures) Act 1986. Fish 
were deeply anesthetised (complete loss of response to manual stimulation) prior to blood 
collection and were sacrificed either by destruction of the brain or trans-spinal severance. All 
efforts were made to minimise distress to the animals. 
For the fish studies carried out at Brunel University London, these were done under both 
Project and Personnel Licences granted by the UK Home Office, and in accordance with 
Brunel University London’s ethical policies. 
2.2.2. Laboratory studies - Fathead minnow flow-through exposure studies to WwTW 
effluents 
2.2.2.1. Experimental design 
The Swindon WwTW effluent was tested in two different fish tests both before and after the 
addition of the advanced GAC treatment at the Swindon WwTW (Four experiments in total; 
Experiments 1 and 2, 21-day VTG Tests, and Experiments 3 and 4, Pair-Breeding Tests). 
Tests on the same type of effluent were run simultaneously in two adjacent rooms due to 
space requirements (the standard effluent was tested from 28 May to 18 June 2009 whilst 
the GAC effluent was tested between 16 March to 6 April 2009). The experimental designs 
for the two tests are illustrated in Figure 9 and Appendix Figures A 1 and A 2. 
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For both the VTG Test and the Pair Breeding Test, fish were held in flow-through aquaria 
which contained various dilutions of the effluent under test (standard effluent at 100%, 50% 
and 25% dilution, and GAC at 100% only) together with a positive control (10 ng/L EE2 for 
the VTG Test and 20 ng/L for the Pair Breeding Test) and a ‘clean’ dilution water control 
(control) (see Appendix Figures A 3 and A 4).  
For the VTG Tests (Experiments 1 (standard effluent) and 2 (GAC effluent)) a total of 160 
FHMs were used (Experiment 1; 96 fish and Experiment 2; 64 fish). Two tanks of 8 male fish 
per treatment (n=8 males in each of 2 replicate tanks) were set up and an additional tank of 
16 male fish (in 2 tanks) were set up to determine baseline reproductive physiology. All fish 
were acclimated to the flow-through for 7 days. After 7 days acclimation, the 16 baseline fish 
were sampled (see Section 2.2.2.7). The fish in the treatment tanks were then exposed to 
dilution water (control), 10 ng/L EE2 (+ve control) or effluent (standard effluent at 100%, 
50% and 25%, and GAC effluent at 100%). All experimental fish (80 for standard effluent 
exposure and 48 for GAC effluent exposure) were sampled at the end of the exposure 
period. 
To initiate each Pair Breeding Test (Experiments 3 (standard effluent) and 4 (GAC effluent)), 
pairs of male and female FHMs were placed into eight replicate glass aquaria per treatment; 
total of 16 fish per treatment (Experiment 3; 80 fish and Experiment 4; 48 fish). The fish were 
acclimated to the test conditions for 14 days and the spawning substrates were checked 
daily at 11 am ± 1 hr to confirm spawning activity. At the end of this acclimation, all fish had 
fully acclimated to the test conditions and had spawned at least once. The egg number was 
then determined daily for each pair of fish, over a pre-exposure period of 3 weeks, to provide 
pair-specific data for egg production. Dosing of control, 20 ng/L EE2 or effluent (standard 
effluent at 100%, 50% and 25% and GAC at 100%) was then initiated and the number of 
eggs spawned by each pair of fish determined daily for the 3-week exposure period. All 





Figure 9. Schematic showing the timescale and endpoints for the fathead minnow exposure studies. (A) the Vitellogenin Test (Experiments 1 
and 2), and (B) the Pair Breeding Test (Experiments 3 and 4). SSCs; Secondary sexual characteristics
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2.2.2.2. Experimental animals 
Fathead minnow used in each experiment were bred from stocks maintained at the aquatic 
facility at Brunel University London, and were kept according to the United Kingdom Animals 
(Scientific Procedures) Act 1986 guidelines. The ages and average weights of the fish at the 
start of the baseline period (VTG Test) and pairing up period (Pair Breeding Test) are shown 
in Table 1. 
 
Table 1. Age and average weight of fathead minnows at the start of the Vitellogenin Test and 
Pair Breeding Test exposures to standard and GAC treated effluent. 
Effluent Vitellogenin Test  Pair Breeding Testing 
Standard 
Experiment 1: 
7 months post hatch  
(average male weight 2.6 g) 
Experiment 3: 
7 months post hatch  
(average male weight 3.1 g and 
female weight 2.5 g) 
GAC 
Experiment 2: 
11 months post hatch  
(average male weight 3.7 g) 
Experiment 4: 
11 months post hatch  
(average male weight 5.3 g and 
female weight 3.0 g). 
 
 
For the VTG Test, only male fish were selected for the exposure study instead of a mixture 
of males and females as previously reported (Thorpe et al., 2008), to minimise the possible 
influence of female fish-derived oestrogenic steroids as a confounding factor in the 
assessment of oestrogenic activity of the effluent. This also reduced the number of fish 
utilised, as female fish were not used for the VTG endpoint assessment.  
Three weeks prior to the onset of each experiment, sexually maturing males (onset of the 
development of the SSCs; nuptial tubercles and a dorsal fatpad) and females (presence of 
an ovipositor) were selected and separated into single sex tanks to prevent spawning 
activity. During this 3-week acclimation period, the fish were held in a recirculation system 
and were acclimated to clean dechlorinated water at 25 ± 1 oC, with a 16 h light: 8 h dark 
photoperiod. The fish were fed adult Gamma irradiated frozen brine shrimp twice daily 
supplemented with Tetramin Tropical Flake food once daily, ad libitum during this period. 
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During pre- and exposure periods, the fish were fed with adult Gamma irradiated frozen 
brine shrimp (VTG Test fish were fed 50mg/g fish and Pair Breeding Test fish were fed 0.25 
g/tank of 2 fish) once daily and were supplemented with Tetramin Tropical Flake food once 
daily. 
2.2.2.3. Water supply and test apparatus 
The supply of water to the flow-through laboratory dosing system was dechlorinated tap 
water (5 and 10 µm carbon-filtered). In all experiments, the tanks were gently aerated at the 
surface, using a glass pipette, to maintain dissolved oxygen concentrations at >70% of the 
air saturation value. 
Water temperatures were monitored daily while pH levels were checked twice weekly. 
Ammonia, nitrite, and nitrate were monitored on a daily basis using test strips (Precision 
Laboratories, Moulton, UK). Dilution water and test chemical flow rates were checked twice 
weekly. During the tests, flow rates (40 ml/min for VTG Tests and 20 ml/min for Pair 
Breeding Tests) to the individual aquaria provided >75% replacement in a 12-hour period. 
(N.B. this flow rate was higher and the feed rate lower than that suggested in the 
Demonstration Programme protocol because in our own pilot studies, lower flow rates and 
higher feed rates as specified in the protocol caused accumulation of uneaten food in the 
aquaria and this led to elevated nitrite and ammonia levels and death of the fish). 
For the VTG Test, 20 L tanks each held 8 male fish. For the Pair Breeding Test, one male 
and one female were housed in 8 L tanks together with a spawning chamber that consisted 
of a PVC half gutter (80 mm wide 110 mm diameter) on top of a glass tray (130 x 110 x 30 
mm (length x width x depth)) containing a 0.5 cm2 stainless steel mesh (Figure 10). This 





Figure 10. The spawning chamber; PVC half guttering inserted on top of a glass tray 
containing a stainless steel mesh. 
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2.2.2.4. Wastewater treatment works effluents 
Batches of the standard effluent were delivered twice weekly (6 batches of effluent in total) 
whilst batches of GAC effluent were delivered once weekly (3 batches in total). All effluent 
batches were delivered using an industrial stainless steel tanker, collected at the WwTW and 
immediately transported to the testing facility. On arrival at Brunel University London 
(between 10.30-11.30 am), the effluent was transferred into a fully enclosed stainless steel 
holding tank and chilled to between 8 and 10 oC. The effluent was pumped via a peristaltic 
pump from the storage tank to the test aquaria via a glass holding tank, where it was first 
heated to 18 oC. Tank heaters were then used to raise the temperature in the test aquaria to 
25 oC. The pH of each batch of effluent was checked on arrival. The pH values ranged from 
7.8 to 8.0 and dissolved oxygen concentrations were above 80%. The effluent storage 
system was fully drained and flushed with water immediately prior to the delivery of each 
batch.  
2.2.2.5. Oestrogen positive controls 
For the oestrogen positive controls, EE2 (98% purity) was purchased from Sigma-Aldrich 
Company Ltd., Gillingham, UK. Solvent-free stock solutions were prepared twice a week by 
adding 1 mL of a concentrated stock solution of EE2 (prepared at 20 mg/L in high-
performance liquid chromatography (HPLC) grade acetone; Fisher Scientific UK Ltd., 
Loughborough, UK) to a 10 L glass vessel. After evaporation of the acetone, 10 L of dilution 
water was added and the solution was stirred overnight on a magnetic stirrer. The solvent-
free stock was then dosed to the glass mixing vessels, where it was mixed with the dilution 
water to provide a nominal test concentration of 10 ng/L (VTG tanks) and 20 ng/L (pair 
breeding tanks). 
2.2.2.6. Measurement of oestrogenic activity and concentrations of steroid oestrogens 
On days 7, 14 and 21, water samples were collected using silanised glassware and 
transferred to amber bottles containing preservative (Standing Committee of Analysts, 
2008). From each VTG Test (Experiments 1 and 2) tank a total of 4.5 L water sample was 
collected, and a composite 4.5 L water sample was collected from the pair breeding tanks 
(Experiments 3 and 4). Each batch of effluent delivered to the laboratory was also sampled 
at the collection point in Swindon, on arrival at the lab and from the effluent storage tank at 
the end of each batch.  All samples were immediately couriered to the analytical lab 
(Thames Water, Reading, UK) to be solid phase extracted on the day of collection followed 
by analytical determination of steroid oestrogens (E1, E2 and EE2 analysed by liquid 
chromatography with tandem mass spectrometry (LC-MS/MS); Standing Committee of 
Analysts, 2008). For the total oestrogenic activity (analysed by Centre for Environment, 
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Fisheries and Aquaculture Science, Weymouth, UK), the E2 equivalent concentration 
(E2EQ) was calculated using the YES (Thomas et al., 2001). 
2.2.2.7. Fish sampling 
At the end of the study, all fish in all tanks were sacrificed according to UK Home Office 
regulations. Fish were anaesthetised with ethyl 3-aminobenzoate methanesulfonate salt 
(MS222; Sigma-Aldrich Company Ltd.) at 500 mg/L and buffered with 1M NaOH to pH 7.4. 
Whilst under anaesthetic, blood was collected from the caudal peduncle using heparinised 
capillary tubes and transferred to ice-cold 1.5 mL microfuge tubes (Alpha Laboratories, 
Eastleigh, UK), each containing one drop (~5 µL) of aprotinin (protease inhibitor; MP 
Biomedicals Germany GmbH, Eschwege, Germany). Following blood collection, the fish 
were killed by the destruction of the brain. Microfuge tubes were centrifuged (7000 × g; 5 
min, 4 oC) and the plasma was removed and stored at −80 oC until required for analysis of 
VTG. Fork lengths and wet body weights of the fish were recorded to the nearest 1 mm and 
0.01 g, respectively, and the condition factor derived by expressing the cube of the fork fish 
length as a function of the wet body weight. The gonads were removed, wet weighed to the 
nearest 0.001 g and the Gonadosomatic Index (GSI) derived by expressing the gonad 
weight as a percentage of the total body weight. The numbers of tubercles on the snout of 
each fish were recorded and the dorsal fatpad removed and wet weighed to the nearest 
0.001 g.  
2.2.2.8. Vitellogenin analysis 
Plasma VTG concentrations were measured by using a commercially available FHM VTG 
ELISA kit (Biosense Laboratories AS, Bergen, Norway). The ELISA utilises specific binding 
between antibodies and VTG to quantify VTG in plasma samples from FHM. The 
manufacturer’s protocol was followed and VTG in standards (0.05-50 ng/ml) and samples 
(diluted to 1:50, 1:5,000 and 1:500,000) were incubated for 1.5 hr at room temperature (20-
25 oC) in microplate wells that come pre-coated with a specific capture antibody. Between 
this and all subsequent incubations, plates were washed with a phosphate buffered saline 
(PBS; pH 7.3) / 0.05% Tween-20 wash buffer using a WellWash (Thermo Scientific, 
ThermoFisher Scientific, Hemel Hempstead, UK). The plates were then incubated for 30 
mins at room temperature, with a VTG-specific detecting antibody labelled with the enzyme 
horseradish peroxidase, that creates a sandwich of VTG and antibody. The enzyme activity 
was then determined by addition of a chromogenic substrate (3,3',5,5'-Tetramethylbenzidine) 
that gave a coloured product measured at 450 nm using a plate reader (Molecular Devices, 
San Jose, USA). As the colour intensity was directly proportional to the amount of VTG 
present, regression analysis using a log-log plot of the VTG standard data was used to 
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calculate the concentrations of VTG, after multiplying by the dilution factor to determine the 
concentration in the original samples. 
In total 7 assays were carried out (5 assays standard effluent and 2 assays GAC effluent), 
and the DL was 5 ng/ml and the inter-assay variability was 17%.  
2.2.2.9. Statistical analysis 
Where concentrations were reported at below the DL, for statistical purposes half the DL 
was used in calculations. All biological results are expressed as a mean ± standard 
deviation. To investigate effects of the effluent exposure and of the positive control on body 
weight, length, GSI, SSCs and VTG concentrations, data were compared to the control using 
GraphPad Prism 8 version 8.0.1 (GraphPad Software, La Jolla California USA; 
www.graphpad.com). Data were tested using the D'Agostino and Pearson test, and where 
the assumptions of normality and homogeneity of variance were met, these were analysed 
using one-way ANOVA followed by Dunnett's multiple comparisons test (F value with 
degrees of freedom in subscript). Where n was too small or data failed to meet these 
assumptions, analysis was carried out using the Kruskal-Wallis test followed by Dunn’s 
multiple comparisons test (H value with sample sizes (n)). To investigate the effects on 
reproductive activity, the mean cumulative distribution of the egg production data over the 
21-day pre-exposure and exposure periods were compared for each treatment group using 
the Kolmogorov-Smirnov test (D value with sample sizes (n)). Differences were considered 
significant if the p values were ≤0.05 (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
2.2.3. Field studies – wild roach collected from the River Ray downstream of the Swindon 
WwTW 
2.2.3.1. Site selection and fish sampling 
In 2005, prior to the GAC installation, 145 mature roach were collected downstream of the 
Swindon WwTW. Sampling sites were chosen along a 3 km section of the River Ray 
downstream from the point of discharge, from National Grid Reference: SU124866 at 
Sparcells to SU122873 at Moredon Bridge (Figure 11). The Environment Agency’s fisheries 
teams collected a total of 145 mature roach by electrofishing. Fish were collected mid-April 
to avoid the spawning season from late April to early June 2005. Fish were then taken to the 
Environment Agency’s National Fisheries Laboratory, Brampton, UK, and fish scales, 
plasma, gonads and bile were collected for processing. 
For the 2013 sampling, five years after the addition of the GAC treatment to the WwTW, two 
sites were chosen along the River Ray downstream from the point of discharge; Site 1 at 
National Grid Reference: SU124866 at Sparcells and Site 2 at SU122873 at Moredon Bridge 
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(Figure 11 and Figure 12). Power analysis indicated that a minimum sample size of 25 male 
fish (80% power) was required to determine if there was significant reduction in the 
incidence of intersex to baseline levels (0.5% of male fish; Geraudie et al., 2010) following 
the installation of the GAC.  
Mature roach were collected by electrofishing in collaboration with Hull International 
Fisheries Institute, University of Hull, UK (see Appendix A 5 and A 6). Twelve fish were 
collected from Site 1 and 44 from Site 2; a total of 56 fish. The fish were collected late 
November 2013 and were transported back to Brunel University London, Uxbridge, UK for 
processing. 
For Home Offices purposes, the fish were anaesthetised with neutrally buffered MS222 (500 
mg/L; Sigma-Aldrich Company Ltd.) and blood samples were collected from the caudal 
artery with a heparinised syringe. Following collection of the blood sample, the fish were 
killed by destruction of the brain. The blood was then transferred to Eppendorf tubes (Alpha 
Laboratories, Eastleigh, UK) containing one drop (~5 µL) of aprotinin (Sigma-Aldrich 
Company Ltd.), and samples were kept on ice until centrifugation at 12,000 g for 5 minutes. 
The plasma was pipetted to a fresh tube and immediately frozen on dry ice. The plasma 
samples were then transferred to -80 oC storage until ready for VTG analysis. 
Fork length and wet weight were measured, and the condition factor was calculated by 
expressing the cube of the length as a percentage of the weight. Scale samples were taken 
from each fish for age determination. 
For histopathological analysis and intersex determination, the gonads were dissected, and 
the macroscopic sex was determined by eye. The gonads were weighed, and the GSI was 
calculated by expressing the gonad weight as a percentage of the total weight less the 
gonad weight. The gonads were then fixed in Bouins (Sigma-Aldrich Company Ltd.) for 24 
hours and then stored in 70% industrial methylated spirits (IMS) until ready for tissue 
processing (histopathology). 
For the assessment of possible endocrine activity in the bile of wild roach, the gall bladder 
was also dissected, and these were placed in cryovials that was snap frozen in liquid 





Figure 11. Locations of the 2005 and 2013 fish sampling sites along the River Ray together 
with the location of the Swindon Wastewater Treatment Works (WwTW). The 2005 sampling 








Figure 12. Locations of the two 2013 sampling sites; Site 1, National Grid Reference: 




2.2.3.2. Analysis of fish material 
2.2.3.2.1. Fish aging 
The fish were aged by counting the number of annuli (winter checks where the circuli are 
closely spaced) on each fish scale using a microfiche reader (Mann, 1973). 
2.2.3.2.2. Gonadal analyses 
After histological fixation, each pair of ovaries or testes was cut into three parts (anterior, 
median and posterior) using a microtome blade (MB35, Thermo Scientific, ThermoFisher 
Scientific), and from each part a 3-5 mm portion of gonad was taken and placed into a 
biopsy cassette (Histosette II, Simport™, Fisher Scientific).  The cassettes were then 
processed using a Leica tissue processor (model TP1020, Leica Biosystems (UK) Ltd., 
Milton Keynes, UK), to dehydrate the tissues and impregnate them with paraffin wax (W1, 
Thermo Scientific, ThermoFisher Scientific). The processor program was set with the 
following timings:  
Step no. Treatment Purpose Time (hours) 
1 70% IMS Dehydration 3 
2 90% IMS Dehydration 2.5 
3 95% IMS Dehydration 1.5 
4 100% IMS Dehydration 1.5 
5 100% IMS Dehydration 1.5 
6 100% IMS Dehydration 1.5 
7 100% IMS Dehydration 1.5 
8 Histoclear Clearing 1.5 
9 Histoclear Clearing 1.5 
10 Histoclear Clearing 1.5 
11 Wax Wax infiltration 1.25 
12 Wax Wax infiltration 1.25 
 
Following completion of the processing, the tissue samples were embedded in wax blocks 
(total of 6 pieces of gonad tissue per fish). Wax embedded blocks were sectioned at 3 µm on 
a rotary microtome (model RM2235, Leica Biosystems (UK) Ltd.), floated out on a water 
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bath (Electrothermal, Cole Parmer, Stone, UK) and mounted on PolysineTM slides (Menzel 
Gläser, Thermo Scientific, ThermoFisher Scientific). The slides were dried overnight on a 
slide drying bench (Electrothermal), and were then stained with Gurr haematoxylin (VWR, 
East Grinstead, UK) and 1% eosin aqueous (Pioneer Research Chemicals Ltd., Colchester, 
UK) using an automated stainer (Stainmate, Thermo Scientific, ThermoFisher Scientific) with 






1 Histoclear Dissolves wax 15 
2 100% IMS Hydration 2 
3 90% IMS Hydration 2 
4 70% IMS Hydration 2 
5 Tap water (running) Rinse 2 
6 Gurr haematoxylin Stains cell nuclei blue 10 
7 Tap water (running) Remove excess 10 
8 Acid / IMS Dechlorination 20 secs 
9 Tap water (running) Rinse 20 secs 
10 LiCO3 Salt 20 secs 
11 Tap water (running) Rinse 20 secs 
12 1% eosin (aqueous) Stains cytoplasm pink 20 secs 
13 Tap water (running) Remove excess 5 
14 70% IMS Dehydration 2 
15 90% IMS Dehydration 2 
16 100% IMS Dehydration 5 
17 Histoclear Remove IMS, binding agent 5 
 
Following staining, slides were sealed with Histomount (National Diagnostics, Hessle, UK) 




For each fish sampled, all of the 6 sections were examined by light microscopy and the sex 
of each fish was determined (Nolan et al., 2001). As several stages of gametogenesis 
coexist at a given time, the preponderant stage occurring inside the gonad was used to 
characterise the stage of development (Table 2).  
For fish that looked predominantly male when the gametes were examined under light 
microscopy, the reproductive duct was also examined to see how many points of attachment 
there were; one point indicated a sperm duct (normal for males) whereas two points 
signifying an ovarian cavity terminating in an oviduct (normally only observed in females but 
also an indication of feminisation of male fish). The number of oocytes in the testes of 
intersex fish was counted microscopically, and each section was scored using an Intersex 
Index ranging from 0 (normal male testis) to 7 (100% ovarian tissue) (Jobling et al., 2006) 
(Table 3). The Intersex Index scores for each of the 6 sections were then averaged for each 
fish. 
Because the roach were sampled at different times of the year, the 2013 roach gonads were 
compared with roach caught from spring-fed Calverton fish farm in November, February, 
March and April to determine whether the gonadal maturity was as would be expected for 
the time of year of sampling. 
 
Table 2. Scoring systems used to derive stage of maturity based on Billard (1986) for male 
fish and Tyler and Sumpter (1996) for female fish. 
Sex Stage Cell type 
Male 
I Spermatagonia only 
II Mainly spermatagonia with <50% spermatocytes 
III Some spermatids but >50% spermatocytes 
IV Some spermatozoa but >50% spermatids 
V >50% spermatozoa 
VI Spent 
Female 
I Oogonia only 
II >50% primary oocytes (perinuclear and Balbiani body stage) 
III Some primary oocytes but >50% cortical alveoli stage 
IV >50% cortical alveoli and <50% vitellogenic 





Table 3. Scoring system used to determine the Intersex Index score for each section (from 




0 Normal male testis 
1 Multifocal ovotestis with 1–5 oocytes (usually singly) scattered 
among the testicular tissue 
2 Multifocal ovotestis, 6–20 oocytes often in small clusters scattered 
among the testicular tissue 
3 Multifocal ovotestis, 21–50 oocytes in clusters 
4 >50 and <100 oocytes. Section is usually multifocal and has the 
appearance of a mosaic of testicular and ovarian tissue 
5 
>100 oocytes, usually multifocal but could also be focal with 
clearly identifiable zones of ovarian and testicular tissue 
separated from the testicular tissue 
6 
>50 per cent of the gonadal tissue on the section is ovarian and is 
clearly separated from the testicular tissue by epithelial cells and 
phagocytic tissues 
7 100 per cent of gonadal tissue on the section is ovarian 
 
 
2.2.3.2.3. Vitellogenin analysis 
For the quantification of VTG in plasma samples collected in 2005, a carp VTG ELISA 
previously validated for use with roach (Tyler et al., 1996) was utilised with a DL of 35 ng/ml 
VTG (Tyler et al., 1999).  
For the quantification of plasma samples collected in 2013, a commercial carp VTG ELISA 
kit based on the assay developed by Tyler et al. (1999) was utilised (Biosense Laboratories 
AS, Bergen, Norway). The manufacturer’s protocol was followed and VTG in standards 
(0.24-250 ng/ml) and samples (diluted to 1:50, 1:5,000 and 1:500,000) were incubated with a 
series of antibodies and the enzyme activity was then determined by addition of a 
peroxidase substrate (o-phenylenediamine; OPD) that gave a coloured product measured at 
492 nm using a plate reader. Plasma VTG concentrations were calculated as described in 
Section 2.2.2.8. 




To determine comparability of VTG data between the two sampling occasions and methods, 
six plasma samples from the 2005 roach survey were reanalysed alongside the 2013 female 
plasma samples using the Biosense carp VTG ELISA kit. The Biosense commercial kit used 
to analyse the samples collected in 2013 was based on the pre-commercialisation method 
by Tyler et al. (1999) that was also used to analyse the samples collected in 2005. These six 
2005 samples were chosen to reflect the range of concentrations recorded in 2005. 
The 2013 male and female plasma samples were analysed at different times and therefore a 
subsample of nine male plasma samples from the 2013 sampling were also reanalysed 
along with the female plasma samples from the 2013 sampling in the same Biosense carp 
VTG ELISA assay. 
2.2.3.2.4. Bile analysis 
All chemicals were purchase from Sigma-Aldrich Company Ltd. unless stated otherwise. 
2.2.3.2.4.1. Enzymatic hydrolysis of bile samples 
For the analysis of the roach bile collected in 2005, the deconjugation, solid phase extraction 
and analysis for oestrogenic activity and anti-androgenic activity were carried out at the 
University of Sussex, Brighton, UK, according to Gibson et al. (2005). In brief, enzymatic 
hydrolysis of the samples used glucuronidase type VII-A from E. coli (1000 U/ml) and 
sulphatase type VI from A. aerogenes (2 U/ml). The activity of individual enzymes was 
tested with standard substrates; nitrophenol glucuronide and nitrophenol sulphate (10 µg 
substrate in 100 µl water). The hydrolysis took place in 0.1 M phosphate buffer (0.2 M 
sodium dihydrogen orthophosphate: 0.2 M disodium hydrogen orthophosphate: water 
(43.85:6.15:50.00, v/v/v) at pH 6.0) for 16 hours at 37 oC and the reactions were stopped 
with 90 µl glacial acetic acid. 
Prior to analysing the bile samples in 2013, the efficiency of the glucuronidase type VII-A 
from E. coli and sulphatase type VI from A. aerogenes was rechecked using conjugated 
oestrogens; β-oestradiol 17-(β-D-glucuronide) sodium salt (E2-G; Santa Cruz Biotechnology, 
Inc, Dallas, USA) and β-oestradiol 3-sulphate sodium salt (E2-S). The deconjugation was 
specific for the glucuronidase but there was no deconjugation with the sulphatase (see 
Appendix Figure A 7). To rectify this, the method was modified by carrying out the enzymatic 
hydrolysis of the bile with β-glucuronidase type HP-2 from H. pomatia (Sigma-Aldrich 
Company Ltd.; ≥100,000 units/ml with ≤7,500 units/ml sulphatase). For the 2013 samples, 
the hydrolysis took place using 10 µl H. pomatia ‘snail juice’ in 990 µl 0.1M phosphate buffer 
for 16 hours at 37 oC, and the reaction was stopped with 90 µl glacial acetic acid. The 
deconjugation rate with the ‘snail juice’ was 103.2% (ranging from 101 to 107%) with the E2-
G and 23.7% (ranging from 20.5 to 29.4%) with the E2-S.  
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2.2.3.2.4.2. Solid phase extraction 
In 2005, OASIS HLB cartridges (6 cc, 150 mg; Waters, Milford, MA, USA) were used to 
extract hydrolysed bile extract. The hydrolysed bile was diluted with the addition of 2 ml 
HPLC grade water (3 ml total). Cartridges were primed with 5ml methanol (meOH) followed 
by 5 ml HPLC water acidified with 1% acetic acid and the samples were then loaded onto 
cartridges and washed through with 2 ml HPLC water. After drying the cartridges under 
vacuum for 30 mins, samples were eluted sequentially into glass conical tubes (Corning Life 
Sciences, Tewksbury, USA), using 5 ml meOH and 3 ml acetonitrile (HPLC grade solvents 
from Fisher Scientific). Samples were then evaporated under a flow of nitrogen, 
reconstituted in 500 µl ethanol (etOH), and stored at 4 oC until analysis using recombinant 
yeast screens. 
For the 2013 samples, the same solid phase cartridges and method were followed although 
the cartridges were eluted with 5 ml meOH, 3 ml dichloromethane and 3 ml hexane (HPLC 
grade solvents from Fisher Scientific) to improve extraction efficiency of anti-androgens 
(Rostkowski et al., 2011). The SPE recovery rate for the bile samples hydrolysed in 2013 
was 76.3% (ranging from 70.7 to 79.9%) for the E2 spike and 67.3% (ranging from 64 to 
71%) for the flutamide spike. 
2.2.3.2.4.3. Recombinant yeast oestrogen and anti-androgen screens 
The recombinant hER and hAR yeast strains were developed by Glaxo Wellcome. The 
standard YES and AYAS were used to determine the amount of oestrogenic and anti-
androgenic activity in the bile samples collected in 2005, and have been described 
previously (YES, Routledge and Sumpter, 1996; AYAS, Sohoni and Sumpter, 1998). 
These yeast assays were modified for analysis of the 2013 bile extracts, as any toxic activity 
in the sample can lead to false positive activity in the AYAS using the standard method 
(discussed further in Chapters 3 and 4).  
2.2.3.2.4.4. Modified recombinant yeast oestrogen and anti-androgen screen procedure 
2.2.3.2.4.4.1. Preparation of medium and buffers 
10x Synthetic defined medium (10x SD-medium): The 10x SD-medium was prepared by 
dissolving 67 g yeast nitrogen base without amino acids (BD Difco, Wokingham, UK) and 
200 g glucose in HPLC grade water and adjusting the final volume to 1 L. The solution was 
then sterilised by filtration (0.2 µm, cellulose acetate; Nalgene, Thermo Scientific, 
ThermoFisher Scientific) under sterile conditions and dispensed to polypropylene centrifuge 




10x Dropout medium (10x DO-medium): The 10x DO-medium was prepared by adding 2000 
mg L-Serine, 1000 mg L-Threonine, 750 mg L-Valine, 500 mg L-Leucine, 250 mg L-
Phenylalanine, 150 mg L-Isoleucine, 150 mg L-Tyrosine, 100 mg Adenine, 100 mg L-
Arginine,  500 mg L-Aspartic acid, 500 mg L-Glutamic acid, 100 mg L-Histidine-HCl, 150 mg 
L-Lysine-HCl, 100 mg L-Methionine to HPLC grade water and adjusting the final volume to 
0.5L. The solution was then sterilised by filtration (0.2 µm, cellulose acetate) under sterile 
conditions and dispensed to polypropylene centrifuge tubes. The aliquots were stored at ≤ -
18 oC for up to 12 months. 
20 mM Copper (II) sulphate (CuSO4): The CuSO4 solution was prepared by adding 0.1596 g 
CuSO4 to HPLC grade water and adjusting the final volume to 50 ml. The solution was then 
sterilised by passing through a syringe filter (0.2 µm, polyethersulfone; Whatman, GE 
Healthcare Life Sciences, Little Chalfont, UK) into a sterile glass bottle, under sterile 
conditions.  
Growth medium: Under sterile conditions, 5 ml 10 x SD-medium and 5 ml 10 x DO-medium 
were added to a glass bottle containing 40 ml sterile HPLC grade water.  
Exposure medium: The exposure medium was prepared on the day required by adding 125 
µl CuSO4 solution to 50 ml of growth medium. 
LacZ-buffer (Z-buffer): To 400 ml HPLC grade water, 8.05 g sodium phosphate dibasic, 2.75 
g monosodium phosphate, 0.375 g potassium chloride and 0.123 g magnesium sulphate 
were added, and the pH was adjusted to 7.0. The buffer was made up to 0.5 L and 
autoclaved at 121 oC for 15 min. 
10% SDS: 10 g sodium dodecyl sulphate was added to sterile HPLC grade water and 
stirred. This was made up to 100 ml and then transferred to a sterile glass bottle.  
Assay buffer (quantities for 1 plate): Just prior to use, 24 mg ortho-Nitrophenyl-β-galactoside 
(oNPG) was dissolved in 11.9 ml Z-buffer. Once in solution, 32 µl 2-mercaptoethanol and 
120 µl 10% SDS were added. 
2.2.3.2.4.4.2. Assay procedure 
Chemicals were serially diluted in etOH and 10 µl volumes were transferred to 96-well flat-
bottom plates (Sarstedt AG & Co, Nümbrecht, Germany) where the etOH was allowed to 
evaporate to dryness.  Then, 200 µl exposure medium containing yeast (final cell number of 




For the oestrogen screens, the positive control E2 was included in each assay (stock 
concentration at 2x10-7 M and serially diluted in etOH to achieve final concentrations from 10-
8 M to 4.88x10-12 M).  
The positive control, flutamide, was included in every AYAS (stock solution at 10-3 M and 
serially diluted in etOH to achieve final concentrations of 5 x 10-5 M to 2.44 x 10-8 M in the 
wells). For antagonistic screens, DHT at 2x10-9 M was also added to the medium prior to 
adding it to all wells.  
The plates were taped closed and shaken for 2 mins on a plate shaker. The plates were then 
incubated at 32 oC for 68 ± 1 hours. After the incubation period, the yeast cells were 
resuspended by shaking for 2 mins and then 50 µl of suspension was transferred to a new 
plate containing 50 µl growth medium (i.e. diluted by half). The plates were then shaken 
again for 2 mins before taking pre-lysis plate readings at 620 nm to determine yeast turbidity. 
The yeast cells were then lysed with 4 freeze/thaw cycles (4 mins on dry ice followed by 4 
mins at 42 oC) and finally shaken for 2 mins. Freshly made assay buffer was then added to 
each plate (100 µl per well) by reverse pipetting and the plates were transferred to a 37 oC 
incubator. The β-galactosidase (β-gal) in the cell lysate then caused the clear medium to 
turn yellow and plate readings were taken at 420 nm and 620 nm after 30, 60 and 90 mins 
incubation. The 90 min readings were used for all analyses. 
The half maximal effective concentration (EC50) was calculated using 4-parameter plot 
equations using SoftMax Pro version 5.0.1 (Molecular Devices Limited, Wokingham, UK); 
the concentration at which 50% of activity of the positive control, E2, was obtained. Similarly, 
the half maximal inhibitory concentration (IC50) was calculated as the concentration of 
flutamide required to produce a 50% inhibition of the DHT-induced activity. 
Oestradiol equivalent (E2EQ) and flutamide equivalent (FLUTEQ) concentrations were 
calculated using 4-parameter plot equations after correcting for any dilution or concentration 
factors. 
2.2.3.3. Statistical analysis 
To determine the roach sample size, power analysis (CHI-squared test; GraphPad StatMate, 
San Diago, USA) using the 2005 intersex incidence data was employed.  
Where concentrations were reported at below the DL, for statistical purposes half the DL 
was used in calculations. All biological results are expressed as a mean ± standard 
deviation. GraphPad Prism 8 was used for statistical analyses. Data were tested using the 
D'Agostino and Pearson test, and where assumptions of normality and homogeneity of 
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variance were met, the 2013 data was compared with the 2005 data using a t-test (t value 
with degrees of freedom in subscript). Where n was too small or data failed to meet these 
assumptions, data were compared with the 2005 data using the non-parametric Mann-
Whitney Test (U value with sample sizes (n)). The proportions of intersex fish and females 
with uncharacteristically immature ovaries were compared using Fisher's exact test. Where 
VTG plasma samples were reanalysed at a later date, comparisons were made using the 
Wilcoxon matched-pairs signed rank test (Spearman correlation coefficient rs with sample 




2.3.1. Laboratory studies - Fathead minnow flow-through exposure studies to WwTW 
effluents 
Water quality parameters (ammonia, nitrite, and nitrate) were within acceptable ranges (see 
Appendix Tables A 1 - A 12). Tank water temperature, pH, and flow rates (dilution water and 
test chemical) were also within acceptable ranges (see Appendix Tables A 13 – A 16). 
2.3.1.1. Oestrogenic content of the standard and GAC treated effluents within the test 
system over the course of the in vivo experiments 
Both analytical chemistry (LC-MS/MS) measurements for E1, E2 and EE2 (the principal 
oestrogens prevalent in WwTW effluents), and in vitro analysis (E2EQ determined using the 
YES) for measurement of total oestrogenic activity were used to characterise the 
oestrogenic content of the effluent delivered to Brunel University London and in the tank 
water within the exposure system. The mean values derived from these measurements (± 
standard deviation) are summarised in Figure 13. The variation in oestrogenic content 
between the individual batches of effluent delivered to the laboratory and the persistence of 
the measured oestrogenic activity for each batch of effluent, both in transit and during the 
holding period, can also be seen in Table 4 (standard effluent) and Table 5 (GAC effluent).  
Whilst there was a variation in the concentrations of steroid oestrogens and in the 
oestrogenic activity both within (at time of collection, on arrival at Brunel University London, 
and at the end of the batch) and between batches of effluent, none were significant, 
indicating their stability within the test system. Unexpectedly, the GAC effluent exposure 













































































































































































































































Figure 13. Measurements of steroid oestrogens taken to investigate how the concentrations 
in either standard treated effluent (black bars) or GAC treated effluent (grey bars) changed 
through the course of each short-term experiment. Mean concentrations of individual steroid 
oestrogens (E1, E2 and EE2, measured by LC-MS/MS) and total oestrogenic activity (E2EQ 
measured in the YES) measured on arrival at Brunel University London, at the end of the 
batch (taken from the stainless steel holding tank) and in the fish tanks (VTG Test and Pair 
Breeding Test) receiving 100% effluent. (A) E1, (B) E2, (C) EE2, and (D) E2EQ. For the 
standard effluent, n=6 on arrival and at end of batch and n=12 in fish tanks, and for the GAC 
effluent, n=3 on arrival and at end of batch and n=6 in fish tanks. Error bars represent mean 
± standard deviation; none of the concentrations changed significantly through the course of 
the experiments.  
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Table 4. Stainless steel holding tank concentrations of E1, E2, EE2 and E2 equivalent 
concentrations (E2EQ) measured in batches of standard effluent on collection, arrival at the 
laboratory, and at the end of the batch (taken from the stainless steel holding tank). 
Effluent Time E1 E2 EE2 E2EQ 
Batch Taken ng/L ng/L ng/L ng/L 
1 at collection 0.58 2.2 2.48 1.12 
 on arrival 0.18 0.85 <0.04 3.07 
 at end 2.37 0.31 <0.04 1.6 
2 at collection 0.58 <0.03 1.08 0.58 
 on arrival 2.52 0.05 <0.04 1.44 
 at end 0.47 0.37 <0.04 3.89 
3 at collection <0.04 <0.03 <0.04 1.6 
 on arrival 1.27 0.14 <0.04 5.06 
 at end 1.44 0.08 0.37 1.25 
4 at collection 1.97 1.19 0.93 0.51 
 on arrival 1.29 <0.03 0.25 0.9 
 at end 1.31 <0.03 0.23 2.31 
5 at collection 6.31 <0.03 0.04 0.58 
 on arrival 0.4 <0.03 0.11 1.38 
 at end 0.83 0.43 <0.04 1.34 
6 at collection 1.12 0.22 <0.04 2.12 
 on arrival 2.77 0.8 0.24 2.57 
 at end 1.26 <0.03 <0.04 3.34 
 
 
Table 5. Stainless steel tank concentrations of E1, E2, EE2 and E2 equivalent 
concentrations (E2EQ) measured in batches of GAC treated effluent on collection, arrival at 
the laboratory, and at the end of the batch (in the stainless steel holding tank). 
Effluent Time E1 E2 EE2 E2EQ 
Batch Taken ng/L ng/L ng/L ng/L 
1 at collection <0.04 <0.03 <0.04 <0.5 
 on arrival 0.61 2.14 0.61 <0.5 
 at end 2.26 2.00 3.00 <0.5 
2 at collection <0.04 <0.03 <0.04 <0.5 
 on arrival 1.11 0.54 1.46 <0.5 
 at end 0.72 0.23 0.05 0.68 
3 at collection 0.04 <0.03 0.19 <0.5 
 on arrival 0.14 <0.03 0.11 0.52 




The concentrations of steroid oestrogens and oestrogenic activity measured in the laboratory 
test systems are summarised in Figure 14 and below:  
Oestrone and oestradiol: 
The concentrations of the natural steroid oestrogens present in the control tanks were 
generally low but were often higher than their quantitation limits (0.03 ng/L for E2 and 0.04 
ng/L for E1), probably due to excretion of these steroids into the water by the fish. 
Accordingly, the concentrations of these steroids were higher in the control tanks of the pair 
breeding systems (Experiments 3 and 4, containing males and females) than in the VTG 
Test system (Experiments 1 and 2, containing only males). In the standard effluent test 
system, the concentration of E1 in the VTG Test (Experiment 1) fish tanks with the 50% and 
100% effluent were significantly greater than the control concentrations (H=35.86, 
n1=n2=n3=n4=n5=12, p=0.0086 and <0.0001, respectively). Likewise, in the GAC effluent 
VTG Test system (Experiment 2), the concentration of E1 was significantly higher in the 
100% effluent fish tanks than the control tanks (H=12.06, n1=n2=n3=6, p=0.0375). In the 
standard effluent test system, the concentration of E1 in the Pair Breeding Test (Experiment 
3) fish tanks with 100% effluent was significantly greater than the control concentrations 
(H=20.55, n1=n2=n3=n4=n5=6, p=0.0077). There were no statistical differences in the E2 
concentrations measured in any of the fish treatment tanks. 
Ethinylestradiol:  
The concentrations of EE2 measured in the control tanks were, as expected, close to or at 
the limit of quantitation (0.04 ng/L) in each experiment. For the positive control tanks, the 
amounts of EE2 measured were approximately half the nominal concentrations (nominal 20 
ng/L EE2 for the Pair Breeding Test and 10 ng/L for the VTG Test). In the standard effluent 
and in the GAC effluent, EE2 concentrations were extremely low (the standard effluent mean 
was 0.17 ± 0.35 ng/L EE2 in the VTG Test (Experiment 1) and 0.12 ± 0.24 ng/L in the Pair 
Breeding Test (Experiment 3); the GAC mean was 0.9 ± 0.66 ng/L EE2 in the VTG Test 
(Experiment 2) and 0.30 ± 0.42 ng/L in the Pair Breeding Test (Experiment 4)) and although 
the effluent EE2 concentrations were higher than in the control tanks (ranging from 0.03 to 
0.06 ng/L EE2), this was not statistically significant due to the variability in the concentrations 
of EE2 between different batches of effluent. 
2.3.1.2. Biological effects of effluent exposure under laboratory test conditions 
2.3.1.2.1. Experiments 1 and 2 Fathead minnow Vitellogenin Test 
There was no evidence that exposure for up to 21 days to the WwTW effluents or the 





The size (length and weight) of the male FHM were not significantly different following 
exposure to EE2 and effluent in both of the VTG Tests (standard or GAC; Figure 15). 
Compared with the control fish, there was no significant difference between the condition 
factor of the male FHM following exposure to EE2 and effluent in both VTG Tests 
(Experiment 1 standard and Experiment 2 GAC effluent; Figure 16).  
 
 
Figure 14. Mean concentrations of individual steroid oestrogens (E1, E2 and EE2, measured 
by LC-MS/MS) and oestrogenic activity (E2EQ measured in the YES) in the fish tanks (± 
standard deviation). (A) VTG Test with standard effluent (n=12), (B) VTG Test with GAC 
treated effluent (n=6), (C) Pair Breeding Test with standard effluent (n=6), and (D) Pair 
Breeding Test with GAC treated effluent (n=3). The bars represent mean values ± standard 










































































































































































































































































































































































































































D Experiment 2 (GAC)
 
Figure 15. Lengths and weights of male fathead minnows measured at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A, 
lengths; C, weights) and GAC treated effluent (B, lengths; D, weights). During the exposure 
period male fathead minnows (n=8 males in each of 2 replicate tanks) were exposed to 
effluent, or to the negative (control) or positive (10 ng EE2/L) control. The bars represent 
mean values ± standard deviation. None of the treatments produced a significant effect 





Figure 16. Condition factor and Gonadosomatic Index (GSI) of male fathead minnows 
measured at the end of the baseline period and after 21 days exposed in the VTG Test to 
the standard effluent (A, condition factor; C, GSI) and GAC treated effluent (B, condition 
factor; D, GSI). During the exposure period male fathead minnows (n=8 males in each of 2 
replicate tanks) were exposed to effluent, or to the negative (control) or positive (10 ng 
EE2/L) control. The bars represent mean values ± standard deviation. Statistically different 




































































































































































































In the VTG Tests, the control GSIs were higher than the baseline GSI values and this was 
particularly apparent for Experiment 1 (standard effluent, F5,90=7.338, p<0.0001; Figure 16C) 
where the baseline values were lower than for Experiment 2.  
Male plasma VTG 
There was clear evidence of increases in plasma VTG, of five orders of magnitude relative to 
the controls, in the fish exposed to the positive control EE2 (Figure 17A; H=44.51, 
n1=n2=n3=n4=n5=n6=16, p<0.0001, and Figure 17B; H=35.93, n1=n2=n3=n4=16, p<0.0001). 
However, there were no significant differences in the VTG concentrations in any of the 



























































































































Figure 17. Vitellogenin concentrations measured in the plasma of male fathead minnows at 
the end of the baseline period and after 21 days exposed in the VTG Test to the standard 
effluent (A) or GAC treated effluent (B). During the exposure period male fathead minnows 
(n=8 males in each of 2 replicate tanks) were exposed to effluent, or to the negative (control) 
or positive (10 ng EE2/L) control. The scatter dot plots show individual values and the 
whiskers represent the mean VTG concentration ± standard deviation. Statistically different 
from control values; ****p<0.0001. 
 
Male Fatpad Index 
The baseline male FHM sampled just before the start of the exposure period had a 
significantly lower FPI (mean FPI 0.28) than the control fish (mean FPI 2.37) sampled at the 




n1=n2=n3=n4=n5=n6=16, p<0.0001; Experiment 1; Figure 18A). There was no significant 
difference in the FPI between the baseline FHM and the control fish in the GAC VTG Test 
(Figure 18B), but in this experiment the baseline FPI was higher at the start of the exposure 
period (FPI 0.87).  
The FPI was also affected by exposure to the standard treated effluent; a significant 
suppression of the growth of the fatpad was seen in the both the 50% and 100% effluent 
treatments relative to the controls (H=37.66, n1=n2=n3=n4=n5=n6=16, p=0.0238 and 0.0009, 
respectively). No effects on the FPI were seen in the fish exposed to EE2 (Experiment 1 and 
2) or the GAC effluent (Experiment 2).   
 
 
Figure 18. Mean Fatpad Indices (FPI) measured in male fathead minnows at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A) and 
GAC treated effluent (B). During the exposure period male fathead minnows (n=8 males in 
each of 2 replicate tanks) were exposed to effluent, or to the negative (control) or positive 
(10 ng EE2/L) control. The scatter dot plots show individual values and the whiskers 
represent the mean FPI ± standard deviation. Statistically different from control values; 







































































































B Experiment 2 (GAC)
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Male tubercle number 
No statistical differences were seen with male tubercle numbers in any of the fish in the VTG 
Test with standard effluent (Experiment 1; Figure 19A). In the VTG Test with GAC effluent 
(Experiment 2; Figure 19B), the control fish (sampled at the end of the 21-day exposure) 
exposed to dilution water had significantly more tubercles (tubercle number 11.25, 
F3,60=9.469, p=0.0027) compared with the baseline fish sampled at the start of the exposure 
period (tubercle number 3.88). In addition, there was a significant suppression in male 
tubercle development with EE2 exposure in Experiment 2 compared with the control fish 
(F3,60=9.469, p=0.0039). No significant differences were seen with male tubercle number 
with the fish exposed to the GAC effluent. 




Figure 19. Mean tubercle number measured in male fathead minnows at the end of the 
baseline period and after 21 days exposed in the VTG Test to the standard effluent (A) and 
GAC treated effluent (B). During the exposure period male fathead minnows (n=8 males in 
each of 2 replicate tanks) were exposed to effluent, or to the negative (control) or positive 
(10 ng EE2/L) control. The scatter dot plots show individual values and the whiskers 














































































































2.3.1.2.2. Experiments 3 and 4 Fathead minnow Pair Breeding Test 
In Experiment 3 (standard effluent exposure), three male fish died two days prior to the end 
of the trial and so the remaining EE2 treatment fish were sacrificed two days early to ensure 
no further deaths. Postmortem examination revealed kidney failure due to over production of 
VTG. High VTG concentrations have previously been linked with renal failure and elevated 
mortality (Herman and Kincaid, 1988). During the course of Experiment 3, an additional 4 
fish died (control tanks, 1 male and 1 female FHM; 50% effluent tanks, 1 male and 1 female 
FHM; see Appendix Tables A 19 and A 20). No fish died during the course of Experiment 4 
(see Appendix Tables A 21 and A 22).  
Biological measurements 
The fish length (Figure 20) of both male and female FHM were not significantly different from 
the control fish following exposure to EE2 and effluent, in both of the Pair Breeding Tests 
(standard and GAC effluent).  
The fish weights (Figure 21) were not significantly different from the control fish for both male 
and female fish exposed in the Pair Breeding Test with standard effluent (Experiment 3) and 
also for the female fish exposed to GAC effluent (Experiment 4). However, the male fish 
exposed to EE2 in the GAC Pair Breeding Test (Experiment 4) did weigh significantly less 
than the control male fish (F2,21=3.454, p=0.0302). 
Compared with the control fish, there was no significant difference between the condition 
factor of the both male and female FHM following exposure to EE2 and effluent in both of the 
Pair Breeding Tests (Experiment 3 standard effluent and Experiment 4 GAC effluent; Figure 
22). Similarly, the GSI values for male and female FHM exposed in both of the Pair Breeding 






Figure 20. Lengths of male and female fathead minnows measured after being exposed in 
the Pair Breeding Test for 21 days to the standard effluent (A, males; C, females) and GAC 
treated effluent (B, males; D, females). During the exposure period 8 replicate pairs of 
fathead minnows were exposed to effluent, or to the negative (control) or positive control 
(+ve control; 20 ng EE2/L). The bars represent mean values ± standard deviation. None of 















































































































































































Figure 21. Weights of male and female fathead minnows measured after being exposed in 
the Pair Breeding Test for 21 days to the standard effluent (A, males; C, females) and GAC 
treated effluent (B, males; D, females). During the exposure period 8 replicate pairs of 
fathead minnows were exposed to effluent, or to the negative (control) or positive control 
(+ve control; 20 ng EE2/L). The bars represent mean values ± standard deviation. 
Statistically different from control values; *p<0.05. 
 
Plasma vitellogenin 
As expected, there was a significant induction of VTG in the EE2-treated male fish compared 
with the control male fish for both the Pair Breeding Tests (Experiment 3 standard effluent; 
H=18.98, n1=7,n2=7,n3=8,n4=7,n5=8, p=0.0002; Figure 24A, and Experiment 4 GAC; 







































































































































































the male FHM control VTG concentrations and any of the effluent-exposed male fish for both 
the standard and GAC effluent Pair Breeding Tests.  
Similarly, for the female fish, there were also no significant differences between the control 
VTG concentrations and the values for the fish exposed to standard (Figure 24C) and GAC 
effluent (Figure 24D). Also, there was no significant difference between the EE2 exposed 
female FHM (9,641,076 ± 8,834,021 ng/ml VTG) compared with the control female FHM 
(5,989,596 ± 2,051,597 ng/ml VTG) in the standard effluent Pair Breeding Test (Experiment 
3). However, the EE2 exposed female FHM in the GAC Pair Breeding Study (Experiment 4) 
had significantly elevated VTG concentrations (approximately 10-fold higher) compared with 
the control female FHMs (61,276,798 ± 57,547,003 ng/ml VTG compared with 5,675,081 ± 
1,707,044 ng/ml VTG; H=7.980, n1=n2=n3=8, p=0.0218). 
Fatpad Index 
The FPIs were not significantly different from the control values for male fish exposed in the 
Pair Breeding Test with standard effluent (Experiment 3; Figure 25A) and also for the male 
fish exposed to GAC effluent (Experiment 4; Figure 25B). 
Tubercle number 
The tubercle numbers for the male fish exposed in both the standard (Experiment 3) and 
GAC effluent Pair Breeding Tests (Experiment 4) were not significantly different from the 





Figure 22. Condition factor of male and female fathead minnows measured after being 
exposed in the Pair Breeding Test for 21 days to the standard effluent (A, males; C, females) 
and GAC treated effluent (B, males; D, females). During the exposure period 8 replicate 
pairs of fathead minnows were exposed to effluent, or to the negative (control) or positive 
control (+ve control; 20 ng EE2/L). The bars represent mean values ± standard deviation. 



















































































































































































































































































































































Figure 23. Gonadosomatic Index (GSI) of male and female fathead minnows measured after 
being exposed in the Pair Breeding Test for 21 days to the standard effluent (A, males; C, 
females) and GAC treated effluent (B, males; D, females). During the exposure period 8 
replicate pairs of fathead minnows were exposed to effluent, or to the negative (control) or 
positive control (+ve control; 20 ng EE2/L). The bars represent mean values ± standard 





Figure 24. Vitellogenin concentrations measured in the plasma of fathead minnows after 21 
days in the Pair Breeding Test exposed to the standard effluent (A; males, C; females) and 
GAC treated effluent (B; males, D; females). During the exposure period 8 replicate pairs of 
fathead minnows were exposed to effluent, or to the negative (control) or positive control 
(+ve control; 20 ng EE2/L). The scatter dot plots show individual values and the whiskers 
represent mean VTG concentration ± standard deviation. Statistically different from control 










































































































































































































































































































Figure 25. Mean Fatpad Indices (FPI) measured in male fathead minnows after 21 days in 
the Pair Breeding Test in which they were exposed to the standard effluent (A) and GAC 
treated effluent (B). During the exposure period 8 replicate pairs of fathead minnows were 
exposed to effluent or to the negative (control) or positive control (+ve control; 20 ng EE2/L). 
The scatter dot plots show individual values and the whiskers represent mean FPI ± 





In the Pair Breeding Test with the standard effluent (Experiment 3), there were reductions in 
mean cumulative egg production in the exposure period relative to the pre-exposure period 
for pairs of fish in all treatments except for the 25% standard effluent treatment (Control, 
45.4% reduction, D=0.3810, n=21, p=0.0949; 25% effluent, 2.7% increase, D=0.1905, n=21, 
p=0.8407; 50% effluent, 32% reduction, D=0.1905, n=21, p=0.8407; 100% effluent, 33.6% 
reduction, D=0.3333, n=21, p=0.1938; Figure 27).  Only in the positive control treatment (20 
ng/L EE2), however, was the reduction in egg production statistically different from that seen 





Figure 26. Mean tubercle number measured in male fathead minnows after 21 days in the 
Pair Breeding Test in which they were exposed to the standard effluent (A) and GAC treated 
effluent (B). During the exposure period 8 replicate pairs of fathead minnows were exposed 
to effluent, or to the negative (control) or positive control (+ve control; 20 ng EE2/L). The 
scatter dot plots show individual values and the whiskers represent mean tubercle number ± 
standard deviation. None of the treatments produced a significant effect compared with the 
control values. 
 
In the GAC effluent in Experiment 4, there was a reduction (33.7%) in the mean cumulative 
egg production relative to the pre-exposure period for pairs of fish exposed to the control 
treatment, although this difference was not statistically significant (D=0.3810, n=21, 
p=0.0949; Figure 28). Similarly, both the undiluted GAC effluent and the positive control 
treatments caused reductions in mean cumulative egg production (100% effluent, 35.9% 
reduction, D=0.3333, n=21, p=0.1938; EE2, 46.4% reduction, D=0.3810, n=21, p=0.0949) 
relative to the pre-exposure period.  
For raw data for both Pair Breeding Tests (standard and GAC effluent) see Appendix Tables 
A 19 – A 22 (length, weight, condition factor, GSI, VTG, FPI and tubercle number) and 






















































































































































































































Figure 27. Experiment 3; cumulative egg production in Pair Breeding Test fathead minnows 
over a 21-day pre-exposure period (all FHMs exposed to control water; filled symbols) and 
then over a 21-day exposure period (unfilled symbols). During the exposure period 8 
replicate pairs of FHMs were exposed to 100%, 50% and 25% effluent, or to the negative 
(control) or positive control (+ve control; 20 ng EE2/L). Statistically different from pre-
exposure period; *p<0.05. 
 









































































Figure 28. Experiment 4; cumulative egg production in Pair Breeding Test fathead minnows 
over a 21-day pre-exposure period (all FHMs exposed to control water; filled symbols) and 
then over a 21-day exposure period (unfilled symbols). During the exposure period 8 
replicate pairs of FHMs were exposed to 100% GAC treated effluent, or to the negative 




2.3.2. Field based studies – wild roach collected from the River Ray downstream of the 
Swindon WwTW 
2.3.2.1. Biological measurements 
The male and female fork lengths of roach collected in 2013 were significantly longer 
(t66=2.305, p=0.0243 and U= 994.5, n1=92, n2=36, p=0.0004, respectively) than those 
collected in 2005 (Figure 29). The fork length for the roach sampled in 2013 were between 
113-237 mm, and whilst these were significantly longer, they fitted within the broader range 
of the fish lengths from the 2005 sampling; namely 63-286 mm. The mean weights of the 
male and female roach sampled in 2005 were 71.2 g and 112.7 g, respectively. Both male 
and female roach sampled in 2013 weighed significantly more than those sampled in 2005 
(95.6 g, U=293.5, n1=48, n2=20, p=0.0113 and 145.5 g, U=1074, n1=91, n2=36, p=0.0023, 
respectively; Figure 30).  
The condition factor for fish collected in 2013 were compared with those collected in 2005 























Figure 29. Fork lengths of male and female roach sampled from the River Ray in 2005 
(dotted plots) and 2013 (striped plots). The bars represent mean values ± standard 





















Figure 30. Weights of male and female roach sampled from the River Ray in 2005 (dotted 
plots) and 2013 (striped plots). The bars represent mean values ± standard deviation. 






















Figure 31. Condition factor of roach sampled from the River Ray in 2005 (dotted plot) and 
2013 (striped plot). The bars represent mean values ± standard deviation. Not statistically 






2.3.2.2. Age structure of River Ray roach 
The age structure of the roach caught at the 2005 sampling sites appeared to have a normal 
distribution and ranged from 1+ to 8+ years old. (Table 6). The age structure of the roach 
caught in 2013 ranged from 3+ to 6+ years (Table 7).  
The fish length and age structures of the fish sampled in 2013 were compared with those 
sampled in 2005 in Figure 32. 
 
Table 6. Mean length and age of wild roach sampled from the River Ray in 2005. One fish 




















63 127 154 186 206 233 258 286 
Standard 
deviation 
 9 18 15 14 18   
Number 1 28 37 38 33 5 1 1 
 
 
Table 7. Mean length and age of wild roach sampled from the River Ray in 2013. One fish 





















  163 193 212 218   
Standard 
deviation 
  28 49 17 13   






















Figure 32. Age structure and length of roach sampled from the River Ray in 2005 (red 
circles) and 2013 (blue triangles).  
 
 
2.3.2.3. Sex ratio, gonadal histology and gonad growth of River Ray roach 
In the 2005 survey, a total of 145 fish were sampled and it was possible to sex 140 
individuals; 92 females and 48 males. Of the male fish, 27.1% were intersex (n=13) and the 
ages of these intersex fish ranged from 2 to 6 years. In 2013, 56 fish were sampled; 36 
females and 20 males. Of these male fish, 15% were intersex (n=3; all collected from Site 2) 
and were either 3 or 4 years of age. Although the overall percentage of males with intersex 
was lower in 2013, this reduced proportion of intersex fish was not significantly different from 
proportion of intersex fish observed in 2005 (p=0.3594; Fisher’s exact test). The fish 
sampled in 2005 had a sex ratio of 66% female: 9% intersex: 25% male compared with a 
sex ratio of 64% female: 5% intersex: 30% male for those sampled in 2013 (Figure 33). 
For the intersex roach sampled in 2005, the Intersex Index ranged from 0.167 (a few primary 
oocytes on one gonadal section of one gonad only) to 2 (all sections with oocyte numbers 
ranging from 1-21 oocytes per section) and averaged 0.513 ± 0.56. The distribution of these 
oocytes was multifocal rather than focal (Nolan et al., 2001). In 2013, there were only 3 




Figure 33. Sex ratio of the fish collected from the River Ray downstream of the Swindon 
WwTW; (A) in 2005, and (B) in 2013. The percentage of fish that were intersex was 9% 
(2005 sampling; n=13) and 5% (2013 sampling; n=3). The percentage of male fish that were 
intersex are indicated in brackets; 27.1% in 2005 and 15% in 2013. 
 
 
averaged 0.278 ± 0.19. These Intersex Index scores were not significantly different from the 
2005 scores (U= 9.500, n1=11, n2=3, p=0.3159). The severity of intersex from the two 
samplings was compared in Figure 34. Whilst some of the male fish collected in 2005 had a 
feminised sperm duct with 2 points of attachment (i.e. an ovarian cavity), all male fish 
collected in 2013 had normal sperm ducts with only one point of attachment. 
The GSI for the male testes were significantly higher for the fish collected in November 2013 
than for the fish collected in spring 2005 (t50=2.878, p=0.0059; Table 8). Unlike the male fish, 
the GSI for the female ovaries were significantly lower for the fish collected November 2013 
than for the fish collected spring 2005 (U=1259, n1=91, n2=36, p=0.0421; Table 8). The GSIs 
of the intersex fish collected in 2013 were not significantly different from the intersex fish 















Figure 34. Severity of intersex of the male roach with intersex gonads (testicular oocytes 
and/or an ovarian cavity). In 2005, 13 male fish were found to be intersex and in 2013, 3 of 
the male fish were intersex. The scatter dot plot shows individual values and the whiskers 
represent the mean ± standard deviation.  
 
 
Table 8. Gonadosomatic indices (GSIs) of wild roach sampled from the River Ray in 2005 
and 2013 (mean ± standard deviation). The 2013 GSI values which are significantly different 
from respective 2005 values are denoted by stars; *p<0.05, **p<0.01. 
GSI 
Roach sampled in 2005 
(n=139) 
Roach sampled in 2013 
(n=56) 
Male 4.298 ± 1.333 5.299 ± 0.74 ** 
Intersex 4.089 ± 1.519 5.086 ± 0.658 


























Most studies investigating endocrine endpoints in fish gonads focus primarily on intersex 
occurrence, intersex severity and feminised reproductive ducts (Bahamonde et al., 2013; 
Sumpter, 2005). However, additional assessments on gonad development in both males and 
females can also shed light on reproductive health.   
In 2005, 79% of males had spermiating gonads (Stage V), whereas in 2013 100% of males 
had less mature Stage II gonads (Figure 35). These findings are typical of both the 
month/season they were sampled (Geraudie et al., 2010). 
In 2005, just over 80% of the females had ‘typical’ gonads for their age and time of sampling 
(Figure 36). Of the 92 females sampled in 2005, 59 female fish were in the final stages of 
maturation with a high GSI (Figure 37) and greater than 50% vitellogenic oocytes (Stage V)  
and one female was spent (Stage VI), as might be expected for the mid-April sampling time 
(Geraudie et al., 2010) . A further sixteen females were 1 or 2 years old and ranged from 
Stage II (only primary oocytes) to Stage IV (mainly cortical alveolus stage oocytes), typical of 
younger fish (Geraudie et al., 2010). However, another sixteen females of mature age (3-7 
years of age) had gonads that were uncharacteristically immature in appearance (Stage I-IV; 
17.4%; Figure 38) (Jobling et al., 2002a; Tyler and Sumpter, 1996). Whilst two of these 
uncharacteristically immature female fish were 3 years old and the developmental stage may 
be linked to the young age, the remaining 14 fish were 4+ years old. In Figure 38, the dotted 
line indicates the 3+ age that one would expect female roach to have reached maturity 
(stage V-VI) (Epler et al., 2005), and for fish sampled in 2005 many 3+ fish had 
uncharacteristically immature (stage I-IV) gonads.  
In 2013, one female had immature Stage II ovaries, and this developmental stage may be 
linked to the fish’s relatively young age of 3 years (Figure 38). None of the other females in 
the 2013 sampling had under-developed for age gonads as seen in the 2005 samples. The 
remainder of the females (97.2%) had ovaries with greater than 50% vitellogenic oocytes 
(Stage V). On comparing the proportion of uncharacteristically immature female roach, there 
was a significant difference between the number of female fish in 2005 (n=16, 17.4%) and 






Figure 35. Male histology. Image A shows a normal testis sampled April 2005, at x 20 
magnification. It is close to spermiation with the arrow indicating the sperm duct (SD). Image 
B at x 100 magnification is an example of a testis collected from a fish in November 2013, 
and at stage II the predominant cells are spermatogonia. Image C at x 100 magnification is 
an example of a testis collected from a fish in 2005, and at stage V the predominant cells are 
spermatozoa. Image D at 400 x magnification shows an intersex gonad section (Intersex 
Score 1) from a roach testis collected in 2005. A few scattered oocytes (shown with arrows) 




Figure 36. Female histology. Images showing normal immature ovary at x 20 (A) and x 100 
(B) magnification. The ovarian cavity can be observed in image A (OC) and a developing 
cortical alveolus oocyte can be observed in image B (CA). Image C shows a mature ovary at 
x 20 with many vitellogenic oocytes (filled with yolk and surrounded by a thick cell wall or 
zona radiata) compared with an ovary from a fish of a similar age but with immature and 

































Figure 37. Gonadal stage of maturity of female roach sampled from the River Ray in 2005 
(A) and 2013 (B) plotted against GSI. The scatter dot plots show individual values and the 
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Figure 38. Gonadal stage of maturity of female roach sampled from the River Ray in 2005 
(red circles) and 2013 (blue triangles) plotted against fish age. The dotted line indicates the 
age that one would expect female roach to have reached maturity (Epler et al., 2005). Note 




Many of the female roach sampled in both 2005 and 2013 contained atretic oocytes, and in 
2005 the average number of atretic oocytes per section ranged from 0 to 48.3, whereas in 
2013 the number ranged from 0 to 15 (Table 9). Whilst there were lower numbers in the 
ovaries of the roach sampled in 2013 than for those sampled in 2005, this difference was not 
significant (U=939, n1=67, n2=35, p=0.1002).  
 
Table 9. Number of atretic oocytes (average of 6 sections) found in the ovaries of wild roach 
sampled from the River Ray downstream of Swindon WwTW in 2005 and 2013 (mean ± 
standard deviation). The 2005 sampling was prior to the installation of GAC to the WwTW, 
and the 2013 sampling was 5 years after GAC was installed to the WwTW. 
Atretic oocytes  
(average per 6 sections) 
Roach sampled in 2005 Roach sampled in 2013 
Range 0 - 48.3 0 - 15 
Mean ± standard deviation 5.564 ± 8.813 5.443 ± 4.613 
 
 
2.3.2.4. Plasma vitellogenin of River Ray roach 
For the quantification of plasma samples collected in 2013, a commercial carp VTG ELISA 
kit based on the assay developed by Tyler et al. (1999) was utilised (Biosense Laboratories 
AS, Bergen, Norway). For an example standard curve see Appendix Figure A 8. 
The quantification of VTG in plasma samples used two different ELISA methods (the pre-
commercialisation method by Tyler et al. (1999) and the Biosense commercial kit) and also 
took place over a number of years. To determine comparability of VTG data, subsamples of 
plasma from 2005 and male plasma from 2013 were also included (reanalysed) in the ELISA 
used to determine the 2013 female plasma VTG concentrations; the VTG values were 
adjusted accordingly. The VTG concentrations of the six 2005 samples reanalysed at a later 
date were significantly different from the values obtained when analysed at the time of 
collection (rs= 0.8286, n=6, p=0.0313; Table 10 and Appendix Figure A 9). These 2013 
concentrations were on average around 5-fold lower, and the 2005 plasma sample values 
were adjusted to enable comparisons to be made.  
Additionally, a significant difference in VTG concentrations was found when a subsample of 
9 male samples from the 2013 sampling were reanalysed with the 2013 female plasma 
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samples at a later date (the male samples analysed in the first instance were on average 
0.65 lower than when reanalysed with the female samples; rs= 0.9833, n=9, p=0.0195; Table 
11 and Appendix Figure A 9).  
Unadjusted VTG concentrations can be seen in Table 12 and Appendix Figure A 10, and 
adjusted VTG concentrations can be seen in Table 13 and Figure 39.  
 
 
Table 10. Comparison of 2005 plasma sample vitellogenin concentrations analysed by the 
two different carp ELISA methods (a carp VTG ELISA, previously validated for use with 
roach (Tyler et al., 1996) and the commercial Biosence ELISA). The regression coefficient 
R2 = 0.979 (see Appendix Figure A 9). The concentrations were significantly different 
(p=0.0313) and the 2005 sample concentrations were adjusted by a factor of 5.1 to take into 
account this difference. 
Fish 
no. 
Mean vitellogenin concentration (ng/ml) 
Roach sampled 2005, analysis based 
on Tyler et al. (1999) ELISA 
Roach sampled 2005, reanalysed in 
2017 using Biosense ELISA kit 
10 4,300,000 992,834 
17 81 12 
24 2,500,000 1,111,732 
49 2,755,000 664,000 
111 16,794 1,463 






Table 11. Comparison of 2013 male plasma sample vitellogenin concentrations analysed 
using the same method (Biosense carp VTG ELISA kit) but in different years (2015 and 
2017). The regression coefficient R2 = 0.9916 (see Appendix Figure A 9). The 
concentrations were significantly different (p=0.0195) and the 2013 male sample 
concentrations were adjusted by 0.65 to take into account this difference. 
Fish 
no. 
Mean vitellogenin concentration (ng/ml) 
Male roach sampled 2013, analysed 
in 2015 using Biosense ELISA 
Male roach sampled 2013, 
reanalysed in 2017 using Biosense 
ELISA 
1 23 25 
3 208 545 
8 385 933 
11 12 12 
16 45,133 118,156 
25 198 519 
26 12,801 33,750 
27 12 12 
29 48 47 
 
 
Table 12. Comparison of unadjusted VTG concentrations measured in wild roach samples 
collected from the River Ray in 2005 and 2013. Unadjusted mean values are expressed ± 
standard deviation. VTG values significantly different from respective 2005 values are 
denoted by stars; **p<0.01, ***p<0.001, ****p<0.0001. 
Histological  
Sex 
Mean vitellogenin concentration (ng/ml) 
Roach sampled 2005 
(n=118) 
Roach sampled 2013  
(n=56) 
Male  722,009 ± 1,518,246 3,560 ± 11,142 ** 
Intersex 1,759,236 ± 2,048,997 1,056 ± 1,763 
Male and intersex 993,663 ± 1,709,877 3,185 ± 10,281 *** 




Table 13. Comparison of adjusted VTG concentrations measured in wild roach samples 
collected from the River Ray in 2005 and 2013. Adjusted mean values are expressed ± 
standard deviation. VTG values significantly different from respective 2005 values are 
denoted by stars; ****p<0.0001. 
Histological  
Sex 
Mean adjusted VTG concentration (ng/ml) 
Roach sampled 2005 
(n=118) 
Roach sampled 2013 
(n=56) 
Male  142,689 ± 300,049 5,477 ± 17,141 
Intersex 347,675 ± 404,940 1,625 ± 2,713 
Male and intersex 196,376 ± 337,920 4,900 ± 15,817 




In 2005, prior to the GAC upgrade, the average plasma VTG concentration for male 
(including intersex) roach was 196,376 ± 337,920 ng/ml, whereas in the 2013 survey, after 
the GAC upgrade, the mean male (including intersex) roach plasma VTG concentration was 
4,900 ± 15,817 ng/ml; although this reduction was not significant (U=394, n1=42, n2=20, p= 
0.7008; Table 13; Figure 39).  
In contrast to the males, there was a significant increase in female VTG concentrations in 
2013 (7,785,099 ± 3,842,592 ng/ml) when compared with those females sampled in 2005 
(420,559 ± 432,034 ng/ml, U=73, n1=76, n2=36, p<0.0001; Table 13; Figure 39).  
When GSIs were plotted against VTG concentrations for the fish collected in 2005, there 
appear to be two different populations of VTG concentrations (‘low responders’ and ‘high 
responders’), but these did not correlate with GSI (Figure 40). When comparing the 2013 fish 







Figure 39. Adjusted plasma VTG concentrations in male (including intersex) and female 
roach sampled from the River Ray in 2005 (dotted plots; prior to the GAC installation) and in 
2013 (striped plots; after the GAC WwTW upgrade). The violin plots include lines at the 
median and quartiles. VTG values significantly different from respective 2005 values are 





Figure 40. Comparing plasma VTG concentrations in (A) male and (B) female roach 
sampled from the River Ray in 2005 (prior to the GAC WwTW upgrade) plotted against GSI. 
















































































Figure 41. Comparing plasma VTG concentrations in (A) male and (B) female roach 
sampled from the River Ray in 2013 (after the GAC WwTW upgrade) plotted against the 
GSI. Scattered dot plots represent individual values. 
 
 
2.3.2.5. Oestrogenic and anti-androgenic activity of River Ray roach bile  
In 2005, bile concentrations were not determined for the female roach, so comparisons can 
only be made between male and intersex fish.  
When male and intersex fish bile E2EQ concentrations were compared, there were no 
significant differences between the 2005 male bile concentrations and the 2005 intersex bile 
concentrations. Similarly, the E2EQ concentrations did not differ significantly between the 
2013 male bile and 2013 intersex bile concentrations. However, in the 2013 samples the bile 
E2EQ concentrations were significantly higher for both male (U=35, n1=25, n2=15, p<0.0001) 
and intersex fish (U=3, n1=11, n2=3, p=0.0385) than those collected in 2005 (Figure 42). For 
bile anti-androgenic activity quantification, the FLUTEQ concentrations in around 90% of the 
samples were below the DL of the assays carried out in 2005 and 2013 (2005; DL=0.30 
ng/ml and 2013; DL=0.34 ng/ml) and therefore statistical comparisons cannot be made. 
For raw data for the roach sampled from the River Ray in 2005 and 2013, see Appendix 
Tables A 25 and A 26. 
The results from the in vivo lab-based exposure studies with FHM and the roach collected 
from the River Ray in 2005 and 2013 are summarised in Table 14. 









































































Figure 42. Bile oestradiol equivalent (E2EQ) concentrations collected from male and intersex 
fish in 2005 (dotted plots; prior to the GAC WwTW upgrade) and 2013 (striped plots; after 
the GAC WwTW upgrade). The bars represent mean values ± standard deviation. 
Statistically different from the 2005 sampling values; *p<0.05, ****p<0.0001.  
 
2.4. Discussion 
2.4.1. Lab-studies - Fathead minnow flow-through exposure studies to WwTW effluents 
2.4.1.1. Oestrogenic content of the standard and GAC effluents 
It has been previously demonstrated that the FHM tests can be used to assess the effects of 
oestrogenic chemicals and oestrogenic effluents on reproduction (Ankley et al., 2001; Brian 
et al., 2007; Harries et al., 2000; Kramer et al., 1998; Thorpe et al., 2007). 
Measurement of the natural steroidal oestrogens, E1 and E2, the synthetic oestrogen EE2, 
and the in vitro assessment of total oestrogenic activity (E2EQ YES measurements) showed 
that there were low levels of steroid oestrogens in both the standard and the GAC effluents. 
As observed by others, E1 was often the most abundant oestrogen of those measured 
(Ekman et al., 2018). Indeed, Liu et al. (2020) detected E1, E2 and EE2 in 96%, 81 and 68% 
of Chinese surface water samples, respectively. Due to the lower potency of E1 (Lange et 
al., 2012) this steroid has been less of an environmental concern, but recent work suggests 
that fish are able to metabolise E1 back into the more potent E2 (Ankley et al., 2017; Tapper 
et al., 2020) and overlooking it could underestimate risk to the environment. 
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Table 14. Summary table of changes (one arrow) and statistically significant changes (two arrows) of different parameters. Endpoints following 
exposure of fathead minnow (FHM) to standard and GAC-treated effluent were compared with dilution water (control) in two in vivo studies 
(Vitellogenin Assay and Pair Breeding Assay). Endpoints were also compared for roach collected from the River Ray in 2013 after the addition 
of GAC to the Swindon Wastewater Treatment Works with fish collected before the GAC plant was installed in 2005. NC; no change. 
Endpoints 
FHM - Vitellogenin Assay FHM - Pair Breeding Assay 
Roach from the 








Length NC NC NC NC  
Weight NC NC NC NC  
Condition Factor NC NC NC NC NC 
GSI NC NC NC NC  
Tubercle number NC NC NC NC  
Fatpad Index  NC  NC  
Intersex incidence      
Uncharacteristically 
immature 
     
Atretic eggs      
Vitellogenin NC NC NC NC  
Egg counts   NC NC  
Bile E2EQ      
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The higher E2 and EE2 concentrations in the GAC effluent than the standard effluent, was 
not seen when the total oestrogenic activity (E2EQ) was measured via the in vitro YES. 
However, the concentrations of steroids in the standard treated effluent are likely to be 
underestimated due to matrix effects (Itzel et al., 2017; Taylor, 2005) or because the steroids 
were present as conjugates/metabolites (Kumar et al., 2011). The use of the YES bioassay 
gives an estimate of total oestrogenicity whereas the analytical methods look to identify the 
individual steroids and do not necessarily detect metabolites. The E2EQ YES values are 
therefore more likely to give a better prediction of in vivo effects than the analytical chemistry 
results (Volker et al., 2016). Direct comparisons of the absolute levels of oestrogens in the 
standard and GAC effluents as measures of removal efficiency are not possible here though 
because the standard and GAC effluent exposures were conducted at different times of the 
year.  
Panter et al. (2002) exposed FHMs to EE2 and their tank concentrations were between 40 
and 50% of nominal values, and it was established that the low measured EE2 
concentrations were at least in part due to losses because of adsorption to the test system. 
Our positive control EE2 tank concentrations were similarly about half the nominal values 
and may also be due to adsorption to the test system. Despite the sometimes biologically 
active concentrations of steroid oestrogens present in the effluents leaving the storage tank, 
particularly at the end of the batch, the concentrations measured in the aquaria were often 
below biologically active concentrations and sometimes even below DLs. This could be due 
to adsorption but might also be due to uptake by the fish (Panter et al., 2002).  
2.4.1.2. The sensitive biomarker, vitellogenin, was not induced by the standard or 
GAC effluent  
Male FHMs were exposed to either control, effluent (both standard and GAC), or positive 
control (EE2) in the VTG Test (Experiments 1 and 2) and the Pair Breeding Test 
(Experiment 3 and 4) for a period of 21 days.  Whilst the male fish exposed to EE2 had a 
significant induction of plasma VTG in all four experiments, none of the male fish exposed to 
effluent (either standard or GAC) showed induction of plasma VTG, indicating insufficient 
levels of oestrogens in the Swindon effluent to elicit this well-known biomarker of oestrogenic 
activity. This result was unexpected, given that the analytical chemistry reported 
concentrations of EE2 ≥1 ng/L in the effluent storage tank feeding the test aquaria that are 
known to induce VTG in male FHM (Flick et al., 2014; Lange et al., 2001; Pawlowski et al., 
2004). Because the effluent failed to induce a VTG response in male FHM, it seems that 
either the analytical measurements in the effluent of >1 ng/L EE2 were overestimated or the 
vitellogenic response was underestimated because the EE2 was in a form that was not 
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bioavailable to the fish (e.g. conjugated or bound to particles). This shows the importance of 
using a combination of chemical analysis and biological endpoints for assessing the effects 
of sewage effluents.  
In the Pair Breeding Test (Experiment 3 and 4), exposure of the female FHMs to the EE2 
positive control did not increase the plasma VTG in Experiment 3 (standard effluent) but 
caused a 10-fold increase (p=0.0218) in the females exposed to EE2 in Experiment 4 (GAC 
effluent). The females used in Experiment 3 (7 months) were younger than those used in 
Experiment 4 (11 months), but if this was the reason for the different sensitivities, the 
younger female FHM might have been expected to be more sensitive. However, some fish 
did die in these EE2 tanks in Experiment 3 and the remainder were sampled 2 days early, 
and this is likely to have affected the mean VTG concentration. 
2.4.1.3. Observed reductions in fecundity may have been due to lower feeding rates 
rather than the oestrogenic effects of effluent 
Decreases in egg production following exposure to steroidal oestrogen are often seen at 
concentrations of the oestrogen that induce VTG concentrations in males above a threshold 
of 1 mg/ml (Kramer et al., 1998; Thorpe et al., 2007). In this investigation, concentrations of 
plasma VTG were often 10 times higher than this 1 mg/ml and so the suppression of egg 
production seen in the Experiment 3 positive control (EE2) was as expected. 
Surprisingly, there were also reductions in the egg production in the control tanks with both 
standard (Experiment 3) and GAC effluent (Experiment 4) Pair Breeding Tests. This may 
have been due to alterations to the prescribed feeding regime, which were introduced to 
prevent the build-up of nitrite and ammonia (both toxic to fish) with the low flows to the fish 
tanks. There was also a reduction in egg production seen with the 50% and 100% standard 
effluent and as all replicates and treatments were fed in the same way, this reduction could 
have been due to the reduced feed too. Interestingly, the 25% effluent exposed fish was the 
only treatment where the cumulative egg production was not lower than the pre-exposure 
period. Others have reported an increase in fecundity following exposure of FHM to 20% 
WwTW effluent (Cavallin et al., 2016), and whilst it is possible that the extra nutrients in the 
25% standard effluent were sufficient for egg production to be sustained, this was not 
reflected in the biological parameters, such as, fish weight and condition factor. Filby et al. 
(2010) carried out pair-breeding exposures with FHMs using standard and GAC effluent and 
found that with both effluents there was a similar inhibition of egg production but no inhibition 
with the EE2 positive control. They therefore considered this fall in egg production to be due 




For the pair-breeding test with the GAC effluent (Experiment 4), there was a similar 
reduction in egg production in all treatments. This reduction was most pronounced (although 
not significant) with the EE2 treatment. 
2.4.1.4. The development/suppression of SSCs were variable 
For the VTG Test (Experiment 1 and 2), the male FHM FPI (Experiment 1, standard effluent; 
p<0.0001) and tubercle number (Experiment 2, GAC; p=0.0027) increased significantly 
during the exposure period. This was as expected as the FHM in the male-only tanks would 
have had a further 3 weeks to set up social hierarchies of dominance leading to increased 
SSCs (Ivanova et al., 2017). The increase in FPI (only significant in standard effluent VTG 
Test, Experiment 1) and tubercle number (only significant in GAC effluent VTG Test, 
Experiment 2) during the exposure period may also be due to fish of two different ages being 
used for the exposures; 7 months old male FHM for Experiment 1 and 11 months old for 
Experiment 2. However, Coady et al. (2017) found SSCs to be correlated with body weight 
and one would therefore have expected to see the significant increases in the 11 months old 
FHM. Increases in FPI and tubercle number might also have been more likely in the younger 
FHM than the older fish, but these endpoints did not develop consistently.  
Whilst standard effluent did not induce VTG production in male fish (Experiment 1), the male 
fish exposed to the standard effluent had a significant suppression of fatpad development 
(Experiment 1; with 50% and 100% effluent) compared with the control fish during the 
exposure period. There was no suppression of the fatpad growth in the EE2 exposed fish in 
this experiment, indicating that the disruption to normal fatpad development could be due to 
the presence of other EDCs in effluent, such as anti-androgens (Bahamonde et al., 2013; 
Filby et al., 2010; Gross-Sorokin et al., 2004).  
In the Pair Breeding Tests, both the FPI and the tubercle number values were higher than for 
the VTG Test fish, and this was as expected due to the presence of female fish. In both the 
VTG Tests (Experiments 1 and 2) and the Pair Breeding Tests (Experiments 3 and 4), there 
were no reductions in number of tubercles with either the standard or GAC effluent. 
Therefore, the FPI was a more sensitive endpoint than the tubercle number, as has been 
observed by others (Filby et al., 2010; Harries et al., 2000; Miles-Richardson et al., 1999). 
We did see a significant repression in the growth of tubercles in Experiment 2 (VTG Test) 
with the EE2 compared with the control males, such that they did not develop in line with the 
tubercle development of the control fish between the start and the end of the 21-day 
exposure period. This was not observed with the Pair Breeding Test EE2 treatment, perhaps 
because the males were actively breeding at the start of this test, and therefore likely to have 
higher tubercle numbers before the exposure period started.  
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Although fish from all experiments were within the age range specified in the EDDP protocol 
(between 4 and 12 months at the start of the study), the OECD 21-day Fish Assay (OECD, 
2018a) does specify a FHM age of 20 ± 2 weeks, and for all experiments the FHM were 
older than OECD guidelines. Age and timing of exposure could be critical when assessing 
SSC and as for others (Armstrong et al., 2016; Harries et al., 2000; Panter et al., 2012), the 
age and timing of maturity may have affected our FPI and tubercle number results. 
Additionally, here all-male tanks were used whereas the OECD guidelines specify mixed sex 
tanks (2 male and 4 female FHM) and this ratio was chosen to optimise reproduction 
(Armstrong et al., 2016) and may also lead to more consistent SSC scores. It is also worth 
noting that the OECD fish test guidelines (OECD, 2018a; b) give details for rating tubercles, 
but whilst the guidelines cite the size of the fatpad as a potentially important SSC, no 
guidance is given and standard practise is to limit assessments to visual observations 
(Wheeler et al., 2020).  
2.4.2. Field studies – wild roach collected from the River Ray downstream of the Swindon 
WwTW 
2.4.2.1. Roach sampled following addition of GAC at the WwTW were longer and 
heavier 
When comparing the biological parameters of the wild fish collected in 2013 from the River 
Ray with those collected in 2005, there was no statistical difference in condition factor. 
However, for the fish collected in 2013, both males and females were significantly longer and 
heavier than those collected in 2005 were. Fish collected downstream of sewage discharges 
have been found by others to have greater growth (longer and heavier; McMaster et al., 
2005; Tetreault et al., 2011) and this was thought to be due to nutrient enrichment in 
nutrient-limited rivers. However, we observed greater growth following the addition of the 
GAC where the nutrients were likely to have been lower. It is possible that following the 
GAC, cleaner river water meant a healthier river with more macroinvertebrates for the roach 
to feed on, although Johnson et al. (2019) did not observe any noticeable impact on River 
Ray macroinvertebrates during this period of GAC treatment.  
Although there are differences between the two samples, prevalence and severity of intersex 
increase with age and size (Gross-Sorokin et al., 2006; Jobling et al., 2006), therefore it is 
unlikely we have underestimated possible endocrine disrupting effects in 2013. Pottinger et 
al. (2011), investigating non-reproductive endpoints in sticklebacks collected from the River 
Ray both before and after the GAC addition to the Swindon WwTW, also found a higher 
growth rate post-remediation, and proposed that factors present in the effluent before the 
GAC addition influenced the health of the stickleback populations downstream. 
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2.4.2.2. Improved male roach reproductive health following the installation of GAC at 
the WwTW 
Spermatogonia were the most abundant cell type in the testes of fish sampled in late 
November 2013 and spermatozoa were the most abundant cell type in April to June 2005, 
as observed by Billard (1986).  
The percentage of female fish was very similar when comparing the sex ratios of the fish 
collected in 2013 (64%) with those collected in 2005 (66%).  
When Geraudie et al. (2010) sampled roach from a low contaminated site, 54.5% were 
found to be female fish and this value was not considered significantly different from the 
expected 1:1 ratio. Pottinger et al. (2011) observed a female-skewed sex ratio of 
sticklebacks sampled from the River Ray before the GAC addition but following the addition 
of the GAC to the Swindon WwTW this ratio was not significantly different to unity. However, 
using a genetic sex probe (Lange et al., 2020), Baynes et al. (2020) found female-skewed 
sex ratios in roach at many sites in the UK with various WwTW effluent inputs, and the sex 
ratio observed in our study of the River Ray is therefore not atypical. 
For the fish sampled in 2013, 15% of male fish were intersex compared with 27.1% of the 
male fish collected in 2005. Unfortunately, because only 20 of the fish caught in 2013 were 
males, even though there was a reduction in the number of intersex males, this was not 
significant. In a study carried out by Jobling et al. (1998), between 4% and 100% of male fish 
in different UK rivers were found to be intersex, and later Jobling et al. (2002a) found 
approximately 10 percent of fish from reference sites to be intersex. In addition, Bjerregaard 
et al. (2006) examined male roach collected from Danish reference sites and found a 
background presence of 4.8% intersex, and roach collected from the site with the highest 
proportion of sewage effluent were found to be 26.5% intersex. Lukšienė et al. (2000) found 
only one intersex fish out of 949 roach sampled in Sweden and in another study by Geraudie 
et al. (2010), where 474 roach were collected, no intersex fish were recorded. Geraudie et 
al. concluded that the incidence of intersex is extremely low (below 0.5%) under natural 
conditions. The intersex incidence seen in 2013 could therefore represent continued 
exposure to low concentrations of oestrogens and/or anti-androgens, even following the 
addition of GAC to the WwTW. As with the fish collected in 2013, the fish collected from 
reference sites by Jobling et al. (2002a) had a very low Intersex Index scores (<1). At this 
low incidence observed in 2013, it is unlikely that this intersex condition alone would lead to 
population level effects (Harris et al., 2011), especially as Hamilton et al. (2014) found roach 




The roach collected in 2013 were from 2008 to 2011-year classes. As the GAC at the 
WwTW was installed in 2008, some of these roach from the River Ray may have been 
exposed to standard effluent, especially the 6+ fish. However, our 6+ year old fish collected 
in 2013 did not have feminised ducts (thought to be permanent, indicating early exposure; 
Jobling et al., 1998). Also, whilst some have observed the severity of intersex to be 
influenced by age (Gross-Sorokin et al., 2006; Jobling et al., 2009; Lange et al., 2011), for 
both sets of roach sampled in 2005 and 2013 there was no indication that the severity was 
linked to age (i.e. length of exposure to the effluent in the river). 
2.4.2.3. Improved female reproductive health following the installation of GAC at the 
WwTW 
Ovarian atresia is a common degenerative process and can be observed at all stages of the 
reproductive cycle, but normally occurs most frequently post spawning (Lange et al., 2011), 
and these residual oocytes (atretic) are then digested and absorbed by macrophages 
invading the ovaries (Geraudie et al., 2010). Not surprisingly, atresia is thought to be largely 
a result of environmental stress, but reduced feeding also causes a progressive increase in 
atresia (Tyler and Sumpter, 1996). Investigators have reported ovarian disruption with 
oestrogenic compounds (Kiparissis et al., 2003) and anti-androgens (Makynen et al., 2000), 
as well as exposure to high concentrations of WwTW effluent (100% effluent, ovaries 
contained degenerative primary and secondary oocytes; Lange et al. (2011) and effluent 
contaminated rivers had a greater level of ovarian atresia; Jobling et al. (2002a)). Atretic 
oocytes were seen in several of the 2005 females and for some gonads the atretic oocytes 
predominated. This atresia may therefore be the result of oestrogenic and/or anti-androgenic 
activity in the River Ray prior to the addition of the GAC at the WwTW. There was a 
significant reduction in the number of female roach with uncharacteristically immature 
ovaries in the 2013 roach collected following the addition of the GAC at the WwTW. This 
result could be due to a reduced EDC concentrations in the GAC effluent. In the 2013 
females there were small numbers of atretic oocytes on the edges of the gonad sections. 
Geraudie et al. (2010) observed biphasic development of ovaries and considered that this 
indicated that gonadal maturation was interrupted, and oocytes were probably partially 
absorbed in December. The presence of degenerating oocytes in the 2013 ovaries collected 
at the end of November may therefore be part of a normal process, and not be linked to the 




2.4.2.4. Reduced male plasma vitellogenin concentrations following addition of GAC 
to the WwTW, but concentrations were still elevated 
The VTG concentration measured in the male roach collected in 2013 from Site 1 was 241 
ng/ml and in the male (including intersex) roach collected from Site 2 was 6,064 ng/ml, with 
an average of 4,900 ng/ml (Site 1 plus Site 2). Considering that Site 1 was closer to Swindon 
WwTW, one might have expected to see intersex fish and the plasma VTG concentrations to 
have been higher here. However, as only four male fish were collected from this site one 
cannot draw any conclusions, but it is possible that other waste streams enter the River Ray 
between the two sites. 
The fish collected from the River Ray in 2005 were collected at a different time of year (late 
April to early June) to those collected in 2013 (late November). Since the season has been 
shown to affect the oestrogenic potency of effluents (Harries et al., 1999), comparisons were 
made between the 2013 male plasma VTG concentrations and with the potable water control 
male fish sampled at the same time of year as part of another study (Baynes et al., 2012). 
The 2013 male fish were found to have significantly lower VTG concentrations than the 
potable water control fish, but Baynes et al. noted that their VTG concentrations were higher 
than expected and linked these to exposure to natural oestrogens present in the fish tanks. 
Jobling et al. (2002a) measured VTG concentrations in roach from two reference sites 
collected at the end of October, and found the concentrations to be 100 and 15 ng/ml. 
Jobling et al. (2002a) considered that the concentration at 100 ng/ml was above basal 
concentrations, and was possibly a result of exposure to endogenous oestrogens via the diet 
and/or water, but also considered that the difference may be due to normal interpopulation 
variability. Geraudie et al. (2010) measured roach VTG concentrations over a period of 18 
months and found male plasma basal concentrations to be 24 ng/ml and rising to 120 ng/ml 
during the spawning period (February to April). Our male (including intersex) plasma VTG 
concentrations of 4,900 ng/ml are over an order of magnitude higher than typical basal 
concentrations, indicating that the fish may still be being exposed to EDCs even after the 
addition of the GAC treatment to the WwTW. Therefore, these elevated VTG concentrations 
may be due to water soluble EDCs not being retained by the GAC (Snyder et al., 2007) or 
breakthrough due to saturation of the GAC (Baynes et al., 2012).  
Kidd et al. (2007) reported a positive correlation between increased hepatic VTG expression 
and plasma VTG and intersex incidence following exposure of FHMs to EE2 in a whole lake 
experiment. However, we observed no such correlation between plasma VTG and intersex 
with either the fish sampled in 2005 or those sampled in 2013, and the driver for the intersex 
that we observed may therefore be non-oestrogenic mediated pathways, as suggested by 
Bahamonde et al. (2013). The 2005 male plasma VTG concentrations were highly variable 
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and seemed to fall into two different populations irrespective of GSI, with some fish being 
more sensitive than others to oestrogenic contaminants in the river water. This has been 
reported previously by Beresford et al. (2011), who found FHM VTG to be highly variable in 
lab-based studies, even within the same treatment group. Biales et al. (2007) thought that 
this variation could be due to genetic variation in the degree of the response of the fish as, of 
the genes examined, only the VTG gene was variable. Purdom et al. (1994) also looked at 
plasma VTG in wild rainbow trout exposed to effluents and found the concentrations were 
raised above the baseline by 500 to 50,000 times. Similarly, the ‘high male responders’ 
collected from the River Ray in 2005 had plasma VTG values about 10,000 times higher 
than the ‘low male responder’ values. More recently, Wheeler et al. (2019) examined control 
data from 49 FHM studies and found high intra- and inter-laboratory variability for VTG and 
therefore considered this endpoint to be of limited use during study interpretation. 
The female roach had significantly higher plasma VTG concentrations when collected in 
November 2013 than in spring 2005. Whilst the spring 2005 concentrations were similar to 
concentrations reported by Geraudie et al. (2010) and Scott et al. (2013) for female roach 
sampled at this time of year, these same authors reported lower VTG concentrations when 
they sampled female fish in November. Whilst different methods were used for the detection 
of the VTG at the two different times of the year, both methods were based on work by Tyler 
et al. (1996) and are not likely to be the reason for this discrepancy. Other factors (e.g. water 
temperature) may also be playing a part here, but due to the different seasons, it is not 
possible to make any definite conclusions. 
The male GSIs were significantly different between the two samplings and one would have 
expected the testes collected in 2005 to have a higher GSI than those collected in 
November, in preparation for spawning. Oestrogenic and/or anti-androgenic effluent entering 
the river could also have led to lower circulating plasma T concentrations in the fish, 
resulting in reduced GSIs. However, as many of the sperm ducts of the 2005 male fish were 
full of sperm, it is just as likely that the lower GSIs were because some were part spent. 
2.4.2.5. Bile E2EQ and FLUTEQ values do not reflect the intersex or vitellogenin 
results 
In 2005, bile E2EQ and FLUTEQ values were only determined for the male and intersex fish. 
The method utilised separate glucuronidase and sulphatase enzymes and the efficiencies of 
these enzymes had been previously determined using nitrophenyl glucuronide and 
nitrophenol sulphate (Gibson et al., 2005).  However, when analysing the bile samples 
collected in 2013 using E2-G and E2-S, the sulphatase from Aerobacter aerogenes did not 
deconjugate the E2-S. Steroid sulphates are known to be difficult to deconjugate using 
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enzymatic hydrolysis and some authors have used acid hydrolysis (Hauser et al., 2008) or 
digestive juice from Helix pomatia instead (Pedersen et al., 2017). Therefore, for the later 
samples analysed in 2013, H. pomatia digestive ‘snail juice’ was used for deconjugations. 
Whilst the ‘snail juice’ sulphatase activity has the broadest specificity and is commonly used 
in bioanalysis for hydrolysing both glucuronide and sulphatase conjugates (Gomes et al., 
2009), our results show that the sulphate hydrolysis was still incomplete; only 23.7% 
deconjugation occurred. However, as most conjugates are thought to be in the glucuronide 
moiety (Gomes et al., 2009), we did not try to further improve this sulphate deconjugation 
efficiency. 
Houtman et al. (2004) carried out bioassay-directed fractionation of bile and identified many 
xenobiotic compounds at relatively high concentrations but found that the majority of the 
oestrogenic activity in the bile was due to the presence of E2. Female E2EQs from bile 
collected in 2013 were significantly higher than the males E2EQ values, and this higher 
activity is thought to be due to the natural oestrogens present in the female bile. 
The male and intersex E2EQ determined for the 2005 samples averaged 53.43 and 61.91 
ng/ml, respectively, and these are lower than values determined by Gibson et al. (2005) for 
fish exposed to WwTW effluents, but higher than values from their reference fish bile. Values 
from fish collected following the GAC treatment in 2013 were significantly higher both for the 
male and intersex fish (120.5 and 103.0 ng/ml, respectively), but these values may be higher 
due to the improved enzymatic hydrolysis method used.  
Some authors have found a correlation between plasma VTG induction and bile E2EQ (e.g. 
Legler et al., 2002) but others have not (e.g. Ros et al., 2015). We found no correlation 
between plasma VTG induction and bile E2EQ in male and intersex fish collected in both 
2005 and 2013. This suggests that the incidence of intersex is not the result of oestrogens 
but of EDCs with non-oestrogenic activity.  
Many of the endpoints that we have examined suggest that anti-androgens are present in 
the effluent, particularly in the standard effluent. For FLUTEQ, we were unable to compare 
our results with previously reported values as so many were below the DL (only 12% (2005) 
and 15% (2013) had detectable concentrations). For our bile samples with anti-androgenic 
activity, no efforts were made to identify the anti-androgenic culprits as this was beyond the 
scope of this work, but even when chemicals have been identified these often only account 
for a proportion of the activity seen (Hill et al., 2010; Rostkowski et al., 2011). 
2.4.3. Has the reproductive health of the fish living in the river improved following the 
addition of the GAC to the WwTW? 
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Grover et al. analysed the oestrogen content of the final effluent entering the River Ray prior 
to the installation of the GAC plant, and found the E2EQ concentration to be unexpectedly 
low at <5 ng/L (Grover et al., 2011a; Grover et al., 2011b). Balaam et al. (2010) also found 
the concentration of oestrogens in the River Ray to be lower than concentrations predicted 
by a model utilised by Johnson and Williams (2004), and Balaam et al. thought that this was 
due to biological nutrient removal leading to better than expected performance at the 
WwTW. Following the addition of GAC to the Swindon WwTW, Grover et al. (2011b) could 
not detect E1, E2 and EE2 analytically, and there was a significant reduction in many of the 
pharmaceuticals determined (84-99%) although for some of the pharmaceuticals the 
removal efficiency by the GAC was poor (e.g. 17% for propranolol).  
In addition, Katsiadaki et al. (2012) measured spiggin concentrations (a biomarker of 
androgenic exposure) in wild female stickleback fish collected from the River Ray. When the 
stickleback fish were collected from the River Ray prior to the addition of the GAC at the 
WwTW, the spiggin concentration increased with distance from the effluent discharge point, 
indicative of the effluent containing anti-androgenic compounds that were suppressing the 
spiggin production closer to the WwTW. In addition, following the addition of the GAC 
treatment, the spiggin concentrations in female fish returned to the levels seen in the fish 
collected from the control site. Pottinger et al. (2011) measured the activity of 
monooxygenase cytochrome P4501A (to determine exposure to PAHs) in sticklebacks 
collected from the River Ray, but did not find a decline in the activity following the addition of 
GAC to the Swindon WwTW, and considered that the primary route of exposure was not via 
the water column but attached to particles. 
From this work, it seems there may have been a reduction of oestrogenicity in the Swindon 
WwTW effluent even before the GAC addition, as reflected by the low VTG concentrations 
measured in the male FHM in 2009 compared with the high plasma VTG concentrations 
measured in male roach in 2005. Before the installation of the GAC, disc filters were 
introduced at the Swindon WwTW, and this may have been the reason for the reduced 
oestrogenic activity before the GAC addition. Post addition of the GAC, roach collected from 
the River Ray in 2013 had much reduced plasma VTG concentrations and a reduction in the 
incidence (and severity) of intersex. However, it is clear from some of the FHM results seen 
(e.g. Fatpad Indices), that there were chemicals in the standard effluent with other modes of 
action present (i.e. not oestrogens and more likely anti-androgens). When Grover et al. 
(2011a) carried out spot water sampling of the River Ray, the anti-androgenic activity 
reduced from 148.8 to 22.4µg FLUTEQ/L following addition of the GAC. Grover et al. also 
found that the YES and AYAS values were related to each other, suggesting a coexistence 
of both types of activities. However, we did not find any VTG induction in any of our FHM lab 
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tests to be able to relate VTG concentrations with the oestrogenic content of the effluent. 
Where the VTG concentrations were elevated in the roach, even after the addition of the 
GAC, these did not mirror the bile E2EQ or FLUTEQ. Recent work by Hamilton et al. (2020) 
looked for evidence of adaptation to oestrogenic pollution but found none for selection in 
oestrogen-dependent genes. However, Hamilton et al. found an allele shift at the AR in the 
River Lee population (historically contaminated with WwTW effluents) and thought that this 
resulted from historical contamination with endocrine disrupting pesticides, i.e. due to anti-
androgens and not oestrogens. 
Volker et al. (2016) examined advanced water treatments for the removal of EDCs and 
found that activated sludge removed >59-91%. However, high anti-androgenic activity 
persisted in the final effluent following activated sludge treatment, despite the fact that 
several of the known anti-androgens are hydrophobic and hence should be well removed by 
sorption to the sludge particles, e.g. the antibacterial and antifungal agent, triclosan. Not only 
was anti-androgenic activity ineffectively removed by the activated sludge, but at some of the 
sampling periods anti-androgenic activity was formed; either activity pre-treatment was 
masked by androgens or degradation resulted in more active compounds. Similarly, Bain et 
al. (2014) also found an increase in anti-androgenic activity after secondary treatment 
compared with influent and concluded that androgens masked the anti-androgenic activity in 
the influent. There are also reports of androgenic and oestrogenic activity being almost 
completely removed by the wastewater treatment process but that anti-androgenic 
compounds resist removal and are more likely to then enter our rivers, even with the addition 
of advanced treatments (Gehrmann et al., 2018). As for the bile samples where glucuronide 
conjugates were easy to deconjugate and sulphates were harder, so glucuronide steroid 
conjugates in effluent will be completely transformed in wastewater treatment whilst sulphate 
conjugates will only be partially removed (Kumar et al., 2011).  
Chemicals are present in the Swindon WwTW effluent and are having effects on fish. The 
most pronounced effects on FHM in the lab-based studies were the demasculinising effects 
(reduced male FPI) when exposed to the standard effluent in the lab. In the absence of 
plasma VTG induction in these male fish, the culprits are likely to be anti-androgenic rather 
than oestrogenic compounds. In the wild roach collected from the River Ray, there was a 
marked improvement following the GAC treatment; a reduction in the incidence and severity 
of intersex and a reduction in the plasma VTG concentration. Both are indicative of a marked 
decrease in the amount of oestrogens entering the River Ray, but a low incidence of intersex 
is still present and male VTG concentrations are still at least an order of magnitude above 
baseline concentrations.  This work considers that chemicals enter the River Ray solely from 
the Swindon WwTW, but chemicals may also enter via non-point routes. These include 
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chemicals associated with agricultural land (e.g. herbicides, veterinary pharmaceuticals; 
Fairbairn et al., 2016) and chemicals associated with buildings and roads (e.g. PAHs; Zgheib 
et al., 2012), that may enter the River Ray through runoff. In addition, in February 2005 
9800L of diesel spilled into the River Ray upstream of the sampling site (Smith et al., 2010). 
Thus, both before and after the addition of the GAC to the WwTW, chemicals present in the 
river may also come from non-point sources.  
In 2014, the GAC plant at the Swindon WwTW was switched off; GAC plants are expensive 
and energy intensive to run and their utility as a cost-effective treatment have been 
questioned (Baynes et al., 2012; Gilbert, 2012a). It remains to be seen if endocrine 
disruption in fish living downstream of the effluent outfall will return to the levels seen in 
2005. My next chapter sets out to identify anti-androgenic compounds that are present in 
WwTW effluents and river water and to use the AYAS to determine how potent the 
compounds present are.  
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3. In vitro testing of chemicals for (anti-)androgenic activity 
3.1. Introduction 
Endocrine disrupting chemicals in the environment are a cause for concern as they may be 
inadvertently affecting the reproductive health of wildlife and humans (reviewed by Colborn 
et al., 1993; Hotchkiss et al., 2008). For example, in humans, exposure to EDCs has been 
associated with delayed onset of puberty and cancer in women (Colborn et al., 1993) and 
reduced sperm counts and increased rates of testicular cancer in men (Sharpe and 
Skakkebaek, 1993; Toppari et al., 1996).  
Most of the early research in this field concentrated on natural and man-made chemicals that 
mimic steroidal oestrogens (called xenoestrogens). However, the field of EDCs has now 
developed beyond oestrogens, and chemicals with other types of endocrine activity are also 
being studied (reviewed by Sumpter, 2005). Androgens are a major class of steroid 
hormones in vertebrates that have key functions in the development and maintenance of the 
male reproductive system, acting through binding to nuclear ARs or by interfering with the 
production of steroidogenic enzymes that catalyse the production of steroids (Gray et al., 
2006). Environmental chemicals can interfere with androgen action and disrupt these 
processes. For example, Howell et al. (1980) discovered that pulp mill effluent was 
responsible for the masculinisation of female mosquitofish, Gambusia affinis holbrooki, living 
downstream of where the effluent entered the river. Due to the complex nature of pulp mill 
effluent, the exact chemical(s) responsible for this masculinisation, an elongation of the anal 
fin, have yet to be identified (Kamali et al., 2016; Parks et al., 2001; Singh and Chandra, 
2019). In another study, Larsson and Forlin (2002) observed male-biased sex ratios of 
eelpout collected from close to another pulp mill, and suggested this to be due to 
masculinising agents in the pulp mill effluent. Similarly, Orlando et al. (2004) reported that 
cattle feedlot effluent (containing 17 β-trenbolone, the active metabolite of the androgenic 
growth promotor trenbolone acetate) entering rivers was responsible for significant 
alterations in the reproductive biology of wild FHM, with a demasculinisation of male fish and 
a defeminisation of female fish. The demasculinisation of the male reproductive system has 
also been observed in the aquatic environment. For example, following a spill of DDT, which 
was metabolised to the potent anti-androgen p,p’-DDE, male alligators in Lake Apopka 
(Florida, USA) were found to be have a reduction in penis size and plasma T concentrations 
(Guillette et al., 1996).  
An increasing number of structurally diverse non-steroidal compounds are now being 
identified as AR agonists and/or antagonists (able to bind to the AR but block its 
transcriptional activity) in vertebrates. Whilst the modes of action of oestrogens and anti-
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androgens differ, they can result in similar phenotypic effects (Filby et al., 2007; Sohoni and 
Sumpter, 1998). Androgen antagonists that competitively bind to the AR and block the action 
of the endogenous androgens can disrupt the fine balance of oestrogens and androgens, 
resulting in an oestrogenic internal environment where androgenic activity is reduced, and 
oestrogens predominate (Sohoni and Sumpter, 1998). The resulting effects are suggestive 
of oestrogenic exposure. Many of these compounds are extensively used every day in 
personal care products, fire retardants, pesticides, food products and pharmaceutical 
products, and their high volume use has led to detectable concentrations in the environment 
(Liscio et al., 2014; Urbatzka et al., 2007). This has raised interest in characterising and 
identifying further contaminants that might interact with the AR, especially as there are 
growing concerns over the possible impacts on human health, such as reduced sperm 
production and altered genital development in males (Skakkebaek et al., 2001). Whilst fewer 
chemicals appear to possess androgenic activity than possess oestrogenic activity, many 
oestrogen mimics, e.g. bisphenol A, have also been shown to have some structural features 
that give them anti-androgenic activity as well (Paris et al., 2002; Sohoni and Sumpter, 
1998). 
Traditional animal-based testing methods are slow and costly, and the low efficiency and 
high cost have generated a huge backlog of untested existing chemicals, and untested new 
chemicals awaiting approval prior to entering production (Zhang et al., 2018). There is a 
need to develop new approach methodologies that satisfy the regulatory requirements and 
are acceptable and affordable to society (Fischer et al., 2020).  
New approaches that support the humane treatment of experimental animals through the 3R 
principles (reduction, refinement, and replacement; Russell and Burch, 1959), with a shift 
away from traditional animal studies to target-specific, mechanism-based, biological 
observations, are largely obtained using in vitro assays (Tice et al., 2013). Although in vivo 
assays such as the rat pubertal and Hershberger assay remain “gold standard” for 
determining androgenic activity, multiple in vitro assays for detecting endocrine activity have 
now been developed for assessing chemical toxicity and health risk (Szafran et al., 2020). In 
vitro studies include fewer confounding factors, and are suitable for determining the direct 
effects of chemicals on a specific tissue or cell type (Celino-Brady et al., 2021). Whilst in 
vitro methods can be carried out using HTP screening and are cheaper in comparison with 
animal models, they must be used in conjunction with in vivo testing as existing in vitro 
systems cannot fully take into account bioaccumulation, metabolism, and availability to the 
target cell, or alternative pathways for endocrine disruption. 
112 
 
Most in vitro methods of compound screening use receptor-ligand binding assays, transient 
reporter gene assays (nucleic acids introduced into transfected cells that are not 
permanently incorporated into the cellular genome), mammalian cell lines that have been 
stably transfected with the androgen-responsive reporter gene (the plasmid DNA 
successfully integrated into the cellular genome and passed on to future generations of the 
cell), or recombinant yeast assays. All these assays have limitations. Screening for receptor-
ligand binding is not able to discern whether a chemical has the ability to act as an agonist or 
an antagonist (Schapaugh et al., 2015). Transient reporter gene assays do not reflect 
physiological conditions because target DNA sequences are overexpressed, and the 
transfections maintain their responsiveness for only a limited time (Terouanne et al., 2000). 
These assays often produce highly variable results due to different transfection efficiencies 
from replicate to replicate (Wilson et al., 2002).  
Currently there are several reliable in vitro tests for (anti-)androgenic activity, and these are 
generally based on either stably transfected mammalian cell lines (Korner et al., 2004) or 
yeast cells (Sohoni and Sumpter, 1998). Mammalian cell lines have been stably transfected 
with androgen-responsive reporter genes and are widely used, for example, the human 
prostatic PALM cell line (Terouanne et al., 2000), the human AR CALUX cell line (Sonneveld 
et al., 2005), and the MDA-kb2 cells stably expressing the androgen responsive luciferase 
reporter gene (Wilson et al., 2002). Stable reporter gene assays have been described for 
androgens but these sometimes use slow growing prostatic cell lines or are not selective in 
their response because of expression of other nuclear receptors (Sonneveld et al., 2005; 
Szafran et al., 2020), for example, the expression of PRs or GRs in addition to the AR (CHO-
AR-Luc, Roy et al., 2004; PALM, Terouanne et al., 2000; MDA-kb2, Wilson et al., 2002). 
Yeast assay systems have some advantages, for example, increased robustness, easier 
handling and low cost of reagents (Lopreside et al., 2019). They do also have some 
drawbacks, such as the poor transport of substances across the cell wall (Gaido et al., 1997) 
and limited metabolic capability, although Beresford et al. (2000) found their YES to have the 
means to metabolise methoxychlor. Whilst some chemicals can be converted to either more 
or less active metabolites, neglecting to determine metabolism can lead to both false 
negative and false positive results. The relevance of metabolic activation is widely 
recognised, especially as most immortalised cell lines have very low metabolic competence 
(van Vugt-Lussenburg et al., 2018). This was addressed by van Vugt-Lussenburg et al. 
(2018) who successfully incorporated metabolic enzymes to improve predictability of reporter 
gene assay results with the CALUX system, and found the endocrine activity of 23 of the 27 
chemicals tested to be affected by metabolism.  
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Yeast-based assays can have lower sensitivity than similar assays using vertebrate cells 
(Lopreside et al., 2019; Wangmo et al., 2018). Therefore, extraction/preconcentration is 
generally required and this increases the assay time and may cause higher specific toxicity 
that could cause artefacts (Lopreside et al., 2019). However, whilst Leusch et al. (2017) 
found that yeast-based assays were somewhat less sensitive than their mammalian 
counterparts, the higher tolerance of yeast-based assays to solvents meant that the most 
sensitive yeast assay (Sohoni and Sumpter, 1998) was comparable to the mammalian 
reporter gene assays. 
When testing some samples for antagonistic activity using the YAS and AR-CALUX assay, 
significant differences were seen between the YAS and AR-CALUX results, with the YAS 
showing strong antagonistic activity that was not replicated using the AR-CALUX (Mertl et 
al., 2014). Mertl et al. (2014) considered the YAS results to be false positives resulting from 
interference with the yeast cell. Mansouri et al. (2020) found a significant discrepancy 
between in vitro AR activity and the results of the in vivo Hershberger assay, especially in 
the antagonist mode, and most of the discrepancies were because the in vivo activity 
occurred at internal concentrations well above the upper limit of testing in the in vitro assays. 
Challenging chemicals that give false positives (e.g. caused by cell stress, or only active in 
metabolically competent cells) are problematic when only a few assays are carried out, and 
a battery of tests is therefore required (Judson et al., 2017). 
In 1998, the OECD set about revising and developing a new Test Guidelines Programme for 
testing and assessing chemicals for endocrine disrupting activity (Huet, 2000). The 
framework consisted of five levels, each corresponding to a different level of biological 
complexity; Level 1 using existing data and non-test information, Level 2 utilising in vitro 
assays to provide mechanistic information and Levels 3-5 using in vivo test systems for a 
more definitive understanding of the effects. This OECD guidance document on 
standardised tests was updated in 2018 to reflect scientific advances in the use of test 
methods and assessment of the endocrine activity of chemicals (OECD, 2018d). The Level 2 
in vitro assays provide data about selected endocrine mechanism(s)/pathway(s) using 
mammalian and non-mammalian methods. Assays to determine oestrogenic and androgenic 
activity use stably transfected mammalian cell lines; ER (ERα-HeLa-9903 and VM7Luc4E2 
human cell lines) and AR (AR-EcoScreen, derived from a Chinese hamster ovary cell line). 
Recently, three bioassays for the determination of oestrogenic activity in water and 
wastewater have been standardised and have resulted in international standards (two yeast-
based assays using Saccharomyces cerevisiae and Arxula adeninivorans, and one human 
cell-based reporter assay (ER-CALUX); Wangmo et al, 2018). 
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To more quickly and cost effectively evaluate potential EDCs, in vitro screening is shifting 
towards HTP screening, potentially as replacements for lower-throughput in vitro and in vivo 
tests (reviewed in Fischer et al., 2020). These HTP screening techniques are now routinely 
used in combination with computational methods and information technology to investigate 
how chemicals interact with biological systems both in vitro and in vivo (e.g. Huang et al., 
2016; Szafran et al., 2020; Thomas et al., 2019). HTP assays, though, can be used to better 
capture the diverse array of chemicals currently in use and to allow the development of 
computational models to better predict in vivo EDC activity (Szafran et al., 2020). 
Recent work with ToxCast/Tox21 mammalian HTP assays showed a high degree of 
conservation between human and vertebrate ARs (McArdle et al., 2020). The high degree of 
cross-species conservation of structural and functional aspects of key endpoints (e.g. ER 
and AR) suggests that these systems should also be useful for nonmammalian vertebrates, 
at least at the level of screening and prioritising chemicals for endocrine activity (Ankley et 
al., 2016). Translating in vitro results to in vivo has been found to be complicated and 
Wangmo et al. (2018) found good correlations were only observed for those compounds 
acting via direct binding to the sex steroid receptor. 
However, whilst HTP screening represents an efficient and standardised approach to 
chemical testing, there is uncertainty as to applicability of the data for hazard identification 
and risk assessments (Fay et al., 2018). The adverse outcome pathway (AOP) framework 
has been proposed as a means to help provide this linkage (Kleinstreuer et al., 2016).  
Knowledge of physiological and toxicological pathways has allowed the development of 
AOPs, which consist of a series of key events linking a molecular initiating event (e.g. 
receptor binding) to an adverse outcome (e.g. individual/population response) via a series of 
causal key event relationships (e.g. organ/tissue responses) (Martyniuk et al., 2020). The 
AOP framework combines relevant information and defines how measurable perturbations in 
response to environmental stressors lead to an adverse outcome or an event of regulatory 
concern (Fischer et al., 2020). One adverse outcome of concern is the interference of 
chemicals with sex hormone synthesis, regulation, and function, potentially disturbing 
reproduction and foetal development (WHO-UNEP, 2013).  
The REACH legislation entered into force in 2007 and is a regulation of the EU adopted to 
increase the protection of human health and the environment from the risks that can be 
posed by chemicals. The REACH deadline for registering existing substances manufactured 
or imported in quantities from 1 to 100 tonnes per year in the EU was on 31 May 2018. Pre-
registration a total of 145,297 unique substances/entries were submitted to the European 
Chemicals Agency, and since 2008 a total of 23,118 substances have been registered 
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(https://echa.europa.eu/information-on-chemicals/, downloaded 22/12/2020). Similarly, the 
US EPA TSCA Chemical Substance Inventory, first published in 1979, now lists more than 
86,000 chemicals (https://www.epa.gov/tsca-inventory/about-tsca-chemical-substance-
inventory). 
These EDCs enter the aquatic environment via WwTW, and endocrine activity is regularly 
found when river water and sediments are extracted and tested in in vitro assays (reviewed 
in Wangmo et al., 2018). Some have sought to identify the chemicals responsible for the 
observed endocrine activity, but the chemicals identified often only account for a proportion 
of the activity (for example, Hill et al., 2010; Rostkowski et al., 2011; Tousova et al., 2017). It 
would not be feasible to test environmental samples for all the registered substances in an 
attempt to identify the substances responsible for the endocrine disrupting activity, so a 
different approach needs to be adopted. As a result of the wide range of potential EDCs and 
the fact that they will be present in water as a complex mixture of contaminants, chemical 
analysis alone is insufficient to monitor EDCs. Instead, in vitro bioassays indicative of 
hormonal activity can be applied to assess endocrine activity in environmental waters 
(Leusch et al., 2017). Some environmental contaminants can act as antagonists which, if 
present in a sample, can reduce the agonist response in vitro, emphasising the importance 
of evaluating both agonism and antagonism in environmental samples. Further sample 
processing, such as fractionation, may help to separate the effect of agonists and 
antagonists (Leusch et al., 2017). 
Prior to my thesis, Green (2014) set out to identify the anti-androgenic chemicals responsible 
for anti-androgenic activity observed in WwTW effluent and river samples from the UK, using 
an EDA approach (Desbrow et al., 1998). The samples were extracted by solid phase 
extraction and then fractionated by HPLC. The fractions were subsequently tested in the 
YAS and AYAS, and positive fractions then underwent a broad scan by GC-MS to tentatively 
identify the constituent chemicals. The highest number of chemicals were detected in two of 
the effluent samples (1,063 and 982 chemicals), but only 16% and 25% of the chemicals 
could be identified by this analytical method and the mass spectral library. Many of the 
chemicals were of domestic origin, and included fatty acids, fragrances and flavourings, 
personal care products, and pharmaceuticals. Other industrial chemicals were also identified 
such as flame retardants and plasticisers. 
In total 109 chemicals found in the river water and effluent samples were identified by Green 
(2014), and this chapter of my thesis aims to further characterise these chemicals; to find out 
what individual chemicals from WwTW effluents have (anti-)androgenic activity and how 




3.2. Materials and methods 
3.2.1. Chemicals 
All chemicals were purchased from Sigma-Aldrich (Dorset, UK), with the exception of diethyl 
phthalate (DEP), DEHP and dibutyl phthalate (DBP) that were purchased from Greyhound 
Chemical Service (Birkenhead, UK). 
Positive control chemicals, DHT (≥99% pure) and flutamide (99% pure) were prepared in 
etOH (>99.7%, Hayman Speciality Products, Essex, UK), at 10-6M and 10-3M, respectively. 
Details of test chemicals are listed in Table 15. At the time of purchase, two of the chemicals 
were not available through Sigma-Aldrich, 12-methyl tetradecanoic acid methyl ester and 11-
H-benzo(b)fluorene, and these chemicals were therefore not tested.  
Unless otherwise stated, all test chemicals were prepared at a starting concentration of 10-
2M in etOH. Four chemicals were not soluble in 100% etOH and methyl nonadecanoate, 
carbamazepine and carbamazepine 10,11-epoxide were dissolved in 50:50 etOH:ethyl 
acetate (stock at 5x10-3M), and chrysene was dissolved in 25:75 etOH:ethyl acetate (stock 
at 2.5x10-3M). Ethyl acetate is known to dissolve some plastics at high concentrations. To 
mitigate this issue, the chemicals prepared in etOH:ethyl acetate were diluted in the first well 
of the plate into etOH to give a further 1:2 dilution of the stock, leading to concentrations of 
either 2.5x10-3M or 1.25x10-3M. 
In initial yeast (anti-)androgen screens, some chemicals caused a reduction in yeast turbidity 
(i.e. they were toxic) and were diluted for repeat testing. Dodecanoic acid, 1H-
benzimidazole, 2,4-di-tert-butylphenol, 4-chloro-3,5-dimethyl-phenol, 9H-fluorene, 
dehydroabietic acid, dihydromethyl jasmonate, diphenylacetic acid methyl ester and N-ethyl-
4-methyl benzenesulphonamide were further diluted in etOH to a stock concentration of 10-
3M, and chlorophene, N,N-dimethyl-1-dodecanamine and terbutryn were diluted to a stock 
concentration of 10-4M. For other chemicals, strong anti-androgenic activity in the initial 
screen was such that the chemical also had to be diluted to 10-3 or 10-4M to be able to obtain 
the full dose-response curve (fluoranthene, triclosan, triphenyl phosphate and methyl 
triclosan). 
All stocks were stored in sealed glass vials at 4 oC.  
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3.2.2. Recombinant yeast (anti-)androgen screens 
The recombinant hAR yeast strain was developed by Glaxo Wellcome and details of the 
YAS and AYAS have been described previously (Sohoni and Sumpter, 1998; Tyler et al., 
2000). 
In brief, yeast cells were transfected with the human AR gene together with expression 
plasmids; the androgen response element and the lac-Z gene encoding the enzyme β-gal. In 
the screen for agonistic activity, the yeast cells were incubated in medium containing the test 
chemical and substrate (chlorophenol red-β-D- galactopyranoside; CPRG), and active 
ligands induced β-gal expression. The β-gal was then secreted into the medium and caused 
the substrate to change colour from yellow to red, and this was measurable by absorbance. 
When screening for antagonist activity, DHT was added to the assay medium and the ability 
of the test chemical to inhibit the colour change was determined. 
3.2.3. Recombinant yeast (anti-)androgen screen procedure 
The medium components were prepared, and the standard assay procedure was followed 
(Sohoni and Sumpter, 1998; Tyler et al., 2000). Chemicals were serially diluted in etOH and 
10 µl volumes were transferred to 96-well flat-bottom plates (Sarstedt AG & Co, Nümbrecht, 
Germany) where the etOH was allowed to evaporate to dryness. Then, 200 µl medium 
containing CPRG and yeast (final cell number of 5 x 105 cells/ml) were added to each well. 
Included with every assay were two negative controls; plus and minus etOH. For the 
androgen screen the positive control, DHT, was included in each assay (stock concentration 
at 10-6M and serially diluted in etOH to achieve final concentrations from 5x10-8M to 2.44x10-
11M). Test chemicals, when diluted in the assay medium, resulted in a maximum well 
concentration of 5x10-4M (those with solubility issues had a maximum well concentration of 
2.5x10-4M or 1.25x10-4).  
For antagonistic screens, DHT was added to all wells at a non-saturating concentration that 
raised the background to 65% of the maximal response (2x10-9M) so as to distinguish 
between agonistic and antagonistic activity. The pharmaceutical anti-androgen, flutamide, 
was included as the positive control in every AYAS (stock solution at 10-3M and serially 
diluted in etOH to achieve final concentrations of 5 x 10-5M to 2.44 x 10-8M in the wells after 
the addition of the medium). Three negative controls were included; plus and minus etOH 
with medium including DHT, and plus etOH and medium without DHT. 
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Table 15. This table gives details of all the chemicals tests, including alternate names, a description, the Catalogue Number, CAS Number, 
molecular weight, and purity: 
No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
1 Dimethyl adipate Hexanedionic acid dimethyl 
ester 
Fatty acid 186252 627-93-0 174.19 ≥99% 
2 Methyl heptadecanoate Heptadecanoic acid methyl 
ester 
Fatty acid H4515 1731-92-6 284.48 ≥99% 
3 Methyl nonadecanoate Nonadecanoic acid methyl 
ester 
Fatty acid N5377 1731-94-8 312.53 ≥98% 
4 Methyl Palmitate Hexadecanoic acid methyl 
ester 
Fatty acid P5177 112-39-0 270.45 ≥99% 
5 Monomethyl phthalate Methyl phthalate Plasticiser 36926 4376-18-5 180.16 
 
6 Methyl palmitoleate 9-Hexadecanoic acid methyl 
ester 
Fatty acid P9667 1120-25-8 268.43 ≥99% 
7 Methyl octanoate 
 
Fatty acid 260673 111-11-5 158.24 99% 
8 Benzophenone 
 
Photo initiator/UV absorber 442842 119-61-9 182.22 
 
9 12-Methyl tetradecanoic 
acid methyl ester 
 
Fatty acid M3664 5502-94-3 242.4 ≥98% 
10 N-Butylbenzene 
sulfonamide 
NBSS Plasticiser B90653  3622-84-2 213.3 99% 
11 Myristic acid Tetradecanoic acid Fatty acid M3128 544-63-8 228.37 ≥99% 
12 Decanoic acid 
 
Fragrance/flavouring C1875 334-48-5 173.26 ≥98% 
13 Tris (2-butoxyethyl) 
phosphate 
 
Plasticiser/flame retardant 130591 78-51-3 398.47 94% 
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No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
14 Triphenylphosphine oxide  Flame retardant T84603 791-28-6 278.28 98% 
15 Dodecanoic acid Lauric acid Personal care product L556 143-07-7 220.32 98% 
16 Fluoranthene  PAH 423947 206-44-0 202.25 98% 
17 Triclosan 5-chloro-2-(2-4-
dichlorophenoxy) phenol 
Antimicrobial 72779 3380-34-5 289.54 ≥97% 
18 Triphenyl phosphate  Plasticiser/flame retardant 241288 115-86-6 326.28 ≥99% 
19 Pyrene  PAH 82648 129-00-0 202.25 ≥99% 
20 Methyl triclosan  Metabolite/Antimicrobial 34228 4640-01-1 303.57  
21 HHCB Galaxolide 1 and 2 isomers Fragrance W520608 1222-05-5 258.4 50% in 
diethyl 
phthalate 
22 Pentadecanoic acid 
 
Fatty acid P6125 1002-84-2 242.4 ~99% 




M3378 124-10-7 242.4 ≥99% 
24 Methyl decanoate Decanoic acid methyl ester Fatty acid W505501 110-42-9 186.29 ≥99% 
25 Methyl pentadecanoate Pentadecanoic acid methyl 
ester 
Fatty acid P6250 7132-64-1 256.42 98.5% 
26 Methyl stearate Octadecanoic acid methyl 
ester 
Fatty acid S5376 112-61-8 298.5 ~99% 
27 3-Methylphenol 
 











No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
29 Triethyl phosphate  Flame retardant/plasticiser 538728 78-40-0 182.15 ≥99.8% 
30 Phthalic anhydride 
 
Precursor compound for 
plasticisers 
320064 85-44-9 148.12 ≥99% 
31 Tributyl phosphate 
 
Flame retardant/plasticiser 00675 126-73-8 266.31 ≥99% 
32 2-Ethylhexanoic acid 
 
Paint and varnish driers/ 
plasticisers/stabilisers for 
PVC 




Flame retardant 119660 115-96-8 285.49 97% 
34 Benzo(a)pyrene 
 
PAH B1760 50-32-8 252.31 96% 
35 Methyl oleate cis-9-Octadecenoic methyl 
ester 
Fatty acid O4754 112-62-9 296.49 ≥99% 
36 Diethyl phthalate DEP Plasticiser PT-20 84-66-2 222.24 97-99% 
37 Chrysene 
 
PAH 245186 218-01-9 228.29 98% 
38 Isoproturon 
 
Herbicide 36137 34123-59-6 206.28 
 
39 Di(2-ethylhexyl) phthalate DEHP Plasticiser PT-7 117-81-7 390.56 97-99% 
40 Dibutyl phthalate DBP Plasticiser PT-17 84-74-2 278.34 97-99% 
41 Chlorophene 2-Benzyl-4-chlorophenol Preservative 548618 204-385-8  218.68 95% 
42 11-H-benzo(b)fluorene 
 
PAH 123595 243-17-4 216.28 98% 
43 Phenobarbital  Barbiturate - sedative-
hypnotic/ anticonvulsant 




No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 









I4883 15687-27-1 206.28 ≥98% 
46 Methyl 2-(4-isobutyl 
phenyl)propanoate 








Active metabolite of 
carbamazepine 






CDS000448 41784-08-1 171.62 
 
50 1,4 Dioxane 
 
Stabilizer for 1,1,1-
trichloroethane used in 
aluminium containers 





CDS011908 54549-72-3 180.2 
 
52 10-oxo-octadecanoic acid 
methyl ester 
Methyl 10-undecenoate Flavouring/odour removal 115126 111-81-9 198.3 96% 
53 12-Methyl tetradecanoic 
acid methyl ester 
Methyl 12-methylmyristate Fatty acid M3789 5129-66-8 256.42 ≥97% 
54 1-Butoxy-2-propanol 1-tert-Butoxy-2-propanol Industrial solvent, cleaner, 
degreaser 
433845 57018-52-7 132.2 99% 
55 1H-Benzimidazole 
 
Fungicide 194123 51-17-2 118.14 98% 
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degradation product of a 
biocide 
168653 615-22-5 181.28 97% 
57 2-(Methylthio)pyridine 
  




decyne -4,7-diol, mixture of 
(±) and meso 
Surfactant 278386 126-86-3 226.36 98% 
59 2,4-Di-tert-butylphenol 2,4-Di-tert-butylphenol Intermediate in 
manufacture of UV 
stabiliser, pharmaceuticals 
& fragrances 




Agent to improve 
germination, plant health 
and yield 
153931 719-22-2 220.31 98% 
61 2-Ethylhexyl diphenyl 
phosphate 
 
Plasticiser/Flame retardant 34064 1241-94-7 362.4 
 
62 2-Methyl butanoic acid 
methyl ester 








(S)-(+)-Carvone Fragrance/flavouring 435759 2244-16-8 150.22 96% 
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No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
65 2-Methylbutanoic acid Isovaleric acid Fragrance/flavouring 129542 503-74-2 102.13 99% 
66 2-Phenyl-2-propanol 
 
Fragrance/catalyst/solvent P30802 617-94-7 136.19 97% 
67 2-Toluene sulphonamide o-Toluenesulfonamide Intermediate for production 
of saccharin/plasticiser 
257990 88-19-7 171.22 99% 
68 3-(4-methoxyphenyl)-2-










Isophorone Solvent in printing inks, 
paints etc./ intermediate 
I18709 78-59-1 138.21 97% 
70 3,4-Dimethyl-2,5-furandione 2,3-Dimethylmaleic 
anhydride 
Intermediate D167800 766-39-2 126.11 98% 
71 3,7-Dimethyl-1,6-Octadien-
3-ol 




Antimicrobial C38303 88-04-0 156.61 99% 
73 4-hydroxy-3-methoxy-
benzaldehyde 
Vanillin Flavouring/fragrance V1104 121-33-5 152.15 99% 






65420 943-89-5 178.18 ≥98% 
75 4-Methoxymethylphenol 
 
Flavouring W267104 93-51-6 138.16 ≥98% 
76 4-tert-Butylcyclohexanone 
 
Fragrance B92303 98-53-3 154.25 99% 
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Fragrance/flavouring W354201 3796-70-1 194.31 ≥97% 
78 9,12-Octadecadienoic acid 
methyl ester 
trans-9,12-Octadecadienoic 
acid methyl ester 




PAH 128333 86-73-7 166.22 98% 
80 Acetyl tri-n-butyl citrate Tributyl O-acetylcitrate Plasticiser/flavouring 388378 77-90-7 402.48 98% 
81 Acetylcedrene Methyl cedryl ketone Fragrance W522805 32388-55-9 246.39 
 




Flavouring B1334 100-52-7 106.12 ≥99% 
84 Benzeneacetaldehyde Phenylacetaldehyde Fragrance/flavouring 107395 122-78-1 120.15 ≥90% 
85 Benzothiazole 
 
Precursor of vulcanisation 
accelerator, flavouring, 
antimicrobial 
101338 95-16-9 135.19 96% 
86 Butanedioic acid dimethyl 
ester 
Dimethyl succinate Flavouring W239607 106-65-0 146.14 98% 
87 Camphor 
 
Preparation of mothballs/ 
plasticiser 
148075 76-22-2 152.23 96% 
88 Dehydroabietic acid 
 
Synthesis of plastics (PP), 
surfactants 
SMB00089 1740-19-8 300.44 ≥95% 
89 Dihydromethyl jasmonate Methyl dihydrojasmonate, 
mixture of cis and trans 
Fragrance W340804 24851-98-7 226.31 ≥96% 




No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
91 Diphenylacetic acid methyl 
ester 
Methyl diphenylacetate Chemical, organic 
intermediate 





322377 87-85-4 162.27 99% 
93 Hexamethyldisiloxane 
 
Solvent in organic synthesis 52630 107-46-0 162.38 ≥98.5% 
94 Hexanal dimethyl acetal 1,1-Dimethoxyhexane Fragrance/flavouring 547174 1599-47-9 146.23 98% 
95 Ketoisophorone 4-Oxoisophorone Fragrance/flavouring W342106 1125-21-9 152.19 ≥98% 
96 Methyl propyl ketone 2-Pentanone Surface coating/flavouring 471194 107-87-9 86.13 99.5% 
97 Methylbenzaldehyde p-Tolualdehyde Fragrance/flavouring/ 
pharmaceutical & dyestuff 
intermediate 





Raw material for 
surfactants, germicides, and 
bactericides 





Plasticiser 415367 80-39-7 199.27 98% 
100 Nonanal 
 
Fragrance N30803 124-19-6 142.24 95% 




Production of polymers/ 
indirect food additive 
411779 107-58-4 127.18 97% 
103 Octamethylcyclotetrasiloxane 
 
Used in production of 
silicone/ textiles/personal 
care products 




No. Chemical Alternate name Description Cat. no. CAS no. Mol. wt. Purity 
104 Phenoxyacetic acid methyl 
ester 
Methyl phenoxyacetate Pharmaceutical 
intermediate 
275638 2065-23-8 166.17 99% 
105 Propyl benzene (2,2-Dimethyl-1-propyl) 
benzene 
Fuel/fuel additive 359076 1007-26-7 148.24 ≥97% 
106 Squalene 
 
Moisturiser in cosmetics/ 
adjuvant in vaccines 
S3626 111-02-4 410.72 ≥98% 
107 Terbutryn 
 
Herbicide/pesticide 45677 886-50-0 241.36 
 
108 Tridecanoic acid methyl 
ester 
Methyl tridecanoate Fatty acid T0627 1731-88-0 228.37 ≥97% 
109 Xylene isomer  Xylenes Fuel/solvent in 
pharmaceutical, printing, 
rubber, and leather industries 





The plates were taped closed and shaken for 2 mins on a plate shaker. The plates were 
then incubated at 32 oC for 36 hours followed by 36 hours at room temperature. After the 
incubation period, absorbance readings were taken at 540 and 620 nm using a 
Spectramax 340PC microplate reader (Molecular Devices Limited, Wokingham, UK). 
The second absorbance (620 nm) was a measure of cell density and hence yeast 
growth, and this was especially important as high concentrations of some chemicals can 
inhibit the growth of the yeast cells or cause cell lysis (producing clear yellow wells). The 
absorbance values were corrected for cell density using to the following equation:  
Corrected value = chemical540nm-(chemical620nm-etOH blank620nm). 
All chemicals were tested in duplicate. For initial screenings, chemicals were not tested 
in the androgen screen, because in the AYAS, by raising the background to 65% of the 
maximal response, it is possible to distinguish between agonistic and antagonistic 
activity. For later experiments, chemicals were tested in both the YAS and AYAS.  
Where activity was observed in the first test, the chemicals were retested. Active 
chemicals were tested between 2 and 7 times in a total of 13 YAS and 16 AYAS.  
The EC50 for the positive control, DHT, was calculated using 4-parameter plot equations 
produced with SoftMax Pro version 5.0.1 (Molecular Devices Limited, Wokingham, UK). 
Similarly, the IC50 was calculated as the concentration of flutamide producing 50% 
inhibition of the DHT-induced activity.  
Potency values were calculated by dividing the flutamide IC50 by the chemical IC50, 
and the higher the number the more potent the chemical relative to flutamide. 
Potencies for anti-androgens are given the following symbols: 
+  very weak; <0.02 times the potency of flutamide 
++  weak; 0.02-0.199 times the potency of flutamide  
+++  moderate; 0.2-5 times the potency of flutamide 
++++  strong; >5 times the potency of flutamide 
The anti-androgenic activity of both 9H-fluoranthene and acetylcedrene ‘crept’ across 
the assay plate (i.e. activity was found in wells not directly exposed to the test chemical) 
and these 2 chemicals had to be retested on separate plates to make sure this 
behaviour did not impact on other test chemicals or controls. 
Where chemicals were toxic, resulting in clear yellow wells, the stocks were further 




Photos to demonstrate typical multiwell plates with positive control standard curves 
(YAS; DHT, AYAS; flutamide) and negative control (etOH) can be seen in Figure 43.  
The mean EC50 for the 13 androgen experiments was 9.49x10-10M ± 4.87x10-11M or 275 
± 14 ng/L, as indicated by the dotted line in Figure 44. The mean IC50 for the 16 AYAS 
experiments was 3.78x10-6M ±3.13x10-7M or 1066 ± 118µg/L, as indicated by the dotted 
line in Figure 45. See Appendix Tables A 27 and A 28 for raw data. 
Examples of the 4-parameter plots used to calculate DHT positive control EC50s and 
flutamide positive control IC50s are shown in Figure 46. 
 
Figure 43. Photos showing typical yeast screen results after 3 days incubation with the 
chromogenic substrate CPRG. (A) Androgen screen; the positive control, 
dihydrotestosterone (DHT), standard curve with red wells (left hand side) at highest 
concentrations caused by β-gal converting the yellow CPRG substrate to chlorophenol 
red, and the negative control, ethanol (etOH) remaining yellow in the absence of β-gal. 
(B) Anti-androgen screen (all well containing DHT); the positive control, flutamide 
(FLUT) standard curve, with red wells at all but the highest flutamide concentrations 
where the flutamide is blocking the AR receptor so that no β-gal is released, and the 
wells remain yellow. For the negative control (etOH) all the wells have turned red due to 




Figure 44. Response of the yeast androgen screen to dihydrotestosterone (DHT) 
positive control and ethanol negative control (mean ± SE). The mean EC50 for the 13 
experiments was 9.49x10-10M ± 4.87x10-11M or 275 ± 14 ng/L, as indicated by the dotted 
line (see Appendix Table A 28 for raw data).  
 
 
Figure 45. Response of the yeast anti-androgen screen to flutamide positive control and 
ethanol negative controls (ethanol and ethanol minus DHT in the medium) (mean ± SE; 
mean ± SE). The IC50 for the 16 experiments was 3.78x10-6M ±3.13x10-7M or 1066 ± 




Figure 46. Examples of standard curves produced using SoftMax Pro version 5.0.1 
(Molecular Devices Limited, Wokingham, UK). (A) Androgen screen positive control DHT 
standard curve and (B) Anti-androgen screen positive control flutamide standard curve. 
A 4-parameter fit has been applied to each curve. The C-value gives the point of 
inflection; (A) the EC50, and (B) the IC50. 
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4-P Fit: y = (A - D)/( 1 + (x/C)^B ) + D: A B C D R^2
Plot#1 (Standards@Anti-Yeast Androgen Screen... 2.078 2.073 6.47e-6 1.171 0.999
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Curve Fit Option - Fixed Weight Value:  1
Conc (M)
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3.3.1. Possible androgens 
The results of all yeast experiments are presented in Table 16. Of the 107 chemicals 
tested, only three showed androgenic activity in the YAS; methyl decanoate, 2-
ethylhexanoic acid and ibuprofen (Figure 47). All three chemicals were very weak 
androgens with a maximal absorbance below the DHT EC50 and therefore potency 
measurements could not be calculated, although by extrapolation of the curves the 
potencies of these chemicals would have been at least a million times less than that of 
DHT. The highest ibuprofen concentrations (above 10-4M) showed a reduction in 540nm 
absorbance readings and this was accompanied by a reduction in turbidity (620nm) in 
these wells, indicating toxicity. 
 
 
Figure 47. Yeast androgen results showing plots for the DHT positive control, ethanol 
negative control, and the 3 test chemicals showing very weak androgenic activity; methyl 
decanoate, 2-ethylhexanoic acid and ibuprofen. Each plot is the mean of duplicate 
values ± standard error.   
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3.3.2. Possible anti-androgens 
In the AYAS, there was a reduction in the yeast turbidity at the highest concentrations 
for 18 chemicals and when this was observed it is mentioned in Table 16. Twelve of 
these 18 chemicals (tris (2-butoxyethyl) phosphate, triphenylphosphine oxide, HHCB, 
tributyl phosphate, 1H-benzimidazole, 2,4-di-tert-butylphenol, 4-chloro-3,5-dimethyl-
phenol, dihydromethyl jasmonate, N,N-Dimethyl-1-dodecanamine, N-ethyl-4-methyl 
benzenesulphonamide, terbutryn, and tridecanoic acid methyl ester) appeared to be 
anti-androgenic, although the raised background was accompanied by a noticeable 
reduction in turbidity, indicating that the chemicals were likely to be toxic. This was 
confirmed when these chemicals were retested at a lower (non-toxic) concentration and 
the apparent anti-androgenic activity was no longer present. 
Twenty of the chemicals showed anti-androgenic activity (Table 16; benzophenone, N-
butylbenzene sulphonamide, myristic acid, dodecanoic acid, fluoranthene, triclosan, 
triphenyl phosphate, pyrene, methyl triclosan, chlorophene, 1-[4-(hydroxy-1-
methylethyl)phenyl] ethanone, 2-(methylthio)benzothiazole, 9,12-octadecadienoic acid 
methyl ester, 9H-fluorene, acetylcedrene, alpha cedrol, benzeneacetaldehyde, 
dehydroabietic acid, diphenylacetic acid methyl ester, and hexamethylbenzene), 
although for two of these chemicals repeat assays gave inconsistent results (N-
butylbenzene sulphonamide and triphenyl phosphate).  
Of the chemicals showing anti-androgenic activity, fluoranthene, triclosan, methyl 
triclosan and chlorophene were the most potent, with a potency great than the positive 
control, flutamide. Triphenyl phosphate, pyrene, 9H-fluorene, and dehydroabietic acid 
had similar potency values to flutamide. Benzophenone, N-butylbenzene sulphonamide, 
myristic acid, dodecanoic acid, 2-(methylthio)benzothiazole, acetylcedrene, alpha cedrol, 
and diphenylacetic acid methyl ester were less potent than flutamide, and 1-[4-(hydroxy-
1-methylethyl)phenyl] ethanone, 9,12-octadecadienoic acid methyl ester, 
benzeneacetaldehyde, and hexamethylbenzene had only very weak activity. 
An example of four of these chemicals with anti-androgenic activity in the AYAS can be 





Figure 48. Yeast anti-androgen results showing plots for the flutamide positive control 
and ethanol (etOH) negative control, together with 4 of the test chemicals showing anti-
androgenic activity; fluoranthene, triphenyl phosphate, triclosan and methyl triclosan. 
Each plot is the mean of duplicate values ± standard error. 
 
3.3.3. Possible superagonists 
For twelve of the chemicals, when co-administered with DHT in the AYAS, there was a 
heightened response above the raised background, suggesting that these 12 chemicals 
possessed androgenic activity. As the purpose of this testing was to look for (anti-
)androgenic activity, the chemicals were then tested in the YAS and not retested in the 
AYAS. On testing these twelve chemicals in the YAS, no androgenic activity was 
observed. This heightened response above the DHT raised background is normally 
indicative of androgenic activity, and hence here we term this response as 
‘superagonism’ (Table 16; dimethyl adipate, methyl heptadecanoate, methyl palmitate, 
monomethyl phthalate, methyl octanoate, decanoic acid, methyl myristate, methyl 








Table 16. Results of all chemicals tested in the yeast (anti-)androgen. Potencies for anti-
androgens are given the following symbols; + (very weak; <0.02 times the potency of 
flutamide), ++ (weak; 0.02-0.199 times the potency of flutamide), +++ (moderate; 0.2-5 
times the potency of flutamide), and ++++ (strong; >5 times the potency of flutamide), 
and for inconsistent results the symbols are in brackets. 






1 Dimethyl adipate 627-93-0 No activity Superagonist 
 
2 Methyl heptadecanoate 1731-92-6 No activity Superagonist 
 
3 Methyl nonadecanoate 1731-94-8 No activity No activity 
 
4 Methyl Palmitate 112-39-0 No activity Superagonist 
 
5 Monomethyl phthalate 4376-18-5 No activity Superagonist 
 
6 Methyl palmitoleate 1120-25-8 Not tested No activity 
 
7 Methyl octanoate 111-11-5 No activity Superagonist 
 
8 Benzophenone 119-61-9 Not tested ++ Reduced 
turbidity at 10-
2M 
9 12-Methyl tetradecanoic 






3622-84-2 Not tested (++) Inconsistent 
results 
11 Myristic acid 544-63-8 Not tested ++ Toxic at 10-2M 
12 Decanoic acid 334-48-5 No activity Superagonist 
 
13 Tris (2-butoxyethyl) 
phosphate 
78-51-3 Not tested No activity at 
10-3M 




14 Triphenylphosphine oxide 791-28-6 Not tested No activity at 
10-3M 




15 Dodecanoic acid 143-07-7 Not tested ++ Toxic at 10-2M 
16 Fluoranthene 206-44-0 Not tested ++++ 
 
17 Triclosan 3380-34-5 Not tested ++++ 
 
18 Triphenyl phosphate 115-86-6 Not tested (+++) Inconsistent 
results 










20 Methyl triclosan 4640-01-1 Not tested ++++  
21 HHCB 1222-05-5 Not tested No activity at 
10-3M 




22 Pentadecanoic acid 1002-84-2 No activity No activity 
 
23 Methyl myristate 124-10-7 No activity Superagonist  




25 Methyl pentadecanoate 7132-64-1 No activity Superagonist  
26 Methyl stearate 112-61-8 Not tested No activity  
27 3-Methylphenol 108-39-4 No activity No activity  
28 2-Ethyl-1-hexanol 104-76-7 No activity Superagonist  
29 Triethyl phosphate 78-40-0 No activity No activity  
30 Phthalic anhydride 85-44-9 No activity No activity  
31 Tributyl phosphate 126-73-8 Not tested No activity at 
10-3M 










115-96-8 Not tested No activity  
34 Benzo(a)pyrene 50-32-8 Not tested No activity  
35 Methyl oleate 112-62-9 No activity Superagonist  
36 Diethyl phthalate 84-66-2 Not tested No activity  
37 Chrysene 218-01-9 Not tested No activity  
38 Isoproturon 34123-59-
6 
Not tested No activity  
39 Di(2-ethylhexyl) phthalate 117-81-7 Not tested No activity  
40 Dibutyl phthalate 84-74-2 Not tested No activity  










42 11-H-benzo(b)fluorene 243-17-4   Not tested 
43 Phenobarbital 50-06-6 Not tested No activity  
44 Diclofenac sodium salt 15307-79-6 Not tested No activity  




46 Methyl 2-(4-isobutyl 
phenyl)propanoate 
61566-34-5 Not tested No activity  
47 Carbamazepine 298-46-4 Not tested No activity  
48 Carbamazepine 10,11-
epoxide 
36507-30-9 Not tested No activity  
49 1-(4-aminophenyl)-
ethanone 
41784-08-1 No activity No activity  




54549-72-3 No activity +  
52 10-oxo-octadecanoic acid 
methyl ester 
111-81-9 No activity No activity  
53 12-Methyl tetradecanoic 
acid methyl ester 
5129-66-8 No activity No activity  
54 1-Butoxy-2-propanol 57018-52-7 Not tested No activity  
55 1H-Benzimidazole 51-17-2 No activity No activity at 
10-3M 
Reduced 




615-22-5 No activity ++  
57 2-(Methylthio)pyridine 18438-38-5 No activity No activity  
58 2,4,7,9-Tetramethyl-5-
dicyne-4,7-diol 




















719-22-2 No activity No activity  
61 2-Ethylhexyl diphenyl 
phosphate 
1241-94-7 No activity No activity  
62 2-Methyl butanoic acid 
methyl ester 








2244-16-8 No activity No activity  
65 2-Methylbutanoic acid 503-74-2 No activity No activity  
66 2-Phenyl-2-propanol 617-94-7 No activity No activity  






No activity No activity  
69 3,3,5-Trimethyl-2-
cyclohexen-1-one 
78-59-1 No activity No activity  
70 3,4-Dimethyl-2,5-
furandione 
766-39-2 No activity No activity  
71 3,7-Dimethyl-1,6-
Octadien-3-ol 
78-70-6 No activity No activity  
72 4-Chloro-3,5-dimethyl-
phenol 







Toxic at 10-2M 
73 4-hydroxy-3-methoxy-
benzaldehyde 
121-33-5 No activity No activity  


















3796-70-1 No activity No activity 
 
78 9,12-Octadecadienoic 
acid methyl ester 
2566-97-4 No activity + 
 
79 9H-Fluorene 86-73-7 No activity +++ Creeps 
80 Acetyl tri-n-butyl citrate 77-90-7 No activity No activity 
 
81 Acetylcedrene 32388-55-9 No activity ++ Creeps 
82 alpha cedrol 77-53-2 No activity ++ 
 
83 Benzaldehyde 100-52-7 No activity No activity 
 
84 Benzeneacetaldehyde 122-78-1 No activity + 
 
85 Benzothiazole 95-16-9 No activity No activity 
 
86 Butanedioic acid dimethyl 
ester 
106-65-0 No activity No activity 
 
87 Camphor 76-22-2 No activity No activity 
 




+++ Toxic at 10-2M 





at 10-2M.  
90 Dihydromyrcenol 18479-58-8 No activity No activity 
 
91 Diphenylacetic acid 
methyl ester 
3469-00-9 No activity ++ Reduced turbidity 
at 10-2M 
92 Hexamethylbenzene 87-85-4 No activity + 
 
93 Hexamethyldisiloxane 107-46-0 No activity No activity 
 











95 Ketoisophorone 1125-21-9 No activity No activity  
96 Methyl propyl ketone 107-87-9 No activity No activity  



















100 Nonanal 124-19-6 No activity No activity  
101 Nonanoic acid methyl 
ester 
1731-84-6 No activity No activity  
102 N-tert-Butylacrylamide 107-58-4 No activity No activity  
103 Octamethylcyclotetra-
siloxane 




No activity  
104 Phenoxyacetic acid 
methyl ester 
2065-23-8 No activity No activity  
105 Propyl benzene 1007-26-7 No activity No activity  
106 Squalene 111-02-4 No activity No activity  





Toxic at 10-2M 
108 Tridecanoic acid methyl 
ester 

















The European Chemicals Agency currently contains information on around 145,000 
chemicals, and this list is continuously growing. It is not possible to test all of these as 
individual chemicals and what has been monitored for so far represents only a small 
proportion of the chemicals potentially present in the environment (Heiger-Bernays et al., 
2018; Scott et al., 2018). When Alygizakis et al. (2019) examined WwTW effluent 
samples across 9 countries, of the 280 chemicals detected, 25–67% were 
pharmaceuticals, 5-30% were industrial chemicals, 3-21% were pesticides, 3-23% were 
psychoactive drugs and 2-17% antibiotics. Due to the structurally diverse nature of these 
chemicals many end up in the aquatic environment, and undetectable concentrations 
often means that chemical analysis is not sufficiently sensitive rather than that the 
chemicals are absent (Itzel et al., 2019). 
Our yeast YAS was only able to detect androgenic activity in three of the 107 chemicals 
tested (<3%) and found anti-androgenic activity in 20 of the chemicals tested (19%). In a 
study by Kojima et al. (2004), 200 pesticides were tested for (anti-)androgenic activity by 
a reporter gene assay using Chinese hamster ovary cells. Of the chemicals tested, none 
were found to have androgenic activity, but 66 were found to have anti-androgenic 
activity (33%) with 34 of these having both oestrogenic and anti-androgenic activity 
(17%). Araki et al. (2005), in another study, screened 253 industrial chemicals using AR-
EcoScreen cells but only found two AR agonists (<1%) and nine AR antagonists (3.6%). 
Our results are very much in agreement with these findings; that is, more chemicals 
possessed anti-androgenic activity than possessed androgenic activity.  
3.4.1. Possible androgens 
In my chemical set, the three androgenic chemicals had only very weak (unquantifiable) 
activity, and of these, ibuprofen produced the highest response. Ibuprofen is a widely 
used non-steroidal anti-inflammatory drug, and a study by Kristensen et al. (2011) found 
an association between intrauterine exposures and risk factors for developing male 
reproductive disorders. In an in vitro yeast luciferase assay, Ezechias et al. (2016) found 
ibuprofen to exhibit a dose-dependent antagonism towards the AR, rather than the 
agonism seen in this study. Ji et al. (2013) also tested ibuprofen in adult zebrafish and, 
following a 14-day exposure, found that females had increased concentrations of E2 and 
T and males had decreased T concentrations, although this effect was not thought to be 
due to androgenic activity but rather by alteration of aromatase activity, a steroidogenic 
enzyme involved in converting androgens to oestrogens. 
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Whilst no reports of methyl decanoate having androgenic activity could be found in the 
literature, 2-ethyl hexanoic acid has been linked with developmental toxicity, although 
being positive to the peroxisome proliferator-activated receptor-alpha rather than the AR 
in the CALUX assay (Kroese et al., 2015).   
3.4.2. Possible anti-androgens 
Twelve of our test chemicals caused a reduction in the raised background alongside a 
reduction in the turbidity (i.e. the number of yeast cells). We concluded that this 
reduction was due to toxicity, because when these chemicals were diluted to remove the 
toxicity, there was no activity. Of these twelve chemicals, dihydromethyl jasmonate has 
also been reported by others to have no anti-androgenic activity (Araki et al., 2005). 
Similar to our results, Simon et al. (2016) found 2,4-di-tert-butylphenol to be inactive, 
whereas Mertl et al. (2014) reported anti-androgenic activity. However, tris (2-
butoxyethyl) phosphate, HHCB, 4-chloro-3,5-dimethyl-phenol and terbutryn have all 
been reported in the literature as having anti-androgenic activity. Some of these results 
may be actually a misinterpretation of toxicity, as no tests for toxicity were carried out 
during the in vitro testing for anti-androgenic activity of tris (2-butoxyethyl) phosphate 
(Liscio et al., 2014), 2,4-di-tert-butylphenol (Mertl et al., 2014), and 4-chloro-3,5-
dimethyl-phenol (Liscio et al., 2014). Likewise, when Huang et al. (2011b) examined 
data from the screening of approximately 3000 chemicals against a panel of 10 human 
nuclear receptors, more compounds were active in the antagonist mode than the agonist 
mode, and the authors considered this due to cytotoxicity interfering with results in the 
antagonist mode. However, others did carry out parallel tests for toxicity (terbutryn, Araki 
et al., 2005; HHCB, Ermler et al., 2011) and the different results observed may therefore 
be due to differences in the test systems used, i.e. mammalian versus yeast cells. For 
two of our toxic chemicals (2,4-di-tert-butylphenol and N,N-Dimethyl-1-dodecanamine), 
this toxicity did ‘creep’ across the plate to affect other wells. Previously, oestrogenic 
activity of alkylphenols, in the YES, has also been reported to creep across plates to 
wells not dosed with the compound, but the toxicity at the higher concentrations did not 
creep in these oestrogenic compounds (Beresford et al., 2000). 
In agreement with others, we found no anti-androgenic activity for 3-methyl phenol 
(Satoh et al., 2005), 2-ethyl-1-hexanol (Araki et al., 2005), 2,6-Di-tert-butyl-p-
benzoquinone (Simon et al., 2016), 2-phenyl-2-propanol (Simon et al., 2016), 3-(4-
methoxyphenyl)-2-propenoic acid 2ethylhexyl ester (Vinggaard et al., 2008), 3,3,5-
trimethyl-2-cyclohexen-1-one (Araki et al., 2005; Simon et al., 2016), benzaldehyde 
(Araki et al., 2005), and camphor (Araki et al., 2005; Simon et al., 2016). Likewise, we 
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found no activity with isoproturon and this is in agreement with Vinggaard et al. (2008) 
and Ait-Aissa et al. (2010), but not with Orton et al. (2009) where the ‘Brunel’ yeast 
AYAS was also used. However, this chemical when tested by Orton et al. showed a 
sharp decline in response at the higher concentrations (often indicative of toxicity), and 
this apparent activity may therefore not in be real. We also saw no anti-androgenic 
activity when testing carbamazepine, whereas Liscio et al. (2014) found weak anti-
androgenic activity. 
For one of the groups of chemicals tested, phthalates, there are mixed reports in the 
literature regarding anti-androgenic activity, depending on the paper or test method 
employed. In our yeast-based assay, DEP, DEHP and DBP did not show any anti-
androgenic activity, which is in agreement with Roy et al. (2004), Vinggaard et al. 
(2008), Simon et al. (2016), and Freyberger et al. (2010). However, Tamura et al. (2006) 
and Christen et al. (2010) did find DEP to show anti-androgenic activity using MDA-kb2 
cells, and Lorenzetti et al. (2010) did observe a weak effect that was considered 
indicative of a mixed agonist/antagonist effect with LNCaP cells. As no anti-androgenic 
activity was observed by other laboratories using different mammalian cell lines (PALM, 
Freyberger et al., 2010; CHOK1, Roy et al., 2004; TARM-Luc, Simon et al., 2016; 
Vinggaard et al., 2008), the lack of activity is not restricted to yeast-based assays. 
There have also been discrepancies in the in vivo literature (reviewed in Svechnikov et 
al., 2016), and whilst some phthalates alter reproductive development in an anti-
androgenic fashion, the mechanism of action does not appear to involve either the ER or 
AR (Gray et al., 2001; Marcoccia et al., 2017). The presence of anti-androgenic activity 
in other in vitro assays could therefore be false positive results or involve other 
mechanisms of action that are not AR receptor mediated.  
Twenty of our test chemicals showed anti-androgenic activity, although for two of these 
chemicals this activity was inconsistent. Triphenol phosphate produced inconsistent anti-
androgenic results in our repeat assays, although others have also observed anti-
androgenic activity in vitro (Liscio et al., 2014) and in vivo it has also been shown to 
significantly decrease fecundity following a 21-day adult zebrafish exposure study (Liu et 
al., 2013). Our anti-androgenic activity was observed with triphenol phosphate only in 
our first testing, and it is possible that this chemical became inactive during storage due 
to degradation. Additionally, N-butylbenzene sulphonamide gave inconsistent results in 
our AYAS assay and this compound has been reported by others (Simon et al., 2016) to 
be inactive. However, the assay utilised by Simon et al., derived from the human 
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mammary gland adenoma T47-D cell line, appears to be less sensitive than our yeast 
assay because, whilst they saw oestrogenic activity with benzophenone, they saw no 
anti-androgenic activity with benzophenone. However, in support of our benzophenone 
results, others have similarly reported anti-androgenic activity (Suzuki et al., 2005; 
Tamura et al., 2006). 
For a number of the active chemicals tested by us, others have also reported anti-
androgenic activity in the literature. We found fluoranthene to be a potent anti-androgen 
(more potent than flutamide) and this has also been reported by both Vinggaard et al. 
(2008) and Araki et al. (2005). Triclosan is also a potent androgen antagonist in our 
study and many other publications have previously reported similar activity. For 
example, Vinggaard et al. (2008) reported an IC25 of 3-10 µM and Tamura et al. (2006) 
reported an IC50 of 7.5µM. However, Christen et al. (2010) observed an enhancement 
of DHT induced activity (superagonism) using MDA-kb2 cells and this activity could be 
blocked by flutamide. In this study we found chlorophene to be a potent antagonist 
(more potent than flutamide) and similarly Rostkowski et al. (2011) found chlorophene to 
be more potent than flutamide. However, Lange et al. (2015) carried out an in vitro study 
of 11-ketotesterone (an androgen found in fish) induced activation of stickleback ARα 
and ARβ but saw no inhibition with chlorophene. Lange et al. considered that the lack of 
an inhibition was due to the relatively low sequence identity between the human AR and 
stickleback AR. Pyrene was of a similar anti-androgenic potency to flutamide and has 
also been found to be anti-androgenic by others (Tamura et al., 2006; Vinggaard et al., 
2008). We also found 9H-fluorene to have a similar potency to flutamide, although no 
activity was seen when it was tested by Araki et al. using AR-EcoScreenTM cells derived 
from a Chinese hamster ovary cell line (Araki et al., 2005).  
Many of our results are similar to those already reported by others in the literature. 
However, whilst both Vinggaard et al. (2008) and Tamura et al. (2006) found chrysene to 
be very weakly anti-androgenic, no activity was seen by ourselves. Also, when 
benzo[a]pyrene was tested for anti-androgenic activity, we found no activity. This is 
different to results reported by both Ermler et al. (2011) and Tamura et al. (2006), who 
found benzo[a]pyrene to be androgenic at higher concentrations and anti-androgenic at 
lower concentrations using MDA-kb2 cells, although Ermler et al. did encounter solubility 
issues. Others report benzo[a]pyrene to have only anti-androgenic activity (i.e. no 
androgenic activity at the higher concentrations; Charles et al., 2005; Vinggaard et al., 
2008). However, whilst many cite the anti-androgenic effect of benzo[a]pyrene in vitro, 
Charles et al. (2005) found no activity in the Hershberger assay. Additionally, an in vivo 
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zebrafish exposure study linked the developmental outcomes to aromatase inhibition 
(i.e. less androgens were converted to oestrogens; Alharthy et al. (2017), so the in vitro 
activity reported in the literature may in fact be artefactual. 
Where others have reported seeing anti-androgenic activity in in vitro based assays, 
often these reports have used mammalian cell-based assays rather than yeast cell-
based assays. In addition to the cells potentially behaving differently (including having 
different susceptibilities to chemical toxicity), many mammalian cell-based assays 
deliver the chemical in dimethyl sulphoxide (DMSO), and solubilities (and therefore 
availability) of chemicals may thus be different to yeast-based assays typically using 
etOH as solvent. Additionally, some report using higher chemical stock concentrations 
than tested by myself (1M; Araki et al., 2005) and this may also account for 
discrepancies when lower concentrations were tested. 
3.4.3. Possible superagonists 
In androgen responsive mammalian tissues, T is converted to the more potent DHT by 5 
α-reductase enzymes, and inhibiting these enzymes leads to a reduction in DHT 
synthesis (Aggarwal et al., 2010). Liang and Liao (1992) discovered that certain naturally 
occurring unsaturated fatty acids were able to inhibit 5 α-reductase in cultured cells. Liu 
et al. (2009a) further found fatty acids were able to inhibit the proliferation of LNCaP 
prostate cancer cells. The most potent was dodecanoic acid, followed by myristic acid 
and then pentadecanoic acid. In our yeast screen for anti-androgenic activity we saw 
anti-androgenic activity with dodecanic acid and myristic acid, but not with 
pentadecanoic acid. However, as T was not present in our yeast assay, it is not clear 
how blocking the conversion of T to DHT would create an anti-androgenic effect.  
As it is unlikely that the conversion of T to DHT is the reason for the superagonism, 
another possibility might be due to an alteration in the yeast cell membrane fluidity. 
When Alexandre et al. (1996) exposed Saccharomyces cerevisiae to decanoic acid, a 
medium-chain fatty acid, the plasma membrane H+-ATPase activation induced by the 
decanoic acid correlated with an alteration in membrane lipid constituents, with a 
resultant increase in membrane fluidity. It is therefore conceivable that in our studies 
fatty acids behaving as superagonists might alter the yeast cell membrane and allow the 
DHT to more readily enter the cell. S. cerevisiae do possess 3-oxo-5-alpha-steroid 4-
dehydrogenase that contributes to dolichol-linked oligosaccharide biosynthesis and 
polyprenol degradation and is homologous to human SRD5A3 steroid 5 alpha-reductase 
3 (www.yeastgenome.org). These compounds might therefore be interfering with this 
pathway and as dolichol is an important cellular membrane component may be altering 
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the ability of the DHT to enter though the yeast cell wall. Additionally, there is evidence 
showing that the fatty acids methyl palmitate and methyl oleate have an androgenic 
effect in the Hershberger rat assay (Seres et al., 2014), but when we tested these two 
chemicals in the absence of DHT, no androgenic activity was seen. However, it could be 
that these fatty acids both affect the permeability of the cell wall and act as very weak 
androgens, but it is only in the presence of the DHT that this ‘superagonism’ is apparent. 
Many of the chemicals that behaved as superagonists were fatty acids, although 
monomethyl phthalate, 4-methoxycinnamic acid and methylbenzadlehyde were not. 
Others have similarly seen superagonism, for example, Ermler et al. (2010) found that 
genistein had little to no activity when tested on its own but when tested with DHT 
induced an androgenic response greater than that of DHT. In the MDA-kb2 cell line, 
Christen et al. (2010) found the flame retardant BDE-100 and antimicrobials triclosan 
and triclocarbon to have no or weak agonistic activity, but they enhanced the DHT-
dependent activation of AR-responsive gene expression by 150%, 180% and 130%, 
respectively. This superagonism is not specific to the AR, and superagonism when 
testing genistein has also been observed by Legler et al. (1999), Sonneveld et al. (2005) 
and Berckmans et al. (2007), in different oestrogen responsive reporter gene assays. 
Additionally, the potentiation of the feminising effects of EE2 have been observed in vivo 
in stickleback fish and also rats exposed to EDCs (triclosan, chlorophene and 
dichlorophene; Lange et al. (2015), and triclosan; Stoker et al. (2010).  
These examples of previously reported superagonism are not with fatty acids, and whilst 
there are reports of superagonism with triclosan (Christen et al., 2010; Lange et al., 
2015; Stoker et al., 2010), we saw strong anti-androgenic activity with our yeast-based 
assay instead. Araki et al. (2005) suggested that superagonism could be due to 
synergism via AR and GR transcriptional mechanisms, although our yeast cells do not 
have a GR receptor, and therefore this mechanism cannot explain our results. Stoker et 
al. (2010) also proposed that triclosan either enhanced the interaction of the EE2 with 
the ER or it increased endogenous oestrogen concentrations by inhibiting their 
clearance or catabolism. As our test system did not have an ER or EE2 to interact with 
it, triclosan might be capable of directly inhibiting the AR and having feminising effects.  
3.4.4. Further work 
In addition to checking for toxicity, the potential for false positives can be reduced by 
checking that a strong antagonist is able to block the ability of an agonist to bind to a 
receptor, i.e. whether the response is specific or non-specific (Dent et al., 2019; Juberg 
et al., 2014). For chemicals with anti-androgenic activity, the addition of DHT would 
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enable recovery of the signal if the response was mediated through the AR (Fic et al., 
2014). Parallel inhibition of activity in YES and YAS would also indicate that there was 
non-specific inhibition of induction, i.e. not mediated through the receptor (Fic et al., 
2014).  
These tests were not investigated as part of this study, although they might have helped 
to clarify where toxicity was confounding results. Especially as inconsistencies were 
evident, both when retesting chemicals and also when comparing our results in the 
literature. Instead, for chemicals that tested positive, these were then retested in a 
modification of the yeast (anti-)androgen screen, for confirmation of activities. This work 
is presented in Chapter 4. 
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4. Comparison of two in vitro assays for the determination of (anti-) 
androgenic activity of environmental chemicals 
4.1. Introduction 
As outlined earlier (Chapter 3, Section 3.1), the OECD conceptual framework for testing 
EDCs consists of five levels of testing, investigating different levels of biological 
complexity and sources of data, including in vitro assays (Level 2) which provide vital 
foundation data prior to higher level tests (Levels 3-5) using animal models (OECD, 
2018d). 
In Chapter 3, I tested a large number of chemicals (>100) identified from WwTW 
effluent, for androgenic and anti-androgenic activity using a yeast-based in vitro assay 
system. Whilst testing these chemicals for (anti-)androgenic activity, I came across 
several unexpected results (inconsistencies when retesting chemicals with the AYAS, 
and also some inconsistencies with results published by others) that highlighted some of 
the difficulties that can arise when interpreting results from yeast-based in vitro screens. 
These issues could affect data interpretation and lead to the mislabelling of some of the 
chemicals as EDCs, and a false positive result might lead to in vivo investigations 
leading to unnecessary costs and wasted resources. In contrast, false negatives might 
mean that chemicals do not get investigated further, leading to exposure to the 
environment and people.  
The primary issues identified in Chapter 3 were 1) possible false positives for anti-
androgenic activity which may be caused by chemical toxicity reducing cell viability, or 
‘edge effect’ caused by evaporation, both leading to an altered colourmetric response in 
the assay (presented in Sections 3.3.2 and 3.4.2), and 2) the possibility that some 
chemicals may be ‘superagonists’ (presented in Sections 3.3.3 and 3.4.3).   
Therefore, to refine these results, the in vitro assay was modified, and the results from 
the two assays were then compared to find out which was the most reliable. In this 
Chapter, I used the modified yeast-based assay system to retest all of the androgenic, 
anti-androgenic and superagonist chemicals to confirm the activity observed in Chapter 
3. Additionally, the issues of cytotoxicity and the ‘edge effect’ were investigated further 
to see if they could lead to false positive anti-androgenic activity.  
As found in Chapter 3, Sections 3.3.3, some chemicals had no androgenic activity but 
were able to enhance the activity of DHT, thus acting as ‘superagonists’. We do not yet 
know how superagonists might function, but it is possible that these chemicals are able 
to alter the yeast cell wall permeability and enhance the transport of the chemical into 
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the cell. For example, many of the ‘superagonists’ were fatty acids and this group of 
compounds have been described as ‘penetration enhancers’ (Williams and Barry, 2004). 
Methoxyacetic acid, the active metabolite of ethylene glycol, is an established testicular 
toxicant (Bagchi et al., 2011). In co-transfection studies by Jansen et al. (2004) using 
human hepatic carcinoma (HepG2) cells, two short-chain fatty acids (methoxyacetic acid 
and valproaic acid) were found to markedly increase cellular sensitivity to nuclear 
hormone receptor ligands by enhancing the transcriptional efficiency of ligand activated 
nuclear hormone receptors. The short-chain fatty acids did not affect the EC50 of the 
receptor ligands in the presence of methoxyacetic acid, so Jansen et al. (2004) 
concluded that the effect was not exerted at the ligand binding step. Other short-chain 
fatty acids were also tested, and the carboxylic acid component was found to be 
important for the enhanced hormone activity. Bagchi et al. (2011) also investigated the 
effects of methoxyacetic acid using an androgen-responsive mouse testicular Leydig cell 
line, either on its own or in combination with T. Methoxyacetic acid was able to both 
enhance and antagonise AR activity, and affected many cellular processes including ion 
transport, apoptosis, cell adhesion, phosphorylation and transcription. 
Assays for cytotoxicity measure whether a compound or sample is toxic to cells and in 
most assays either the cell number, cell proliferation or cell viability are measured. The 
determination of cell number in yeast-based assays is usually carried out by monitoring 
absorbance at 600 or 620nm and looking for a reduction in turbidity indicative of toxicity 
(Archer and van Wyk, 2015; Liscio et al., 2014; Ma et al., 2014). Yeast cells have also 
been observed microscopically for damage as an indication of toxicity (Tamura et al., 
2006). 
There are a number of tests available for toxicity that measure different end points of cell 
death. The tryphan blue exclusion assay relies on the fact that viable cells are 
selectively permeable to certain dyes, and membranes of dead cells lack this selectivity. 
The ratio of live cells (clear cytoplasm) to dead cells (blue cytoplasm) is determined 
visually by use of a haemocytometer (Strober, 1997). Another parameter for cell death is 
the integrity of the cell membrane, which can be measured by the leakage of lactate 
dehydrogenase (LDH) by damaged cells. In addition, the metabolic activity of viable cells 
is the basis of a number of colourimetric assays, for example, the ‘MTT assay’ relies on 
the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) by 
the mitochondrial dehydrogenase of viable cells to a blue formazan product that can be 
measured spectrophotometrically (Mosmann, 1983).  
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It is more common to use an assay to directly determine cytotoxicity, but often this 
involves setting up plates in parallel (one for antagonist and one for cytotoxic activity), 
although Berckmans et al. (2007) developed a method using transgenic MELN for 
testing for oestrogenicity and LDH-leakage using a single plate. Weyermann et al. 
(2005) used the LDH, MTT, neutral red and adenosine triphosphate cytotoxicity assays 
to determine the toxicity of triton X-100, chloroquine, sodium azide and ketamine on 
fibroblast cells. The results seen with triton X-100 were comparable with all four assays. 
However, for chloroquine and sodium azide major differences were found with the four 
assays. Assays like LDH and MTT, which rely on enzymatic reactions, could be 
influenced by enzyme inhibitors, leading to misleading results. Hamid et al. (2004) 
compared alamar blue and MTT assays for the HTP screening of 177 drugs using the 
hepatoma cell line, HepG2. Both assays performed consistently, although the 
alamarBlue® assay was slightly more sensitive for most of the drugs tested. 
Cellular screening experiments are often carried out in 96-well plates and multiple day 
incubations can lead to loss of growth medium due to evaporation, particularly in the 
outer wells (Berg et al., 2001; Zimmermann et al., 2003). This can lead to an ‘edge 
effect’ or ‘hook effect’ to the elevated background around the edge of the plate and, 
depending on the size of the ‘edge effect’, this could be misled for anti-androgenic 
activity (anti-androgenic activity also leads to a reduction in colour).  
Prior to testing anticancer drugs, Faessel et al. (1999) characterised the statistical 
properties of an in vitro cell growth inhibition assay. Multiwell plate row and column 
parabolic growth patterns were seen with the most pronounced being the column effect. 
Faessel et al. examined several different parameters, e.g. different multiwell plates, 
multichannel pipette, plate reader, position in incubator, and differential evaporation. 
However, the underlying cause was not discovered so a randomisation step was 
developed for the growth assay. Others have also reported methods, for example, 
removing controls from the periphery plates, to eliminate edge effects (Juberg et al., 
2014).  
Similarly, Patel et al. (2005), using a 3-(4,5-dimethylthiazol-2-yl)-5(3-
carboxymethonyphenol)-2-(4-sulfophenyl)-2 H-tetrazolium assay, found that with 
evaporation in the outer wells there was an increase in absorbance compared to the 
inner wells. When the cells were counted, though, there was no difference in the cell 
numbers between the rows, and the decreased volume was consistent with the 
increased absorbance. However, whilst there may not be a quantifiable difference in cell 
number in these outer wells, Walzl et al. (2012) found significantly different cell 
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metabolism when using the alamarBlue® assay; both an increase in dye concentration 
and a reduction in cellular metabolic activity. Walzl et al. (2012) managed to restore 
these differential effects with the use of a humidity chamber to reduce evaporation.  
It is often hard to compare results of different in vitro assays, as their responses can 
vary due to use of different cell lines and protocols. Therefore, International Organisation 
for Standardisation (ISO) standardised bioassay protocols have been developed, 
including two for yeast-based assays for oestrogenic activity: 
• ISO 19040-1. Water quality – Determination of the estrogenic potential of water 
and wastewater – Part 1: Yeast estrogen screen (YES, Saccharomyces 
cerevisiae) 
• ISO 19040-2. Water quality – Determination of the estrogenic potential of water 
and wastewater – Part 2: Yeast estrogen screen (A-YES, Arxula adeninivorans; 
Hettwer et al., 2018)  
The former of these yeast-based assays uses a similar recombinant yeast strain as used 
for my research outlined in Chapter 3. However, both of these assays are for testing for 
oestrogens and none have yet been developed for (anti-)androgenic assessment. 
In this chapter, the chemicals identified in Chapter 3 with androgenic (3 chemicals, 
Section 3.3.1), anti-androgenic (20 chemicals; Section 3.3.2) or superagonistic activity 
(able to enhance activity of DHT in the AYAS; 12 chemicals; Section 3.3.3), were 
retested using a modified method based on the International Organization for 
Standardization protocol; ISO 19040-1:2018.  
In addition, the issues highlighted in Chapter 3 have been further scrutinised to try to 
identify the reason for the observed results: 
• toxic chemicals can lead to reduction in the colourimetric response that can be 
misinterpreted as anti-androgenic activity. Nystatin (a fungicide) was used to kill 
the yeast cells to assess its effect on the DHT-elevated background in both the 
AYAS and the MTT assay. Comparisons were then made between colourimetric 
absorbance readings and the absorbance readings for turbidity. 
• the ‘edge effect’ (a reduction in the colourimetric absorbance around the 
periphery of the multiwell plate) can be misdiagnosed as anti-androgenic activity. 
Different sealing tapes, to prevent evaporation during the 3 day incubation 
period, were used to see if the ‘edge effect’ could be minimised. 
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• the position that a chemical is pipetted into a multiwell plate may affect the 
response due to the ‘edge effect’. The well position in multiwell plate and its 
effect on anti-androgenic potency relative to flutamide was investigated. 
This investigation illustrates potential issues encountered which may affect data 
interpretation and lead to the mislabelling of certain chemicals as EDCs.  
 
4.2. Materials and methods 
4.2.1. Chemicals 
All chemicals used to prepare medium and components for the assays were purchased 
from Sigma-Aldrich (Dorset, UK) unless stated otherwise. 
Positive control chemicals, namely DHT (≥99% pure) and flutamide (99% pure), were 
purchased from Sigma-Aldrich. DHT and flutamide were prepared at stock 
concentrations of 10-6M and 10-3M in etOH (>99.7%; Hayman Speciality Products, 
Essex, UK), respectively. All test chemicals were prepared at a starting concentration of 
10-2M unless otherwise stated (see Chapter 3 for further details). All stocks were stored 
in sealed glass vials at 4 oC. 
4.2.2. Recombinant yeast (anti-)androgen procedures 
4.2.2.1. Yeast (anti-)androgen assay without yeast cell lysis 
Using the standard YAS (Sohoni and Sumpter, 1998), in the presence of androgens β-
gal was secreted into the medium, causing the substrate, CPRG, to change colour from 
yellow to red and this was measurable by reading the absorbance at 540 nm. For the 
standard AYAS, DHT was added to all the wells and where anti-androgens were present 
this blocked the colour development and the substrate remained yellow. Both standard 
methods are described in Chapter 3. 
4.2.2.2. Yeast (anti-)androgen assay with yeast cell lysis (adapted from ISO 
19040-1:2018 Water quality - Determination of the estrogenic potential of water and 
wastewater - Part 1: Yeast estrogen screen (Saccharomyces cerevisiae)) 
The preparation of medium and buffers is described in Chapter 2, Section 2.2.3.2.4.3.  
For the modified YAS the positive control, DHT, was included in each assay (stock 
concentration at 10-6M and serially diluted in etOH to achieve final concentrations from 
5x10-8M to 2.44x10-11M).  
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The positive control, flutamide, was included in every modified AYAS (stock solution at 
10-3M and serially diluted in etOH to achieve final concentrations of 5 x 10-5M to 2.44 x 
10-8M in the wells). For antagonistic screens, DHT at 2x10-9M was also added to the 
medium prior to addition to all wells.  
The assay procedure is described in Chapter 2, Section 2.2.3.2.4.3. In brief, chemicals 
were serially diluted in etOH and 10 µl volumes were transferred to 96-well flat-bottom 
plates where the etOH was allowed to evaporate to dryness. Then, 200 µl exposure 
medium containing yeast (final cell number of 5 x 105 cells/ml) was added to each well, 
and the plates were sealed and incubated at 32 oC. After incubation the yeast cells are 
lysed with freeze/thaw cycles and assay buffer containing the substrate oNPG was 
added to all wells. Any β-gal in the cell lysate caused the clear medium to turn yellow 
and plate readings were taken at 420 nm (colour) and 620 nm (turbidity) after 30, 60, 
and 90 mins incubation. The 90 min readings were used for all analyses. 
4.2.2.3. Investigation of issues with the potential to cause false positive results 
when screening for anti-androgenic activity 
4.2.2.3.1. MTT assay for investigating the effects of toxicity on anti-androgenic 
activity 
Nystatin was used to observe the effects of toxicity on the DHT response in the AYAS. 
Nystatin was prepared at 120 mg/L in meOH and stored in a sealed vial at 4 oC. MTT 
(used to measure metabolic activity), was prepared at 5 mg/ml in PBS, filter sterilised 
and stored in aliquots at -20 oC.  
For the MTT assay, the nystatin was serially diluted in etOH at 1/1.3 dilutions to elongate 
the transition from toxic to non-toxic concentrations, and this gave final well 
concentrations of 6 to 0.3 mg/L. As described in Chapter 3, 10 µl volumes were then 
transferred to the assay plate and allowed to evaporate to dryness. Then, 180 µl 
medium containing yeast (final cell number of 5 x 105 cells/ml) and DHT at 2x10-9M was 
added to each well. The plates were taped closed and shaken for 2 mins on a plate 
shaker. The plates were then incubated at 32 oC for 68 ± 1 hours. 
After the 3 day incubation period, 20 µl of MTT was added to each well containing 180 µl 
medium (total volume 200 µl). Plates were covered with foil and incubated at 32 oC for 3 
hours (shaking after 0, 1 and 2 hours) and during this time yellow tetrazolium MTT was 
reduced by metabolically active cells into intracellular purple formazan crystals. The 
medium was carefully aspirated from each well (150 µl) so as not to disturb the cells, 
and this was replaced with 150 µl DMSO. The plates were then shaken for 30 mins to 
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solubilise the crystals prior to reading at 570 nm (colour) and 620 nm (turbidity) on a 
plate reader. 
Alongside this MTT assay plate, a further two plates were set up with the same serial 
dilutions of nystatin for running in the standard AYAS, with absorbance reading at 540 
nm (colour) and 620 nm (turbidity), and the modified AYAS with cell lysis with 
absorbance readings at 420 nm (colour) and 620 nm (turbidity). 
4.2.2.3.2. Different sealing tapes to prevent evaporation causing the ‘edge effect’ 
that can be misdiagnosed as anti-androgenic activity 
To investigate if possible ‘edge effect’ can be influenced by different sealing tapes, both 
the standard AYAS and the modified method with lysis were performed with just etOH 
(normally negative control), i.e. no additional chemicals were included in these assays. 
Ethanol was added to all wells in a 96-well plate and was allowed to evaporate to 
dryness. Media containing DHT was then added to all wells and plates were sealed with 
the different tapes, namely tape (i), Browne autoclave indicator tape, and tape (ii) Bel-
Art® Write-on™ Label Tape, prior to incubation at 32 oC. 
4.2.2.3.3. Well position in multiwell plate and its effect on anti-androgenic potency 
relative to flutamide 
Benzeneacetaldehyde was chosen to investigate the issue of well position, as it had a 
clear dose-response curve in the AYAS with no indication of toxicity. 
Benzeneacetaldehyde along with the positive control (flutamide) and negative control 
(etOH) were tested in the AYAS using the method without lysis. The two chemicals 
(flutamide and benzeneacetaldehyde) were pipetted to different rows in multiwell plates; 
into the outer rows or inner rows (see Figure 60 insets illustrating plate layouts). Sealing 
tape (i) was used to seal the plates prior to incubation at 32 oC for 3 days. 
4.2.3. Data Analysis 
All test chemicals were tested in duplicate in every experiment, and each chemical was 
tested in at least two separate experiments. Plotted values are means ± standard error. 
The absorbance values were corrected for cell density using the following equation: 
Corrected value = chemical420 or 540nm-(chemical620nm-etOH blank620nm). 
The EC50s and IC50s were calculated using 4-parameter plot equations with SoftMax 
Pro version 5.0.1. Potency values were calculated by dividing the flutamide IC50 by the 






Photos illustrating typical standard curves can be seen in Figure 49. The EC50 for the 
YAS using the method with lysis was 8.89x10-10 ± 4.51x10-11M or 258 ± 13 ng/L (n=6, 
Figure 50). The IC50 for the AYAS using the method with lysis was 1.03x10-5 ± 8.59x10-
7M or 3834 ± 237 µg/L (n=11, Figure 51). See Appendix Tables A 29 and A 30 for raw 
data. 
 
Figure 49. Photos showing typical yeast screen results after 3 days incubation followed 
by cell lysis and incubation with the chromogenic substrate oNPG. Chemicals were 
diluted from left (high concentration) to right (low concentration). (A) androgen screen; 
the positive control, dihydrotestosterone (DHT), standard curve with yellow wells at 
highest concentrations caused by β-gal converting the clear oNPG substrate to the 
yellow o-nitrophenol, and the negative control, ethanol (etOH) remaining clear in the 
absence of β-gal. (B) anti-androgen screen (all wells containing DHT); the positive 
control, flutamide (FLUT) standard curve, with yellow wells at all but the highest 
flutamide concentrations where the flutamide is blocking the AR receptor so that no β-
gal is released, and the wells remain clear. For the negative control (etOH) all the wells 




Figure 50. Mean ± SEM of the positive control, DHT, and the negative control, ethanol, 
from 6 androgen screens using the cell lysis method. The DHT EC50 for the 6 
experiments was 8.89x10-10M ± 4.51x10-11M, as indicated by the dotted line (see 
Appendix Table A 30 for raw data). 
 
 Figure 51. Mean ± SEM of the positive control, flutamide, and the ethanol negative 
controls (ethanol and ethanol minus DHT in the medium) from 11 anti-androgen screens 
using the cell lysis method. The IC50 for the 11 experiments was 1.03x10-5M ± 8.59x10-
7M, as indicated by the dotted line (see Appendix Table A 30 for raw data). The ethanol 





4.3.1. Comparison of the standard YAS with the lysis method for detecting androgenic, 
anti-androgenic and superagonism activity 
Over 100 chemicals were tested in the standard AYAS (presented in Chapter 3, Section 
3.2.1). Where chemicals tested positive for (anti-)androgenic activity or behaved as 
superagonists, these were repeated in the modified AYAS with yeast cell lysis.  
4.3.1.1. Androgenic activity 
Using the standard YAS with no lysis, three chemicals were found to have very weak 
androgenic activity (methyl decanoate, 2-ethyl hexanoic acid and ibuprofen; Figure 52A). 
The activity of these 3 androgens was too weak to quantify. At the higher ibuprofen 
concentrations (>10-4M) there was a reduction in the androgenic activity due to a 
reduction in the yeast turbidity (i.e. at these test concentrations this chemical was toxic). 
When these 3 chemicals were tested for androgenic activity using the modified method 
with cell lysis, no androgenic activity was seen (Figure 52B), although there was a 
reduction in absorbance with ibuprofen due to toxicity at concentrations above 10-5M 
(the top 6 wells). 
4.3.1.2. Anti-androgenic activity 
Thirty two chemicals showed anti-androgenic activity in the standard AYAS with no lysis. 
For twelve of these chemicals there was a distinct reduction in turbidity and on diluting 
these chemicals to non-toxic concentrations, anti-androgenic activity was no longer 
observed. Therefore, twenty chemicals were anti-androgenic using the method without 
lysis, with no apparent reduction in the turbidity readings. Of these twenty chemicals, 18 
also showed anti-androgenic activity in the assay with cell lysis and the potencies using 
the two methods correlated well (R2 = 0.8789; Table 17 and Figure 53). Two chemicals 
were anti-androgenic using the standard method with no lysis but had no activity using 
the modified method with cell lysis; myristic acid and triphenyl phosphate. The structures 
of the eighteen chemicals showing (anti-)androgenic activity with both methods are 
shown in Figure 54. The chemical properties and environmental concentrations of the 







Figure 52. Androgen screen results seen in (A) the standard androgen screen with no 
cell lysis and (B) the modified anti-androgen screen with cell lysis. The plots are for 
mean values ± SEM for dihydrotestosterone (DHT) positive control, negative control 





Table 17. Comparison of potency values for 20 chemicals possessing anti-androgenic 
activity using the standard yeast anti-androgen screen without cell lysis and the modified 
method with cell lysis. Potency values are relative to the positive control, flutamide, and 
values above 1 are more potent than flutamide. The results are colour coded; strong in 
red (>5 times the potency flutamide), moderate in orange (0.2-5 times the potency of 
flutamide), weak in yellow (0.02-0.199 times the potency of flutamide) and very weak in 




Chemical Cas no. 
Anti-androgenic potency 





17 Triclosan 3380-34-5 9.865 15.736 
41 Chlorophene 120-32-1 12.662 10.166 
20 Methyl triclosan 4640-01-1 8.488 8.859 
16 Fluoranthene 206-44-0 5.113 6.768 
88 Dehydroabietic acid 1740-19-8 1.158 2.194 
19 Pyrene 129-00-0 3.268 1.520 
79 9H-Fluorene 86-73-7 0.485 0.475 
81 Acetylcedrene 32388-55-9 0.151 0.294 
91 
Diphenylacetic acid methyl 
ester 
3469-00-9 0.161 0.237 
82 alpha cedrol 77-53-2 0.030 0.144 
84 Benzeneacetaldehyde 122-78-1 0.034 0.134 
56 2-(methylthio)benzothiazole 615-22-5 0.063 0.129 
10 N-Butylbenzene sulfonamide 3622-84-2 0.172 0.117 
8 Benzophenone 119-61-9 0.020 0.104 








54549-72-3 0.016 0.071 
92 Hexamethylbenzene 87-85-4 0.018 0.014 
18 Triphenyl phosphate 115-86-6 0.517 0.000 




Figure 53. Anti-androgen screen results; mean potency values (± SEM; n≥2) for 20 
chemicals (see Table 17 for chemical details) using the standard anti-androgen screen 
with no cell lysis (red bars) and the modified method with cell lysis (blue bars).  
Potency values are relative to the positive control, flutamide, and values above 1 are 
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Figure 54. Structures of the eighteen anti-androgenic chemicals with activity observed 
using both yeast screen methods, grouped in order of activity; strong to very weak 
activity. Most have one or more benzene ring within the structure and below are 





Table 18. Chemical characteristics of the most potent anti-androgens (strong and moderate activity) together with their reported environmental 
concentrations (no information was available for methyl triclosan as this is a metabolite and not a parent compound). 
Chemical 
no. 


















17 Triclosan 3380-34-5 15.736 4.621 4.76 2.81 3.29 <3-135c 
41 Chlorophene 120-32-1 10.166 112 3.6 2.04 0.268 86-191c 
20 Methyl triclosan 4640-01-1 8.859      
16 Fluoranthene 206-44-0 6.768 0.1297 5.16 3.07 2.57 <1-29.6d 
88 Dehydroabietic acid 1740-19-8 2.194 2.412 4.8 0.5 5.69 130-170e 
19 Pyrene 129-00-0 1.520 0.2249 4.88 2.89 0.556 -840f and 750-4890g 
79 9H-Fluorene 86-73-7 0.475 1.339 4.18 2.42 1.37  




3469-00-9 0.237 21.41 3.72 2.12 0.067 
 
a – Log bioconcentration factor (LogBCF) = 0.6598 LogKow - 0.333 + correction 
b - normalised for 10g fish 
c – Arlos et al. (2015); d – Tousova et al. (2017); e – McMartin et al. (2002); f – Kolpin et al. (2002); g – Kotti et al. (2018); h – Klaschka et al. 
(2013) 




4.3.1.3. Chemicals able to enhance activity of DHT in anti-androgen screen 
(superagonists) 
In 2013 and 2014 when the chemicals were initially tested in the standard AYAS with no 
lysis, twelve chemicals (many being fatty acids) had no obvious androgenic activity in 
the YAS but in the AYAS they were able to heighten the response above the raised 
background in the presence of DHT, normally suggestive of androgenic activity (see 
Chapter 3, Section 3.3.3). In the absence of androgenic activity, these 12 chemicals 
were enhancing the DHT response, i.e. behaving as superagonists.  
At a later date in 2017, four of the more active fatty acids (dimethyl adipate, methyl 
heptadecanoate, methyl palmitate and methyl octanoate) were used as examples in the 
AYAS to compare the results observed using the method without lysis (Figure 55A) and 
the method with lysis (Figure 55B). 
In 2016 and later in 2018, assays were run to try to get a better understanding for the 
reason for the enhanced activity in the AYAS but in these years no superagonism was 
apparent. That is, the earlier results did not repeat. 
4.3.1.4. Investigation of issues with the potential to cause false positive results 
when screening for anti-androgenic activity 
4.3.1.4.1. MTT assay for investigating the effects of toxicity on anti-androgenic 
activity 
Nystatin was used to observe if toxicity could induce false positive results in the 
standard AYAS, i.e. cause a reducing effect on the DHT-elevated absorbance readings. 
Results are shown for the standard AYAS (540 nm and 620 nm absorbance readings 
are compared; Figure 56A), and the modified AYAS with lysis (420 nm and 620 nm 
absorbance readings are compared; Figure 56C). The standard AYAS 540 nm 
absorbance readings are also compared with the MTT assay 570 nm readings (Figure 
56B). For the MTT assay, at the top four nystatin concentrations (wells 1-4; 6-2.7 mg/L; 
Figure 56B) the 570 nm absorbance readings are low, due to toxicity. When the 540 nm 
absorbance results from the standard AYAS were overlaid with the MTT 570 nm results 
(Figure 56B), where there was a lack of metabolic activity due to the nystatin’s toxicity at 
570 nm, there was also no colour development at 540nm that would normally be seen 
with DHT in the AYAS. At the nystatin concentration that was partially toxic (well 5; 2.1 
mg/L) there was an increase in both the 540nm (standard AYAS) and 570 nm (MTT 
assay) absorbance readings, and at the other nystatin concentrations (wells 6-12; 1.6-




Figure 55. Superagonist results seen in (A) the standard anti-androgen screen with no 
cell lysis and (B) the modified anti-androgen screen with cell lysis. The plots are for 
mean values ± SEM for the flutamide positive control, the negative control (ethanol), and 
four fatty acids; dimethyl adipate, methyl heptadecanoate, methyl palmitate and methyl 
octanoate. Also included is an ethanol standard curve from the androgen screen run 










Figure 56. Results from screens monitoring yeast turbidity using nystatin as a positive 
control to kill the yeast (highest concentration in Well 1 (6 mg/L nystatin) diluting to 
lowest concentration in Well 12 (0.3 mg/L nystatin)). The background absorbance was 
raised by adding DHT to the medium in all wells and at the highest nystatin 
concentrations, there was a drop in both colour and turbidity; (A) anti-androgen screen 
using the standard method without lysis, (B) standard anti-androgen screen compared 
with the MTT assay, and (C) the modified anti-androgen screen with lysis. The bars 
represent the colourimetric absorbance at 3 different wavelengths (CPRG; 540 nm, 
MTT; 570 nm, oNPG; 420 nm) and the lines shown the yeast turbidity read at 620 nm (A 
and C) or 540 nm colour (B). In (A) the oval marks the discrepancy between the CPRG 
(540 nm) and turbidity (620 nm) readings when using the standard method without lysis. 
In (A) this drop in the 540 nm reading without a corresponding drop in turbidity could be 
interpreted as anti-androgenic activity, whereas in the modified yeast method with lysis 
(C) the corresponding drop in turbidity indicates the toxicity observed in the MTT assay 
(B).   
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as would be expected due to the DHT present in the wells. Similarly, for the modified 
AYAS with lysis, the nystatin was toxic in the first 4 wells (620 nm and 420 nm; Figure 
56C) and at the more dilute nystatin concentrations there was a decrease in the toxicity 
matched by an increase colourimetric response due to the DHT in the wells.  
However, for the standard AYAS without lysis, in well 5 (Figure 56A) the nystatin was 
not visibly toxic (no reduction in the 620 nm absorbance), but there was less colour 
development at 540 nm. That is, in the standard screen the nystatin did not appear to be 
toxic but there was less colour development that might indicate anti-androgenic activity, 
if only turbidity was used as an indicator of toxicity (which it frequently is). 
 
4.3.1.4.2. Different sealing tapes to prevent evaporation causing the ‘edge effect’ 
that can be misdiagnosed as anti-androgenic activity 
In the standard screen the ‘edge effect’ (measured by absorbance at 540 nm) was a 
pronounced reduction in the 540 nm absorbance reading with sealing tape (i) (Figure 
57A), as well as a visible reduction in the well volume around the edge of the plate. This 
‘edge effect’ around the edge of the plate was not accompanied by a reduction in yeast 
turbidity (measured by absorbance at 620 nm; Figure 57B).  
For the standard AYAS and the method with lysis, two different sealing tapes were 
compared to determine if they influenced ‘edge effect’ (a drop in the raised absorbance 
around the edge of the plate). The sealing tapes were used for the duration of the 3 day 
incubation. For the sealing tape (i), the ‘edge effect’ was obvious (540 nm absorbance; 
Figure 58A) and similarly, there was no reduction of the turbidity readings around the 
edge of the plate (620 nm absorbance; Figure 58B). For the sealing tape (ii), the ‘edge 
effect’ was not obvious (540 nm absorbance; Figure 58C) and similarly, there was no 
reduction of the turbidity readings around the edge of the plate (620 nm absorbance; 
Figure 58D). 
The two types of sealing tape were also tested in the modified AYAS with cell lysis. The 
‘edge effect’ with tape (i) was much reduced (420 nm absorbance; Figure 59A), and 
similarly there was no effect on the turbidity readings (620 nm absorbance; Figure 59B). 
When carrying out the AYAS with lysis, for the plate sealed with tape (ii) there was no 
‘edge effect’ (420 nm absorbance; Figure 59C), or effect on the turbidity readings 





Figure 57. The influence of the plate column and plate row on the ‘edge effect’ at 540 
nm (colourimetric) and 620 nm (turbidity) absorbance values using the standard anti-
androgen screen method without lysis. All wells contained ethanol (evaporated to 
dryness) and media containing DHT, and plates were sealed with tape (i), to prevent 
evaporation during the 3 day incubation. (A) shows a pronounced ‘edge effect’ with a 
reduction in the 540 nm absorbance reading, most visible in the outside rows; Row A 
and H, and also the outside columns; Column 1 and 12. Each well has the same 
concentration of DHT, however the lower 540 nm absorbance in the outer rows/columns, 
could be misinterpreted as anti-androgenic activity. (B) shows the turbidity, 620 nm 
absorbance readings, in the same plate. The turbidity (620 nm) does not have the same 
reduction as the colourmetric (540 nm) readings. Both plots represent individual values 





Figure 58. Different sealing tapes and their influence on the ‘edge effect’ values in the standard AYAS without cell lysis. All wells contain 
ethanol (evaporated to dryness) and media containing DHT, and plates were sealed with tape to prevent evaporation during the 3 day 
incubation. (A) shows the 540 nm absorbance readings for the plate sealed with sealing tape (i) and (B) the 620 nm absorbance values 
(turbidity) for the same plate. (C) shows the 540 nm absorbance readings for the plate sealed with sealing tape (ii) and (D) the 620 nm 


















Figure 59. Different sealing tapes and their influence on the ‘edge effect’ values in the modified AYAS with cell lysis. All wells contain ethanol 
(evaporated to dryness) and media containing DHT, and plates were sealed with tape to prevent evaporation during the 3 day incubation. (A) 
shows the 420 nm absorbance readings for the plate sealed with sealing tape (i) and (B) the 620 nm absorbance values (turbidity) for the same 
plate. (C) shows the 420 nm absorbance readings for the plate sealed with sealing tape (ii) and (D) the 620 nm absorbance values (turbidity) 




4.3.1.4.3. Well position in multiwell plate and its effect anti-androgenic potency 
relative to flutamide 
When flutamide was pipetted into outer rows A and H, the maximum absorbance value 
was 2.373 and the IC50 was 2.76x10-6M (Figure 60A), whereas when flutamide was 
pipetted in to middle rows D and E the maximum absorbance value was 2.529 and the 
IC50 was 2.58x10-6M (Figure 60B). The reverse was true when the positions of the 
positive control and the test chemical were swapped, and when benzeneacetaldehyde 
was pipetted into middle rows D and E, the maximum absorbance was 2.474  and the 
IC50 was 7.37x10-5M (Figure 60A), whereas when benzeneacetaldehyde was pipetted 
in to outer rows A and H the highest absorbance was 2.421 and the IC50 was 4.87x10-
5M (Figure 60B). That is, the outer rows have lower maximal absorbance values as they 
are affected by the ‘edge effect’ and chemicals are less affected when they are pipetted 
into the middle rows. The position that the chemical was pipetted on the plate did also 
alter the position of the slope of the curves and the potency of benzeneacetaldehyde 
relative to flutamide in plate layout A (Figure 60) was 0.037 and for plate layout B the 





Figure 60. Pipetting to different positions in the multiwell plate and effect on chemical 
potency. Plots describing how the position of the chemical on a 96-well plate can 
influence perceived activity in the standard anti-androgen screen method without cell 
lysis.The positive control (flutamide; blue diamonds), the negative control (ethanol; red 
squares), and the example test chemical (benzeneacetaldehyde; green triangles) were 
pipetted into different positions in the multiwell plate (see insets). In (A) flutamide is 
pipetted at the edge of the plate in rows A and H and benzeneacetaldehyde is pipetted 
to rows D and E. In (B) the positions are reversed and flutamide is pipette to rows D and 
E and benzeneacetaldehyde is pipetted to rows A and H. Sealing tape (i) was used to 
seal the plates prior to incubation. For both plate layouts, ethanol is pipetted to rows C 




4.4.1. Comparison of the standard YAS with the lysis method for detecting androgenic, anti-
androgenic and superagonism activity 
There are a number of reliable in vitro tests for (anti-)androgenic activity and these are 
generally based on either mammalian cell lines (Korner et al., 2004) or yeast cells (Sohoni 
and Sumpter, 1998). When testing chemicals for (anti-)androgenic activity in this thesis using 
the standard YAS and AYAS (Sohoni and Sumpter, 1998), a number of issues were 
encountered that had the potential to influence the results and could lead to a chemical 
being wrongly labelled. 
4.4.1.1. Androgenic activity 
Using the standard YAS to test 107 chemicals for activity, only three had androgenic activity 
(methyl decanoate, 2-ethyl hexanoic acid and ibuprofen) and all gave sub-maximal 
responses that were too weak to quantify. There are no reports in the literature of methyl 
decanoate or 2-ethylhexanoic acid possessing either in vitro or in vivo androgenic activity 
(latest Web of Science search 22/12/2020) and a search of PubChem 
(https://pubchem.ncbi.nlm.nih.gov/, downloaded 22/12/2020) of HTP screens utilising AR 
bioassays with MDA cells showed either no activity or inconclusive activity for both methyl 
decanoate or 2-ethylhexanoic acid. Differences in activity when using different test systems 
have been explained by others as being due to a difference in toxicity, different permeability 
of the cell wall/membrane, or the fact that yeast cells lack mammalian-specific coactivators 
(Christiaens et al., 2005). However, yeast cells would be more likely to underestimate activity 
rather than overestimate it, due to the less permeable cell wall (Soto et al., 2006). Given that 
no androgenic activity was seen when using the modified YAS with cell lysis, the results 
seen here may be due to artefacts. 
For ibuprofen, at concentrations above 10-4 M there was a reduction in turbidity, and this 
meant that the curve did not attain its maximal absorbance. However, even by extrapolating 
the curve, the potency would have been at least a million times less than the potency of 
DHT. No androgenic activity was seen with ibuprofen when using the modified yeast screen 
with cell lysis, but the ibuprofen was toxic to the yeast cells at the highest concentrations, so 
androgenic activity may not have been seen for this reason. Why the ibuprofen would be 
more toxic using the method with cell lysis is unclear, as whilst the preparation of the 
medium was different, the concentrations of the individual components were almost 
identical. I could find no reports in the literature of ibuprofen possessing androgenic activity 
(latest Web of Science search 22/12/20), but ibuprofen has been demonstrated to have anti-
androgenic activity in a bioluminescent yeast assay (Ezechias et al., 2016) and has been 
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linked with anti-androgenic effects in humans (depression of T production; Kristensen et al., 
2018). As ibuprofen is able to interact with the AR, the yeast may have behaved differently to 
the chemical (as an agonist and not an antagonist) due to the near toxic concentrations, or 
produced false positive androgenic activity triggered by cell stress at concentrations 
approaching toxicity (Escher et al., 2019; Fay et al., 2018; Judson et al., 2017). 
4.4.1.2. Anti-androgenic activity 
For some of the chemicals tested in this thesis, other laboratories found them to have anti-
androgenic activity, but we did not. For example, tris (2-butoxyethyl) phosphate and triphenyl 
phosphate (Liscio et al., 2014), HHCB (Orton et al., 2014), benzo[a]pyrene (Tamura et al., 
2006; Vinggaard et al., 2008), DEP (Christen et al., 2010; Tamura et al., 2006), chrysene 
(Vinggaard et al., 2008) and (Tamura et al., 2006), and carbamazepine (Liscio et al., 2014). 
For a number of these chemicals we noticed toxicity that might have been misinterpreted as 
antagonistic activity by others, e.g. tris (2-butoxyethyl) phosphate. At concentrations close to 
toxicity cells activate numerous defence mechanisms (described as cytotoxic burst), and 
these can potentially lead to non-specific activation of reporter genes (Escher et al., 2019). 
However, for other chemicals, e.g. benzo[a]pyrene, we did not notice any sign of toxicity, but 
in this case it is worth noting that the benzo[a]pyrene was poorly soluble and may not have 
been taken up by the yeast cells.  
On searching PubChem (https://pubchem.ncbi.nlm.nih.gov/, downloaded 22/12/2020) for 
confirmation of AR antagonistic activity, the results were a mix of inactive, inconclusive and 
active for a number of these chemicals. The HTP bioassays mainly use MDA-kb2 cells with 
the test chemicals dissolved in DMSO, and therefore even with similar bioassay protocols, 
consistent results are limited. 
4.4.1.3. Chemicals able to enhance activity of DHT in anti-androgen screen 
(superagonists) 
Using the standard AYAS method, twelve chemicals produced an enhanced response above 
that produced by baseline DHT. However, in the YAS, in the absence of DHT, these 
chemicals had no androgenic activity and hence we term them ‘superagonists’. Some of the 
‘superagonist’ compounds were fatty acids. These chemicals could be acting as penetration 
enhancers rather than actually enhancing the activity at the AR, i.e. the fatty acid could be 
aiding DHT entry into the cells or the secretion of β-gal into the medium.  
This superagonism was seen with both our standard and modified AYAS methods (without 
cell lysis and with cell lysis) but the results were not reliable in that the superagonism was 
noticed in 2013, 2014, and 2017, but not in 2016 and 2018. Fresh chemicals were 
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purchased at the start of this work in 2013 and 2014, and again in 2017 when the 
superagonists were repeated in the modified AYAS with cell lysis. It is therefore possible that 
the superagonism was observed when the chemicals were fresh but not after they had been 
stored. However, due to the long periods between assays, there would have been different 
batches of yeast and media used for many of the experiments, making it difficult to be 
consistent despite following a Standard Operating Procedure. These differences may have 
impacted on the sensitivity of the cells to the various chemicals, and perhaps the cell wall 
was more/less penetrable at different times, depending on this sensitivity. Unfortunately, due 
to time constraints I was not able to investigate this phenomenon further. 
This potentiation of the response has also been observed with genistein using both gene 
reporter assays for anti-oestrogens (Legler et al., 1999; Sonneveld et al., 2005) and for anti-
androgens (Ermler et al., 2010). Similarly, the potentiation of the response has also been 
observed with triclosan in gene reporter assays for both anti-oestrogens (Ahn et al., 2008) 
and for anti-androgens (Ahn et al., 2008; Christen et al., 2010).  
Superagonism observed in vitro has also been observed in vivo. For example, when Knag et 
al. (2013) exposed stickleback fish to naphthenic acids, no androgenic effect was observed 
when tested alone, but when tested with DHT there was a potentiation of the spiggin 
induction (androgenic) response in a dose-dependent manner. But when this experiment 
was repeated with seawater rather than freshwater, there was no longer a potentiation of the 
spiggin signal, and Knag et al. (2013) suggested that possibly the composition of the 
naphthenic acids was different when in the saltwater. The potentiation of the feminising 
effects of EE2 have also been observed in vivo in roach (Lange et al., 2015) and rats 
exposed to EDCs (Stoker et al., 2010), and given that this phenomenon has been observed 
in a number of different instances (with different chemicals, different cell lines, different 
receptors, in vitro and in vivo) it seems likely that the response is not receptor mediated.   
4.4.1.4. MTT assay for investigating the effects of toxicity on anti-androgenic activity 
Toxic effects of chemicals in vitro can cause misleading results in the AYAS, as both anti-
androgenic activity and toxicity cause a drop in the DHT-elevated absorbance, either 
because the action of DHT is blocked (anti-androgenic) or cell death means that the cells no 
longer respond to the DHT (toxic), and both lead to a reduction in β-gal.  In vitro testing is 
therefore often carried out alongside tests for toxicity. Using the standard AYAS (see 
Chapter 3, Section 3.3.2), a number of the chemicals that we tested were either toxic (giving 
a clear yellow well with no red colour developing) or caused a reduction in the yeast turbidity 
at the higher concentrations (together with an inhibition in the development of the red 
colour). Hence where anti-androgenic activity was observed for chemicals that were toxic at 
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the higher concentrations, the results may in fact be due to cytotoxicity. Similarly, when 
Huang et al. (2011a) examined data for approximately 3000 environmental chemicals from 
the Tox21 pilot-phase collection against a panel of 10 nuclear receptors including the AR, a 
total of three hundred and twenty three compounds were identified as potentially cytotoxic. 
False positive activities are often caused by cell stress at concentrations approaching toxicity 
(Judson et al., 2016). 
Due to the potential for chemicals at/close to cytotoxic concentrations to cause false positive 
results, the antifungal nystatin was used to see how ‘killing’ the yeast cells affected the DHT 
enhanced colourimetric absorbance readings. The reduction in the DHT colourimetric 
response in the AYAS due to nystatin (Figure 56B) and modified method with lysis (Figure 
56C), was compared with the respective turbidity readings at 620 nm and the absorbance at 
570 nm in the MTT assay.  
In the MTT assay (a measure of metabolic activity), the four highest concentrations of 
nystatin (6-2.7 mg/L) caused toxicity and these same results were mirrored in the standard 
AYAS (Figure 56B). Similarly, for the modified AYAS with cell lysis, the toxicity was mirrored 
by low colourimetric values (Figure 56C). Therefore, a drop in the MTT values in the MTT 
assay and the turbidity values in the modified AYAS with lysis both gave a good indication of 
toxicity. However, for the standard AYAS, whilst there was a lack of colour change at 540 nm 
due to the toxicity of nystatin, this was not reflected at almost toxic concentrations (Figure 
56A), where there was little alteration in the yeast turbidity absorbance value. Because the 
standard AYAS relies on the secretion of the β-gal into the medium, under mildly toxic 
conditions or prior to cell death, β-gal secretion could continue even as the cells are being 
killed by the nystatin, and hence false positive anti-androgenic activity might be observed.  
Chemicals may also be non-toxic but exert their effects in other ways. For example, Liscio et 
al. (2014) used a yeast-based assay to identify two antifungal agents with high relative 
potency in anti-androgenic fractions following fractionation of river water samples; these 
were propiconazole and miconazole. However, when using the AR-CALUX assay, which 
uses mammalian cells, these two compounds were found to have very weak anti-androgenic 
activity. Conazole fungicides inhibit ergosterol synthesis, which is necessary for creating 
yeast cell wall membranes, and although Liscio et al. observed no effects on yeast growth, it 
is possible that the antifungal agents affected the yeast cell function in other ways. Kjaerstad 
et al. (2010) examined the effects of conazole antifungals using a panel of in vitro assays 
and found the critical mechanism for endocrine disruption to be the disturbance of steroid 
biosynthesis, rather than receptor binding. 
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4.4.1.5. Different sealing tapes to prevent evaporation causing the ‘edge effect’ that 
can be misdiagnosed as anti-androgenic activity 
Using the standard AYAS procedure using autoclave tape (i) to seal the 96-well assay 
plates, we observed a distinct ‘edge effect’ or ‘hook effect’ to the 540nm absorbance 
readings. Similar to Patel et al. (2005), we saw no reduction in turbidity across the plate but 
there was a visible reduction in the volume in the outer wells of the plate. In the standard 
AYAS, this ‘edge effect’ causes a reduction in colour in the outer wells that could be 
misinterpreted as anti-androgenic activity. On using a different, less porous tape to seal the 
plate, this ‘edge effect’ was much reduced. For the modified screen where the cells are 
lysed, only a proportion (25%) of the well contents was removed from the assay plate and 
transferred to a fresh plate for cell lysis, and using this method the ‘edge effect’ was also 
much reduced with both tapes. Zimmermann et al. (2003) also examined different tapes and 
materials to compare their ability to minimise water evaporation from a 96-well plate while 
maintaining oxygen supply as high as possible. Evaporation was quantified by weighing the 
plate filled with water but an optimal product with high oxygen permeability and low 
evaporation was not found.   
Whilst a tighter seal did reduce evaporation in our AYAS and resulted in a reduced ‘edge 
effect’, by using a less porous tape it is possible that less oxygen was available for aerobic 
growth. Snoek and Steensma (2007) compared the composition of yeast cell walls when 
growing under aerobic and anaerobic conditions, and under anaerobic conditions the yeast 
cells could no longer synthesise sterols but instead required them to be added to the media. 
As sterol is necessary for producing the cell wall, there is a possibility that the cell wall could 
have been altered when using the less porous tape, but nevertheless there did not appear to 
be any difference in the turbidity measurements with the second less porous tape.  
4.4.1.6. Well position in multiwell plate and its effect anti-androgenic potency relative 
to flutamide 
The position that a chemical is pipetted into a plate did alter the potency of that chemical 
relative to flutamide. This was due to the ‘edge effect’ with the standard AYAS and with 
sealing tape (i). Reducing the ‘edge effect’ by using the less porous tape to seal the plate 
and/or the modified method with cell lysis rather than the standard AYAS, is likely to 
minimise this difference in potency depending on the pipetting position (although due to time 
constraints this was not confirmed). Alternatively, the outer wells could be left unused 
(although this does not make good use of the wells) or chemicals pipetted into different 




4.4.2. Advantages and disadvantages of the two different yeast screens for (anti-) 
androgenic activity 
The standard yeast screen methods without cell lysis has the advantage that the colour 
development of the screen can easily be monitored over a period of time, because the yeast 
secretes the β-gal into the medium, whereas with the modified cell lysis method no colour 
development is seen until after lysis and incubation with the substrate. The standard method 
without lysis is a quicker screen to perform, as the method with cell lysis requires transferring 
a proportion of the medium in each well to another plate for lysing. This transfer process can 
also increase variability if the cells are not well resuspended. The cell lysis method, though, 
could be sped up by lysing the cells with lyticase rather than freeze/thawing, and this might 
additionally produce less variable readings.  
The standard screen method could lead to misinterpretations due to toxicity, as it did for two 
of the chemicals presented in Chapter 3. Also, when comparing the two methods (with or 
without cell lysis) in the YAS, three chemicals were shown to be androgens in the standard 
YAS method (methyl decanoate, 2-ethylhexanoic acid and ibuprofen) but not in the modified 
method with cell lysis, and hence these activities were possibly false positives. I found the 
modified method with cell lysis to be less prone to false positives for both androgenic and 
anti-androgenic activity, and therefore believe it to be a more robust method.  
4.4.3. Are the most potent anti-androgens likely to cause harm to the environment? 
The structures of chemicals containing AR antagonist properties are extremely diverse 
(Vinggaard et al., 2008). During AR binding, the H12 functions as a lid, which closes 
(agonist) or moves away from the LBP (antagonist), and AR antagonists are therefore 
usually bulkier than agonists and thus require a wider binding pocket than agonists 
(presented in Chapter 1, Section 1.2).  
The most potent of the anti-androgens that I tested were four carbon ring structures (as for 
DHT) (Table 17 and Figure 54). In general, the smaller the structure the less the activity 
(most of the compounds with moderate activity had a 3-ring structures, those with weak 
activity had a 2-ring structures and those with very weak activity had a single-ring. An 
aromatic side chain has been shown to have a significant role in the anti-androgenic potency 
of parabens (Ding et al., 2017), and for many of the more potent anti-androgen that I tested 
this was also the case. Three of the potent chemicals had one or more chlorines and this 
has also been shown to increase AR binding (Singh et al., 2000). Ding et al. (2017), reported 
that larger side chains were unable to dock into the AR LBD, and perhaps for the three fatty 
acids that only had weak activity this was due to their longer chain length. 
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The most potent anti-androgens were assessed for their ability to cause harm to the 
environment. For these chemicals, the potency, the water solubility, octanol/water partition 
coefficient (LogKow), log bioconcentration factor (LogBCF), and half-life are presented in 
Table 18.  
Chemicals with a high water solubility (>1 g/L) will partition to water and not to particles such 
as sludge, sediments, and soil, and vice versa for chemicals with low solubility (<0.1 g/L). 
Highly soluble chemicals are more likely to present a potential exposure concern for aquatic 
organisms in surface waters, and for humans via drinking water, but the more potent 
compounds identified in this chapter were only slightly soluble (e.g. triclosan, has a solubility 
of 4.621 mg/L). In addition, chemicals with a LogKow greater than 4 are hydrophobic and are 
again more likely to partition with particles, as was the case for the LogKow for most of our 
compounds. Of more concern are compounds with a LogKow between 2 and 4 (e.g. 
chlorophene and diphenylacetic acid), as these can be readily absorbed and are more likely 
to accumulate in aquatic organisms; Meador et al. (2016) found most of the compounds 
detected in fish to have high LogKow values. Stackelberg et al. (2007) also found the 
primary route of removal for hydrophobic analytes (LogKow > 4) was adsorption onto GAC 
during the wastewater treatment process and in surface waters it was the most hydrophilic 
classes that were detected, namely pharmaceuticals with LogKow value less than 1. 
According to the Sustainable Futures/P2 Framework Manual, 2012 (EPA-748-B12-001), any 
compound with a LogBCF ≥ 3.7 has a high bioconcentration potential, a value of 3 has a 
moderate bioconcentration potential and below 3 has a low bioconcentration potential. Many 
of our active compounds have a LogBCF close to 3 (triclosan, pyrene and acetylcedrene; 
Table 18) but only one exceeded 3 (fluoranthene; Table 18).  
Another chemical property is the half-life; anything with a value greater than 2 days meets 
the Persistence Criteria set by the EPA for new chemicals 
(http://www.epa.gov/oppt/newchems/pubs/pbtpolcy/htm). Four of the anti-androgenic 
compounds identified in this chapter fall into this category; triclosan, fluoranthene, 
dehydroabietic acid and acetylcedrene. Longer half-life means that triclosan, fluoranthene, 
dehydroabietic acid and acetylcedrene are more likely to bioaccumulate in in animals and 
bioconcentrate through the food chain (Wangmo et al., 2018), although the LogBCF for 
dehydroabietic acid is very low (Table 18). The most soluble of our active compounds, 
chlorophene and diphenylacetic acid methyl ester, did have very short half-lives but, despite 
this, chlorophene has been detected in surface waters at concentrations from 86-191ng/L 
(Arlos et al., 2015). In addition, whilst acetylcedrene has a long half-life, it is only at low 
concentrations in the aquatic environment and therefore not such a concern. 
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Fluoranthene is one of the 48 compounds on the List of Priority Substances in the Field of 
Water Policy, with an EQS of 6.3 ng/L (WFD (Classification, Priority Substances and 
Shellfish Waters) Regulations (Northern Ireland) 2015). However, fluoranthene is only on 
this list as an indicator of other, more dangerous, PAHs. About 817,800 tonnes of high 
temperature coal tar pitch, which contains fluoranthene and pyrene, was produced in one 
year and production leads to PAH emissions (Fluoranthene EQS dossier, 2011). Given the 
production volume, potency, chemical properties, and the environmental concentrations of 
fluoranthene and pyrene, these compounds should be considered as hazardous. Especially 
as, whilst they are likely to be associated with particles rather than partitioned to water, 
zebrafish exposed to freely dissolved fluoranthene and pyrene in the presence of suspended 
particles had an elevated uptake rate due to exposure via ingestion (Zhai et al., 2018). 
Triclosan and its metabolite, methyl triclosan, were both potent anti-androgens and methyl 
triclosan is more persistent and toxic and found more commonly in fish than triclosan (Rudel 
et al., 2013). Due to its potency, the US Food and Drug Administration has banned triclosan 
from some household products and it is being considered for banning and/or replacement in 
products around the world (Cavanagh et al., 2018). Since this ban the production of triclosan 
has dropped and in 2013, 4,760 tonnes were produced worldwide compared with 6,581 
tonnes in 2011 (Triclosan Market Report, 2016). Triclosan has been widely detected in 
surface water (e.g. Arlos et al., 2015; Fuzzen et al., 2016; Kolpin et al., 2002; Meador et al., 
2016; Scott et al., 2018) and in human urine (mean of spot samples 23.3 µg/L; Pollack et al., 
2016). Whilst I found triclosan to be a potent anti-androgen in vitro, Pernoncini et al. (2018) 
found no evidence of (anti-)androgenic activity in the in vivo Hershberger assay at a dose as 
high as 8 mg/kg. Furthermore, Mihaich et al. (2017) weighted up the evidence in over 35 
peer-reviewed in vitro and in vivo studies for an assessment of the endocrine activity of 
triclosan, and concluded that their assessment indicated that triclosan was not acting as an 
agonist or antagonist within the oestrogen, androgen, thyroid or steroidogenic pathway. 
Considering that triclosan is able to bioconcentrate (900 - 2100 times in algae; Coogan et al., 
2007) and has a long half-life with a potent metabolite, this chemical is still a potential 
concern despite the questionable in vivo activity. Indeed, due to the frequency of detection in 
surface waters and exceedance of the PNEC (30 ng/L; Liu et al., 2020), triclosan appears on 
several priority lists as a high to moderate risk to the environment (Liu et al., 2020; Tousova 
et al., 2017; Zhou et al., 2019)  
Whilst several of the chemicals tested in this chapter possessed anti-androgenic activity that 
was weaker than the potent anti-androgen, flutamide, it is important to consider that the 
chemicals present in the environment will occur as a mixture. For compounds that exhibit the 
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same mode of action one would expect additive effects (Ermler et al., 2011), and many weak 
anti-androgenic chemicals might together be sufficient to cause disruption. 
In this chapter I have looked extensively at two in vitro tests for (anti-)androgenic activity. 
However, no single assay can be expected to be ‘the best’ and any activity seen in vitro 
needs to be confirmed in vivo to ensure that the bioaccumulation, metabolism, and 
availability to the target cell, or alternative pathways for endocrine disruption of the 
compounds, and thus the final health effects, are assessed. Only by using a suite of assays, 
as described in the OECD conceptual framework for evaluating chemicals for endocrine 
disruption (OECD, 2018d), is it possible to lower the likelihood of mislabelling chemicals as 
EDCs. Currently there are no validated fish tests for anti-androgens, and although the 
Androgenised Female Stickleback Screen (AFSS; a variant of the 21-Day Fish Assay; 
OECD, 2018c) has more power to identify anti-androgens than the OECD TG 229 or TG 230 
(OECD, 2018a; b), this test has a more limited range of endpoints. The AFSS is an assay for 
identifying endocrine active chemicals with (anti-)androgenic activity in fish using sexually 
mature female sticklebacks, that are specifically dosed with DHT to induce spiggin 
production (androgenised females). Chemicals blocking the AR receptor reduce this spiggin 
production, indicating anti-androgenic effect (Katsiadaki et al., 2006). An alternative in vivo 
assay with the ability for identifying anti-androgens is the Juvenile Medaka Anti-Androgen 
Screening Assay (OECD, 2018c), but this assay awaits validation.  
In Chapter 5, next I investigate potential biomarkers for (anti-)androgenic activity in the FHM, 
a species regularly used in OECD test guidelines to identify oestrogenic, androgenic, and 





5. Do fathead minnows possess a spiggin-like protein that could be used as 
a sensitive bio-marker of (anti-)androgen exposures?  
5.1. Introduction 
Small-bodied freshwater fish are commonly used in regulatory testing for EDCs. Currently 
there are only a few fish tests that assess chemicals for (anti-)androgenic activity, and these 
do so by monitoring for changes in SSCs; gonopodial development in mosquito fish (Howell 
and Denton, 1989), papillary process development in medaka (Seki et al., 2006), and 
tubercle number and size of fatpad in FHM (Ankley et al., 2001). These endpoints often lack 
sensitivity (i.e. are not responsive to low concentrations of androgenic compounds; Muldoon 
and Hogan, 2016) and some are scored on a subjective scale so may be subject to bias 
(Ankley et al., 1998). SSCs can also be affected by the hierarchical status of the fish, making 
it difficult to attribute a change in appearance to exposure to an EDC (Muldoon and Hogan, 
2016).  
To date there is only one adequate androgen dependant biomarker that has been developed 
in fish for the screening of (anti-)androgens (Katsiadaki et al., 2006; Katsiadaki et al., 2002). 
This screen uses the three-spined stickleback (Gasterosteus aculeatus), a fish native to 
most inland coastal waters north of 30°N. The kidney of the male stickleback hypertrophies 
during the breeding season, when the secondary proximal epithelial cells synthesise a glue 
glycoprotein, spiggin (the Swedish name for the three-spined stickleback being spigg). The 
spiggin is secreted into the urinary bladder and is then used to stick plant material together 
to form a nest (Borg, 1994). Following fertilisation of the eggs, the male subsequently cares 
for the eggs until shortly after they hatch.  
Androgen-dependent spiggin can also be induced in the kidneys of female stickleback fish in 
response to endogenous androgens, where it can be determined by measuring the KEH or 
by using an ELISA for spiggin (Katsiadaki et al., 2002). European bullhead exposed to 
trenbolone acetate also had dose-dependent kidney hypertrophy (linked to the production of 
glycoprotein containing mucus), which was quantified using the KEH measurement (Villeret 
et al., 2013). However, the bullhead KEH measurement was a less sensitive endpoint than 
stickleback KEH. Androgenised female stickleback fish can also be used to screen for 
endogenous anti-androgens (Katsiadaki et al., 2006) and is partially validated as an OECD 
test (OECD, 2018c). More recently, spiggin transcription was significantly down regulated 
when stickleback fish were exposed to the anti-androgen flutamide although surprisingly the 
flutamide did not affect the transcription of AR receptors (Fitzgerald et al., 2020). 
Jones et al. (2001) characterised three different spiggin subunits (α, β and γ), and these 
spiggin subunits were found to have highest similarity to Xenopus mucin B.1 (28%), rat 
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MUC2 (27%), human MUC5AC (27%), human von Willebrand factor (VWF; 26%) and 
murine otogelin (25%). Later, a phylogenetic study by Kawahara and Nishida (2006) showed 
that spiggin was related to vertebrate mucins, avian ovomucins, zebrafish otogelins, and 
mammalian zonadhesin, although more closely so to mucins than otogelins (Kawahara and 
Nishida, 2006).  
Mucins are major glycoprotein components of mucus and are either membrane bound (in 
humans and mice; MUC1, MUC3, MUC4, MUC12, MUC13, MUC15, MUC16 and MUC17) or 
secreted (in human and mice; MUC2, MUC5B, MUC5AC, MUC6 and MUC19) (Lang et al., 
2007). The secreted mucins are large glycoproteins that cover the epithelial cell surfaces of 
the respiratory, digestive and urogenital tracts, forming gel-like structures, thereby protecting 
against harmful molecules and microorganisms (Lang et al., 2007). Most vertebrates have 5 
to 6 secreted gel-forming mucin genes and these share a similar structure with considerable 
sequence homology in the conserved regions (Perez-Vilar and Hill, 1999). A characteristic 
protein structural domain of the gel-forming mucins is the von Willebrand factor type D 
domain (VWD) named after its occurrence in the VWF (Figure 61).  
The MUC2, MUC5AC, MUC5B have a domain architecture which is –  
(VWD-C8-TIL)-( VWD-C8-TIL)-(VWD-C8-TIL)-PTS-(VWD-C8-TIL) 
The MUC6 and MUC19 have the same domain structure but lack the C-terminal VWD-C8-
TIL unit. There is a highly variable region in the 5’ end of the MUC19 that is lacking in other 
gel-forming mucins.  
Although MUC19 is present in fish, amphibians, and mammals, it does not appear to be 
present in birds. In contrast, MUC6 is present in birds but is missing in most teleost species 
(Lang et al., 2016). Whilst spiggin is found in the kidney of male stickleback fish (Kawahara 
and Nishida, 2006), human and mouse MUC19, the most closely related mucin to spiggin, 
are found in the sub-maxillary gland (Chen et al., 2004). Phylogenetic analysis revealed 
porcine sub-maxillary gland mucin to be the same as pMUC19 (Zhu et al., 2011). Thus, the 
expression pattern of the spiggin gene may have changed after the divergence of tetrapods 
and fish (Kawahara and Nishida, 2006). 
More recent work by Kawahara and Nishida (2007) using the genome sequence of the 
three-spined stickleback showed that there are at least five spiggin genes and analyses of 
these sequences suggested that an ancestral spiggin gene originated from a member of the 
mucin gene family. The occurrence of a single spiggin homologue was also demonstrated in 
zebrafish, medaka, torafugu and spotted green puffer fish (Kawahara and Nishida, 2006; 
Kawahara and Nishida, 2007). Expression analysis was carried out on zebrafish and 






Figure 61. Gel-forming mucins are evolutionarily related to the von Willebrand factor and possess domain structures that are highly conserved 
(D1-D4). Organisms represented are human (hMUC2, hMUC5AC, hMUC6, hMUC19, hOtogelin, hVWF and hZonadhesin) and the stickleback 
G. aculeatus (Spiggin α).  
Abbreviations: PTS; proline, threonine, serine rich domains, VWD; von Willebrand factor type D domain, Cys-knot; C-terminal cystine knot-like 
domain, C8; Cysteine rich C8 domains, TIL; Trypsin Inhibitor like cystine rich domain, VWC; von Willebrand factor type C domain, VWA; von 
Willebrand factor type A domain, MAM; meprin, A-5 protein, and receptor protein-tyrosine phosphatase mu, AbfB; Apha-L-arabinofuranosidase 









found in both male and female torafugu. No glue-like protein produced in the torafugu kidney 
has been reported, which suggests that the function of this spiggin differs from that in the 
stickleback. All the spiggins and the medaka spiggin homologue shared the VWD domain 
structure, but no other domains characteristic of the translated products of secreted mucins 
(MUC2, 5AC, 5B and 19) were identified (Kawahara and Nishida, 2006).  
In addition to male stickleback fish producing spiggin, several other fish species have 
sexually dimorphic mucus production as part of their reproductive processes, generally 
involving parental care. For example, the male grass goby has a pair of sperm-duct glands 
that produce mucus bands in which sperm are embedded (Giacomello et al., 2006), the male 
Bristlenose catfish has snout mucin-producing goblet cells whilst females have none 
(Giacomello et al., 2008), and the pharyngeal organ of the Siamese fighting fish produces 
mucus to aid nest building by male fish (Kang and Lee, 2010). Specialised renal mucus 
production has also been identified in the Australian catfish, but the presence of the mucus 
was not seasonal, so the function was thought not to be related to reproduction (Kelly and 
Gibson-Kueh, 2017). 
Since spiggin is androgen dependent, one would expect to find higher AR expression in 
male kidney compared with other tissues, and no difference in kidney AR expression 
compared to other tissues in species without spiggin. Indeed, for most fish species, no 
sexual dimorphism in AR expression in the kidney is known, however, in the stickleback, 
zebrafish, half-smooth tongue sole and rice field eel, AR expression is higher in the kidney 
than in other tissues (Hoffmann et al., 2012). 
In North America, the FHM is the most common small model fish used to assess oestrogenic 
and androgenic chemicals.  Sexually mature male fish develop large nuptial tubercles on the 
snout and a dorsal fatpad that is rich in mucus (Smith and Murphy, 1974). Breeding males 
are territorial and actively defend against other males intruding on their nest site. Following 
spawning, the male guards the eggs from predation as well as rubbing its fatpad against the 
spawning substrate to clean the eggs. In the FHM, exposure of female fish to androgenic 
chemicals results in an induction of nuptial tubercles (Smith and Murphy, 1974). The adult 
males and females are easily distinguished from one another when in breeding condition; 
the males are usually larger and darker than the females. The FHM has a rapid lifecycle, 
reaching reproductive maturity in four to five months post hatch, and the reproductive cycle 
can be controlled with temperature and photoperiod manipulation (Harries et al., 2000). In 
the FHM, several endpoints are responsive to oestrogens (vtg, sex-steroid production, 
decreased nuptial counts in males, delayed maturation and decreased fecundity and fertility) 
and to androgens (SSCs – nuptial tubercle growth, alterations in size of the dorsal fatpad, 
alterations in shape, colouration and breeding behaviours); for example, Miles-Richardson et 
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al. (1999) and Ankley et al. (2003). In terms of oestrogen responsiveness, the FHM, medaka 
and zebrafish may be more suitable species with more established test methods. However, 
the stickleback can be used to simultaneously assess androgen and oestrogen exposure in 
a single fish using fully quantitative endpoints (Muldoon and Hogan, 2016). In addition, 
Katsiadaki et al. (2006) found the spiggin endpoint measured by the ELISA to be 400-4000x 
more sensitive than FHM nuptial tubercle formation following MT exposure, and is the 
preferred method for determining spiggin concentration because KEH measurements are 
more time consuming. 
Expression of the male SSCs in fish is under the control of the AR (Borg, 1994). In teleost 
fish, 11-KT is generally considered to be the major circulating androgen as well as the most 
potent one (Borg, 1994) although it has recently been demonstrated that DHT plays a role in 
early development and reproduction (Martyniuk et al., 2013). Female fish seem to be more 
strongly affected by androgen exposure than males (Ekman et al., 2011; Martinovic et al., 
2008; Pawlowski et al., 2004). Martinovic et al. (2008) hypothesised that this was due to the 
lower concentrations of endogenous T in females, making it easier for androgen mimics to 
compete. Similarly, juveniles with lower circulating androgen concentrations should be more 
sensitive than adults, although Sone et al. (2005) found adults to be more sensitive than 
fry/juveniles. Whilst females appear to be more sensitive to androgens than male fish, this 
may not necessarily be true for anti-androgens. Indeed, (Martinovic-Weigelt et al., 2011) 
found zebrafish male reproductive systems to be more extensively impacted following 
exposure to the known anti-androgens vinclozolin and flutamide. 
Spiggin induction in female stickleback fish is currently the best test for (anti-)androgens, but 
spiggin is specific to stickleback fish and cannot be used as an endpoint in the any other 
laboratory test species. For studies where several endpoints have been measured, 
molecular endpoints appear to be among the most sensitive (Scholz and Mayer, 2008). 
However, when examining molecular end-points, the changes in gene expression are 
transient (Ankley and Johnson, 2004; Sone et al., 2005) and proteins are therefore expected 
to be more stable biomarkers of EDCs (Denslow et al., 2012). FHM also have sexually 
dimorphic mucus production as part of their reproductive process, and FHM may possess a 
spiggin-like protein that could be used as a sensitive bio-marker of (anti-)androgen 
exposure, to provide an additional endocrine endpoint to commonly used OECD regulatory 
fish tests. This spiggin-like protein, if found, could be collected non-invasively, and fish would 
therefore not need to be sacrificed (Bahamonde et al., 2019; Barkowski and Haukenes, 
2014; Tarnawska et al., 2019). 
Whilst my long-term aim was to find a new protein biomarker, the preliminary work described 
in this chapter looked for the sexually dimorphic expression of spiggin-like targets in different 
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tissues collected from male and female FHM. The tissues chosen were external tissues 
where sexually dimorphic features have been previously described (dorsal fin, snout, 
fatpad), other tissues where publications have reported sexually dimorphic mucus production 
(kidney, mouth), and positive control tissues (brain, gonad, liver). Gene expression was 
quantified using qPCR. Of interest, were spiggin-like genes with low expression in females 
and higher expression in male FHM. Tubercle number and FPI were also determined, to 
enable a comparison of these SSCs with the molecular expression data. 
 
5.2. Materials and methods 
5.2.1. Bioinformatics; Basic Local Alignment Search Tool searching and phylogenetic 
analysis 
The National Center for Biotechnology Information (NCBI) website 
(http://www.ncbi.nlm.nih.gov) was checked for spiggin and spiggin-like genes using the 
search term ‘spiggin’. Cluster analysis of the ‘spiggin’ sequences was then carried out using 
the Welcome Sanger Institute SeqTools (https://www.sanger.ac.uk/science/tools/seqtools). 
One spiggin sequence from each cluster was then used to search for FHM ‘spiggin-like’ 
sequences using the translated Basic Local Alignment Search Tool (BLAST; 
www.blast.ncbi.nlm.nih.gov/). Potential FHM nucleotide sequences were then translated 
using ExPASy (www.web.expasy.org/translate/), and reverse BLAST to confirm similarity to 
spiggin. 
The NCBI website (www.ncbi.nlm.nih.gov/) was then searched for mucin and mucin-like 2, 
5AC, 5B, 6 and 19 protein sequences in human, mouse, and different fish species. These 
sequences together with the translated FHM ‘spiggin’ sequences were aligned using the 
multiple sequence alignment program Clustal Omega, available from the European 
Bioinformatics Institute (https://www.ebi.ac.uk/Tools/msa/clustalo/).  
Geneious Prime 2019 (version 2019.0.4; https://www.geneious.com/geneious-prime-faq/) 
was used to build a distance-based Neighbour Joining tree, and this tree was rooted to 
Human MUC2. 
The bioinformatics work carried out in 2013 was repeated in 2018, just prior to starting the 




5.2.2. Fish sampling 
5.2.2.1. First sampling of different tissue from male and female fathead minnows 
An actively reproducing pair of FHMs (approx. 14 months old) kept under flow-through 
conditions were humanely sacrificed according to UK Home Office procedures using a lethal 
dose of MS222 (500 mg/L adjusted to pH 7.4; Sigma-Aldrich, Gillingham, UK) followed by 
trans-spinal severance. The following tissues were collected; snout, mouth area, fatpad, 
dorsal fin, brain, gonad, liver. Between obtaining samples, dissection instruments were 
cleaned with RNase AWAY® (Sigma-Aldrich). Following collection, the tissues were 
immediately snap frozen in cryovials in liquid nitrogen and then transferred to -80 oC for 
long-term storage. 
5.2.2.2. Second sampling of snout tissues from male and female fathead minnows 
Fathead minnows (10 male and 10 female fish, approx. 16 months old) were obtained from 
Scymaris (Brixham, UK). The male fish were kept in separate flow-through tanks due to 
aggressive behaviour towards the females, and whilst not reproductively active, the males 
did have obvious SSCs (fatpads; Figure 62, and tubercles; Figure 63). Fish were humanely 
sacrificed according to UK Home Office procedures using a lethal dose of benzocaine (500 
mg/L; Alfa Aesar by Thermo Fisher Scientific, Heysham, UK), followed by trans-spinal 
severance. Measurements were taken of fork length, wet weight, and the male fish nuptial 
tubercles and fatpads were photographed. Dissection instruments were cleaned between 
fish tissues using sequential washes of 10% household bleach, MilliQ water and 70% etOH. 
The snout, mouth area, and dorsal fin were dissected. The fatpad was also dissected from 
male fish and weighed, and the FPI calculated (FPI = [fatpad weight/body weight] × 100). 
Tissues were then transferred to cryovials containing 5-10 volumes of RNAlater® Solution 
(Life Technologies, Carlsbad, USA). Further tissues were collected; namely brain, gonad, 
liver and kidney. The gonad was weighted and the GSI calculated (GSI = [gonad 
weight/body weight] × 100). Similarly, these were transferred to cryovials containing 
RNAlater® Solution, but due to the size of the ovaries, after weighing only one was 
transferred to the cryovial for storage. 
All cryovials were stored at 4 oC overnight and were then transferred to -20 oC for longer-
term storage. 
The male fish nuptial tubercles photographs were examined using ImageJ 




Figure 62. Photograph showing tank of male FHMs with dorsal fatpads of varying sizes. 




Figure 63. Photograph of male FHM snout showing raised nuptial tubercles. (Panasonic 
Lumix DC Vario camera, macro setting)  
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5.2.3. Ribonucleic acid extraction and complementary deoxyribonucleic acid synthesis 
All surfaces were routinely decontaminated using 1% Distel (Tristel Solutions Ltd., Snailwell, 
UK) to prevent DNA contamination. 
Ribonucleic acid (RNA) extractions were carried out using the NucleoSpin® RNA Plus kit 
(Macherey Nagel Bioanalysis™, Düren, Germany). Tissue homogenisation and lysis utilised 
5 mm stainless steel beads (Qiagen, Manchester, UK) that were prepared by washing with 
100% etOH and autoclaving. Eppendorf 2 ml Safe-Lock centrifuge tubes (Stevenage, UK) 
were used and into each tube, one sterile bead and 350 µl kit Lysis Buffer were added. The 
FHM tissues were then added to the tubes (tissues stored in RNAlater® were blotted on 
tissue to remove excess liquid) and immediately homogenised using a TissueLyser II 
(Qiagen) for 1 min at 30 Hz followed by a further 1 min after inverting the tube inserts in the 
holders. 
Homogenised lysates were added to the NucleoSpin® gDNA Removal Column and after 
spinning, the column (together with the bound genomic DNA; gDNA) was discarded. Binding 
solution (100 µl) was added to each of the flow-through samples and was mixed well by 
pipetting up and down. This mix was then transferred to the NucleoSpin® RNA Plus Column 
and after spinning the column, the bound RNA was then washed twice with Wash Buffer. 
The bound RNA was then eluted with two 20 µl volumes of RNase-free water. RNA was then 
quantified spectrophotometrically using a Nanodrop One (Thermo Fisher Scientific, Paisley, 
UK), and purity was assed using a ratio of absorbance at A260nm and A280nm. Ratios above 1.8 
indicated good quality RNA that was devoid of contamination.  
To further check the structural integrity of the extracted RNA (i.e. to check the RNA was not 
degraded), an aliquot was run on a 0.8% agarose gel. To 100 ml 1 x Tris-borate EDTA buffer 
(TBE; Sambrook and Russell, 2001), 0.8 g of agarose (Sigma-Aldrich) was added and was 
melted using a microwave. Once cooled to hand-hot, 2 µl of GelRed™ Nucleic Acid Gel 
Stain (Biotium, Hayward, CA, USA) was added and the gel was cast in a gel mould with a 
comb in position. 
Equal volumes of RNA (2 µl) and 2 x RNA Loading Buffer (2 µl; Thermo Fisher Scientific) 
were pipetted to microfuge tubes and heat denatured at 72 oC for 2 mins on a Dri-Block® 
(Techne, Cole-Parmer, Stone, UK), then immediately transferred to ice. The denatured 
samples were run on an agarose gel along with lanes containing 2 µl of 1kb ladder (Bioline 
Reagents Ltd., London, UK), for 30 mins at 110 Volts. Structural integrity was confirmed by 
visual inspection of the 28S and 18S rRNA bands using a BioDoc-It™ imaging system 
(Analytik Jena AG, Jena, Germany). For most of the samples extracted, the RNA quality was 
good and two distinct ribosomal RNA bands were seen (28S and 18S; Figure 64). 
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Unfortunately, the RNA quality for the testis and ovary were poor and the two ribosomal 
bands were not clear, possibly due to overloading of the NucleoSpin® column. Additionally, 
the quantity of RNA extracted from the female fatpad was too low (<50 ng/µl). No qPCR 
results are therefore available for these three tissues. 
To remove any residual gDNA, the RNA samples were further treated with DNase I 
recombinant (Roche Diagnostics, Mannheim, Germany), a DNA-specific endonuclease that 
hydrolyses DNA. The following volumes were used: 
 40 µl RNA in RNase free H2O 
 4 µl 10x Incubation Buffer (included with DNase I recombinant) 
 1 µl DNase I recombinant (10 units) 
The tubes were then incubated on a dry block at 37 oC for 10 mins. 
Following DNase I treatment, the RNA was precipitated overnight as follows, using the co-
precipitant, GlycoBlue™ (Invitrogen, Thermo Fisher Scientific) to aid RNA precipitation and 
increase the pellet visibility: 
 1 µl GlycoBlue 
4 µl 5M sodium acetate (0.1 x volume) 
125 µl 100% etOH (2.5 x volume; stored at -20 oC) 
 
Figure 64. Image of RNA samples run on a 0.8% agarose gel alongside a 1 kb 
HyperLadder™. The 28S and 18S bands indicate good quality RNA. The lane indicated by 






The tubes were then stored at -20 oC overnight. The following day, the tubes were spun for 
30 mins at 13,000 rpm in a microfuge pre-cooled to 4 oC. The supernatants were then 
carefully removed and 150 µl 70% etOH (stored at -20 oC) was added to wash the RNA 
pellet. Following a further spin for 15 mins at 13,000 rpm and at 4 oC, the supernatants were 
carefully removed, and the pellet air-dried for 10 mins. Depending on the size of the pellet, 
between 20 and 60 µl RNase-free water was added and the pellet gently resuspended. The 
RNA was again quantified using the Nanodrop One, and a total of 2 µg RNA was required 
for complementary DNA (cDNA) synthesis. 
For first-strand cDNA synthesis, the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Thermo Fisher Scientific) was used. RNA samples were diluted to 1 µg in 10 µl 
diethyl pyrocarbonate (DEPC) H2O (Life technologies, Paisley, UK) in duplicate, for minus 
(no reverse transcriptase control; NRT) and plus reverse transcriptase. 
Into a PCR tube strip (BRAND GmbH, Wertheim, Germany) aliquots of the 2x RT master mix 
were added, each containing: 
2 µl 10x RT Buffer 
0.8 µl 25x dNTP Mix (100mM) 
2 µl 10x RT Random Primers 
1 µl MultiScribe™ Reverse transcriptase (or 1µl DEPC H2O for NRT control) 
4.2 µl DEPC H2O 
To this PCR tube strip, the 10 µl diluted RNA samples were added, followed by pipetting up 
and down two times to mix the contents (total volume 20 µl). The tube strips were then 
sealed and briefly centrifuged to spin down contents and eliminate air bubbles. 
The tube strips were subsequently loaded onto the thermal cycler (Biometra GmbH, 
Göttingen, Germany) and the program was run using the following conditions: 
Settings Step 1 Step 2 Step 3 Step 4 
Temperature (oC) 25 37 85 4 
Time (minutes) 10 120 5 ∞ 
 
At the end of the program, 130 µl DEPC H2O was added to all tubes (150 µl total volume) 
and they were then stored at -20 oC until ready for qPCR. 
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5.2.4. Primer design 
Previously reported reference gene primers were used for ribosomal protein l8 (rpl8), 
hypoxanthine phosphoribosyltransferase 1 (hprt1) and tata box binding protein (tbp) (Filby 
and Tyler (2007); Table 19), for normalising for differences in the amount of starting template 
between samples.  
Two sex specific primers were also chosen; VTG primers specific to female fish (Cavallin et 
al., 2015), and Hushi tarazu factor-1 (FTZ-F1) homologue primers specific to male fish (ff1d, 
previously reported as male specific in zebrafish; von Hofsten and Olsson, 2005). The ff1d 
primers together with the spiggin-like primers were designed using NCBI Primer-BLAST to 
have a melting temperature (Tm) of 60 oC and an amplicon size between 70 and 120bp 
(Table 20). 
5.2.5. Quantitative PCR 
For qPCR, the following controls were included on each plate: 
• no template control (NTC; cDNA was substituted with DEPC H2O) to check 
buffers and solutions for DNA contamination and to assess for primer-dimers 
• NRT prepared in Section 5.2.3 to check that there was no amplification due to the 
presence of gDNA in the sample 
• inter-plate calibrator (IPC; a common sample used in every plate with the hpbt 
primer set) 
Primer pairs were prepared by diluting each 1 in 100: 
1 µl Forward primer + 1 µl Reverse primer + 98 µl DEPC H2O (total volume 100 µl) 
qPCR reactions were performed using iTaq™ Universal SYBR Green® Supermix (Bio-Rad, 
Mercules, CA, USA), and a master mix was prepared as follows: 
 5 µl SYBR® Green 
 2.5 µl diluted primer pair 
 1.5 µl DEPC H2O 
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Table 19. qPCR primers and product size for FHM reference genes (Filby and Tyler, 2007) 
Target 
gene 
Forward primer (5’-3’) Reverse primer (5’-3’) 
Product 
(bp) 
rpl8 CTCCGTCTTCAAAGCCCATGT TCCTTCACGATCCCCTTGATG 102 
hprt1 GATGAAGAGCAAGGTTATGAC ACACAGAGCAACGATATGG 165 
tbp CTCAAGGGCTGGCTTCTC ACTGGCTGTGGTGTAAGAC 97 
 




Forward primer (5’-3’) Reverse primer (5’-3’) 
Product 
(bp) 
ff1d DT343801.1 GGCCCCATGTACAAACGAGA TGGTGATGACAGCAAAGGGG 105 
vtg AF13034 TCACCACATACGCCAAAAAGC CAAGTCTAAAGCCCGTCTGGTT 69 
Spiggin-like? DT131813.1 AGAAGACCCCCTGAAACCCT GGGGTGGAGGTGGAGGTATT 80 
Spiggin-like? DT267220.1 AAGGCACTTGTACTGAGCCC CTCCTTGAAGGGCACACACT 89 
Spiggin-like? DT347638.1 ACCACTACCAGGGAGCGTAT GACACTGAAAGGGGTGAGGG 77 
198 
 
The Master Mix was pipetted to each well (9 µl per well) of the qPCR plate (Bio-Rad) using a 
multichannel pipette. The cDNA (1 µl) was then added, pipetting samples in triplicate, to give 
a final volume of 10 µl. Plates were sealed with optically transparent film (Bio-Rad) and spun 
briefly to 4000 rpm to remove any air bubbles and to spin contents down. All reactions were 
carried out using a CFX96™ Real-Time System (Bio-Rad).  
The first qPCR runs did not include a melt curve so that the products could be run on a 2% 
agarose gel (as previously described) to check that the amplicon was the expected size. 
Following qPCR, when products were run on an agarose gel, these all produced a single 
band of the correct size (see Figure 65 for an example of an amplification plot and Figure 66 
for an example of qPCR products run on a gel).  
Later, melt curve analyses were performed to validate the specificity of the PCR amplicons 
and the following cycling protocol was used: 
 
Polymerase 
activation and DNA 
denaturation at  
95 oC 
Denaturation at  
95 oC 
Annealing/ 
extension and plate 
read at 60 oC 
Melt curve analysis 
(0.5 oC increments) 
3 mins 10 secs 30 secs 65-95 oC 
 
For all tested genes, the dissociation (melt curve) analysis demonstrated that only one peak 








Figure 65. An example of an amplification plot; NTC (no amplification), inter-plate calibrator 
(IPC; FHM liver; Cq ~25) and FHM snout samples with one primer set (Cq ~20). The 
horizontal line indicates the quantification cycle (Cq).  
 
 
Figure 66. Image of qPCR products run on a 2% agarose gel alongside a 50 bp 





Figure 67. Typical denaturation curve (melt peak) performed after qPCR cycling; NTC (no 
melt peak), inter-plate calibrator (IPC; FHM liver) and FHM snout samples with one primer 
set with melt peak at approximately the same temperature (~79 oC).  
 
Guidelines for Minimum Information for Publication of Quantitative Real-Time PCR 
Experiments (MIQE) were considered (Bustin et al., 2009; Taylor et al., 2010). 
The qPCR data were analysed using the gene study option in the CFX ManagerTM software 
(Bio-Rad). The quantification cycle (Cq), the cycle at which the amplification plot crosses the 
threshold, was set automatically by the software. Amplification curves were checked to 
confirm that the Cq for each sample occurred in the log-linear phase of amplification. 
The NRTs and NTCs were evaluated on each plate to rule out contamination, and plots were 
checked for amplification occurring before a Cq of 35, thus indicating contamination. Target 
stability was calculated as coefficient of variance and the expression stability, M value. 
Relative quantification was carried out with normalisation against three reference targets 
genes (rpI8, hprt1 and tbp) to account for loading differences or other variations represented 
in each sample. The IPC was used to calculate inter-plate variability (coefficient of variance). 
The normalised expressions of the Genes of Interest (GOIs) were analysed to determine 
differences in expression between different tissues. Normalised gene expression was 
calculated using CFX Manager™ software equations as follows: 
201 
 
The Relative Quantity (RQ; ΔCq) for each GOI was calculated with the formula: 








• E = Efficiency of primer and probe set. This efficiency was calculated with the 
formula (% Efficiency * 0.01) + 1, where 100% efficiency = 2 
• Cq (MIN) = Average Cq for the Sample with the lowest average Cq for GOI 
• Cq (sample) = Average Cq for the Sample 
• GOI = Gene of interest (one target) 
The Normalised Expression (ΔΔCq) was the RQ of target normalised to the quantities of the 
reference targets in the biological system. This calculation for normalised expression used 
the calculated RQ: 
Normalised Expression sample (GOI) =                          RQ sample (GOI) 
Where: 
• RQ = Relative Quantity of a sample 
• Ref = Reference target in a run that includes one or more reference targets in each 
sample 
• GOI = Gene of interest (one target) 
5.2.6. Statistics 
For the first FHM sampling, only one male and one female were examined, and no statistical 
comparisons were therefore made.  
For the second FHM sampling, t-tests with GraphPad Prism 8 were used to compare male 
and female data. Where data was not normally distributed and could not be transformed, the 
Mann-Whitney  test was employed. Correlation analysis was used to investigate the 
relationship between the SSCs and the normalised expressions of the GOIs. Differences 
were statistically significant when p<0.05. 
 
GOI 




5.3.1. Bioinformatics; BLAST searching and phylogenetic analysis 
On checking the NCBI website in 2013, there were found to be 27 spiggin nucleotide 
sequences (21 for the three-spined stickleback Gasterosteus aculeatus and 6 for nine-
spined stickleback Pungitius pungitius). When cluster analysis was carried out using the 
Welcome Sanger Institute SeqTools there were eight unique sequences amongst the 27 
sequences retrieved, which could be organised into three clusters.  
In 2013, Taxonomy Browser on the NCBI website identified 391 nucleotide Entrez records 
and 258,504 nucleotide expressed sequence tag (EST) records for FHM. When the 
TBLASTN was used to look for FHM nucleotide sequences with similarities to the spiggin 
sequences (one from each cluster; spiggin α, spiggin β and spiggin 4), there were no 
relevant nucleotide hits. However, there was one potential FHM spiggin-like EST hit 
(Accession Number DT131813). This FHM EST was 722 base pairs long and following 
translation using ExPASy, a BLAST search to check for similarity with spiggin mainly came 
up with mucin-19-like hits, the most closely related mucin to spiggin. Whilst the DT131813 
appears to be aligning with the mouse and human MUC-19 in a non-conserved domain in 
the multisequence alignments, when doing a BLAST search for FHM ESTs, there was poor 
alignment/no hits. With the multiple sequence alignment, and therefore also the phylogenetic 
tree, the DT131813 may not be in the correct position. However, when doing a BLAST 
search looking for FHM ESTS against spiggin α and β, the DT131813 aligned with spiggin α 
in a VWD domain (36% identity; see Appendix Figure A 11) and with spiggin β there was 
alignment with two different VWD domains (43% identity and 25% identity, see Appendix 
Figure A 12). The DT131813 also aligned well with mucin-19-like from the cyprinid 
Sinocyclocheilus graham (81% identity; Appendix Figure A 13). 
In 2018, further searches of the NCBI website came up with two more potential FHM 
spiggin-like EST hits (Accession Numbers DT267220 (826 base pairs) and DT347638 (797 
base pairs)). Following translation using ExPASy, BLAST searches to check for similarity to 
spiggin came up with zonadhesin as well as mucins hits. 
The NCBI website was then searched for mucin and mucin-like 2, 5AC, 5B, 6 and 19 protein 
sequences in human, mouse and different fish species (see Table 21 for Accession 
Numbers). For two of the spiggin homologues identified by Kawahara and Nishida (2007), 
the torafugu and medaka ‘spiggin’, were almost identical to torafugu and medaka mucin-19-
like hits (98 and 94% identity, respectively) found on the NCBI website, and they were 
therefore assumed to be mucin-19 rather than spiggin. However, the zebrafish ‘spiggin’ was 
less similar (65% identity) to muc-19-like and was included in the phylogenetic analysis. The  
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Table 21. Accession numbers for mucin and spiggin protein sequences found on the NCBI 
website. 
Species Protein Abbreviation Accession no. 
Homo sapiens MUC2 HS__MUC2 NP_002448.4 
MUC5B HS_MUC5B NP_002449.2 
MUC5AC HS_MUC5AC NP_001291288.1 
MUC6 HS_MUC6 NP_005952.2 
MUC19 HS_MUC19 NP_775871.2 
Mus musculus MUC2 MM_MUC2 NP_076055.3 
MUC5B MM_MUC5B NP_083077.2 
MUC5AC MM_MUC5AC NP_034974.1 
MUC6 MM_MUC6 NP_001316930.1 
MUC19 MM_MUC19 NP_997126.2 
Maylandia zebra mucin-2-like MZ_MUC2 XP_024659054.1 
mucin-5AC-like MZ_MUC5AC XP_024655160.1 
mucin-19-like MZ_MUC19 XP_014262801.2 
Danio rerio mucin-2-like DR__MUC2 XP_021326453.1 
mucin-5B-like DR_MUC5B XP_021333301.1 
mucin-19-like DR_MUC19 XP_002667130.6 
Takifugu rubripes mucin-2-like TR__MUC2 XP_011605972.1 
mucin-5B-like TR_MUC5B XP_011605978.1 
mucin-5AC-like TR_MUC5AC XP_011618317.1 
mucin-19-like TR_MUC19 XP_011617030.1 
Oryzias latipes mucin-19-like OL_MUC19 XP_023808397.1 
Oreochromis 
niloticus 
mucin-2-like ON_MUC2 XP_025758309.1 
mucin-5B-like ON_MUC5B XP_019202525.1 




Spiggin α GA_SPIG_ALPHA AAK15297.1 
Spiggin β GA_SPIG_B BAS02336.1 
Spiggin 4  GA_SPIG_4 BAE92625.1 




mucin-2s, mucin-5ACs, mucin-5Bs, mucin-6s, mucin-19s and zebrafish ‘spiggin’ sequence, 
together with the four spiggin sequences (three Gasterosteus aculeatus spiggin sequences 
(one from each cluster) and one Pungitius pungitius spiggin sequence), were aligned with 
the translated FHM ESTs using the multiple sequence alignment program, Clustal Omega, 
available from the European Bioinformatics Institute. 
Trimming, so that poorly aligned regions are eliminated, can increase the accuracy of 
resulting sequence alignments (Talavera and Castresana, 2007). However, the FHM ESTs 
aligned with different conserved regions, and it was therefore decided to carry out 
phylogenetic analysis on untrimmed sequences.  
The gel-forming mucin genes had strong consensus in the region of the three conserved 
(VWD-C8-TIL)-(VWD-C8-TIL)-(VWD-C8-TIL) domain structures from approximately 500-
2000 amino acids (Illustrated by red box; Figure 68). Most of the fish mucin proteins map to 
this specific VWD region and their amino acid sequences do not extend beyond this part, 
including the zebrafish ‘spiggin’. Also, two of the three FHM ESTs (DT267220 and 
DT347638) aligned within this conserved region although in different positions, and the third 
EST (DT131813) aligned with human and mouse MUC19, at a less conserved region.  
Spiggin proteins aligned best with the mucin-19 proteins including the zebrafish ‘spiggin-like 
protein’. 
The distance-based Neighbour Joining tree rooted to Human MUC2 contained a side-branch 
with the mammalian MUC19 proteins, M. zebra mucin 19-like, O. niloticus mucin-5B like, and 
the FHM EST DT131813. The DT131813 ‘branch’ of the phytogenetic tree was very long, 
indicating that there was much genetic difference between the DT131813 and the M. zebra 
mucin 19-like. The mammalian MUC6 was only weakly linked to the mucin-19 proteins. 
The EST clone DT267220 clustered with the mucin-2 proteins, and DT347638 with the 





Figure 68. Multiple alignments of gel-forming mucin sequences together with the three FHM spiggin-like ESTs (DT131813, DT347638 and 
DT267220, highlighted in blue), created using Clustal Omega with default settings. The red box indicates the first three conserved VWDs and 




Figure 69. Phylogenetic tree analysis of the gel-forming mucins together with the three FHM 
spiggin-like ESTs, created with Geneious Tree Builder using the Neighbour-Joining method. 
The tree is rooted to Homo sapiens MUC2. The highlighted box in yellow indicates the 
spiggin/MUC19 cluser. The scale bar indicates genetic change; the number of substitutions 





5.3.2. Gene expression results for fathead minnow tissue samples 
5.3.2.1. First sampling; comparing expression levels in different tissues from a male 
and female fathead minnow  
5.3.2.1.1. Quality control and positive controls for sex specificity 
For the different male and female FHM tissues with the positive control and spiggin-like 
genes of interest, a total of 7 plates were run, and the inter-run calibrator had a Cq of 26.31 
± 0.014. The mean coefficient of variance for the three housekeeping genes (hprt1, tbp and 
rpI8) was 0.4763, and the mean expression stability (M value) was 1.2126. The mean 
coefficient of variance values for these heterogeneous samples were within the acceptable 
range of <0.5, but the M value was slightly higher than the acceptable upper limit of 1.0 
(Hellemans et al., 2007). 
The highest expression of the ff1d was with the male brain tissue, with some expression also 
in the female brain and male mouth tissues (Figure 70A and Appendix Table A 33). 
Vitellogenin was strongly expressed in female liver tissue and not in any other tissue (Figure 
70B and Appendix Table A 33).  
5.3.2.1.2. Spiggin-like primers 
Of interest was expression that was sexually dimorphic where expression was higher in male 
tissues than female tissues. For primer set DT131813 (Figure 71A and Appendix Table A 
34), highest expression was in the female kidney (only low expression in the male kidney). In 
addition, DT131813 showed higher expression in the male snout compared with the female 
snout, although this difference was not as apparent. For both the spiggin-like FHM primer 
sets, developed for the DT267220 and DT347638 ESTs (Figure 71B and C and Appendix 
Table A 34), expression was highest in the male snout tissues. As only one male and one 
female fish were sampled for this preliminary work, no statistical analysis was carried out. 
Future work looked solely at FHM snout tissue from male and female fish and 20 snout 
tissues (10 from male FHM and 10 from female FHM) were examined. 
5.3.2.2. Comparing expression levels in snout tissues from male and female FHM 
5.3.2.2.1. Biological results 
The biological endpoints (weight, fork length, condition factor and GSI) of the 10 male FHM 
and 10 female FHM from the second sampling can be seen in Table 22 and Table 23, 
respectively. The male FHM weighed significantly more than the female FHM (6.46 ± 2.26 g 
compared with 3.39 ± 0.44 g; p<0.0001). Similarly, the male FHM fork lengths were 
significantly longer than the female fork lengths (69.10 ± 5.38 mm compared with 59.90 ± 




Figure 70. Bar chart showing normalised expression (ΔΔCq) of two positive control genes of 
interest (A; ff1d and B; vtg) in different tissues from one male (blue bars) and one female 
(red bars) FHM. Bars represent the mean of triplicate values ± SEM. See Appendix Table A 








































































































Figure 71. Bar chart showing normalised expression (ΔΔCq) of three spiggin-like genes (A; 
DT131813, B; DT267220 and C; DT347638) in different tissues from one male FHM (blue 
bars) and one female FHM (red bars). Bars represent the mean of triplicate values ± SEM. 
See Appendix Table A 34 for raw data. 












































































































1 M 3.92 62 47 1.427 1.199 342 17 8.724 
2 M 6.88 74 133 1.507 1.933 329 17 4.782 
3 M 5.33 65 79 1.695 1.482 388 15 7.280 
4 M 4.10 65 80 1.304 1.951 229 15 5.585 
5 M 7.00 71 186 1.659 2.657 885 14 12.643 
6 M 5.08 65 69 1.616 1.358 280 12 5.512 
7 M 4.63 64 75 1.539 1.620 379 18 8.186 
8 M 10.76 75 189 2.267 1.757 1581 17 14.693 
9 M 8.90 76 124 1.805 1.393 788 18 8.854 
10 M 7.99 74 102 1.750 1.277 701 20 8.773 
Mean 6.46 69.10 108.40 1.657 1.663 590.20 16.30 8.503 
Standard 
Deviation 
2.26 5.38 48.89 0.262 0.437 416.60 2.31 3.138 
* Gonadosomatic Index 
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Table 23. Biological endpoints for the ten female FHM fish. 








1 F 3.48 60 457 1.328 13.132 
2 F 3.84 60 534 1.398 13.906 
3 F 3.34 62 463 1.216 13.862 
4 F 3.52 60 444 1.343 12.614 
5 F 3.84 59 669 1.611 17.422 
6 F 2.80 56 494 1.363 17.643 
7 F 2.48 54 271 1.208 10.927 
8 F 3.62 64 426 1.204 11.768 
9 F 3.68 63 446 1.280 12.120 
10 F 3.28 61 283 1.194 8.628 
Mean 3.39 59.90 448.70 1.314 13.202 
Standard Deviation 0.44 3.03 114.36 0.128 2.751 




Figure 72. Graphs for the biological endpoints (weight, fork length, condition factor and Gonadosomatic Index (GSI)) of the ten male (blue bars) 
and ten female (red bars) FHM fish. Bars represent mean and standard deviation. Statistical comparisons between male and female 






























































than the female values; 1.657 ± 0.262 and 1.314 ± 0.128, respectively (p=0.007). The 
female FHM ovaries were large and filled with ripe eggs and, as a result, the GSI values 
were significantly higher than the male FHM GSI values (13.202 ± 2.751 compared with 
1.663 ± 0.437; p<0.0001). 
The plots for the biological endpoints (weight, fork length, condition factor and GSI) are 
presented in Figure 72.  
Correlation analysis was carried out on the male tubercle number and FPI, but there was no 
significant relationship between these two endpoints (p=0.6184) (Figure 73). 
5.3.2.2.2. Molecular results 
5.3.2.2.2.1. Quality control 
For three of the female snout tissues there was either not enough RNA or the RNA quality 
was too poor to proceed further. The n-values were therefore ten for male snout tissues but 
only seven for female snout tissues. 
For the snout tissues, a total of 7 plates were run, and the inter-run calibrator (a different 
sample to that used for the first sampling) had a Cq of 24.72 ± 0.04616. The mean target 
stability value of the three housekeeping genes (rpI8, hprt1, and tbp) was 0.1721 and the 
mean M value was 0.4418. The mean coefficient of variance and M value for these 
homogeneous samples were within the acceptable range of <0.25 and <0.5, respectively 
(Hellemans et al., 2007). 
 










Figure 73. Plot of tubercle number against Fatpad Index (FPI) for the ten male FHM fish. 
Correlation analysis p=0.6184, Pearson r=0.1802, R2=0.0325. 
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5.3.2.2.2.2. Spiggin-like primers 
DT131813 gene expression was significantly greater in female FHM snout than male FHM 
snout (p=0.0001; Figure 74). With the DT267220 primer set, there appeared to be higher 
expression of this target in the male snout tissue than the female snout tissue, but due to 
biological variation this was not significant (p=0.2295; Figure 74). There was also no 
significant difference between the expression of the DT347638 target in male and female 
snout tissues (p=0.9623; Figure 74). 
Correlation analysis was carried out between the tubercle numbers and the normalised 
expression with the three ESTs (DT131813, p=0.3279; DT267220, p=0.4680; DT347638, 
p=0.7257; Appendix Figure A 14) and also between the FPIs and the normalised expression 
with the three ESTs (DT131813, p=0.5367; DT267220, p=0.6321; DT347638, p=0.5135; 



































Figure 74. Bar chart showing normalised expression (ΔΔCq) of the three spiggin-like genes 
(DT131813, DT267220 and DT347638 primer sets) in snout tissues from ten male FHM 
(blue bars) and seven female FHM (red bars). The bars represent mean ± standard 
deviation. For statistical comparisons between male and female values for each primer set; 





5.4.1 Bioinformatics; BLAST searching and phylogenetic analysis 
The release of 250,000 FHM ESTs deposited in the NCBI GenBank in 2005 stimulated the 
development of high-density microarray tools for FHM, and the sequencing and assembly of 
the FHM genome reported by Burns et al. (2016) was an important step in advancing 
molecular characterisation of the FHM. However, compared with zebrafish and medaka, 
there is still a lack of molecular information for the FHM (Burns et al., 2016; Lavelle et al., 
2018).  
Because of this poorly characterised FHM genome, the best approach was to look to see if 
any of the available FHM ESTs showed similarity to spiggin. However, due to the highly 
conserved nature of mucin and related proteins, the use of other teleost species to identify 
spiggin-like proteins in FHM were likely to fit within conserved regions of mucins (Martyniuk 
et al., 2012), and therefore likely to amplify related proteins as well. As expected, there was 
high sequence consensus with the fish and mammalian mucins, and whilst two of the FHM 
ESTs (DT267220 and DT347638) aligned within the conserved (VWD-C8-TIL)-(VWD-C8-
TIL)-(VWD-C8-TIL) domain structure, the DT131813 did not. The phylogenetic tree analysis 
showed that the DT267220 and DT347638 were located with the MUC2 and MUC5 clusters, 
respectively.  
The DT131813 was in a separate cluster from spiggin and was located with M. zebra mucin 
19-like and O. niloticus mucin 5B-like. From the multiple alignments comparison as well in 
the phylogenetic tree, the O. niloticus mucin 5B-like clustered with M. zebra MUC-19 and 
could be wrongly annotated as MUC-5B. Genbank does contain a significant proportion of 
erroneous protein sequences (Lang et al., 2016) and a protein may be missed/ wrongly 
annotated because it was overlooked in the process of genome annotation. When collecting 
additional information by analysing the genomic sequence more carefully against other 
mucin 5s and mucin 19s, the O. niloticus mucin 5B-like had been misannotated and was in 
fact mucin 19-like.  
As reported by (Kawahara and Nishida, 2006), in the phylogenetic tree analysis the mucin-6 
genes clustered with mucin-19 genes, and the mucin-19 genes clustered closely with 
spiggin. Therefore, the FHM EST DT131813 was the most similar to spiggin, based on its 




5.4.2 Gene expression 
5.4.2.1 First sampling; comparing expression levels in different tissues from male and female 
FHM  
The mean stability value (M) for the qPCR reference genes with the different tissues from a 
male and female FHM was slightly above the highest value expected for heterogeneous 
samples. Due to the wide range of tissues from different sexes, the samples were highly 
heterogenous and this slightly higher value might therefore have been expected. In any 
case, the mean coefficient of variation for the reference genes was within range. 
The expression of ff1d in adult zebrafish is restricted to brains, gonads and liver with higher 
expression in testis than ovary (von Hofsten and Olsson, 2005). Ff1d is highly expressed in 
testicular tissue, suggesting an involvement in gonadal steroid synthesis. Unfortunately, the 
quality of the RNA from FHM testis and ovary was insufficient to be able to carry out qPCR 
and therefore looking for testis-specific expression was not possible. Despite the lack of 
gonad tissue due to RNA degradation, there was still higher expression of ff1d in the male 
brain than female brain, as seen in zebrafish (von Hofsten and Olsson, 2005). 
For the female-specific positive control, the VTG expression was restricted to the liver. This 
agrees with other publications where expression was almost exclusively in the liver 
(zebrafish; Islinger et al., 2003). 
For the different tissue samples, there was female specific expression with the DT131813 
target in the kidney, but as this thesis focuses on male specific biomarkers this was not 
considered to be of interest for this study. In contrast, for both the DT267220 and DT347638 
targets, with the snout tissues there was male-specific expression, although as only one fish 
of each sex was sampled, more fish samples need to be collected before any conclusions 
can be drawn. This was of interest because it is possible to sample mucus from fish snouts 
non-invasively (Mosley et al., 2018). In addition, whilst biofluids (e.g. blood, urine, mucus) 
are generally thought to have higher variability than tissues, Ekman et al. (2015) did find that 
the range of variability for the FHM mucus metabolome was similar to other biofluids and 
therefore snout mucus could be a potential biofluid for monitoring influences of (anti-
)androgens. 
5.4.2.2 Second sampling; comparing biological endpoints and expression levels in snout 
tissues from male and female FHM 
As expected, the male FHM fish were both heavier and longer than the female FHM. The 
female GSI was significantly higher than the male GSI, and this is probably also why the 
female condition factor was lower for the female fish, as energy was being put into egg 
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production. Compared with the FHM used in the Pair Breeding Test in Chapter 2, these FHM 
were older and subsequently larger (both heavier and longer). 
There was no significant correlation between tubercle number and FPI. The FHM were 
photographed at the time of the sampling as the traditional method for counting tubercles 
(freezing snouts in liquid nitrogen just before counting by eye) was not used so as not to 
destroy the tissues required for molecular work. Due to the three-dimensional nature of the 
snout, counting the tubercles using photographs was not easy, as not all were in focus. This 
might be the reason why there was no correlation between our tubercle numbers and FPIs. 
However, the two endpoints do not always respond in parallel; Miles-Richardson et al. 
(1999) found the FHM tubercle endpoint in male fish to be more sensitive to E2 exposure 
compared with the fatpad.  In contrast, (Filby et al., 2010) found the male fatpad to be more 
responsive than the tubercles following exposure to WwTW effluent, so the mechanism for 
response may be different. 
The DT131813 target had significantly higher expression in the female snout tissue than the 
male snout tissue. This was not reflective of the first sampling, although in the first instance 
only one male and one female fish were sampled, and conclusions should therefore not be 
drawn from the preliminary work. Seear et al. (2014) speculated that coding for the different 
spiggin genes might be selected to suit local conditions and found that spiggin α was more 
highly expressed than other spiggins in flow-through conditions compared with static 
conditions. More recent analysis of spiggin transcripts found spiggin α to have diverged the 
least from the ancestral MUC19 gene, and Seear et al. (2015) predicted that spiggin α and β 
are secreted as long mucin-like polymers but that further spiggins (C1 and C2) are secreted 
as short monomers, with putative antimicrobial properties. Thus, spiggin α and β are more 
likely to be the ‘glue’ proteins and further spiggins may have different functional properties. 
This DT131813 EST did align better with spiggin β and not so well with α (see Appendix 
Figures A 11 and A 12), and perhaps this is why the expression pattern was not as 
expected, i.e. as the fish were from flow-through tanks, the conditions perhaps selected for 
spiggin α and not β. As this thesis focussed on male specific biomarkers this was not 
considered to be relevant for monitoring for (anti-)androgenic activity but might be suitable 
for (anti-)oestrogenic activity. This difference in expression with the target most closely 
related to spiggin (DT131813) is unlikely to be spiggin-like and more likely to be another 
mucin, especially considering the conserved nature of mucins. Unfortunately, due to the 
highly conserved nature of mucin and related proteins, without additional sequence 
information it would not be possible to further identify this FHM EST DT131813. 
The expression pattern for the other two targets (DT267220 and DT347638) looked 
promising in the preliminary sampling, as snout expression looked to be sexually dimorphic, 
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i.e. had higher expression levels in male than female tissue. However, when more FHM 
were sampled there was no significant difference in the expression levels between snout 
tissues collected from male and female FHM. Particularly with the male expression there 
was high variability, and whilst there was higher expression in the male snout tissues with 
the DT267220 target, this was not significant. 
For none of the ESTs was there correlation with either the tubercle number or the FPI as 
might have been expected, although due to the males being separate from the females and 
not actively breeding, the SSCs could have been reflective of territoriality and not 
reproduction. 
Transcript variability can be high and Cowie et al. (2015) estimated that a sample size of 
greater than 20 FHM would be required to detect a 2-fold change (0.8 power). Cowie et al. 
considered that variability in the gene expression of reproductive transcripts might be more 
pronounced for individuals actively undergoing sex maturation and be less variable in older 
individuals. Our n-values of ten (male FHM) and seven (female FHM) may have been too 
small, although all were sexually mature. For the first sampling, the male and female FHM 
fish pair were set up in a single tank with a spawning tile and were breeding prior to the 
sampling. Unfortunately, for the second sampling the male FHM were kept in separate tanks 
from the female fish due to the aggressive behaviour of the male FHM. Whilst SSCs were 
evident, the expression levels for these fish may have been different, as they were not 
actively breeding. 
Both DT267220 and DT347638 targets were similar to zonadhesin as well as mucin when 
carrying out BLAST searches. Zonadhesin is homologous to both mucins and VWF and is a 
sperm membrane protein that mediates sperm adhesion to the extracellular matrix (zona 
pellucida) of the egg (Hardy and Garbers, 1995). Hardy and Garbers (1995) detected 
porcine zonadhesin mRNA only within the testis, where it was expressed primarily in haploid 
spermatids. Hunt et al. (2005) has also identified a zonadhesin-like gene (ZLG) in fish. 
Unlike mammalian zonadhesin, zebrafish and salmon ZLG were expressed in the gut and 
not the testes and although the function of fish ZLG is not known, expression in the gut and 
absence in the testes, combined with their similarity to gut-expressed genes of the mucosal 
immune system (i.e. FCG Binding Protein and mucin), suggests a non-reproductive function 
for the ZLG. However, when Skillman et al. (2006) exposed rainbow trout to EE2 and 
measured changes in expression of vtg and zlg in liver tissues, a 10.42 fold induction in vtg 
and a 5.05 fold reduction of zlg following the exposure were observed. From the results seen 
here, it is unlikely that the expression seen for DT267220 and DT347638 targets are spiggin-
like. Instead, it is more likely that they are zonadhesin-like.  
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Unfortunately, ESTs only contain partial cDNA sequences and not full-length sequences. As 
a result, it is not possible to design primers that span exons, and without this the primers can 
also bind to gDNA. Designing primers to span exons would make the qPCR step easier, as 
otherwise gDNA can amplify alongside the cDNA. ESTs are also highly likely to be in 
conserved regions of proteins and this makes it difficult to identify specific proteins. For 
future work it would be better to PCR the FHM GOI first from gDNA and to have performed a 
5’RACE to get a full-length sequence. Primers could then be designed to span exons and 
also to avoid conserved domains. Amplification would then be specific to the GOI and not 
pick up similar spiggin-like genes. 
Could there be a zonadhesin-like protein produced in the male snout tissues used to help 
glue the eggs to substrate? For future research with larger numbers of actively breeding 
FHM, it would be interesting to determine if DT267220 and DT347638 increase in female 




6.1. Overall aims and approach: 
Firstly, to determine if the addition of a full scale GAC, advanced wastewater treatment plant, 
could mitigated endocrine disrupting effects frequently observed in fish exposed to standard 
treated WwTW effluents.  
• Both laboratory and field-based assessments of the same effluent were conducted to 
investigate the impacts of the traditional and advanced treatment processes on well 
characterised markers of endocrine disruption in fish, namely, occurrence of intersex 
phenotypes (both eggs and sperm in the gonad) (field assessment), VTG induction in 
male fish (laboratory and field assessments), and disruption to reproductive output 
and SSCs (laboratory assessment).      
To determine if chemicals found in WwTW effluents possessed (anti-)androgenic activity. 
• Over 100 chemicals were investigated via an in vitro yeast test system. 
Thirdly, to identify possible biomarkers which could provide promising additional endpoints 
for detecting (anti-)androgenic activity in a sexually dimorphic fish species i.e. for 
subsequent addition to ecotoxicology regulatory assays. 
• Bioinformatic searches and expression analysis were conducted for male-specific 
molecular markers in a sexually dimorphic fish species. 
 
6.2. Research questions and findings: 
These aims were addressed through 4 research questions, the first being ‘Does the 
addition of an advanced treatment process to a full-scale wastewater treatment plant 
lead to a reduction in endocrine disruption in fish?’ (investigated in Chapter 2). This 
question was addressed using short-term in vivo laboratory exposure studies and a field 
collection of wild roach exposed under natural conditions, to see if the wild fish analysis 
supported the lab-based studies. Whilst a few papers have been published following the 
addition of the GAC to the Swindon WwTW, none looked at long-term effects (5 years after 
the addition of GAC) on fish living downstream of the WwTW.  
Prior to the addition of the GAC treatment, the WwTW effluent had significant 
demasculinising effects on FHM in the lab-based studies. These were not observed post 
GAC. The chemical monitoring of the standard/GAC effluents for E1, E2 and EE2 in the 
FHM tests gave inconsistent results, but the yeast bioassay used to determine the E2EQ did 
not give any better predictions of in vivo effects than the analytical chemistry results, as the 
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total oestrogenic content was at concentrations likely to induce VTG, but no VTG induction 
was observed. This was unexpected as, when roach were sampled from the River Ray in 
2005 to assess the suitability of the site for the end-of-pipe GAC plant at the Swindon 
WwTW, the VTG concentrations in males were elevated to concentrations similar to those 
found in female roach, indicating the presence of oestrogens. However, the FHM exposure 
studies did take place in 2009, 4 years after the 2005 sampling of roach from the River Ray, 
and during this time other modifications that resulted in better treatment of the effluent prior 
to the installation of the GAC plant at the Swindon WwTW, may have occurred. Additional 
monitoring for chemicals with other activities (e.g. anti-androgens) would have made it easier 
to identify what type of activity was responsible for the observed demasculinising effects. In 
the absence of VTG induction, the culprits were thought to be anti-androgens. 
For the lab-based Pair Breeding Test with FHM, only the positive control (EE2) significantly 
reduced egg production; no effects on egg production were observed with the effluent 
treatments. This was unexpected, as it was hypothesised that EDCs thought to be present in 
the effluent would have reduced breeding (in a similar way to the positive control). There are 
a couple of possible explanations as to why egg laying was not reduced by the effluent 
exposures. Firstly, that the effluent did not contain enough oestrogens to inhibit egg laying in 
the FHM (which is supported by the lack of VTG induction in the male FHMs), or secondly, 
that the reduced feeding (to minimise ammonia issues) lowered the reproductive output in 
the control fish (effluent tanks had additional organic matter in comparison), thus reducing 
the ability to detect any subtle effects of the effluent. Increasing the feeding regime for the 
FHM, so that egg production remained constant for control fish during both the pre-exposure 
and exposure period, might have improved the sensitivity of this test. 
Ideally, short-term fish studies assessing effluents should take place at the WwTW, so that 
the effluent does not have to be transported/stored, although the Pair Breeding Test is 
labour intensive, and it would not be practical to carry out such tests at the WwTW. Carrying 
out testing at the WwTW would have allowed for the parallel testing of the standard and 
GAC effluent (not possible at Brunel University London due to the availability of only one 
cooled storage tank) and enabled easier comparisons, especially if enough of the same age 
FHMs were used for both effluent studies. Unfortunately, because FHM are not native to the 
UK, they require a water temperature of 25 oC, and this would add to the expense of 
experiments if sited at the WwTW. 
On comparing the endpoints for the roach collected from the River Ray in 2013 with results 
from the historic sampling in 2005, whilst there were reductions in the biomarkers of 
oestrogen exposure in male roach (VTG, intersex), they were not significant. This lack of 
statistical significance was probably because neither the VTG concentrations nor the 
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proportion of intersex in male fish had reduced to baseline “natural” levels following the GAC 
addition to the WwTW. However, it could also be due to the smaller number of fish collected 
in 2013, as well as the variability of some of the endpoints (e.g. VTG). Comparisons between 
the 2005 and 2013 roach samplings were also complicated because the fish were sampled 
at different times of the year. In contrast, for the female endpoints investigated, there were 
significantly less uncharacteristically immature female roach after the GAC addition, 
indicating an improvement in female reproductive health.  
Whilst there were improvements in the female roach reproductive health, it was not clear if 
this was due to reduced oestrogen concentrations in the river and/or reductions in chemicals 
possessing other type of activities (e.g. anti-androgens). This is because the sampling of the 
roach from the River Ray was not accompanied by any measurements of EDCs (analytical 
chemistry or total activity using bioassays), and this lack of water analytical 
chemistry/bioassay data made it harder to interpret the results. Also, whilst it was important 
to monitor the reproductive health of roach over a longer period of time, this did mean that 
some of the methods used at the first sampling were not exactly the same as the second 
sampling (e.g. the VTG ELISA technique), making comparisons between the different results 
even more challenging. 
On comparing the VTG endpoint in the short-term (lab) and long-term (field) tests, whilst the 
male FHM in 2009 did not have elevated concentrations when exposed to either standard or 
GAC effluent, in 2013 after the GAC addition the male roach still had VTG concentrations 
about an order higher than baseline concentrations. This may have been due modifications 
to the Swindon WwTW between 2005 and 2009 having an effect on the quality of the 
effluent, but may also be because the FHM exposures were to effluent alone compared with 
the field sampling where the river water would have also contain chemicals from non-point 
sources, such as agricultural run-off. The lab-based studies therefore simplify the exposure 
and make the identification of the presence of non-oestrogenic compounds possible and 
helped to pin-point the likely chemicals to anti-androgens. Comparing the short-term and 
long-term tests was not so easy as many of the endpoints were different, however, this was 
also advantageous as it helped to build a bigger picture. By combining the short-term and 
long-term tests, it was possible to consider that the effects on the female roach reproductive 
health could just as likely be due to the presence of other chemicals. 
In fish, EDCs are linked to reproductive disorders, and whilst some studies show that roach 
with mild intersex are able to successfully reproduce (Hamilton et al., 2015), others have 
linked severe intersex in rainbow darter with poor reproductive success (Fuzzen et al., 
2015). Post addition of the GAC, the reproductive effects appear to be minor, but early life 
adverse effects may not manifest until later life, or even later generations (Hamilton et al., 
223 
 
2016). The use of advanced treatments such as GAC are expensive and whilst the GAC did 
succeed in removing the possible anti-androgenic effect of the effluent seen in the FHM, 
perhaps other less intensive methods, such as increasing retention times or tertiary 
treatments such as sand filtration, might have also been sufficient to reduce risks to 
acceptable levels. Especially as it seems, from the FHM study, that even before the addition 
of the GAC in 2009, the oestrogenic effect of the effluent was already much reduced 
compared with when the historic sampling of the roach took place in 2005. 
My second research question, ‘Which individual chemicals from wastewater treatment 
work effluents have (anti-)androgenic activity and how potent are these chemicals?’, 
was addressed by testing 107 chemicals found in WwTW effluent and river water using a 
yeast-based (anti-)androgen screen (investigated in Chapter 3). When testing the chemicals 
in the (A)YAS, some of the results were inconsistent (on retesting chemicals and compared 
with results published by others) and toxicity was considered a possible reason for false 
positives. Therefore, the active chemicals were then retested using a modification of the 
standard method that utilised a final cell lysis step (based on the ISO 19040-1 protocol). The 
results related to the third question ‘Do both in vitro assays for (anti-)androgenic activity 
produce the same results and, if not, which is the most reliable, i.e. least likely to 
produce false positive results?’ (investigated in Chapter 4) are summarised in the 
following table: 
                                   Assay 
Activity       
Standard (A)YAS Modified (A)YAS 
Androgenic 3 0 
Anti-androgenic 20 18 
Superagonist Inconsistent Inconsistent 
 
Whilst three of the 107 chemicals were very weakly androgenic (methyl decanoate, 2-
ethylhexanoic acid and ibuprofen) using the standard YAS method (investigated in Chapter 
3), this activity was not repeatable when the YAS was modified with an additional cell lysis 
step (investigated in Chapter 4). Whilst the most potent of the androgenic chemicals, 
ibuprofen, is widely used for its pain-relieving and anti-inflammatory effects, the potency was 
over a million times less potent than DHT (positive control) and the discrepancy between the 
standard YAS method and the modified assay was therefore small. These results seen with 
the standard YAS were thought to be false positives. 
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Additionally, in the standard AYAS, twenty of the chemicals tested (19%) were found to be 
anti-androgenic, some more potent than the pharmaceutical flutamide. However, for two of 
the chemicals (triphenyl phosphate and myristic acid) identified in the standard AYAS, the 
anti-androgenic activity could not be repeated when the assay was modified, probably 
because toxicity was interfering with the results in the standard assay. Some of the anti-
androgenic chemicals were more potent than the pharmaceutical flutamide (triclosan and its 
metabolite methyl triclosan, chlorophene, fluoranthene and pyrene, and the resin acid 
dehydroabietic acid) used as the anti-androgenic standard. Whilst the most potent of the 
anti-androgens have already been reported in the literature, for many of the less potent 
chemicals these results were novel, for example, acetylcedrene, diphenylacetic acid methyl 
ester, alpha cedrol, benzeneacetaldehyde, 2-(methylthio)benzothiazole. 
Chemicals identified as anti-androgenic in the modified (A)YAS 
Strong 
(more potent than flutamide) 
Moderate 
(similar potency to flutamide) 
Weak/very weak 
(less potent than flutamide) 
Triclosan Dehydroabietic acid alpha cedrol 
Chlorophene Pyrene Benzeneacetaldehyde 





Diphenylacetic acid methyl 
ester 
Benzophenone 








  Hexamethylbenzene 
 
For the anti-androgenic activity thought to be the result of toxicity, the modified AYAS with 
cell lysis was much less likely to give false positive results, and this was especially important 
as many of the chemicals tested were toxic at higher concentrations. This was because with 
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the modified assay with cell lysis, the reduction in colourimetric absorbance due to toxicity 
mirrored the reduction in turbidity readings, but this was not the case with the standard 
assay where toxicity led to reductions in colour before turbidity was reduced. Some 
laboratories routinely carry out assays for toxicity in parallel with the assays for (anti-
)androgenic activity, but this often doubles both the time and the cost of running the assay. 
This modified assay was more complex and lengthier to run, particularly at the cell lysis step 
at the end of the incubation period, but was also more robust, i.e. less prone to false 
positives. This is beneficial as a false positive result might lead to in vivo investigations, 
leading to unnecessary costs, wasted resources and unnecessary use of animals. 
Some chemicals were able to enhance the activity of DHT in the anti-androgen screen rather 
than block the activity, i.e. were superagonists and not anti-androgens. As pollutants in the 
natural environment are most often present as mixtures rather than discrete chemicals, 
chemicals present that enhance the activity of androgens (and possibly chemicals with other 
types of activity), yet have no activity when tested singly, may get overlooked. In fact, most 
regulatory testing is of single chemicals and not mixtures and this type of activity might go 
unnoticed yet has the potential to increase the potency of other chemicals. In this case the 
activity of the steroid DHT was enhanced, which is important as steroids are a major group 
of chemicals found in WwTW effluents. 
In terms of limitations, due to the part-time nature of my PhD, the in vitro yeast assays were 
carried out over a five-year period, and this meant that there was less consistency in the 
assay components. This might also have been the reason for the variable superagonist 
activity. For cost saving, I also used freeze/thawing to lyse the yeast cells rather than 
lyticase, as detailed in the ISO 19040-1:2018 protocol, and this meant that the final stages of 
the assay took longer and smaller assays had to be run, again possibly reducing the 
consistency. 
In stickleback, a sexually dimorphic fish species, males secrete spiggin under the control of 
androgens, which is used to build a nest in preparation for female egg laying. The presence 
of spiggin in female sticklebacks indicates exposure to environmental androgens, and a 
reduction in spiggin in male fish can indicate exposure to environmental anti-androgens. The 
Androgenised Female Stickleback Screen (AFSS) is now partially validated as an OECD 
test. However, spiggin as a biomarker is only applicable to sticklebacks, and this led to my 
fourth and final question, ‘Do FHMs, another sexually dimorphic fish species exhibiting 
paternal parental care, possess a similar spiggin-like protein that could be used as a 
sensitive biomarker of (anti-)androgen exposure, to provide an additional endocrine 
endpoint to commonly used OECD regulatory test guidelines?’. To answer this 
question, I designed primers to FHM ESTs with similarity to spiggin, and carried out qPCRs 
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to look for sexually dimorphic expression in tissues where sexually dimorphic features/ 
mucus production have previously been described. Whilst a spiggin-like protein was not 
discovered, two zonadhesin-like targets were identified in the FHM snout tissues (providing 
potential for non-invasive sampling). As zonadhesin is another glue-like protein that 
mediates sperm adhesion, if sexually dimorphic in FHM, it could be used to provide an 
additional endocrine endpoint to commonly used OECD regulatory test guidelines. The initial 
results looked promising, albeit zonadhesin-like and not spiggin-like gene expression, but on 
repeating the work with larger fish numbers, whilst the expression levels were higher in the 
male FHM, these levels were not significantly different from the female FHM snout 
expression levels.  
Whilst the FHM used for my first expression analysis work were available at Brunel 
University London, this was not the case when it came to analysing these tissues or for my 
second sampling. This meant that, when I was not able to get enough RNA or the RNA was 
degraded, I was not easily able to collect further tissues, and important tissues (testis and 
ovary) were missing from the first analysis. As we no longer had FHM at Brunel University 
London for my second sampling, I was able to obtain the FHM for this expression analysis 
work from another aquatic ecotoxicology facility; Scymaris, Brixham, but as these were 
supplied off site, it was not possible to set these fish up as breeding pairs. This may have 
been why results that initially looked promising for the first sampling were not significant for 
the second sampling with larger fish numbers.  
Whilst there are several fish species used to measure the effects of oestrogenic chemicals in 
the environment (e.g. zebrafish, medaka, fathead minnow), for anti-androgens the 
stickleback is still the recommended species (OECD, 2018c). Sebillot et al. (2014) has also 
thought to use the biomarker ‘spiggin’ in another fish species and developed a sensitive 
specific transgenic medaka model bearing an androgen responsive fluorescent reporter 
construct (green fluorescent protein gene driven by the spiggin promoter) for whole organism 
based environmental screening of (anti-)androgens. This assay (RADAR: Rapid Androgen 
Disruption Adverse Outcome Reporter Assay) is now being considered as an OECD test for 
AR agonists and antagonists.  
The effects of EDCs have only been investigated in a few fish species, mainly because of 
limited genomic information for non-model species including the FHM. Whilst this OECD 
RADAR test looks to be a reliable test for (anti-)androgens, this uses freshly hatched 
medaka that may have limited metabolic capability compared with adult fish. As FHM are 
one of the three recommended species for two OECD tests (OECD TG 229: Fish Short-
Term Reproduction Assay and OECD TG 230: 21-Day Fish Assay), both using adult fish, it 
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would be beneficial to add endpoints to this species rather than add extra species/tests for 
different endpoints (3Rs). If sexually dimorphic ‘zonadhesin-like’ expression was found to be 
androgen dependent, it could be a useful endpoint for monitoring for (anti)-androgens, 
especially as there is the possibility it could be sampled non-invasively. 
 
6.3. Recommendations for future work 
For future work it would be very interesting to investigate the superagonists further. As a 
starting point it would be important to purchase the 12 superagonists once more and to carry 
out the testing with fresh yeast assay components, to determine if the inconsistent activity 
was because they had reached the end of their shelf-life. It would also be interesting to run 
the same chemicals through the yeast anti-oestrogen screen to see if these 12 chemicals 
were similarly able to enhance the activity of the oestradiol present in the medium. If these 
chemicals were then consistently active as superagonists, it would be important to get a 
better understanding of the mechanism by which one chemical is able to enhance the 
activity of another, as this would help to understand if the issue could also be affecting other 
assays, e.g. HTP assays. As the real concern regarding these superagonists is that they 
enhance the uptake of chemicals into fish, assuming that the superagonist response was 
consistent, it would be interesting to determine whether these chemicals were able to affect 
the uptake of other chemicals into fish. 
Because the snout tissue has the potential to be sampled non-invasively, it would be of 
interest to look further at zonadhesin-like expression in FHM, with larger numbers of sexually 
active FHMs, as well as looking at differences in expressions levels in tissues of female fish 
treated with androgens. Further information is now available regarding a FHM zonadhesin-
like gene on the NCBI website, and this would enable the design of primers to span introns 
and avoid amplifying gDNA or other mucins with conserved domains. 
 
6.4. Final conclusions  
There is a need to discover and apply new approaches to replace, reduce and refine the use 
of animals in scientific procedures. The use of in vitro assays can reduce the need for in vivo 
testing, but inappropriate in vitro assays could affect data interpretation and lead to the 
mislabelling of some of the chemicals as EDCs. Modifying and improving the robustness of 
this standard (A)YAS could lead to a reduction in false positive results and subsequent 
reduction in in vivo investigations, thus reducing unnecessary costs/wasted resources along 
with reducing animal usage.  
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Currently there are no validated fish tests for anti-androgens, and although the AFSS (a 
variant of the 21-Day Fish Assay) has more power to identify anti-androgens than the 21-
Day Fish Assay (utilising zebrafish, FHM or medaka), this test has a more limited range of 
endpoints. In the 21-Day Fish Assay, this protocol describes SSC measurements as 
biomarkers of exposure to (anti-)androgens, yet these endpoints often lack sensitivity and 
some are scored on a subjective scale, so may be subject to bias (Ankley et al., 1998; 
Muldoon and Hogan, 2016). An additional biomarker for (anti-)androgens in the FHM would 
greatly enhance this fish test and could reduce the need for the AFSS. This would reduce 
the number of fish tests required when testing chemicals. The zonadhesin-like also looked to 
have the potential to be sampled non-invasively, and this would refine the in vivo test by 
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APPENDIX - FIGURES 
  
Figure A 1. Fish tank room set ups with standard treated effluent. (A) Experiment 1; VTG 
Test, dilution water, positive control (10ng/L EE2) and 100%, 50% or 25% effluent, and (B) 
Experiment 3, Pair Breeding Test, dilution water, positive control (20ng/L EE2) and 100%, 
50% or 25% effluent, sets of 6 or 8 tanks fed dilution water/EE2/effluent via 6- or 8-hole 
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Figure A 2. Fish tank room set ups with GAC treated effluent. (A) Experiment 2; VTG Test, 
dilution water, positive control (10ng/L EE2) and 100% effluent, and (B) Experiment 4; Pair 
Breeding Test, dilution water, positive control (20ng/L EE2) and 100% effluent, sets of 6 or 8 










































Figure A 3. VTG Test fish tank room set up with 20L tanks. Eight male fathead minnows 
were housed per tank. 
 
 
Figure A 4. Pair Breeding Test fish tank room set up with sets of 8L tanks fed dilution 
water/EE2/effluent via 6- or 8-hole mixing chambers. Each tank contained a spawning 






Figure A 5. 2013 sampling – Seine netting the River Ray down stream of Swindon Waste 












Figure A 7. Yeast oestrogen screen results showing percentage deconjugation for oestradiol 
(E2), oestradiol sulphate (E2-S) and oestradiol glucuronide (E2-G) with the enzymes 
sulphatase (type VI from Aerobacter aerogenes; Sigma-Aldrich) and β-glucuronidase (type 




Figure A 8. An example of a standard curve using the Biosense commercial carp VTG 





















Figure A 9. The quantification of VTG in plasma samples used two different Enzyme-linked 
immunosorbent assay (ELISA) methods (the pre-commercialisation method by Tyler et al. 
(1999) and the Biosense commercial carp VTG ELISA kit) and took place over a number of 
years. To determine comparability of VTG data, subsamples of plasma from 2005 (blue 
circles) and male plasma from 2013 (red circles) were reanalysed in the ELISA used to 
determine the 2013 female plasma VTG concentrations (ng/ml). The regression models for 





Figure A 10. Unadjusted plasma VTG concentrations in male (including intersex) and female 
roach sampled from the River Ray in 2005 (dotted plots; prior to GAC installation) and in 
2013 (striped plots; after the GAC WwTW upgrade). The violin plots include lines at the 
median and quartiles. VTG values significantly different from respective 2005 values are 




































Figure A 12. Alignment of DT131813 with spiggin β (Accession number BAS02336) showing 





Figure A 13. Alignment of DT131813 with mucin-19-like [Sinocyclocheilus grahami] 
(Accession number XP_016126944.1) showing 81% identity. 
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Figure A 14. Correlation analysis was carried out between the tubercle numbers and the 
normalised expression with the three ESTs (DT131813, p=0.3279; DT267220, p=0.4680; 
DT347638, p=0.7257) but no significant relationships were found. 
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Spearman r = 0.2364
R2=0.0066
 
Figure A 15. Correlation analysis was carried out between the FPIs and the normalised 
expression with the three ESTs (DT131813, p=0.5367; DT267220, p=0.6321; DT347638, 
p=0.5135), but no significant relationships were found. 
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APPENDIX - TABLES 
Table A 1. Raw fish tank water quality data from Experiment 1, VTG exposure study with 
standard effluent. Ammonia measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
21-May-09 Ac 1
22-May-09 Ac 2 0 0 0 0 0
23-May-09 Ac 3 0.5 0.5 0.5 0.5 0.5
24-May-09 Ac 4 0.5 0.5 0 0.5 0.5
25-May-09 Ac 5 0.5 0.5 0.5 0.5 0.5
26-May-09 Ac 6 0.5 0.5 0.5 0.5 0.5
27-May-09 Ac 7 0.5 0.5 0.5 0.5 0.5
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 -21 0.5 0.5 0.5 0.5 0.5
29-May-09 -20 0 0 0 0 0
30-May-09 -19 0 0 0 0 0
31-May-09 -18 0 0 0 0 0
01-Jun-09 -17 0 0 0 0 0
02-Jun-09 -16 0 0 0 0 0.5
03-Jun-09 -15 0 0 0 0 0
04-Jun-09 -14 0 0 0 0 0
05-Jun-09 -13 0.5 0.5 0.5 0 0
06-Jun-09 -12 0 0 0.5 0.5 0.5
07-Jun-09 -11 0.5 0.5 0.5 0.5 0.5
08-Jun-09 -10 0.5 0.5 0.5 0.5 0
09-Jun-09 -9 0.5 0.5 0.5 0.5 0.5
10-Jun-09 -8 0.5 0.5 0.5 0.5 0.5
11-Jun-09 -7 0.5 0.5 0.5 0.5 0.5
12-Jun-09 -6 0.5 0.5 0.5 0 0.5
13-Jun-09 -5 0.5 0.5 0.5 0.5 0.5
14-Jun-09 -4 0 0 0 0 0
15-Jun-09 -3 0 0 0 0 0
16-Jun-09 -2 0.5 0.5 0.5 0 0.5
17-Jun-09 -1 0 0.5 0.5 0.5 0.5
18-Jun-09 0 0 0 0.5 1
Ammonia (ppm)
Date Day Study day
Acclimation Period
Date Day Study day
Pre Exposure period (Weeks 1 to 3)
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Table A 2. Raw fish tank water quality data from Experiment 1, VTG exposure study with 
standard effluent. Nitrite measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
21-May-09 Ac 1
22-May-09 Ac 2 0 0 0 0 0
23-May-09 Ac 3 0 0 0 0 0
24-May-09 Ac 4 0 0 0 0 0
25-May-09 Ac 5 0 0 0 0 0
26-May-09 Ac 6 0 0 0 0 0
27-May-09 Ac 7 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 -21 0 0 0 0 0
29-May-09 -20 0 0 0 0 0
30-May-09 -19 0 0 0 0 0
31-May-09 -18 0 0 0 0 0
01-Jun-09 -17 0 0 0 0 0
02-Jun-09 -16 0 0 0 0 0
03-Jun-09 -15 0 0 0 0 0
04-Jun-09 -14 0 0 0 0 0
05-Jun-09 -13 0 0 0 0 0
06-Jun-09 -12 0 0 0 0 0
07-Jun-09 -11 0 0 0 0 0
08-Jun-09 -10 0 0 0 0 0
09-Jun-09 -9 0 0 0 0 0.5
10-Jun-09 -8 0 0 0 0 0.5
11-Jun-09 -7 0 0 0 0 0
12-Jun-09 -6 0 0 0.5 0.5 0.5
13-Jun-09 -5 0 0 0.5 0.5 0.5
14-Jun-09 -4 0 0 0 0 0.5
15-Jun-09 -3 0 0 0 0 0
16-Jun-09 -2 0.5 0.5 0.5 0.5 0.5
17-Jun-09 -1 0.5 0.5 0.5 0.5 0.5
18-Jun-09 0.5 0.5 0.5 0.5 0.5
Nitrite (ppm)
Date Day Study day
Acclimation Period
Pre Exposure period (Weeks 1 to 3)
Date Day Study day
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Table A 3. Raw fish tank water quality data from Experiment 1, VTG exposure study with 
standard effluent. Nitrate measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
21-May-09 Ac 1
22-May-09 Ac 2 0 10 10 10 0
23-May-09 Ac 3 10 10 10 10 10
24-May-09 Ac 4 10 25 10 10 10
25-May-09 Ac 5 10 25 25 10 25
26-May-09 Ac 6 0 10 10 10 10
27-May-09 Ac 7 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 -21 10 10 0 10 10
29-May-09 -20 0 10 10 10 25
30-May-09 -19 0 10 10 10 10
31-May-09 -18 10 10 10 10 10
01-Jun-09 -17 0 0 10 10 25
02-Jun-09 -16 0 0 10 25 50
03-Jun-09 -15 10 10 25 25 50
04-Jun-09 -14 0 10 25 25 25
05-Jun-09 -13 10 10 25 25 50
06-Jun-09 -12 0 0 10 10 25
07-Jun-09 -11 10 10 25 25 50
08-Jun-09 -10 0 10 10 10 10
09-Jun-09 -9 10 10 25 10 25
10-Jun-09 -8 0 10 0 0 10
11-Jun-09 -7 0 10 10 25 25
12-Jun-09 -6 10 10 10 10 25
13-Jun-09 -5 10 10 10 25 25
14-Jun-09 -4 10 10 25 25 25
15-Jun-09 -3 0 10 10 10 10
16-Jun-09 -2 10 10 10 25 25
17-Jun-09 -1 10 10 10 10 25
18-Jun-09 10 10 10 10 25
Nitrate (ppm)
Date Day Study day
Acclimation Period
Date Day Study day
Pre Exposure period (Weeks 1 to 3)
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Table A 4. Raw fish tank water quality data from Experiment 2, VTG exposure study with 
GAC effluent. Ammonia measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
09-Mar-09 Ac 1 0.5 0 0.5
10-Mar-09 Ac 2 0.5 0.5 0.5
11-Mar-09 Ac 3 0.5 0 0.5
12-Mar-09 Ac 4 0 0.5 0.5
13-Mar-09 Ac 5 0 0 0
14-Mar-09 Ac 6 0 0 0
15-Mar-09 Ac 7 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 -21 0 0 0
17-Mar-09 -20 0 0 0.5
18-Mar-09 -19 0 0 0
19-Mar-09 -18 0 0 0
20-Mar-09 -17 0 0.5 0
21-Mar-09 -16 0 0.5 0
22-Mar-09 -15 0.5 1 1
23-Mar-09 -14 0 0 0
24-Mar-09 -13 0 0 0
25-Mar-09 -12 0 0 0
26-Mar-09 -11 0 0 0
27-Mar-09 -10 0 0 0
28-Mar-09 -9 0 0 0
29-Mar-09 -8 0.5 0.5 0.5
30-Mar-09 -7 0 0 0
31-Mar-09 -6 0 0 0
01-Apr-09 -5 0 0 0
02-Apr-09 -4 0 0 0
03-Apr-09 -3 0 0 0
04-Apr-09 -2 0 0 0
05-Apr-09 -1 0 0 0.5
06-Apr-09
Ammonia (ppm)
Date Day Study day
Acclimation Period
Pre Exposure period (Weeks 1 to 3)
Date Day Study day
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Table A 5. Raw fish tank water quality data from Experiment 2, VTG exposure study with 
GAC effluent. Nitrite measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
09-Mar-09 Ac 1 0 0 0
10-Mar-09 Ac 2 0 0 0
11-Mar-09 Ac 3 0 0 0
12-Mar-09 Ac 4 0 0 0
13-Mar-09 Ac 5 0 0 0
14-Mar-09 Ac 6 0 0 0
15-Mar-09 Ac 7 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 -21 0 0 0
17-Mar-09 -20 0 0 0
18-Mar-09 -19 0 0 0
19-Mar-09 -18 0 0 0
20-Mar-09 -17 0 0 0
21-Mar-09 -16 0 0 0
22-Mar-09 -15 0 0 0
23-Mar-09 -14 0 0 0
24-Mar-09 -13 0 0 0
25-Mar-09 -12 0 0 0
26-Mar-09 -11 0 0 0
27-Mar-09 -10 0 0 0
28-Mar-09 -9 0 0 0
29-Mar-09 -8 0 0 0
30-Mar-09 -7 0 0 0
31-Mar-09 -6 0 0 0.5
01-Apr-09 -5 0 0.5 0.5
02-Apr-09 -4 0.5 0.5 0.5
03-Apr-09 -3 0.5 0.5 0.5
04-Apr-09 -2 0.5 0.5 0.5




Date Day Study day





Table A 6. Raw fish tank water quality data from Experiment 2, VTG exposure study with 
GAC effluent. Nitrate measurements in parts per million (ppm) taken with test strips 
(Precision Laboratories, Moulton, UK).
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
09-Mar-09 Ac 1 0 0 0
10-Mar-09 Ac 2 10 0.5 10
11-Mar-09 Ac 3 0 10 0
12-Mar-09 Ac 4 0 0 10
13-Mar-09 Ac 5 0 0 0
14-Mar-09 Ac 6 0 0 0
15-Mar-09 Ac 7 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 -21 0 0 0
17-Mar-09 -20 0 0 10
18-Mar-09 -19 0 0 10
19-Mar-09 -18 0 0 10
20-Mar-09 -17 0 0 10
21-Mar-09 -16 0 0 25
22-Mar-09 -15 0 0 0
23-Mar-09 -14 0 0 0
24-Mar-09 -13 0 0 0
25-Mar-09 -12 0 0 0
26-Mar-09 -11 0 0 10
27-Mar-09 -10 0 0 10
28-Mar-09 -9 0 0 10
29-Mar-09 -8 0 0 10
30-Mar-09 -7 0 0 10
31-Mar-09 -6 0 0 10
01-Apr-09 -5 0 10 10
02-Apr-09 -4 0 10 10
03-Apr-09 -3 0 10 10
04-Apr-09 -2 0 10 10
05-Apr-09 -1 0 10 5
06-Apr-09
Nitrate (ppm)




Pre Exposure period (Weeks 1 to 3)
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Table A 7. Raw fish tank water quality data from Experiment 3, Pair Breeding exposure 
study with standard effluent. Ammonia measurements in parts per million (ppm) taken with 
test strips (Precision Laboratories, Moulton, UK). 
  
1 +ve Control 25% Effluent 50% Effluent 100% Effluent
30-Apr-09 Ac 1 0.5 0.5 0.5 0.5 0.5
01-May-09 Ac 2 0.5 0.5 0.5 0.5 0.5
02-May-09 Ac 3 0.5 0.5 0.5 0 0.5
03-May-09 Ac 4 0 0 0 0 0
04-May-09 Ac 5 0 0 0 0 0
05-May-09 Ac 6 0.5 0 0 0.5 0
06-May-09 Ac 7 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
07-May-09 -21 0.5 0.5 0 0.5 0.5
08-May-09 -20 0.5 0.5 0 0.5 0.5
09-May-09 -19 0.5 0.5 0.5 0.5 0.5
10-May-09 -18 0.5 0.5 0.5 0.5 0.5
11-May-09 -17 0.5 0.5 0.5 0.5 0.5
12-May-09 -16 0 0 0 0 0
13-May-09 -15 0 0 0 0 0
14-May-09 -14 0.5 0 0 0 0
15-May-09 -13 0 0 0 0 0
16-May-09 -12 0 0 0.5 0 0
17-May-09 -11 0 0 0.5 0 0
18-May-09 -10 0.5 0.5 0.5 0.5 0.5
19-May-09 -9 0.5 0.5 0 0 0
20-May-09 -8 0.5 0.5 0.5 0.5 0.5
21-May-09 -7 0.5 0.5 0.5 0.5 0.5
22-May-09 -6 0.5 0.5 0.5 0.5 0.5
23-May-09 -5 0.5 0.5 0.5 0.5 0.5
24-May-09 -4 0 0 0 0 0
25-May-09 -3 0.5 0 0 0.5 0.5
26-May-09 -2 0.5 0.5 0.5 0.5 0.5
27-May-09 -1 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 1 0 0 0 0 0
29-May-09 2 0 0 0 0 0
30-May-09 3 0 0 0 0 0
31-May-09 4 0 0 0 0 0
01-Jun-09 5 0 0 0 0.5 0.5
02-Jun-09 6 0 0 0 0 0
03-Jun-09 7 0 0 0 0 0
04-Jun-09 8 0 0 0 0 0
05-Jun-09 9 0 0.5 0.5 0.5 0.5
06-Jun-09 10 0 0.5 0.5 0.5 0.5
07-Jun-09 11 0 0.5 0.5 0.5 0.5
08-Jun-09 12 0 0 0.5 0.5 0.5
09-Jun-09 13 0 0 0 0 0
10-Jun-09 14 0 0 0 0 0
11-Jun-09 15 0 0 0 0 0
12-Jun-09 16 0 0.5 0 0 0.5
13-Jun-09 17 0 0 0 0 0.5
14-Jun-09 18 0 0 0 0 0.5
15-Jun-09 19 0 0 0.5 0.5 1
16-Jun-09 20 0.5 0.5 0.5 0.5 1




Date Day Study day
Study dayDate Day
Day Study day
Exposure period (Weeks 4 to 6)
Pre Exposure period (Weeks 1 to 3)
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Table A 8. Raw fish tank water quality data from Experiment 3, Pair Breeding exposure 
study with standard effluent. Nitrite measurements in parts per million (ppm) taken with test 
strips (Precision Laboratories, Moulton, UK).
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
30-Apr-09 Ac 1 0 0 0 0 0
01-May-09 Ac 2 0 0 0 0 0
02-May-09 Ac 3 0 0 0 0 0
03-May-09 Ac 4 0 0 0 0 0
04-May-09 Ac 5 0 0 0 0 0
05-May-09 Ac 6 0 0 0 0 0
06-May-09 Ac 7 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
07-May-09 -21 0 0 0 0 0
08-May-09 -20 0 0 0 0 0
09-May-09 -19 0 0 0 0 0
10-May-09 -18 0 0 0 0 0
11-May-09 -17 0 0 0 0 0
12-May-09 -16 0 0 0 0 0
13-May-09 -15 0 0 0 0 0
14-May-09 -14 0 0 0 0 0
15-May-09 -13 0 0 0 0 0
16-May-09 -12 0 0 0 0 0
17-May-09 -11 0 0 0 0 0
18-May-09 -10 0 0 0 0 0
19-May-09 -9 0 0.5 0 0 0
20-May-09 -8 0 0 0 0 0
21-May-09 -7 0 0 0 0 0
22-May-09 -6 0 0 0 0 0
23-May-09 -5 0 0 0 0 0
24-May-09 -4 0 0 0 0 0
25-May-09 -3 0 0.5 0 0 0
26-May-09 -2 0 0 0 0 0
27-May-09 -1 0 0.5 0 0 0
.
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 1 0 0 0.5 0.5 0
29-May-09 2 0 0 0.5 0.5 0.5
30-May-09 3 0 0 0 0.5 0.5
31-May-09 4 0.5 0.5 0.5 0.5 0.5
01-Jun-09 5 0.5 0.5 0.5 0.5 0.5
02-Jun-09 6 0 0.5 0.5 0.5 0.5
03-Jun-09 7 0.5 0.5 0.5 0.5 0.5
04-Jun-09 8 0.5 0.5 0.5 0.5 0.5
05-Jun-09 9 0 0 0 0.5 0
06-Jun-09 10 0 0 0 0 0.5
07-Jun-09 11 0 0 0 0 0.5
08-Jun-09 12 0 0.5 0 0 0.5
09-Jun-09 13 0 0.5 0 0.5 0.5
10-Jun-09 14 0 0.5 0 0.5 0.5
11-Jun-09 15 0 0.5 0 0 0
12-Jun-09 16 0.5 0.5 0 0 0
13-Jun-09 17 0.5 0.5 0 0 0
14-Jun-09 18 0.5 0.5 0 0 0
15-Jun-09 19 0.5 0.5 0 0 0
16-Jun-09 20 0.5 0 0 0 0
17-Jun-09 21 0.5 0 0 0 0
Date Day Study day
Exposure period (Weeks 4 to 6)
Nitrite (ppm)
Date Day Study day
Acclimation Period
Date Day Study day
Pre Exposure period (Weeks 1 to 3)
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Table A 9. Raw fish tank water quality data from Experiment 3, Pair Breeding exposure 
study with standard effluent. Nitrate measurements in parts per million (ppm) taken with test 
strips (Precision Laboratories, Moulton, UK). 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
30-Apr-09 Ac 1 10 0 10 0 0
01-May-09 Ac 2 0 0 0 0 0
02-May-09 Ac 3 0 0 0 0 0
03-May-09 Ac 4 0 0 0 0 0
04-May-09 Ac 5 0 0 0 0 0
05-May-09 Ac 6 0 0 0 0 0
06-May-09 Ac 7 0 0 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
07-May-09 -21 10 10 10 10 10
08-May-09 -20 0 0 0 0 0
09-May-09 -19 0 0 0 0 0
10-May-09 -18 0 0 0 0 0
11-May-09 -17 0 0 0 0 0
12-May-09 -16 0 10 0 10 0
13-May-09 -15 0 10 0 10 0
14-May-09 -14 10 10 10 0 10
15-May-09 -13 0 0 0 10 10
16-May-09 -12 0 0 0 10 0
17-May-09 -11 0 0 10 10 10
18-May-09 -10 0 0 10 0 10
19-May-09 -9 0 10 10 10 10
20-May-09 -8 10 0 0 10 10
21-May-09 -7 10 10 10 10 10
22-May-09 -6 0 10 10 10 10
23-May-09 -5 0 0 10 10 0
24-May-09 -4 10 10 10 10 10
25-May-09 -3 10 10 10 10 10
26-May-09 -2 10 0 10 10 10
27-May-09 -1 0 10 10 10 10
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 1 0 10 10 25 25
29-May-09 2 10 10 25 25 25
30-May-09 3 0 0 10 25 10
31-May-09 4 10 10 10 25 25
01-Jun-09 5 10 10 25 50 50
02-Jun-09 6 10 10 25 50 50
03-Jun-09 7 10 10 25 50 100
04-Jun-09 8 10 10 50 50 50
05-Jun-09 9 10 10 25 50 5
06-Jun-09 10 10 10 10 25 0
07-Jun-09 11 10 10 10 25 50
08-Jun-09 12 10 10 10 25 50
09-Jun-09 13 10 10 10 25 25
10-Jun-09 14 10 10 0 25 25
11-Jun-09 15 0 10 0 10 10
12-Jun-09 16 0 0 10 10 0
13-Jun-09 17 10 10 10 10 10
14-Jun-09 18 25 25 25 10 25
15-Jun-09 19 10 10 10 10 25
16-Jun-09 20 25 0 10 25 50
17-Jun-09 21 10 10 25 25 25
Exposure period (Weeks 4 to 6)
Pre Exposure period (Weeks 1 to 3)
Nitrate (ppm)








Table A 10. Raw fish tank water quality data from Experiment 4, Pair Breeding exposure 
study with GAC effluent. Ammonia measurements in parts per million (ppm) taken with test 
strips (Precision Laboratories, Moulton, UK). 
  
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Feb-09 Ac 1 0.5 0.5 0.5
17-Feb-09 Ac 2 0.5 0.5 0.5
18-Feb-09 Ac 3 0.5 0.5 0.5
19-Feb-09 Ac 4 0.5 0.5 0.5
20-Feb-09 Ac 5 0.5 0.5 0.5
21-Feb-09 Ac 6 0.5 0.5 1.0
22-Feb-09 Ac 7 0.5 0.5 0.5
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
23-Feb-09 -21 0.5 0.5 0.5
24-Feb-09 -20 0.5 0.5 0.5
25-Feb-09 -19 0.5 0.5 0.5
26-Feb-09 -18 0.5 0.5 0.5
27-Feb-09 -17 0.5 0 0
28-Feb-09 -16 1 0.5 0.5
01-Mar-09 -15 0.5 0 0.5
02-Mar-09 -14 0 0.5 0.5
03-Mar-09 -13 0.5 0.5 0.5
04-Mar-09 -12 0.5 0.5 0.5
05-Mar-09 -11 0 0 0.5
06-Mar-09 -10 0.5 0.5 0.5
07-Mar-09 -9 0.5 0.5 0.5
08-Mar-09 -8 0.5 0 0.5
09-Mar-09 -7 0.5 0.5 0.5
10-Mar-09 -6 0.5 0.5 0.5
11-Mar-09 -5 0.5 0.5 0.5
12-Mar-09 -4 0.5 0.5 0.5
13-Mar-09 -3 0.5 0.5 0.5
14-Mar-09 -2 0.5 0.5 0.5
15-Mar-09 -1 0.5 0.5 0.5
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 1 0.5 0.5 0.5
17-Mar-09 2 0.5 0 0.5
18-Mar-09 3 0.5 0.5 1
19-Mar-09 4 1 1 0.5
20-Mar-09 5 0.5 0.5 1
21-Mar-09 6 0.5 1 0.5
22-Mar-09 7 0.5 0.5 1
23-Mar-09 8 0.5 0.5 1
24-Mar-09 9 0.5 0.5 1
25-Mar-09 10 1 0.5 0.5
26-Mar-09 11 0.5 1 0.5
27-Mar-09 12 0.5 0.5 1
28-Mar-09 13 0 0.5 0.5
29-Mar-09 14 0.5 0.5 0.5
30-Mar-09 15 0 0.5 1
31-Mar-09 16 0.5 0.5 1
01-Apr-09 17 0.5 0.5 0.5
02-Apr-09 18 0.5 0.5 0.5
03-Apr-09 19 0 0.5 0.5
04-Apr-09 20 0.5 0.5 0.5
05-Apr-09 21 0.5 0.5 0.5
Date Day Study day
Exposure period (Weeks 4 to 6)
Date Day Study day
Pre Exposure period (Weeks 1 to 3)
Ammonia (ppm)




Table A 11. Raw fish tank water quality data from Experiment 4, Pair Breeding exposure 
study with GAC effluent. Nitrite measurements in parts per million (ppm) taken with test 
strips (Precision Laboratories, Moulton, UK). 
 
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Feb-09 Ac 1 0 0 0
17-Feb-09 Ac 2 0 0 0
18-Feb-09 Ac 3 0 0 0
19-Feb-09 Ac 4 0 0 0
20-Feb-09 Ac 5 0 0 0
21-Feb-09 Ac 6 0 0 0
22-Feb-09 Ac 7 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
23-Feb-09 -21 0 0 0
24-Feb-09 -20 0 0 0
25-Feb-09 -19 0 0 0
26-Feb-09 -18 0 0 0
27-Feb-09 -17 0 0 0
28-Feb-09 -16 0 0 0
01-Mar-09 -15 0 0 0
02-Mar-09 -14 0 0 0
03-Mar-09 -13 0 0 0
04-Mar-09 -12 0 0 0
05-Mar-09 -11 0 0 0
06-Mar-09 -10 0 0 0
07-Mar-09 -9 0 0 0
08-Mar-09 -8 0.5 0.5 0.5
09-Mar-09 -7 0.5 0 0
10-Mar-09 -6 0 0 0
11-Mar-09 -5 0 0 0
12-Mar-09 -4 0 0 0
13-Mar-09 -3 0 0 0
14-Mar-09 -2 0 0 0
15-Mar-09 -1 0 0 0
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 1 0 0 0
17-Mar-09 2 0.5 0 0.5
18-Mar-09 3 0.5 0.5 0.5
19-Mar-09 4 0 0.5 0.5
20-Mar-09 5 0 0 0
21-Mar-09 6 0 0 0
22-Mar-09 7 0 0 0.5
23-Mar-09 8 0 0 0.5
24-Mar-09 9 0 0 0
25-Mar-09 10 0 0 0
26-Mar-09 11 0 0 0
27-Mar-09 12 0 0 0
28-Mar-09 13 0 0 0
29-Mar-09 14 0 0 0.5
30-Mar-09 15 0 0 0.5
31-Mar-09 16 0 0 0
01-Apr-09 17 0 0 0.5
02-Apr-09 18 0 0 0.5
03-Apr-09 19 0 0.5 0.5
04-Apr-09 20 0 0.5 0.5
05-Apr-09 21 0 0 0.5
Date Day Study day
Date Day Study day
Exposure period (Weeks 4 to 6)
Acclimation Period
Pre Exposure period (Weeks 1 to 3)




Table A 12. Raw fish tank water quality data from Experiment 4, Pair Breeding exposure 
study with GAC effluent. Nitrate measurements in parts per million (ppm) taken with test 
strips (Precision Laboratories, Moulton, UK). 
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Feb-09 Ac 1 10 10 0
17-Feb-09 Ac 2 0 10 0
18-Feb-09 Ac 3 0 0 0
19-Feb-09 Ac 4 0 0 0
20-Feb-09 Ac 5 0 0 10
21-Feb-09 Ac 6 0 0 0
22-Feb-09 Ac 7 10 10 25
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
23-Feb-09 -21 25 25 25
24-Feb-09 -20 25 10 25
25-Feb-09 -19 25 25 25
26-Feb-09 -18 25 25 10
27-Feb-09 -17 10 10 10
28-Feb-09 -16 25 10 10
01-Mar-09 -15 10 10 10
02-Mar-09 -14 10 10 10
03-Mar-09 -13 10 10 10
04-Mar-09 -12 10 10 10
05-Mar-09 -11 10 10 10
06-Mar-09 -10 0 10 0
07-Mar-09 -9 10 10 0
08-Mar-09 -8 10 10 10
09-Mar-09 -7 10 10 10
10-Mar-09 -6 10 10 10
11-Mar-09 -5 10 10 10
12-Mar-09 -4 25 25 10
13-Mar-09 -3 25 25 10
14-Mar-09 -2 0 0 0
15-Mar-09 -1 10 10 10
Control +ve Control 25% Effluent 50% Effluent 100% Effluent
16-Mar-09 1 0 0 0
17-Mar-09 2 0 0 25
18-Mar-09 3 10 10 100
19-Mar-09 4 10 10 50
20-Mar-09 5 0 10 10
21-Mar-09 6 0 10 10
22-Mar-09 7 0 0 10
23-Mar-09 8 10 0 10
24-Mar-09 9 0 0 10
25-Mar-09 10 0 0 0
26-Mar-09 11 0 0 10
27-Mar-09 12 0 0 10
28-Mar-09 13 10 10 25
29-Mar-09 14 0 0 25
30-Mar-09 15 10 10 25
31-Mar-09 16 10 10 25
01-Apr-09 17 10 10 25
02-Apr-09 18 10 10 25
03-Apr-09 19 10 10 25
04-Apr-09 20 0 10 25
05-Apr-09 21 0 0 25
Study day
Exposure period (Weeks 4 to 6)
Date Day
Date Day Study day







Table A 13. Raw physicochemistry data for fish tank water from Experiment 1, VTG exposure study with standard effluent.  







Actual SD Actual SD Actual SD Actual SD Actual SD Actual SD
21.00 0.35 20.13 0.53 20.13 1.59 19.75 0.35 20.38 0.53
8.13 0.03 8.22 0.04 8.29 0.07 8.28 0.07 8.22 0.04 8.35 0.05
25.05 0.14 25.35 0.21 25.33 0.11 25.08 0.18 25.23 0.04 25.25 0.07
7.16 0.13 7.48 0.34 7.51 0.06 7.33 0.17 7.18 0.14 7.58 0.19
Actual SD Actual SD Actual SD Actual SD Actual SD Actual SD
5.15 0.17 10.29 0.27 19.92 0.43
20.50 0.52 20.13 0.53 15.08 0.47 10.08 0.43
0.20 0.20
8.17 0.10 8.19 0.09 8.21 0.12 8.23 0.12 8.28 0.09
25.44 50.51 100.00
25.06 0.60 25.26 0.21 24.96 0.21 25.08 0.17 24.84 0.09






25% Effluent 50% Effluent 100% Effluent
Mean Actual effluent flow rate
Mean Actual dilution water flow rate
Mean Positive control flow rate
Mean Temperature
Mean Dissolved Oxygen
Exposure period (Weeks 4 to 6)
Baseline Control "+ve" control
100% Effluent
Mean Actual effluent flow rate
Mean Actual dilution water flow rate
Mean Positive control flow rate
Mean PH
Mean % Effluent
Pre Exposure period (Weeks 1 to 3)
EXPT 1 - VTG STANDARD Start Date: 21-May-09
Treatment Tank Size 20L Number of Replicate Tanks per Treatment Number of Treatments
Baseline Control "+ve" control 25% Effluent 50% Effluent
Types of Treatment Control, +ve control, 25, 50 & 100% final effluent Photo Period16hrs light : 8 hrs darkTotal Flow Rate
Replacement Water Time Temperature of Water
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Table A 14. Raw physicochemistry data for fish tank water from Experiment 2, VTG exposure study with GAC effluent.  







Actual SD Actual SD Actual SD Actual SD Actual SD Actual SD
41.13 1.24 41.75 1.06 41.50 0.71
8.22 0.02 8.18 0.01 8.31 0.01 8.27 0.01
24.95 0.21 25.13 0.04 24.98 0.04 25.43 0.04
7.00 0.12 6.83 0.21 7.16 0.19 7.01 0.03
Actual SD Actual SD Actual SD Actual SD Actual SD Actual SD
43.67 0.75
42.67 1.66 40.54 1.14
0.40 0.41
8.31 0.07 8.33 0.03 8.16 0.07
100.00
25.00 0.09 24.93 0.17 25.12 0.22




Day Zero Control "+ve" control 25% Effluent 50% Effluent
Baseline Control "+ve" control 25% Effluent
Protocol Number
Mean Actual dilution water flow rate
Pre Exposure period (Weeks 1 to 3)
Exposure period (Weeks 4 to 6)
Mean Actual effluent flow rate
Mean Actual dilution water flow rate




Replacement Water Time Temperature of Water
Types of Treatment Control, +ve control & 100% GAC effluent Photo Period 16hrs light : 8 hrs dark
EXPT 2 - VTG GAC Start Date: 9-Mar-09







Mean Positive control flow rate
Mean Dissolved Oxygen
Mean Actual effluent flow rate
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Table A 15. Raw physicochemistry data for fish tank water from Experiment 3, Pair Breeding exposure study with standard effluent.  







Flow rate SD Flow rate SD Flow rate SD Flow rate SD Flow rate SD
21.40 0.88 19.89 1.30 20.24 1.48 19.82 1.28 19.99 1.41
8.30 0.06 8.21 0.08 8.23 0.05 8.36 0.05 8.39 0.06
25.15 0.36 25.07 0.39 24.95 0.44 25.06 0.38 25.43 0.40
7.71 0.18 7.65 0.19 7.71 0.15 7.71 0.14 7.65 0.15
Flow rate SD Flow rate SD Flow rate SD Flow rate SD Flow rate SD
5.36 0.10 9.98 0.06 20.54 0.45
20.06 1.44 19.47 1.39 15.46 1.43 10.00 0.64
0.20 0.02
8.26 0.10 8.13 0.10 8.16 0.08 8.32 0.06 8.31 0.08
25.76 49.95 100.00
25.20 0.23 25.43 0.14 24.87 0.22 24.62 0.19 24.86 0.19
7.68 0.27 7.48 0.18 7.54 0.30 7.67 0.22 7.66 0.17
Number of Treatments
Mean Actual dilution water flow rate







Mean Actual effluent flow rate
Mean Actual dilution water flow rate





Types of Treatment Control, +ve control, 25%, 50% & 100% final effluent Photo Period 16 hrs light : 8 hrs dark Total Flow Rate
Replacement Water Time Temperature of Water
Pre Exposure period (Weeks 1 to 3)
Control "+ve" control 25% Effluent 50% Effluent
Exposure period (Weeks 4 to 6)
Control "+ve" control 25% Effluent 50% Effluent
Mean Actual effluent flow rate
EXPT 3 - PAIR STANDARD Start Date: 30-Apr-09




Table A 16. Raw physicochemistry data for fish tank water from Experiment 4, Pair Breeding exposure study with GAC effluent.  





32hr Temperature of Water 25
o
C
Flow rate SD Flow rate SD Flow rate SD Flow rate SD Flow rate SD
22.71 0.78
23.05 1.77 23.20 1.86
8.19 0.11 8.20 0.09 8.37 0.09
100.00
24.84 0.24 25.32 0.28 25.29 0.23
7.54 0.20 7.52 0.21 7.76 1.09
Flow rate SD Flow rate SD Flow rate SD Flow rate SD Flow rate SD
21.49 0.45
22.00 1.45 21.35 1.46
0.21 0.01
8.30 0.05 8.26 0.04 8.34 0.09
100.00
24.42 0.34 24.71 0.27 24.73 0.35
8.20 0.35 8.11 0.31 8.11 0.35
Total Flow Rate
Replacement Water Time
EXPT 4 - PAIR GAC Start Date: 16-Feb-09
Treatment Tank Size 8.5L Number of Replicate Tanks per Treatment Number of Treatments
Protocol Number
Types of Treatment Control, +ve control & 100% final effluent Photo Period 16 hrs light : 8 hrs dark
Pre Exposure period (Weeks 1 to 3)
Control "+ve" control
100% Effluent
Mean Actual effluent flow rate
Mean Actual dilution water flow rate










Mean Actual effluent flow rate
Mean Actual dilution water flow rate































Baseline 1 M 2.931 57 23 1.583 0.785 0 0 0 0 5 
Baseline 2 M 1.935 54 14 1.229 0.724 2 8 0 0 38 
Baseline 3 M 2.128 48 22 1.924 1.034 1 10 0 0 1,075 
Baseline 4 M 1.831 51 22 1.380 1.202 3 10 0 0 512 
Baseline 5 M 2.209 54 20 1.403 0.905 2 12 22 0.996 116 
Baseline 6 M 2.645 58 43 1.356 1.626 2 12 0 0 103 
Baseline 7 M 2.259 57 31 1.220 1.372 3 14 20 0.885 1,161 
Baseline 8 M 1.636 51 13 1.233 0.795 1 10 0 0 11 
Baseline 9 M 3.599 65 35 1.311 0.972 1 8 0 0 29 
Baseline 10 M 1.583 51 10 1.193 0.632 0 0 0 0 13 
Baseline 11 M 2.037 54 23 1.294 1.129 3 14 0 0 216 
Baseline 12 M 2.116 56 18 1.205 0.851 1 11 0 0 10 
Baseline 13 M 3.051 59 43 1.486 1.409 2 12 77 2.524 169 
Baseline 14 M 2.519 57 13 1.360 0.516 0 0 0 0 10 
Baseline 15 M 2.661 59 50 1.296 1.879 2 12 0 0 12 
Baseline 16 M 1.899 54 13 1.206 0.685 0 0 0 0 8 
Control 17 M 2.06 52 52 1.465 2.524 4 17 84 4.078 9 
Control 18 M 2.72 51 48 2.050 1.765 4 11 83 3.051 67 
Control 19 M 2.12 54 16 1.346 0.755 3 11 42 1.981 793 
Control 20 M 2.57 58 36 1.317 1.401 2 9 32 1.245 41 
Control 21 M 1.7 53 28 1.142 1.647 2 8 18 1.059 89 
Control 22 M 2.79 59 47 1.358 1.685 4 13 38 1.362 16 
Control 23 M 2.75 60 44 1.273 1.600 1 2 40 1.455 44 
Control 24 M 1.88 51 49 1.417 2.606 4 12 26 1.383 32 
Control 25 M 1.92 53 34 1.290 1.771 2 10 48 2.500 11 
Control 26 M 2.52 56 54 1.435 2.143 2 12 112 4.444 13 
Control 27 M 2.22 52 63 1.579 2.838 4 14 24 1.081 34 
Control 28 M 3.06 60 54 1.417 1.765 1 12 20 0.654 5 
Control 29 M 2.82 57 76 1.523 2.695 4 12 72 2.553 785 
Control 30 M 2.54 55 57 1.527 2.244 4 15 64 2.520 62 
Control 31 M 2.46 56 59 1.401 2.398 4 15 42 1.707 30 

























+ve Control 33 M 2.64 58 80 1.353 3.030 4 15 48 1.818 57,543,617 
+ve Control 34 M 3.89 62 77 1.632 1.979 2 9 98 2.519 59,064,708 
+ve Control 35 M 2.03 54 36 1.289 1.773 1 7 45 2.217 41,781,339 
+ve Control 36 M 2.41 57 27 1.301 1.120 0 0 39 1.618 44,387,158 
+ve Control 37 M 2.39 54 50 1.518 2.092 2 14 39 1.632 55,047,387 
+ve Control 38 M 2.69 57 67 1.453 2.491 4 15 59 2.193 31,109,061 
+ve Control 39 M 2.4 55 37 1.443 1.542 1 8 40 1.667 87,930,275 
+ve Control 40 M 1.78 51 27 1.342 1.517 2 13 128 7.191 72,626,635 
+ve Control 41 M 2.9 61 46 1.278 1.586 4 13 170 5.862 41,478,646 
+ve Control 42 M 2.73 58 39 1.399 1.429 1 1 58 2.125 33,664,747 
+ve Control 43 M 1.72 52 22 1.223 1.279 0 0 0 0 47,178,078 
+ve Control 44 M 2.4 55 55 1.443 2.292 2 13 68 2.833 42,328,885 
+ve Control 45 M 3.18 55 53 1.911 1.667 1 6 0 0 45,478,549 
+ve Control 46 M 2.25 56 27 1.281 1.200 0 0 20 0.889 69,584,531 
+ve Control 47 M 1.74 52 27 1.237 1.552 4 15 77 4.425 63,078,799 
+ve Control 48 M 2.52 57 45 1.361 1.786 2 14 56 2.222 72,776,270 
25% Effluent 49 M 1.82 50 38 1.456 2.088 2 10 39 2.143 462 
25% Effluent 50 M 2.78 59 48 1.354 1.727 4 12 17 0.612 656 
25% Effluent 51 M 3.19 60 72 1.477 2.257 4 13 50 1.567 532 
25% Effluent 52 M 2.52 59 36 1.227 1.429 1 7 18 0.714 795 
25% Effluent 53 M 2.99 59 73 1.456 2.441 4 15 82 2.742 93 
25% Effluent 54 M 2.53 54 50 1.607 1.976 4 17 132 5.217 653 
25% Effluent 55 M 1.98 54 26 1.257 1.313 1 2 10 0.505 328 
25% Effluent 56 M 2.35 53 68 1.578 2.894 4 12 54 2.298 74 
25% Effluent 57 M 3.24 60 70 1.500 2.160 4 13 120 3.704 9,270 
25% Effluent 58 M 2.43 60 19 1.125 0.782 0 0 0 0 26 
25% Effluent 59 M 2.5 58 45 1.281 1.800 4 15 30 1.200 27 
25% Effluent 60 M 2.27 56 17 1.293 0.749 0 0 13 0.573 6 
25% Effluent 61 M 3.23 60 69 1.495 2.136 4 12 75 2.322 270 
25% Effluent 62 M 2.27 58 46 1.163 2.026 4 16 33 1.454 941 
25% Effluent 63 M 2.14 56 32 1.219 1.495 1 9 0 0 28 

























50% Effluent 65 M 3.69 65 47 1.344 1.274 2 17 26 0.705 4,822 
50% Effluent 66 M 3.37 59 62 1.641 1.840 4 15 36 1.068 6 
50% Effluent 67 M 2.68 60 34 1.241 1.269 0 0 0 0 12 
50% Effluent 68 M 1.97 51 46 1.485 2.335 1 5 0 0 79 
50% Effluent 69 M 2.62 55 48 1.575 1.832 4 16 68 2.595 18 
50% Effluent 70 M 1.84 51 31 1.387 1.685 4 13 19 1.033 597 
50% Effluent 71 M 2.23 57 24 1.204 1.076 0 0 0 0 3 
50% Effluent 72 M 2.3 52 62 1.636 2.696 3 11 58 2.522 8 
50% Effluent 73 M 2.49 57 31 1.345 1.245 0 0 0 0 38 
50% Effluent 74 M 1.99 53 48 1.337 2.412 3 11 44 2.211 152 
50% Effluent 75 M 2.2 54 35 1.397 1.591 3 14 22 1 12 
50% Effluent 76 M 2.12 54 20 1.346 0.943 0 0 0 0 14 
50% Effluent 77 M 3.79 64 90 1.446 2.375 4 15 83 2.190 150 
50% Effluent 78 M 2.47 58 33 1.266 1.336 0 0 0 0 10 
50% Effluent 79 M 2.48 56 38 1.412 1.532 4 15 28 1.129 73 
50% Effluent 80 M 2.69 60 46 1.245 1.710 2 13 9 0.335 28 
100% Effluent 81 M 1.99 54 30 1.264 1.508 0 0 0 0 771 
100% Effluent 82 M 2.5 57 48 1.350 1.920 3 17 28 1.120 8 
100% Effluent 83 M 3.06 60 38 1.417 1.242 2 13 31 1.013 1,430 
100% Effluent 84 M 2.3 57 29 1.242 1.261 0 0 0 0 9 
100% Effluent 85 M 1.88 53 40 1.263 2.128 2 13 14 0.745 374 
100% Effluent 86 M 2.08 53 36 1.397 1.731 2 12 20 0.962 35 
100% Effluent 87 M 2.74 58 49 1.404 1.788 3 13 0 0 34 
100% Effluent 88 M 2.53 58 40 1.297 1.581 0 0 0 0 3 
100% Effluent 89 M 2.4 55 29 1.443 1.208 0 0 0 0 43 
100% Effluent 90 M 2.47 57 34 1.334 1.377 3 16 25 1.012 13 
100% Effluent 91 M 3.76 65 66 1.369 1.755 1 6 25 0.665 8 
100% Effluent 92 M 2.4 55 57 1.443 2.375 2 14 25 1.042 56 
100% Effluent 93 M 3.82 63 60 1.528 1.571 2 16 68 1.780 66 
100% Effluent 94 M 3.06 62 45 1.284 1.471 1 8 27 0.882 43 
100% Effluent 95 M 1.76 53 12 1.182 0.682 0 0 0 0 21 



























Baseline 1 M 2.435 60 27 1.127 1.109 0 0 0 0 52 
Baseline 2 M 3.616 64 53 1.379 1.466 2 14 100 2.765 56 
Baseline 3 M 2.829 59 63 1.377 2.227 3 12 152 5.373 554 
Baseline 4 M 2.846 54 46 1.807 1.616 0 0 0 0.000 68 
Baseline 5 M 2.098 55 27 1.261 1.287 1 6 20 0.953 130 
Baseline 6 M 4.005 66 49 1.393 1.223 1 8 22 0.549 144 
Baseline 7 M 2.025 54 50 1.286 2.469 0 0 0 0 7 
Baseline 8 M 3.089 64 60 1.178 1.942 0 0 0 0 18 
Baseline 9 M 3.529 65 33 1.285 0.935 0 0 0 0 39 
Baseline 10 M 2.735 60 36 1.266 1.316 0 0 0 0 289 
Baseline 11 M 3.368 58 63 1.726 1.871 2 14 124 3.682 1,569 
Baseline 12 M 2.448 57 16 1.322 0.654 0 0 0 0 12 
Baseline 13 M 3.719 65 52 1.354 1.398 2 8 24 0.645 27,176 
Baseline 14 M 2.618 61 25 1.153 0.955 0 0 0 0 773 
Baseline 15 M 2.457 60 25 1.138 1.018 0 0 0 0 100 
Baseline 16 M 1.899 54 23 1.206 1.211 0 0 0 0 202 
Control 17 M 2.337 58 36 1.198 1.540 2 10 0 0 28 
Control 18 M 2.384 60 15 1.104 0.629 0 0 0 0 21 
Control 19 M 3.482 65 52 1.268 1.493 4 12 75 2.154 2,373 
Control 20 M 4.495 69 69 1.368 1.535 2 12 0 0 114 
Control 21 M 3.195 58 81 1.638 2.535 3 16 99 3.099 865 
Control 22 M 2.773 61 71 1.222 2.560 0 0 0 0 12 
Control 23 M 2.433 58 18 1.247 0.740 0 0 0 0 86 
Control 24 M 2.493 58 41 1.278 1.645 1 10 0 0 85 
Control 25 M 2.462 59 62 1.199 2.518 2 15 32 1.300 82 
Control 26 M 2.179 55 34 1.310 1.560 4 16 20 0.918 226 
Control 27 M 3.045 58 65 1.561 2.135 3 20 9 0.296 1,941 
Control 28 M 3.792 67 77 1.261 2.031 3 16 26 0.686 2,216 
Control 29 M 2.488 59 14 1.211 0.563 0 0 0 0 69 
Control 30 M 3.582 63 64 1.433 1.787 4 16 70 1.954 23,963 
Control 31 M 3.519 63 74 1.407 2.103 2 26 24 0.682 1,440 

























+ve Control 33 M 3.259 64 27 1.243 0.828 0 0 0 0 59,635,414 
+ve Control 34 M 2.138 57 29 1.154 1.356 0 0 0 0 68,930,469 
+ve Control 35 M 2.318 57 30 1.252 1.294 1 4 0 0 157,586,483 
+ve Control 36 M 1.534 48 27 1.387 1.760 2 8 38 2.477 76,558,716 
+ve Control 37 M 2.816 63 23 1.126 0.817 0 0 0 0 108,667,416 
+ve Control 38 M 2.877 62 33 1.207 1.147 0 0 0 0 81,137,478 
+ve Control 39 M 1.993 54 23 1.266 1.154 0 0 0 0 92,357,497 
+ve Control 40 M 2.717 58 51 1.393 1.877 1 4 0 0 126,152,125 
+ve Control 41 M 2.101 58 19 1.077 0.904 1 6 0 0 54,989,002 
+ve Control 42 M 3.315 59 50 1.614 1.508 1 12 0 0 81,324,693 
+ve Control 43 M 3.332 61 40 1.468 1.200 2 14 50 1.501 12,944,459 
+ve Control 44 M 3.468 65 51 1.263 1.471 0 0 0 0 102,704,225 
+ve Control 45 M 2.295 58 28 1.176 1.220 1 10 0 0 34,490,268 
+ve Control 46 M 2.568 59 41 1.250 1.597 0 0 0 0 212,986,175 
+ve Control 47 M 3.718 65 60 1.354 1.614 0 0 0 0 135,599,654 
+ve Control 48 M 3.033 63 29 1.213 0.956 1 8 62 2.044 52,390,732 
100% Effluent 81 M 3.388 64 80 1.292 2.361 3 16 36 1.063 4,366 
100% Effluent 82 M 3.169 64 66 1.209 2.083 4 16 14 0.442 169 
100% Effluent 83 M 3.881 68 62 1.234 1.598 2 18 0 0 85 
100% Effluent 84 M 2.187 54 12 1.389 0.549 1 6 0 0 182 
100% Effluent 85 M 4.638 67 64 1.542 1.380 2 16 0 0 136 
100% Effluent 86 M 3.575 64 71 1.364 1.986 3 14 65 1.818 525 
100% Effluent 87 M 2.937 61 52 1.294 1.771 3 12 29 0.987 781 
100% Effluent 88 M 3.118 62 77 1.308 2.470 4 16 42 1.347 593 
100% Effluent 89 M 3.82 64 87 1.457 2.277 3 20 0 0 119 
100% Effluent 90 M 2.888 63 31 1.155 1.073 1 12 0 0 92 
100% Effluent 91 M 4.319 69 71 1.315 1.644 2 16 0 0 82 
100% Effluent 92 M 2.336 58 39 1.197 1.670 1 4 0 0 112 
100% Effluent 93 M 2.553 57 44 1.379 1.723 2 10 0 0 501 
100% Effluent 94 M 3.205 63 34 1.282 1.061 2 14 0 0 21 
100% Effluent 95 M 2.915 61 59 1.284 2.024 0 0 0 0 273 
100% Effluent 96 M 3.234 61 51 1.425 1.577 3 12 31 0.959 54 
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Control 1 M 3.5 59 39 1.704 1.114 3 15 172 4.914 222  
Control 2 M 4.9 63 106 1.960 2.163 4 17 366 7.469 4,198  
Control 3 M 3.35 56 79 1.908 2.358 3 15 208 6.209 397  
Control 4 M 3.96 58 78 2.030 1.970 3 12 554 13.990 678  
Control 5 M 4.45 64 87 1.698 1.955 4 17 311 6.989 1,085  
Control 6 M           
Control 7 M 3.5 63 47 1.400 1.343 4 18 366 10.457 792  
Control 8 M 3.95 64 66 1.507 1.671 3 16 120 3.038 3,001  
+ve Control 9 M 2.83 53 58 1.901 2.049 3 11 194 6.855 47,958,541  
+ve Control 10 M 3.37 60 61 1.560 1.810 3 15 173 5.134 50,048,316  
+ve Control 11 M 2.81 54 52 1.785 1.851 2 14 160 5.694 31,364,653  
+ve Control 12 M 4.62 61 69 2.035 1.494 1 12 253 5.476 56,265,761  
+ve Control 13 M 2.63 57 28 1.420 1.065 1 9 141 5.361 42,326,354  
+ve Control 14 M 3.97 61 61 1.749 1.537 1 14 177 4.458 99,993,245  
+ve Control 15 M 4.48 63 60 1.792 1.339 2 17 239 5.335 44,488,688 
+ve Control 16 M                    
25% Effluent 17 M 3.64 58 97 1.866 2.665 4 18 172 4.725 21,311  
25% Effluent 18 M 3.63 57 57 1.960 1.570 3 13 411 11.322 541  
25% Effluent 19 M 5.32 67 86 1.769 1.617 4 17 278 5.226 6,784  
25% Effluent 20 M 3.68 64 50 1.404 1.359 3 15 54 1.467 3,877  
25% Effluent 21 M 3.17 60 48 1.468 1.514 4 15 72 2.271 42,187  
25% Effluent 22 M 4.05 65 99 1.475 2.444 3 13 71 1.753 941  
25% Effluent 23 M 4.03 62 63 1.691 1.563 4 20 228 5.658 821  
25% Effluent 24 M 3.89 60 83 1.801 2.134 3 9 162 4.165 4,900  
50% Effluent 25 M 3.99 60 85 1.847 2.130 4 15 93 2.331 6,660  
50% Effluent 26 M 3.49 60 74 1.616 2.120 4 14 133 3.811 775  
50% Effluent 27 M 3.39 56 48 1.930 1.416 4 16 264 7.788 582  
50% Effluent 28 M 3.14 60 65 1.454 2.070 4 15 137 4.363 5,414  
50% Effluent 29 M 3.53 61 69 1.555 1.955 3 14 154 4.363 910  
50% Effluent 30 M 4.06 62 86 1.704 2.118 4 16 157 3.867 10,271  
50% Effluent 31 M           


























100% Effluent 33 M 3.87 64 73 1.476 1.886 3 15 185 4.780 371  
100% Effluent 34 M 2.23 50 37 1.784 1.659 3 13 114 5.112 3,871  
100% Effluent 35 M 2.81 57 62 1.517 2.206 3 13 176 6.263 999  
100% Effluent 36 M 3.29 55 73 1.977 2.219 3 14 181 5.502 32,709  
100% Effluent 37 M 3.03 60 54 1.403 1.782 3 13 93 3.069 311  
100% Effluent 38 M 3.67 58 77 1.881 2.098 4 15 131 3.569 698  
100% Effluent 39 M 2.73 53 96 1.834 3.516 2 10 74 2.711 1,202  





















Control 1 F 1.44 47 150 1.387 10.417 8,056,983 
Control 2 F 1.05 41 201 1.523 19.143 3,203,821 
Control 3 F 1.79 50 205 1.432 11.453 3,269,313 
Control 4 F 2.7 57 297 1.458 11.000 7,372,679 
Control 5 F 1.37 46 142 1.407 10.365 5,645,720 
Control 6 F       
Control 7 F 1.89 48 310 1.709 16.402 7,863,811 
Control 8 F 1.47 47 176 1.416 11.973 6,514,843 
+ve Control 9 F       
+ve Control 10 F 1.86 49 235 1.581 12.634 26,881,449 
+ve Control 11 F 1.42 49 196 1.207 13.803 2,980,511 
+ve Control 12 F       
+ve Control 13 F 1.91 52 205 1.358 10.733 8,528,242 
+ve Control 14 F 1.18 45 135 1.295 11.441 5,288,824 
+ve Control 15 F 1.42 46 116 1.459 8.169 9,853,673 
+ve Control 16 F 1.19 49 347 1.011 29.160 4,313,757 
25% Effluent 17 F 1.66 50 147 1.328 8.855 5,884,171 
25% Effluent 18 F 1.21 47 132 1.165 10.909 4,616,504 
25% Effluent 19 F 1.89 53 218 1.270 11.534 4,152,276 
25% Effluent 20 F 1.78 50 198 1.424 11.124 6,300,294 
25% Effluent 21 F 1.58 50 181 1.264 11.456 4,519,199 
25% Effluent 22 F 1.74 49 235 1.479 13.506 1,351,816 
25% Effluent 23 F 1.8 49 228 1.530 12.667 6,715,822 
25% Effluent 24 F 1.45 46 147 1.490 10.138 4,662,980 
50% Effluent 25 F 1.38 49 147 1.173 10.652 2,760,326 
50% Effluent 26 F 1.76 53 170 1.182 9.659 5,913,898 
50% Effluent 27 F 1.77 52 163 1.259 9.209 7,487,300 
50% Effluent 28 F 1.68 44 292 1.972 17.381 1,835,315 
50% Effluent 29 F 2.14 57 282 1.156 13.178 6,911,821 
50% Effluent 30 F 1.98 50 304 1.584 15.354 6,784,438 
50% Effluent 31 F       



















100% Effluent 33 F 1.59 49 145 1.351 9.119 8,226,767 
100% Effluent 34 F 1.45 47 205 1.397 14.138 6,615,049 
100% Effluent 35 F 1.27 42 186 1.714 14.646 6,032,801 
100% Effluent 36 F 1.58 47 200 1.522 12.658 5,450,322 
100% Effluent 37 F 1.95 52 286 1.387 14.667 6,830,483 
100% Effluent 38 F 1.66 50 106 1.328 6.386 313,309 
100% Effluent 39 F 1.71 48 299 1.546 17.485 3,822,243 
100% Effluent 40 F 1.61 48 225 1.456 13.975 5,230,163 
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Control 1 M 3.64 60 55 1.685 1.511 3 12 313 8.599 277 
Control 2 M 5.558 70 66 1.620 1.187 3 18 192 3.454 101 
Control 3 M 4.723 63 81 1.889 1.715 2 14 368 7.792 349 
Control 4 M 2.541 59 31 1.237 1.220 2 20 82 3.227 116 
Control 5 M 4.138 64 68 1.579 1.643 3 20 210 5.075 970 
Control 6 M 3.429 63 32 1.371 0.933 3 14 186 5.424 95 
Control 7 M 5.32 69 109 1.619 2.049 4 12 172 3.233 4,963 
Control 8 M 3.257 61 59 1.435 1.811 3 12 241 7.399 207 
+ve Control 9 M 3.091 61 48 1.362 1.553 2 14 132 4.270 194,626,684 
+ve Control 10 M 2.476 58 30 1.269 1.212 1 14 99 3.998 157,051,897 
+ve Control 11 M 4.194 63 88 1.677 2.098 2 12 283 6.748 101,689,057 
+ve Control 12 M 1.996 51 32 1.505 1.603 2 12 25 1.253 176,257,134 
+ve Control 13 M 3.165 61 33 1.394 1.043 2 16 197 6.224 100,487,199 
+ve Control 14 M 2.866 59 38 1.395 1.326 2 10 113 3.943 143,697,115 
+ve Control 15 M 1.899 54 21 1.206 1.106 2 10 165 8.689 81,199,884 
+ve Control 16 M 3.342 64 106 1.275 3.172 1 6 36 1.077 149,399,636 
100% Effluent 33 M 3.666 61 59 1.615 1.609 3 14 85 2.319 35,521 
100% Effluent 34 M 4.355 64 82 1.661 1.883 2 12 125 2.870 903 
100% Effluent 35 M 2.426 53 42 1.630 1.731 2 16 66 2.721 269 
100% Effluent 36 M 3.015 59 59 1.468 1.957 2 16 185 6.136 336 
100% Effluent 37 M 5.348 72 96 1.433 1.795 2 12 156 2.917 278 
100% Effluent 38 M 3.379 62 38 1.418 1.125 3 10 220 6.511 118 
100% Effluent 39 M 3.707 64 63 1.414 1.699 4 16 107 2.886 1,054 



















Control 1 F 1.46 51 179 1.101 12.260 4,511,492 
Control 2 F 1.302 42 149 1.757 11.444 5,343,656 
Control 3 F 1.337 47 132 1.288 9.873 4,377,164 
Control 4 F 1.191 42 193 1.608 16.205 4,271,379 
Control 5 F 1.348 46 245 1.385 18.175 8,091,481 
Control 6 F 1.54 50 150 1.232 9.740 4,089,753 
Control 7 F 1.894 53 118 1.272 6.230 8,152,686 
Control 8 F 1.361 49 140 1.157 10.287 6,563,039 
+ve Control 9 F 1.995 55 123 1.199 6.165 91,552,710 
+ve Control 10 F 1.479 50 40 1.183 2.705 102,240,129 
+ve Control 11 F 1.737 54 118 1.103 6.793 153,576,805 
+ve Control 12 F 1.367 48 139 1.236 10.168 7,476,980 
+ve Control 13 F 1.44 48 191 1.302 13.264 4,476,343 
+ve Control 14 F 0.989 43 107 1.244 10.819 14,510,280 
+ve Control 15 F 1.296 49 42 1.102 3.241 101,042,185 
+ve Control 16 F 1.095 44 113 1.285 10.320 15,198,074 
100% Effluent 33 F 1.144 47 111 1.102 9.703 4,779,665 
100% Effluent 34 F 1.078 43 130 1.356 12.059 3,457,706 
100% Effluent 35 F 1.71 52 175 1.216 10.234 3,143,121 
100% Effluent 36 F 1.837 53 276 1.234 15.024 19,897,363 
100% Effluent 37 F 1.201 46 113 1.234 9.409 7,873,889 
100% Effluent 38 F 2.307 54 173 1.465 7.499 8,154,752 
100% Effluent 39 F 1.002 43 87 1.260 8.683 1,767,562 




Table A 23. Raw egg production data from Experiment 3, Pair Breeding exposure study with 
standard effluent. Data collected over a 6 week period; 3 weeks pre-exposure and 3 weeks 
exposure to control (dilution water), positive control (+ve control; 20 ng/L EE2), or to 100%, 





Control +ve Control 25% Effluent 50% Effluent 100% Effluent Control +ve Control 25% Effluent 50% Effluent 100% Effluent
07-May-09 -21 45 63 76 200 167 07-May-09 -21 45 63 76 200 167
08-May-09 -20 49 90 6 55 112 08-May-09 -20 95 153 81 255 279
09-May-09 -19 48 0 136 3 0 09-May-09 -19 142 153 217 258 279
10-May-09 -18 95 127 0 0 115 10-May-09 -18 238 280 217 258 394
11-May-09 -17 0 75 43 20 31 11-May-09 -17 238 355 260 278 425
12-May-09 -16 83 56 60 238 0 12-May-09 -16 321 410 320 515 425
13-May-09 -15 7 49 70 0 57 13-May-09 -15 328 459 390 515 482
14-May-09 -14 82 30 67 3 106 14-May-09 -14 409 489 457 518 588
15-May-09 -13 73 89 50 110 77 15-May-09 -13 483 578 506 629 665
16-May-09 -12 52 134 26 64 24 16-May-09 -12 535 711 532 693 689
17-May-09 -11 27 36 26 43 61 17-May-09 -11 561 748 558 736 750
18-May-09 -10 34 75 112 38 24 18-May-09 -10 596 823 669 774 774
19-May-09 -9 0 0 94 78 106 19-May-09 -9 596 823 763 852 879
20-May-09 -8 126 129 0 48 72 20-May-09 -8 721 952 763 900 951
21-May-09 -7 69 9 32 71 0 21-May-09 -7 790 961 795 971 951
22-May-09 -6 0 71 30 16 20 22-May-09 -6 790 1032 825 987 971
23-May-09 -5 38 92 133 81 115 23-May-09 -5 828 1124 958 1068 1086
24-May-09 -4 20 66 85 54 59 24-May-09 -4 848 1190 1042 1121 1145
25-May-09 -3 47 0 0 40 89 25-May-09 -3 895 1190 1042 1162 1234
26-May-09 -2 12 41 26 0 0 26-May-09 -2 907 1231 1069 1162 1234
27-May-09 -1 89 57 75 31 52 27-May-09 -1 996 1287 1143 1192 1285
Control +ve Control 25% Effluent 50% Effluent 100% Effluent Control +ve Control 25% Effluent 50% Effluent 100% Effluent
28-May-09 1 22 47 68 77 36 28-May-09 1 22 47 68 77 36
29-May-09 2 28 95 0 46 49 29-May-09 2 50 142 68 123 85
30-May-09 3 0 36 77 49 89 30-May-09 3 50 178 146 173 174
31-May-09 4 36 0 75 12 50 31-May-09 4 86 178 220 185 224
01-Jun-09 5 79 0 97 126 0 01-Jun-09 5 165 178 317 311 224
02-Jun-09 6 0 76 28 0 0 02-Jun-09 6 165 254 345 311 224
03-Jun-09 7 11 39 48 0 140 03-Jun-09 7 176 293 393 311 363
04-Jun-09 8 84 0 71 47 61 04-Jun-09 8 260 293 465 358 424
05-Jun-09 9 0 4 53 118 36 05-Jun-09 9 260 297 517 476 460
06-Jun-09 10 57 6 56 50 12 06-Jun-09 10 316 302 573 526 472
07-Jun-09 11 4 56 0 51 9 07-Jun-09 11 320 358 573 577 481
08-Jun-09 12 25 1 111 0 0 08-Jun-09 12 346 359 684 577 481
09-Jun-09 13 6 0 18 0 0 09-Jun-09 13 352 359 702 577 481
10-Jun-09 14 32 0 45 3 122 10-Jun-09 14 383 359 747 580 603
11-Jun-09 15 52 53 104 107 6 11-Jun-09 15 435 412 851 687 609
12-Jun-09 16 32 5 38 0 21 12-Jun-09 16 467 417 888 687 630
13-Jun-09 17 0 2 17 43 23 13-Jun-09 17 467 420 905 730 653
14-Jun-09 18 67 0 35 70 46 14-Jun-09 18 535 420 941 800 699
15-Jun-09 19 23 18 99 0 63 15-Jun-09 19 558 438 1040 800 761
16-Jun-09 20 29 0 98 121 29 16-Jun-09 20 587 1137 921 790
17-Jun-09 21 53 0 38 5 64 17-Jun-09 21 640 1175 926 854
Cumulative egg productionMean egg production/day
Study 
day













Pre Exposure period (Weeks 1 to 3)
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Table A 24. Raw egg production data from Experiment 4, Pair Breeding exposure study with 
GAC effluent. Data collected over a 6 week period; 3 weeks pre-exposure and 3 weeks 
exposure to control (dilution water), positive control (+ve control; 20 ng/L EE2) or to 100% 
GAC effluent. 
 
Control +ve Control 100% Effluent Control +ve Control 100% Effluent
23-Feb-09 -21 35 52 32 23-Feb-09 -21 35 52 32
24-Feb-09 -20 63 61 44 24-Feb-09 -20 99 113 76
25-Feb-09 -19 32 0 87 25-Feb-09 -19 130 113 163
26-Feb-09 -18 0 0 16 26-Feb-09 -18 130 113 179
27-Feb-09 -17 67 66 35 27-Feb-09 -17 197 179 214
28-Feb-09 -16 51 0 20 28-Feb-09 -16 249 179 234
01-Mar-09 -15 13 48 50 01-Mar-09 -15 262 227 283
02-Mar-09 -14 47 63 20 02-Mar-09 -14 309 290 303
03-Mar-09 -13 24 11 106 03-Mar-09 -13 333 301 409
04-Mar-09 -12 0 11 20 04-Mar-09 -12 333 312 429
05-Mar-09 -11 29 31 25 05-Mar-09 -11 362 343 454
06-Mar-09 -10 18 44 0 06-Mar-09 -10 380 387 454
07-Mar-09 -9 35 0 56 07-Mar-09 -9 415 387 509
08-Mar-09 -8 28 39 22 08-Mar-09 -8 443 426 532
09-Mar-09 -7 25 38 22 09-Mar-09 -7 468 464 554
10-Mar-09 -6 48 43 42 10-Mar-09 -6 516 507 596
11-Mar-09 -5 15 26 34 11-Mar-09 -5 531 533 629
12-Mar-09 -4 37 24 34 12-Mar-09 -4 568 557 663
13-Mar-09 -3 19 7 9 13-Mar-09 -3 587 564 672
14-Mar-09 -2 27 0 18 14-Mar-09 -2 613 564 690
15-Mar-09 -1 5 9 8 15-Mar-09 -1 618 573 698
Exposure period (Weeks 4 to 6) Exposure period (Weeks 4 to 6)
Control +ve Control 100% Effluent Control +ve Control 100% Effluent
16-Mar-09 1 0 13 28 16-Mar-09 1 0 13 28
17-Mar-09 2 18 0 21 17-Mar-09 2 18 13 49
18-Mar-09 3 9 0 0 18-Mar-09 3 27 13 49
19-Mar-09 4 45 9 0 19-Mar-09 4 71 22 49
20-Mar-09 5 20 38 22 20-Mar-09 5 91 60 71
21-Mar-09 6 0 27 3 21-Mar-09 6 91 87 74
22-Mar-09 7 21 0 52 22-Mar-09 7 112 87 125
23-Mar-09 8 26 54 42 23-Mar-09 8 138 141 167
24-Mar-09 9 22 0 0 24-Mar-09 9 160 141 167
25-Mar-09 10 23 0 17 25-Mar-09 10 184 141 184
26-Mar-09 11 0 0 63 26-Mar-09 11 184 141 247
27-Mar-09 12 47 15 28 27-Mar-09 12 231 156 275
28-Mar-09 13 0 31 0 28-Mar-09 13 231 187 275
29-Mar-09 14 39 0 3 29-Mar-09 14 269 187 278
30-Mar-09 15 6 18 41 30-Mar-09 15 275 204 319
31-Mar-09 16 37 16 17 31-Mar-09 16 312 220 335
01-Apr-09 17 9 25 0 01-Apr-09 17 321 245 335
02-Apr-09 18 0 0 21 02-Apr-09 18 321 245 357
03-Apr-09 19 17 0 37 03-Apr-09 19 338 245 394
04-Apr-09 20 67 24 54 04-Apr-09 20 404 269 448
05-Apr-09 21 5 38 0 05-Apr-09 21 410 307 448
Date Study day Date Study day
Pre Exposure period (Weeks 1 to 3)
Cumulative egg production
Pre Exposure period (Weeks 1 to 3)
Mean egg production/day
Date Study day Date Study day
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Table A 25. Roach sampled from the River Ray in April 2005. Of the 145 fish sampled, only 140 fish were included in analyses as it was not 





































1 F 5 2000 168 218 1.62 11.9 7.62 y   
arrested/ 
inhibited female 
IV   600 
2 F 5 2000 132.9 195 1.79 19.8 17.51 y   female V   2,600,000 
3 F 5 2000 164.6 210 1.78 37.2 29.20 y   female V   2,575,000 
4  4 2001 43.4 135 1.76 1.4 3.33 y   Missing Missing   73 
5 F 1 2004  63    y   
immature 
female 
II   67 
6 F 5 2000 134.8 197 1.76 22.5 20.04 y   female V   3,020,000 
7 F 5 2000 117.9 198 1.52 16.5 16.27 y   female V   3,410,000 
8 F 4 2001 166.9 207 1.88 40.3 31.83 y   female V   1,150 
9 F 4 2001 122 196 1.62 23 23.23 y   female V   2,300,070 
10 M 3 2002 65.8 164 1.49 4 6.47 n 1,0,0,0,1,0 0.333 intersex    4,300,000 
11 F 4 2001 95.4 178 1.69 16.4 20.76 y   female V   800 
12 F 8 - 347.1 286 1.48 7 2.06 y   
arrested/ 
inhibited female 
II 4.00 <300 54 
13 F 5 2000 186.1 214 1.90 48.8 35.54 y   female V   530 
14 F 4 2001 111.3 184 1.79 22.5 25.34 y   female V   750 
15 F 5 2000 152 205 1.76 30.2 24.79 y   female V   1,105,000 
16 F 6 1999 321.7 249 2.08 74.7 30.24 y   female V   no blood 
17 M 4 2001 82.6 180 1.42 2.3 2.86 n 0,0,0,0,0,0 0 male VI 60.00 N/A 81 
18 F 4 2001 126.1 205 1.46 1.8 1.45 y   
Arrested 
/inhibited female 
II 21.00 <300 2,840,000 
19 F 7 - 250.3 258 1.46 6.3 2.58 y   
arrested/ 
inhibited female 
I 26.00 710.00 1,125,000 
20 M 5 2000 113.5 198 1.46 6.7 6.27 n 2,0,2,3,2,2 0.833 intersex  80.00 <300 4,350,000 
21 M 3 2002 47.1 145 1.54 1.5 3.29 n 0,0,0,0,0,0 0 male V 110.00 <300 328 
22 F 5 2000 165.5 217 1.62 3.1 1.91 y   
arrested/ 
inhibited female 
II 27.00 1138.00 205 
23 F 4 2001 111.5 190 1.63 2.3 2.11 y   
arrested/ 
inhibited female 
II 19.00 1785.00 3,750,000 
24 M 5 2000 94.1 184 1.51 4.2 4.67 n 0,0,0,0,0,0 0 male V 26.00 <300 2,500,000 







































26 M 5 2000 79 172 1.55 3.4 4.50 n 0,0,0,0,0,0 0 male V 47.00 <300 597 
27 F 4 2001 111.4 191 1.60 5.1 4.80 y   
arrested/ 
inhibited female 
II   590 
28 M 5 2000 132.5 210 1.43 6.5 5.16 n 0,0,0,0,0,0 0 male V 50.00 <300 447 
29 M 3 2002 35.6 130 1.62 1.5 4.40 n 0,0,0,0,0,0 0 male V 59.00 <300 no blood 
30 M 4 2001 99.6 188 1.50 3.8 3.97 n 0,0,0,0,0,0 0 male V 60.00 2454.00 901 
31 F 2 2003 39.6 135 1.61 0.2 0.51 y   
immature 
female 
II   2,400 
32 F 5 2000 201.3 220 1.89 41.5 25.97 y   female V   980 
33 F 5 2000 203.7 219 1.94 45.4 28.68 y   female V   650,000 
34 F 3 2002 70.9 160 1.73 15 26.83 y   female V   3,355,000 
35 F 5 2000 124.2 195 1.68 26.1 26.61 y   female V   no blood 
36 F 4 2001 105.3 182 1.75 19.5 22.73 y   female V   2,250 
37 F 4 2001 167.9 215 1.69 3.1 1.88 y   
arrested/ 
inhibited female 
II 20.00 2363.00 3,950,000 
38 F 3 2002 73.5 165 1.64 14.9 25.43 y   female V   610 
32 F 5 2000 201.3 220 1.89 41.5 25.97 y   female V   980 
33 F 5 2000 203.7 219 1.94 45.4 28.68 y   female V   650,000 
34 F 3 2002 70.9 160 1.73 15 26.83 y   female V 8.00 N/A 3,355,000 
35 F 5 2000 124.2 195 1.68 26.1 26.61 y   female V   no blood 
36 F 4 2001 105.3 182 1.75 19.5 22.73 y   female V   2,250 
37 F 4 2001 167.9 215 1.69 3.1 1.88 y   
arrested/ 
inhibited female 
II   3,950,000 
38 F 3 2002 73.5 165 1.64 14.9 25.43 y   female V 14.00 1675.00 610 
39 F   163 211 1.74 28.4 21.10 y   female V 4.00 6987.00 5,510,000 
40 F 4 2001 158.5 206 1.81 34.5 27.82 y   female V 24.00 N/A 2,050 
41 M 4 2001 86.4 182 1.43 4 4.85 n 0,0,0,0,0,0 0 male V 47.00 <300 118 
42 F 5 2000 179.2 215 1.80 38.4 27.27 y   female V   3,200 
43 F 5 2000 182.9 219 1.74 39 27.10 y   female V 50.00 <300 590 
44 F 5 2000 130.6 195 1.76 25.9 24.74 y   female V 59.00 <300 500 
45 F 5 2000 151.1 211 1.61 3.4 2.30 y   
arrested/ 
inhibited female 
II 60.00 2454.00 43 
46 F 5 2000 118.9 204 1.40 4.4 3.84 y   
arrested/ 
inhibited female 
II   2,800 






































48 F 4 2001 124 194 1.70 24.7 24.87 y   female V   300 
49 M 4 2001 70.5 169 1.46 3.5 5.22 n 0,0,0,0,0,0 0 male V 73.00 <300 2,755,000 
50 F 3 2002 75.2 168 1.59 12.6 20.13 y   female V   1,500,000 
51 F 6 1999 348.9 254 2.13 84.6 32.01 y   female V   3,655,000 
52 F 4 2001 146.3 198 1.88 31 26.89 y   female V   300 
53 F 5 2000 228 225 2.00 52 29.55 y   female V   1,360,000 
54 F 4 2001 170.6 215 1.72 37.6 28.27 y   female V   2,690,000 
55 M 6 1999 206 230 1.69 7.7 3.88 n 2,3,4,1,11,1 1.1667 intersex  35.00 <300 no blood 
56 M 3 2002 78.3 175 1.46 3.2 4.26 n 0,1,0,2,0,0, 0.333 intersex  65.00 <300 3,590,000 
57 M 5 2000 94.9 193 1.32 2.7 2.93 y 4,0,0,0,0,0 0.1667 intersex  37.00 <300 4,030,000 
58 F 3 2002 89 175 1.66 18.3 25.88 y   female V   735,000 
59 F 4 2001 77.7 171 1.55 12.2 18.63 y   female V   2,020,000 
60 F 4 2001 99.1 172 1.95 18.8 23.41 y   female V   3,760,000 
61 F 3 2002 115.3 186 1.79 30.6 36.13 y   female V   3,860,000 
62 F 4 2001 112.3 194 1.54 21.2 23.27 y   female V   3,610,000 
63 M 5 2000 100.3 191 1.44 3 3.08 y 0,0,0,0,0,0 0 intersex  54.00 <300 743 
64 M 4 2001 66.2 169 1.37 3.4 5.41 n 0,0,0,0,0,0 0 male V 49.00 <300 489 
65 M 4 2001 71.8 165 1.60 4.1 6.06 n 0,0,0,0,0,0 0 male IV 143.00 <300 103 
66 M 4 2001 82.7 180 1.42 1.6 1.97 n 6,8,1,8,21,9 2 intersex  64.00 <300 3,080,000 
67 M 4 2001 104.5 189 1.55 4.8 4.81 n 0,0,0,0,0,0 0 male V 61.00 <300 2,320 




69 F 2 2003 19.6 108 1.56 0.4 2.08 y   
immature 
female 
II 55.00 1262.00 1,640,000 
70 F 5 2000 152.5 205 1.77 23.3 18.03 y   female V   no blood 
71 F 2 2003 28.7 124 1.51 0.7 2.50 y   
immature 
female 
III 13.00 1946.00 4,750,000 
72 F 2 2003 28.2 117 1.76 0.6 2.17 y   
immature 
female 
II 20.00 2063.00 450 
73 F 2 2003 22.2 109 1.71 1.7 8.29 y   female V   no blood 




II 56.00 1195.00 no blood 
75 F 2 2003 41.2 134 1.71 3.5 9.28 y   
immature 
female 
IV   7,325,000 
































77 F 4 2001 95.3 180 1.63 17.8 22.97 y   female V   3,100,000 
78 F 5 2000 107 190 1.56 17.4 19.42 y   female V   6,700 
79 F 4 2001 126 200 1.58 18.5 17.21 y   female V   1,685,000 
80 F 5 2000 167.7 210 1.81 29.5 21.35 y   female V   no blood 
81 F 5 2000 263.4 234 2.06 54.8 26.27 y   female V   825 
82 F 3 2002 61.8 157 1.60 9 17.05 y   female V   no blood 
83 M 3 2002 49.6 155 1.33 1.5 3.12 n 0,0,0,0,0,0 0 male V 71.00 <300 366 
84 M 5 2000 104 194 1.42 3.3 3.28 n 0,0,0,0,0,0 0 male V 57.00 2351.00 465 
85 M 3 2002 41 144 1.37 1.6 4.06 n 0,0,0,0,0,0 0 male V 54.00 <300 3,625,000 
86 F 2 2003 26.3 122 1.45 4 17.94 y   female V   5,950,000 
87 M 3 2002 55.4 162 1.30 2.6 4.92 n 0,0,0,0,0,0 0 male V 49.00 <300 1,255,000 
88 F 3 2002 53.7 153 1.50 9.1 20.40 y   female V   3,575,000 




90 M 2 2003 50.1 146 1.61 0.9 1.83 n 0,0,0,0,0,0 0 male V 27.00 <300 5,810,000 
91 M 3 2002 30.2 130 1.37 0.8 2.72 n 0,0,0,0,0,0 0 male V   no blood 
92 F 2 2003 23 115 1.51 0.9 4.07 y   
immature 
female 
II   21,000 
93 F 4 2001 107.4 194 1.47 3 2.87 y   
arrested/ 
inhibited female 
II 6.00 <300 15 
94 M 3 2002 42.5 147 1.34 1.7 4.17 n 0,0,0,0,0,0 0 male V 74.00 <300 408 




96 M 3 2002 35.4 138 1.35 1.4 4.12 n 0,0,0,0,0,0 0 male V 49.00 <300 629 
97 F 2 2003 38.5 136 1.53 0.8 2.12 y   
immature 
female 
II 109.00 5759.00 100 
98 F 4 2001 92.7 184 1.49 0.6 0.65 y   spent female VI 18.00 583.00 62 
99 F 2 2003 34.3 135 1.39 1.2 3.63 y   
immature 
female 
II   3,750,000 
100 M 3 2002 65.5 163 1.51 2.8 4.47 n 0,0,0,0,0,0 0 male V   106,000 
101 M 2 2003 32.2 130 1.47 1.4 4.55 n 0,0,0,0,0,0 0 male V   591 
102 M 3 2002 44.4 144 1.49 2.2 5.21 n 0,0,0,0,0,0 0 male V   234 
103 F 3 2002 69.7 172 1.37 1.5 2.20 y   
arrested/ 
inhibited female 





































104 M 3 2002 39.3 139 1.46 1.8 4.80 n  0 male V 11.00 <300 no blood 
105 F 5 2000 185.8 229 1.55 4.7 2.60 y   
arrested/ 
inhibited female 
II 21.00 4105.00 no blood 
106 F 2 2003 32.4 130 1.47 0.7 2.21 y   immature female II 40.00 848.00 119 




108 M 2 2003 31.4 129 1.46 1.8 6.08 y 0,0,0,0,0,0 0 intersex  79.00 <300 no blood 
109 F 2 2003 27.6 123 1.48 0.4 1.47 y   immature female II 47.00 1116.00 no blood 
110 M 2 2003 32.1 130 1.46 0.6 1.90 n 0,0,0,0,0,0 0 male V Missing Missing 254 
111 M 3 2002 57.4 154 1.57 3.8 7.09 n 0,0,0,0,0,0 0 male IV 21.00 <300 16,794 
112 M 3 2002 40.8 142 1.42 1.3 3.29 n 0,0,0,0,0,0 0 male V 75.00 <300 273 
113 M 4 2001 63.6 167 1.37 2.5 4.09 n 2,1,0,0,0,0 0.333 intersex  56.00 <300 71 
114 M 3 2002 46 149 1.39 1.6 3.60 n 1,0,0,0,0,0 0.1667 intersex  95.00 <300 68 
115 M 3 2002 42.7 144 1.43 1.3 3.14 n 0,0,0,2,0,0 0.1667 intersex  69.00 <300 107 






117 M 4 2001 81.8 174 1.55 1.8 2.25 n  0 male V 43.00 <300 84 




119 F 3 2002 51.6 154 1.41 7.9 18.08 y   female V   2,580,000 
120 M 2 2003 22.1 111 1.62 0.3 1.38 n 0,0,0,0,0,0 0 male I 43.00 1538.00 no blood 
121 F 3 2002 68 162 1.60 1.09 1.63 y   female V   6,800,000 
122 F 3 2002 102.2 178 1.81 21.8 27.11 y   female V   5,750,000 
123 F 2 2003 40 125 2.05 3.7 10.19 y   immature female IV   no blood 
124 F 3 2002 70.9 159 1.76 14.6 25.93 y   female V   6,040,000 
125 F 5 2000 181.6 220 1.71 28.1 18.31 y   female V   7,250,000 
126  2 2003 31.3 125 1.60 0.6 1.95    Missing Missing 45.00 2226.00 no blood 
127  2 2003 35.9 129 1.67 4.8 15.43 y   Missing Missing   no blood 
128 F 3 2002 73.4 164 1.66 16.8 29.68 y   female V   1,105,000 
129 F 3 2002 76 165 1.69 12.7 20.06 y   female V   4,710,000 
130 F 3 2002 79 168 1.67 15.6 24.61 y   female V   4,065,000 
131 F 2 2003 38.1 137 1.48 1 2.70 y   immature female II 33.00 4475.00 no blood 
132 F 3 2002 17.6 103 1.61 0.3 1.73 y   
arrested/ 
inhibited female 
II 40.00 2576.00 no blood 





































134 F 3 2002 63.6 158 1.61 11.4 21.84 y   female V   5,960,000 
135 F 2 2003 31.1 128 1.48 0.7 2.30 y   immature female II 62.00 1751.00 no blood 
136 F 2 2003 23.4 119 1.39 0.5 2.18 y   immature female II 
Not 
enough 
 no blood 
137 F 2 2003 33 126 1.65 6.5 24.53 y   female V   no blood 
138 F 2 2003 38.5 134 1.60 6.3 19.57 y   female V   no blood 
139 F 2 2003 38.6 134 1.60 3.9 11.24 y   immature female IV   940,000 
140 F 3 2002 74.2 164 1.68 13.1 21.44 y   female V   5,075,000 







142 F 4 2001 132.8 192 1.88 14 11.78 y   female V   3,175,000 
143 F 5 2000 183.6 211 1.95 42.1 29.75 y   female V   1,040,000 
144  6 1999 191.3 218 1.85 39 25.61 y   Missing Missing   9,025,000 




Table A 26. Roach sampled from the River Ray in November 2013.  
Fish 
no. 





























1 M 4 2010 67.6 168 1.43 3.18 4.93 n 0,0,0,0,0,0 0 male II 66.14 <DL 23 
2 F 6 2008 169.8 212 1.78 22.00 14.89 y   female V 287.55 <DL 9,086,221 
3 M 3 2011 47.4 148 1.46 2.30 5.10 n 0,0,0,0,0,0 0 male II 57.64 <DL 208 
4 F 5 2009 156.5 212 1.64 15.79 11.22 y   female V 779.38 0.46 2,057,824 
5 F 4 2010 64.5 165 1.44 4.26 7.08 y   female V 378.62 <DL 2,128,342 
6 F 5 2009 113.2 192 1.60 12.99 12.96 y   female V 217.21 <DL 16,369,566 
7 F 5 2009 169.7 208 1.89 22.58 15.35 y   female V 200.17 1.00 7,827,507 
8 M 4 2010 53.6 158 1.36 1.91 3.69 n 0,0,0,0,0,0 0 male II 109.87 0.859 385 
9 F 3 2011 51.6 153 1.44 4.32 9.15 y   female V 188.66 <DL 6,780,351 
10 F 5 2009 188.4 220 1.77 21.34 12.78 y   female V 536.01 <DL 5,645,739 
11 M 3 2011 23.7 118 1.44 1.12 4.96 n 0,0,0,0,0,0 0 male II 61.54 <DL 12 






13 F 4 2010 222.9 228 1.88 28.04 14.39 y   female V 735.61 <DL 8,894,592 
14 F 4 2010 109.4 193 1.52 10.95 11.12 y   female V 519.60 <DL 7,395,979 
15 F 5 2009 207.3 233 1.64 21.76 11.73 y   female V 795.01 <DL 6,042,602 
16 M 5 2009 130.7 203 1.56 7.03 5.68 n 0,0,0,0,0,0 0 male II 177.74 <DL 45,131 
17 F 5 2009 212.3 227 1.81 25.29 13.53 y   female V 776.08 <DL 12,315,044 
18 F 5 2009 190.3 222 1.74 26.31 16.05 y   female V 945.55 <DL 11,686,033 
19 F 4 2010 224 232 1.79 28.63 14.66 y   female V 546.75 <DL 7,271,278 
20 F 3 2011 105 193 1.46 9.09 9.48 y   female V 134.39 <DL 3,411,269 
21 F 4 2010 187.1 223 1.69 20.56 12.35 y   female V 386.99 <DL 7,794,625 
22 F 4 2010 188.3 220 1.77 21.13 12.64 y   female V 197.23 <DL 6,998,899 
23 F 5 2009 207.2 227 1.77 27.02 14.99 y   female V 1975.80 <DL 7,781,379 
24 F 3 2011 111.8 187 1.71 14.15 14.48 y   female V 1460.16 <DL 4,925,665 
25 M 4 2010 101 188 1.52 5.10 5.32 n 0,0,0,0,0,0 0 male II 113.66 <DL 198 
26 M 4 2010 91.5 178 1.62 4.81 5.55 n 0,0,0,0,0,0 0 male II 96.73 <DL 12,801 







































29 M 4 2010 130.1 203 1.56 7.73 6.32 n 0,0,0,0,0,0 0 male II 141.27 <DL 48 
30 M 5 2009 106.2 183 1.73 6.96 7.02 n 0,0,0,0,0,0 0 male II 94.44 <DL 76 
31 F 6 2008 231.7 237 1.74 41.10 21.56 y   female V 1108.24 0.87 6,252,489 
32 F 4 2010 87 178 1.54 8.73 11.15 y   female V 1048.53 <DL 2,709,333 
33 M 4 2010 112.4 192 1.59 5.42 5.07 n 0,0,0,0,0,0 0 male II 190.26 <DL 31 




35 F 5 2009 184.8 223 1.67 20.30 12.34 y   female V 690.31 <DL 8,888,113 
36 M 6 2008 178.3 217 1.74 8.84 5.22 n 0,0,0,0,0,0 0 male II 163.86 <DL 451 
37 F 5 2009 144 216 1.43 13.98 10.75 y   female V 534.08 0.36 4,589,736 
38 F  2010 218.1 236 1.66 22.24 11.36 y   female V 1636.40 0.39 6,818,972 
39 F 5 2009 92 182 1.53 10.86 13.39 y   female V 605.79 <DL 6,636,719 
40 M 5 2009 183.8 218 1.77 9.30 5.33 n 0,0,0,0,0,0 0 male II 93.55 0.35 168 
41 F 3 2011 96.5 180 1.65 9.25 10.60 y   female V 372.69 <DL 10,630,607 
42 F 6 2008 155.7 206 1.78 16.04 11.48 y   female V 527.21 <DL 13,889,598 
43 M 4 2010 115.7 193 1.61 6.28 5.74 n 2,0,0,0,0,0 0.167 intersex  77.05 0.421 3,092 
44 F 4 2010 150.5 213 1.56 19.69 15.05 y   female V 1213.07 <DL 15,877,763 
45 F 5 2009 207.9 227 1.78 28.63 15.97 y   female V 1218.42 0.45 8,668,414 
46 F 5 2009 186.9 225 1.64 28.44 17.94 y   female V 1014.61 <DL 5,200,926 
47 M 4 2010 85.2 182 1.41 4.13 5.10 n 0,1,0,0,0,0 0.167 intersex  129.07 <DL 64 
48 F 4 2010 127.8 198 1.65 11.19 9.59 y   female V 621.73 <DL 16,548,915 
49 F 4 2010 83 174 1.58 9.69 13.22 y   female V 550.07 <DL 7,103,383 
50 M 3 2011 64.2 166 1.40 3.44 5.66 n 0,0,0,0,0,0 0 male II 220.98 <DL 323 
51 M 4 2010 110.8 192 1.57 6.11 5.84 n 0,0,0,0,0,0 0 male II 79.60 <DL 12 
52 M 3 2011 48.1 156 1.27 2.04 4.42 n 2,1,0,0,2,0 0.500 intersex  102.95 <DL 12 
53 F 3 2011 126.8 203 1.52 13.90 12.31 y   female V 497.17 <DL 9,373,810 
54 M 5 2009 100.3 188 1.51 4.80 5.03 n 0,0,0,0,0,0 0 male II 140.63 <DL 635 
55 F 3 2011 78.1 176 1.43 9.69 14.17 y   female V 1507.28 0.67 8,474,891 




Table A 27. Standard curves were produced using SoftMax Pro version 5.0.1 (Molecular Devices Limited, Wokingham, UK) and were used to 
calculate EC50s and IC50s. The response of the standard yeast androgen screen (YAS) to dihydrotestosterone (DHT) positive control gave a 
mean EC50 of 9.49x10-10M ± 4.87x10-11M (n=13) and the response of the standard yeast anti-androgen screen (AYAS) to flutamide positive 
control gave a mean IC50 of 3.78x10-6M ±3.13x10-7M (n=16). 
 
  
Standard YAS Standard AYAS



















No. of experiments 13 16
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Table A 28. The response of the standard yeast androgen screen (YAS) to dihydrotestosterone (DHT) positive control (final concentrations 
from 5x10-8M to 2.44x10-11M; mean ± SE; n=13) and the response of the standard yeast anti-androgen screen (AYAS) to flutamide positive 
control (final concentrations of 5 x 10-5M to 2.44 x 10-8M; mean ± SE; n=16). Absorbance readings were taken using a plate reader at 540nm 





absorbance (540nm) DHT SEM
Mean corrected 
absorbance (540nm) Flutamide SEM
5.00E-08 2.5852 0.0371 5.00E-05 1.1972 0.0528
2.50E-08 2.5675 0.0400 2.50E-05 1.1749 0.0512
1.25E-08 2.5465 0.0404 1.25E-05 1.2254 0.0595
6.25E-09 2.5325 0.0403 6.25E-06 1.4092 0.0656
3.13E-09 2.5163 0.0417 3.13E-06 1.6633 0.0657
1.56E-09 2.2627 0.0653 1.56E-06 1.8314 0.0631
7.81E-10 1.6827 0.0640 7.81E-07 1.9465 0.0607
3.91E-10 1.2761 0.0424 3.91E-07 2.0049 0.0565
1.95E-10 1.1605 0.0330 1.95E-07 2.0375 0.0590
9.77E-11 1.1433 0.0342 9.77E-08 2.0424 0.0561
4.88E-11 1.1440 0.0347 4.88E-08 2.0198 0.0560









Table A 29. Standard curves were produced using SoftMax Pro version 5.0.1 (Molecular Devices Limited, Wokingham, UK) and were used to 
calculate EC50s and IC50s. The response of the modified yeast androgen screen (YAS) to dihydrotestosterone (DHT) positive control gave an 
EC50 of 8.89x10-10M ± 4.51x10-11M (mean ± SE; n=6) and the of the modified standard yeast anti-androgen screen (AYAS) to flutamide 




Standard YAS Modified YAS Standard AYAS Modified AYAS
8.43E-10 9.08E-10 3.75E-06 9.45E-06
1.11E-09 7.57E-10 4.53E-06 9.54E-06
1.10E-09 8.55E-10 6.46E-06 9.49E-06
1.23E-09 7.97E-10 4.92E-06 7.18E-06
1.10E-09 9.56E-10 3.64E-06 1.04E-05











Mean 9.49E-10 8.89E-10 3.78E-06 1.03E-05
SE 4.87E-11 4.51E-11 3.13E-07 8.59E-07
No. of experiments 13 6 16 11
DHT EC50 values (M) FLUT IC50 values (M)
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Table A 30. The response of the modified yeast androgen screen (YAS) to dihydrotestosterone (DHT) positive control (final concentrations from 
5x10-8M to 2.44x10-11M; mean ± SE; n=6) and the response of the modified yeast anti-androgen screen (AYAS) to flutamide positive (final 
concentrations of 5 x 10-5M to 2.44 x 10-8M; mean ± SE; n=11). Absorbance readings were taken using a plate reader at 420nm and corrected 









5.00E-08 2.4509 0.0372 1.1769 0.0339
2.50E-08 2.3859 0.0387 1.2300 0.0276
1.25E-08 2.4471 0.0245 1.4935 0.0311
6.25E-09 2.3669 0.0372 1.7736 0.0279
3.13E-09 2.2095 0.0546 1.9270 0.0218
1.56E-09 1.9983 0.0538 2.0297 0.0248
7.81E-10 1.5195 0.0524 2.0444 0.0274
3.91E-10 0.9795 0.0292 2.0335 0.0265
1.95E-10 0.7946 0.0259 2.0521 0.0268
9.77E-11 0.7559 0.0270 2.0858 0.0242
4.88E-11 0.7300 0.0152 2.0558 0.0151
2.44E-11 0.7355 0.0268 2.0205 0.0353
DHT conc 
(M)
Modified YAS (n=6) Modified AYAS (n=11)
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Table A 31. Potency values for the 20 anti-androgenic chemicals in the standard yeast anti-androgen screen (AYAS; mean ± SE). Potencies 















8 Benzophenone 119-61-9 0.013 0.021 0.007 0.032 0.025   0.020 0.004 5 
10 N-Butylbenzene sulfonamide 3622-84-2 0.419 0.078 0.020     0.172 0.124 3 
11 Myristic acid 544-63-8 0.155 0.179 0.019 0.055 0.040 0.130 0.021 0.086 0.025 7 
15 Dodecanoic acid 143-07-7 0.203 0.183 0.034 0.065 0.009 0.072 0.001 0.081 0.031 7 
16 Fluoranthene 206-44-0 9.370 8.098 1.739 1.245    5.113 2.109 4 
17 Triclosan 3380-34-5 13.192 12.313 11.163 2.790    9.865 2.394 4 
18 Triphenyl phosphate 115-86-6 0.858 1.193 0.015 0.000    0.517 0.302 4 
19 Pyrene 129-00-0 2.847 4.230 2.726     3.268 0.482 3 
20 Methyl triclosan 4640-01-1 8.675 6.274 7.669 11.332    8.488 1.068 4 




54549-72-3 0.012 0.019      0.016 0.004 2 




2566-97-4 0.063 0.022 0.011     0.032 0.016 3 
79 9H-Fluorene 86-73-7 0.065 0.426 0.641 0.447 0.845   0.485 0.129 5 
81 Acetylcedrene 32388-55-9 0.239 0.190 0.230 0.046 0.052   0.151 0.043 5 
82 alpha cedrol 77-53-2 0.038 0.021      0.030 0.009 2 
84 Benzeneacetaldehyde 122-78-1 0.030 0.037      0.034 0.004 2 
88 Dehydroabietic acid 1740-19-8 2.255 0.060      1.158 1.098 2 
91 
Diphenylacetic acid methyl 
ester 
3469-00-9 0.250 0.160 0.072     0.161 0.051 3 




Table A 32. Potency values for the 20 anti-androgenic chemicals retested in the modified yeast anti-androgen screen (AYAS; mean ± SE). 
Potencies were calculated by dividing the flutamide IC50 by the chemical IC50, and the higher the number the more potent the chemical 












8 Benzophenone 119-61-9 0.099 0.108 0.104 0.0045 2
10 N-Butylbenzene sulfonamide 3622-84-2 0.144 0.090 0.117 0.0270 2
11 Myristic acid 544-63-8 0.000 0.000 0.000 0.0000 2
15 Dodecanoic acid 143-07-7 0.044 0.160 0.102 0.0580 2
16 Fluoranthene 206-44-0 4.921 3.923 11.459 6.768 2.3633 3
17 Triclosan 3380-34-5 18.685 9.808 18.715 15.736 2.9640 3
18 Triphenyl phosphate 115-86-6 0.000 0.000 0.000 0.0000 2
19 Pyrene 129-00-0 0.782 2.257 1.520 0.7375 2
20 Methyl triclosan 4640-01-1 8.601 9.117 8.859 0.2580 2
41 Chlorophene 204-385-8 13.752 6.580 10.166 3.5860 2
51 1-[4-(hydroxy-1-methylethyl)phenyl] ethanone 54549-72-3 0.090 0.051 0.071 0.0195 2
56 2-(methylthio)benzothiazole 615-22-5 0.133 0.124 0.129 0.0045 2
78 9,12-Octadecadienoic acid methyl ester 2566-97-4 0.090 0.054 0.072 0.0180 2
79 9H-Fluorene 86-73-7 0.706 0.243 0.475 0.2315 2
81 Acetylcedrene 32388-55-9 0.358 0.230 0.294 0.0640 2
82 alpha cedrol 77-53-2 0.171 0.116 0.144 0.0275 2
84 Benzeneacetaldehyde 122-78-1 0.028 0.24 0.134 0.1060 2
88 Dehydroabietic acid 1740-19-8 1.865 2.522 2.194 0.3285 2
91 Diphenylacetic acid methyl ester 3469-00-9 0.281 0.192 0.237 0.0445 2
92 Hexamethylbenzene 87-85-4 0.010 0.017 0.014 0.0035 2
Potency relative to flutamide 
in the modified AYAS
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Table A 33. qPCR expression analysis using positive control targets (ff1d and vtg) with 
different tissues (dorsal fin, brain, kidney, liver, mouth, snout, brain) from one male and one 
female FHM. Expression levels were normalised to three reference genes (rpI8, hprt I and 
tbp). 
Target Sample Expression Expression SEM Mean Cq Cq SEM 
ff1d Female dorsal fin 0.00947 0.00504 37.15 0.76641 
ff1d Female brain 0.90796 0.05273 29.88 0.05489 
ff1d Female kidney 0.01409 0.00035 34.89 0.00000 
ff1d Female liver 0.20210 0.01928 32.58 0.13460 
ff1d Female mouth 0.01800 0.00220 35.21 0.17511 
ff1d Female snout 0.01971 0.00581 35.26 0.42422 
ff1d Male brain 1.30033 0.03331 28.15 0.01333 
ff1d Male dorsal fin 0.03194 0.00075 35.01 0.00000 
ff1d Male fatpad 0.01875 0.00832 36.05 0.63986 
ff1d Male kidney 0.00239 0.00170 37.22 1.02900 
ff1d Male liver 0.01973 0.00093 37.77 0.04498 
ff1d Male mouth 0.71620 0.06663 30.73 0.12794 
ff1d Male snout 0.00742 0.00105 37.43 0.20263 
vtg Female dorsal fin 0.00000 0.00000 36.50 1.13013 
vtg Female brain 0.00000 0.00000 32.65 0.29402 
vtg Female kidney 0.00162 0.00005 22.97 0.04379 
vtg Female liver 4.34537 0.11164 13.11 0.02331 
vtg Female mouth 0.00000 0.00000 35.27 0.51828 
vtg Female snout 0.00000 0.00000 36.23 0.44308 
vtg Male brain 0.00000 0.00000 33.06 1.37545 
vtg Male dorsal fin 0.00005 0.00000 29.30 0.08782 
vtg Male fatpad 0.00000 0.00000 34.17 0.51282 
vtg Male kidney 0.00001 0.00000 30.44 0.11085 
vtg Male liver 0.00002 0.00000 32.78 0.21776 
vtg Male mouth 0.00000 0.00000 35.70 0.74822 




Table A 34. qPCR expression analysis using three spiggin-like targets (DT131813, 
DT267220 and DT347638) with different tissues (dorsal fin, brain, kidney, liver, mouth, 
snout, brain) from one male and one female FHM. Expression levels were normalised to 
three reference genes (rpI8, hprt I and tbp). 
Target Sample Expression Expression SEM Cq SEM 
DT131813 female brain 0.11108 0.01319 0.16460 
DT131813 female dorsal fin 0.09943 0.00539 0.07126 
DT131813 female kidney 1.49912 0.06373 0.05296 
DT131813 female liver 0.03991 0.00372 0.13210 
DT131813 female mouth 0.02644 0.00413 0.22439 
DT131813 female snout 0.79400 0.02230 0.01184 
DT131813 male brain 0.16800 0.01527 0.12135 
DT131813 male fatpad 0.04481 0.00356 0.11105 
DT131813 male dorsal fin 0.06200 0.00892 0.20562 
DT131813 male kidney 0.14003 0.00650 0.06089 
DT131813 male liver 0.12308 0.01365 0.15147 
DT131813 male mouth 0.04982 0.00220 0.05168 
DT131813 male snout 1.25998 0.04477 0.03212 
DT267220 female brain 0.23023 0.07544 0.47034 
DT267220 female dorsal fin 0.05831 0.01238 0.30457 
DT267220 female kidney 0.01677 0.00122 0.09991 
DT267220 female liver 0.04195 0.01440 0.49474 
DT267220 female mouth 0.02144 0.01075 0.72346 
DT267220 female snout 0.03104 0.00304 0.13603 
DT267220 male brain 0.18739 0.03310 0.24992 
DT267220 male fatpad 0.05608 0.01733 0.44492 
DT267220 Male dorsal fin 0.08240 0.02095 0.36578 
DT267220 male kidney 0.04275 0.00875 0.29390 
DT267220 male liver 0.02185 0.00219 0.13488 
DT267220 male mouth 0.04005 0.01280 0.45948 
DT267220 male snout 3.23179 0.17763 0.06850 
DT347638 female brain 0.70485 0.05320 0.09807 
DT347638 female dorsal fin 0.12321 0.01782 0.20609 
DT347638 female kidney 0.06280 0.00367 0.07831 
DT347638 female liver 0.24103 0.02390 0.14081 
DT347638 female mouth 0.21583 0.03224 0.21457 
DT347638 female snout 0.19951 0.03238 0.23089 
DT347638 male brain 1.11835 0.08526 0.09814 
DT347638 male fatpad 1.04255 0.06223 0.08111 
DT347638 male dorsal fin 0.13092 0.00836 0.08754 
DT347638 male kidney 0.23033 0.02121 0.12990 
DT347638 male liver 0.27145 0.05817 0.30482 
DT347638 male mouth 0.48105 0.11001 0.32781 
DT347638 male snout 3.23179 0.45866 0.20081 
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Table A 35. qPCR expression analysis using spiggin-like targets (DT131813, DT267220 and 
DT347638) with snout tissues from ten male and seven female FHM. Expression levels were 
normalised to three reference genes (rpI8, hprt I and tbp). 




DT131813 Snout F1 0.49725 0.02351 22.62 0.05679 
DT131813 Snout F2 0.62864 0.01607 22.07 0.02630 
DT131813 Snout F6 1.49682 0.08089 20.84 0.07161 
DT131813 Snout F7 0.54625 0.00690 22.06 0.01391 
DT131813 Snout F8 0.45893 0.01368 22.28 0.03891 
DT131813 Snout F9 0.48240 0.01130 22.40 0.02216 
DT131813 Snout F10 0.70964 0.01088 22.08 0.01883 
DT131813 Snout M1 0.13387 0.00309 24.03 0.00725 
DT131813 Snout M2 0.25582 0.00713 24.11 0.02842 
DT131813 Snout M3 0.18036 0.00592 24.02 0.03443 
DT131813 Snout M4 0.08363 0.00387 24.85 0.04401 
DT131813 Snout M5 0.05122 0.00183 26.28 0.04127 
DT131813 Snout M6 0.10515 0.00303 24.63 0.03324 
DT131813 Snout M7 0.14343 0.01501 24.46 0.14618 
DT131813 Snout M8 0.18779 0.00474 23.82 0.01216 
DT131813 Snout M9 0.02951 0.00116 26.62 0.05315 
DT131813 Snout M10 0.19706 0.00477 23.74 0.02300 
DT267220 Snout F1 0.00382 0.00090 33.78 0.33740 
DT267220 Snout F2 0.00419 0.00171 33.43 0.58737 
DT267220 Snout F6 0.00310 0.00100 33.89 0.46558 
DT267220 Snout F7 0.00317 0.00066 33.62 0.30036 
DT267220 Snout F8 0.08431 0.00422 28.86 0.06976 
DT267220 Snout F9 0.05654 0.00471 29.62 0.11743 
DT267220 Snout F10 0.00614 0.00007 33.07 0.01040 
DT267220 Snout M1 0.02792 0.00101 30.43 0.04074 
DT267220 Snout M2 0.01982 0.00403 31.93 0.29223 
DT267220 Snout M3 0.00214 0.00035 34.55 0.23024 
DT267220 Snout M4 0.06123 0.00719 29.43 0.16176 
DT267220 Snout M5 0.00574 0.00261 33.57 0.65650 
DT267220 Snout M6 0.03224 0.00174 30.47 0.07364 
DT267220 Snout M7 0.30499 0.01553 27.50 0.06313 
DT267220 Snout M8 0.07161 0.00499 29.34 0.09451 
DT267220 Snout M9 1.62473 0.07396 24.97 0.06276 




Target Sample Expression Expression SEM Mean Cq Cq SEM 
DT347638 Snout F1 0.03283 0.00599 31.51 0.26036 
DT347638 Snout F2 0.03757 0.00271 31.10 0.10099 
DT347638 Snout F6 0.01916 0.00350 32.09 0.26147 
DT347638 Snout F7 0.01498 0.00319 32.21 0.30715 
DT347638 Snout F8 0.13411 0.01111 29.02 0.11808 
DT347638 Snout F9 0.07096 0.01190 30.13 0.24061 
DT347638 Snout F10 0.03059 0.00280 31.59 0.13176 
DT347638 Snout M1 0.02561 0.00186 31.38 0.09980 
DT347638 Snout M2 0.01587 0.00298 33.08 0.26984 
DT347638 Snout M3 0.01003 0.00053 33.16 0.06879 
DT347638 Snout M4 0.05912 0.00370 30.32 0.07491 
DT347638 Snout M5 0.01866 0.00258 32.70 0.19726 
DT347638 Snout M6 0.03939 0.00155 31.01 0.05088 
DT347638 Snout M7 0.33068 0.01333 28.22 0.04438 
DT347638 Snout M8 0.09596 0.00372 29.75 0.04418 
DT347638 Snout M9 1.62473 0.02854 25.80 0.01638 
DT347638 Snout M10 0.00920 0.00122 33.12 0.18983 
 
 
